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Executive 
summary
Approach
This report was prepared by the European Observatory 
on Health Systems and Policies, on the request of the 
European Commission. It begins with the recognition 
that the design and operation of health systems can 
influence vaccine uptake, while noting that there are also 
many factors relating to individuals who chose to, or not 
to, be vaccinated. The report has three components. The 
first is a review of the current situation within the EU 
on vaccine uptake and vaccine-preventable disease. The 
second is an umbrella review of systematic reviews on 
health system related factors influencing vaccine uptake. 
The third is a summary of country fiches that describe 
the organization and delivery of vaccination programmes 
in EU Member States. These were commissioned by the 
European Observatory in May 2018 and drafted in May-
September 2018. The country fiches are included in the 
Appendix of this report.
The number of vaccines available has increased rapidly 
in recent years and while some form part of a common 
package used to immunize children, others are given 
only to particular groups, such as travellers (e.g. yellow 
fever or cholera) or those at occupational risk (e.g. rabies). 
Moreover, the situation is constantly changing, with 
new vaccines being added to schedules and, in a few 
cases, such as smallpox or Paratyphoid A and B, being 
removed, either because the threat no longer exists or 
the vaccine has limited effectiveness. Consequently, a 
comprehensive overview of vaccination in Europe would 
be extremely detailed and, more importantly, soon out of 
date. Therefore, we focused this review on two exemplar 
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vaccines, both well established in routine use everywhere, 
which illustrate many of the issues that affect most or all 
vaccines. The two exemplars are, firstly, one common 
childhood vaccination (against measles) and, secondly, 
one common adult vaccination (against influenza). 
The current situation
In recent years, the European Union (EU) has been 
facing several serious outbreaks of vaccine-preventable 
diseases including measles outbreaks in EU Member 
States. Vaccination coverage rates for the first dose of 
the vaccine against measles vary from 85% in Italy to 
99% in Luxembourg and Hungary, with the average 
for the EU (93.6%) falling below what is required to 
ensure herd immunity. Similar variations can be seen for 
other vaccinations, including influenza immunization 
programmes targeting older adults who are at greater risk 
of severe complications. 
The overview of systematic reviews
The overview of systematic reviews, supplemented 
by European reports and reviews, sought to identify 
the necessary health system factors for the successful 
operation of a vaccination programme. Our starting 
point was that the best results are to be expected within 
a system that includes a set of key components, linked 
together effectively. 
After searching the literature, we identified 45 systematic 
reviews relating to health system factors and childhood 
or influenza vaccination programmes in Europe. While 
wide-ranging, they did not cover the entire health system 
and the focus of the evidence was on public attitudes, 
vaccine hesitancy, inequalities or interventions aimed 
at increasing coverage. Funding, enacting legislation, 
supply of materials and systems for monitoring outcomes 
were not covered by any of the included systematic 
reviews. Only a minority of individual studies related 
to childhood or influenza vaccination programmes in 
Europe, with much of the cited evidence generated in 
the United States. Reports from European organizations 
(WHO Europe, ECDC, VENICE etc.) went some way 
to filling the gap, but these reports tend to be based on 
surveys or the collated opinions of experts rather than 
reviews of interventional or observational studies.
Comparative analysis of country fiches
Governance
In terms of the governance of vaccination programmes, 
there is a dedicated agency in charge of developing and 
overseeing implementation of national vaccination plans 
and programmes in each of the EU Member States. This 
is usually the Ministry of Health or a subordinated 
agency, often supported by technical advisory groups or 
committees. 
In all EU Member States, vaccination programmes are 
organized at the national level, whereas the regional level 
tends to be charged with overseeing implementation 
of vaccinations and monitoring vaccination coverage. 
However, there are some countries where the regional 
level has latitude to modify national vaccination 
programmes and recommendations to local needs. This 
includes Denmark, Germany, Spain and Sweden.
In 9 EU Member States (Bulgaria, Croatia, Czech 
Republic, France, Hungary, Italy, Poland, Slovakia and 
Slovenia), vaccinations against measles are mandatory 
for children, while in the remaining 19 countries 
they are voluntary, but recommended by the relevant 
authorities. However, the distinction between voluntary 
and mandatory immunization is not always clear-cut. 
In several countries (Cyprus, Germany and Greece) 
vaccinations are formally voluntary, but vaccination 
certificates are required for the enrolment of children in 
schools or kindergartens.
In contrast, vaccinations for adults against influenza 
are voluntary in almost all EU Member States. The 
sole exception is Slovakia, where vaccination against 
influenza is mandatory for any person living in social 
care facilities, as well as for any person at increased risk 
of infection due to living or working in an area with the 
presence of avian influenza. 
The countries have embraced a mix of incentives and 
sanctions to improve vaccination coverage. These include 
awareness campaigns, financial rewards for parents or 
health care providers, and financial sanctions or denying 
school or kindergarten entry for those who refuse 
(mandatory or even voluntary) vaccinations.
Specific targeted measures for vulnerable groups of 
the population are adopted in a number of countries 
(including Croatia, Finland, Germany, Greece, Ireland, 
Luxembourg, Malta, the Netherlands, Portugal, 
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Romania, the United Kingdom). These include, in 
particular, actions for refugees and asylum-seekers, often 
as part of routine medical screening upon entry to the 
country. Other countries (including Croatia, the United 
Kingdom, Ireland and Romania) also offer targeted 
measures for minority ethnic groups, such as the Roma 
and Traveller communities. 
Only 12 EU Member States reported using a population 
register as the basis for their vaccination programmes. 
In some of the other countries (e.g. Bulgaria, Estonia, 
Poland, Spain, and the Netherlands in the case of 
influenza), the registries of health care providers (usually 
GPs) or health insurance funds are used to monitor 
vaccination uptake and invite patients for vaccinations.
The methods used to estimate vaccination coverage 
rates also differ between countries. There are differences 
for both the numerator (the number of people being 
vaccinated) and the denominator (the number of people 
who could be vaccinated). Only some countries use 
population registries as the denominator for calculating 
rates. Others use records of health care providers (patient 
lists) and lists of people covered by health insurance 
funds. Calculation of the numerator is based on varied 
sources, including data on reimbursements for providers, 
sales data and reports by health care providers. Some 
countries also use surveys to establish vaccination rates.
Provision
Measles vaccinations for children are provided in most 
EU Member States through primary care physicians or 
nurses. Depending on the organization of primary care 
in the country, this can include paediatricians, general 
practitioners (GPs), school physicians, and nurses in 
various settings, such as GP practices or school health 
services. Given that measles vaccinations for children are 
provided at different ages, with the first shot typically 
given at 12 months and a second shot often several years 
later (the timing of the second shot differs widely between 
countries), different types of providers and professionals 
can be involved. School health services play an important 
role for the second shot in a number of countries, whereas 
pharmacies and pharmacists do not tend to play a role.
For adult vaccinations against influenza, the principal 
health care providers are physicians and nurses in primary 
health care, although with differences between countries 
as to whether this task is performed by physicians, 
nurses, or both. In some countries, vaccinations are 
also offered by public health institutions. Occupational 
health services play an important role in a number of 
countries for those who receive influenza vaccinations 
to protect them against occupational health risks, such 
as health workers. Only six countries (Ireland, Latvia, 
Malta, Portugal, Sweden, and the United Kingdom) 
report the availability of inf luenza vaccinations in 
(some) pharmacies, although these are now also being 
introduced on a pilot basis in Estonia and France.
Financing
In all EU Member States, childhood vaccinations against 
measles are free of charge at the point of delivery. The 
only exception is the private sector in Cyprus, where 
patients have to pay the cost of the vaccine and of the 
vaccination.
For adult vaccinations against influenza, most (21) EU 
Member States provide vaccinations free of charge at 
the point of delivery for those groups of the population 
targeted by the respective national vaccination 
programme, e.g. people aged 65 years and above. In seven 
countries (Austria, Belgium, Bulgaria, Estonia, Latvia, 
Poland and Slovenia) targeted patients need to pay at least 
part of the costs for adult vaccinations against influenza.
Key barriers and facilitators
For measles, the country reports identified a number of 
barriers to effective vaccination coverage, with only five 
countries (Cyprus, Denmark, Luxembourg, Portugal 
and Sweden) not reporting any major barriers. The factor 
mentioned in most country fiches (20 countries) was 
vaccine hesitancy. Seven countries acknowledged a failure 
to reach vulnerable groups of the population. Six of the 
reports mentioned a lack of awareness in the population 
as one of the barriers to effective vaccination coverage. 
Five countries reported insufficient training or vaccine 
hesitancy among health professionals. Factors related to 
the organization, provision and financing of vaccination 
services were only reported by very few countries, with 
two (Latvia and Romania) reporting short-term shortages 
of vaccines, two (Hungary and Lithuania) reporting a 
shortage of resources, and three (Greece, Ireland and 
Lithuania) reporting the lack of a vaccination register as 
barriers.
Of the 28 EU Member States, 25 identified key 
facilitators for effective vaccination coverage against 
measles. The factor mentioned by most (14 countries) was 
the inclusion of measles vaccination in the health services 
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that are publicly funded. This was followed by awareness-
raising campaigns (mentioned in 8 country fiches) and a 
good health service delivery network (7 country fiches). 
Six countries each mentioned public attitudes that were 
conducive to measles vaccination, the important role of 
health professionals, and the existence of a monitoring 
system overseeing vaccinations, while five mentioned 
the mandatory character of measles vaccination, and the 
existence of special incentive schemes.
For adult vaccinations against influenza, 20 of the 28 
countries identified barriers to effective vaccination 
coverage. The most commonly mentioned barrier 
(described in 15 of the country fiches) was lack of 
awareness among the general population, with people 
being unaware of the potentially serious consequences 
of infection. The related issue of vaccine hesitancy 
was pointed out by 11 of the countries, linking low 
vaccination coverage to anti-vaccination movements. The 
existence of out-of-pocket payments as a barrier to higher 
coverage rates was pointed out by 9 countries.
Only 12 of the 28 countries identified facilitators for 
effective vaccination coverage against influenza. These 
include media campaigns to raise awareness in the general 
population and among health workers, the involvement 
of employers and professional societies, outreach services, 
financial incentives for providers of immunizations, and 
the provision of influenza vaccinations in pharmacies.
Conclusion
This report and the underlying country fiches document 
the sustained efforts undertaken by EU Member 
States in addressing vaccine-preventable diseases. They 
provide an insight into what has been achieved, but also 
where further improvements could be made. The main 
perceived barrier for improved vaccination coverage is 
vaccine hesitancy and lack of awareness in the general 
population, but also among health workers. However, 
the country profiles also identify many other actions 
that health systems can take to improve coverage. These 
include a mix of incentives and sanctions, targeted 
measures and outreach services for vulnerable population 
groups, and an expansion of public financing for 
vaccinations against influenza, as well as the removal of 
administrative barriers.
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1 
 Introduction
Martin McKee, Jennifer Priaulx, Bernd Rechel
The development of vaccines has been one of the greatest 
triumphs of scientific medicine. Diseases that once killed 
in the millions have been eradicated, as with smallpox, 
or their impact has been reduced greatly. Even a few 
decades ago, measles, a disease that is entirely vaccine- 
preventable, was still killing vast numbers of children in 
Sub-Saharan Africa and, even in rich countries, it was a 
common cause of death in survivors of childhood cancer 
who were, mistakenly, not immunized. While these 
numbers declined in recent years and measles became 
uncommon in Europe, in mid-2018, the European media 
was reporting outbreaks, and some fatalities (1).
There are many reasons why people are not immunized. 
They fall into three broad categories. The first two relate 
to the individual concerned or, more often, their parents; 
the third relates to the health system. First, they may 
be unaware of the importance of vaccination, especially 
as it is increasingly likely that they have never seen a 
case of the disease in question and do not realise how 
serious its effects can be. Or they may be unaware of 
how to get vaccinated, for example because the necessary 
information is in a language they do not understand. 
Second, they may reject vaccination because they believe, 
wrongly, that it is ineffective or harmful. This belief may 
be specific to vaccines or part of a more general distrust, 
in government or in the corporations that manufacture 
vaccines. Although much attention in the media, the 
public health community, and in published research has 
focused on factors related to the individual and how to 
address them (19–23), as the decision to accept a vaccine 
is at least in part a function of the wider system that 
delivers immunization programmes, it is important that 
questions of uptake are not considered in isolation, and 
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especially not at the expense of understanding how the 
wider system functions and how this affects the overall 
effectiveness of the programmes. Consequently, this 
report focuses on the third of these categories, the impact 
of the health system. 
The seemingly simple act of injecting a vaccine into 
a child is only possible because of the existence of a 
number of well-functioning processes. These include a 
population register to identify those who will benefit and, 
as importantly, to monitor uptake in different groups 
and respond when it falls short of what is expected. Then 
there is a system to procure and distribute the vaccines, 
especially challenging when supplies are limited. There 
is also a need for a system to ensure that there are trained 
health workers available to administer the vaccines, 
with a detailed knowledge of the indications and, in a 
few rare cases, contra-indications. Finally, there should 
be a system of governance, providing oversight of the 
entire system to ensure that it is working in an effective, 
equitable, and sustainable way. Some countries perform 
these functions very well, but others are less successful 
and in many European countries there are persisting, 
and in some cases widening, gaps in coverage, leading to 
outbreaks of what should be preventable disease (17, 18). 
The report has three elements. First, it reviews the 
current situation with regard to vaccine uptake and 
vaccine-preventable disease in the European Union (EU). 
Second, it reports on a systematic review which sought 
to identify those factors related to the health system 
that influence the successful operation of a programme. 
Finally, it reviews in detail the systems that are in place 
in the different EU Member States to deliver vaccination 
services, drawing on information provided in country 
fiches on the organization, provision and financing of 
vaccination programmes in EU Member States (see the 
Appendix). The country fiches were commissioned by 
the European Observatory in May 2018 and, following a 
common data collection tool, covered:
• the governance of all elements necessary to deliver 
vaccination programmes (including agencies 
involved, national vaccination plans, population 
registries, whether vaccinations are recommended or 
mandatory, the existence of sanctions or incentives); 
• the organization and provision of vaccination 
services, including organizations and professionals 
involved (primary health care providers, pharmacies, 
public health facilities, schools, etc.); 
• the financing of vaccination services, including the 
existence of patient co-payments; 
• barriers to and facilitators of effective vaccination 
coverage.
The number of vaccines available has increased rapidly 
in recent years and while some form part of a common 
package used to immunize children, others are given 
only to particular groups, such as travellers (e.g. yellow 
fever or cholera) or those at occupational risk (e.g. rabies). 
Moreover, the situation is constantly changing, with 
new vaccines being added to schedules and, in a few 
cases, such as smallpox or Paratyphoid A and B, being 
removed, either because the threat has been removed or 
the vaccine has limited effectiveness. Consequently, a 
comprehensive overview of vaccination in Europe would 
be extremely detailed and, more importantly, soon out 
of date. Thus, for the purposes of the country fiches 
and the comparative analysis, we focus on two exemplar 
vaccines, both well established in routine use everywhere, 
which illustrate many of the issues that affect most or all 
vaccines. The two exemplars are, firstly, one common 
childhood vaccination (against measles) and, secondly, 
one common adult vaccination (against influenza). 
2 
Vaccine uptake 
and vaccine-
preventable 
disease in the EU
Bernd Rechel
In recent years, the EU has been facing several serious 
outbreaks of vaccine-preventable diseases. This included 
measles outbreaks in EU Member States, with an 
increasing numbers of cases (Figure 1) and deaths 
(Figure 2). Even these numbers however may be an 
underestimate, in particular for Romania, where the 
sustained outbreak has led to delays in reporting to 
international databases (2).
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Figure 1 Measles notification rate per million population in EU/EEA countries, 1 July 2017– 30 June 2018
 
Source: (2)
Figure 2 Number of measles deaths by country, EU/EEA, 1 July 2017– 30 June 2018
 
Source: (3)
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In 2017, only four EU/EEA countries achieved at least 
95% vaccination coverage for both doses of measles-
containing vaccine (Figure 4).
The measles outbreaks can be linked to insufficiently 
high vaccination coverage in some countries (2), or to 
gaps in vaccination coverage among vulnerable groups 
of the population. Overall vaccination coverage differs 
markedly across EU Member States, with many falling 
below the target of 95% coverage which is needed to 
ensure herd immunity (Figure 3). 
Figure 3 Immunization coverage for measles, first dose, 2016
 
Source: (4)
Note: Immunization coverage defined as % of children reaching their second birthday who have been fully vaccinated against measles (1 dose). Data are reported 
annually to, and available from, the Communicable Disease unit at WHO/EURO; data for France refer to 2014; data for Germany, Ireland, Italy, Poland, Portugal, 
Slovenia and the EU average refer to 2015
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Figure 4 Vaccination coverage for the first (upper panel) and second (lower panel) doses of measles-containing vaccine, by country, 
                EU/EEA, 2017
Source: (2)
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EU Member States also differ in the intensity of seasonal 
influenza (Figure 5), whether they recommend seasonal 
influenza vaccination (Figure 6) and in their vaccination 
coverage (Figure 7).
Figure 5 Influenza intensity in Europe 2016–2017
 
Source: (5)
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Map 2. Member States recommending seasonal influenza vaccine for older age groups, 2014–15 and 
2007–08 influenza seasons, 2007–08 (left) and 2014–15 (right) 
Source: National seasonal influenza vaccination survey, December 2015 and July 2009 
≥50 years 
≥55 years 
≥59 years 
≥60 years 
≥65 years 
In Ireland, the National Immunization Technical Advisory Group (NITAG) recommends vaccine for people ≥50 years of age but 
the programme focuses only on people ≥65 years. 
In Belgium, during the influenza season 2007–2008, vaccination was recommended for people 50–64 years of age. In 2014–
2015, vaccination was still advised for this age group but this group was no longer considered high priority. 
In Portugal, vaccination was recommended for people ≥60 years of age in 2014–15; the vaccine is only free of charge for people 
≥ 65 years. 
The recommendation in Spain is for people ≥65 years of age; however, 10 out of 19 regions recommend vaccination for those 
≥60 years of age.  
In Austria, Estonia and Poland, vaccination against seasonal influenza is recommended for all population groups six months or 
older in 2014–15. 
In Austria and Estonia vaccination against seasonal influenza is recommended for all population groups six months or older in 
2007–08. 
In Liechtenstein, vaccination is recommended for people ≥65 years in 2014–15. 
In Malta, vaccination was recommended for people ≥55 years in 2014–15 and 2007–08. 
Chronic medical conditions 
In comparison with earlier VENICE surveys, and notably since the Council Recommendation, a number of countries 
made changes to their seasonal influenza vaccination recommendations and policies, usually with regard to certain 
risk groups. Between 2007–08 and 2014–15, all Member States participating in the surveys recommended seasonal 
influenza vaccination for patients with treatment-induced immunosuppression, disease-induced 
immunosuppression, and metabolic disorders. In addition, influenza vaccine was recommended to those with 
chronic pulmonary, cardiovascular and renal diseases. The number of Member States that recommended seasonal 
influenza vaccine for individuals with hepatic disease increased each year (15 in 2007–08, 27 in 2014–15); 
28 Member States recommended vaccination for people living with HIV/AIDS in 20014–15 vs. 24 in 2007–08. In 
addition, more countries recommended vaccine for those with morbid obesity in 2014–15 than in 2010–11 
(19 Member States vs. 9, respectively) (Figure 1; Annex 2: Table 3).  
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In Liechtenstein, vaccination is recommended for people ≥65 years in 2014–15. 
In Malta, vaccination was recommended for people ≥55 years in 2014–15 and 2007–08. 
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risk groups. Between 2007–08 and 2014–15, all Member States participating in the surveys recommended seasonal 
influenza vaccination for patients with treatment-induced immunosuppression, disease-induced 
immunosuppression, and metabolic disorders. In addition, influenza vaccine was recommended to those with 
chronic pulmonary, cardiovascular and renal diseases. The number of Member States that recommended seasonal 
influenza vaccine for individuals with hepatic disease increased each year (15 in 2007–08, 27 in 2014–15); 
28 Member States recommended vaccination for people living with HIV/AIDS in 20014–15 vs. 24 in 2007–08. In 
addition, more countries recommended vaccine for those with morbid obesity in 2014–15 than in 2010–11 
(19 Member States vs. 9, respectively) (Figure 1; Annex 2: Table 3).  
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Figure 7 Seasonal influenza vaccination coverage rates in older age groups, 29 EU/EEA Member States, 2007–08 to 2014–15 
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While a large body of work has been undertaken 
to explore vaccine hesitancy (the refusal or delay in 
acceptance of vaccines) among the general population 
and health workers (7, 8) and how to address it (9), the 
organization, financing and provision of vaccination 
programmes in Europe have so far received less attention. 
This study aims to shed light on these health system 
related aspects of vaccination programmes, in order to 
identify aspects that could be strengthened to improve 
effective vaccination coverage.
Previous studies have explored the role of national 
advisory groups in immunization policy-making 
processes (10), with an ECDC study on practices of 
immunization policy-making finding that 26 of 28 
participating EU/EEA countries had technical advisory 
groups in place, although with wide variety in structures 
(11). Other work was conducted on the organization and 
quality of HPV vaccination programmes (12), and drivers 
and barriers of rotavirus vaccination in Europe (13). A 
study on adult vaccination policies in Europe found 
major variation in terms of recommendations, funding 
and coverage (14). 
There is also evidence on coverage gaps in vulnerable 
groups of the population, such as migrants and refugees 
(15). A Guide to tailoring immunization programmes 
(TIP) for vulnerable groups was developed by the WHO 
Regional Office for Europe in 2013. By 2016, the tool 
had been used in Bulgaria, Lithuania, Sweden and the 
United Kingdom, aiming to improve vaccination services 
for Roma, pregnant women, migrants and religious 
objectors (16). 

3 
Health system 
barriers
Jennifer Priaulx, Martin McKee
A conceptual framework
This chapter seeks to identify the factors that relate 
to the design and operation of health systems that are 
necessary for the successful operation of a vaccination 
programme. Our starting point is that the best results 
are to be expected within a system that includes a set of 
key components, linked together effectively, with each or, 
ideally, all, actively managed. We identified the following 
components of a comprehensive programme:
• Generating and applying evidence – decisions 
on what vaccines to include, target groups and 
schedules
• Funding – payment for vaccines and those 
administering vaccines
• Enacting legislation – legal basis for immunization, 
including whether it is mandatory, what sanctions 
exist for non-compliance and exemptions
• Setting professional roles – restrictions on who can 
administer vaccines
• Supplying materials – procurement and 
distribution of vaccines
• Registering the population – creation and 
maintenance of a register of those eligible for 
immunization
• Monitoring public attitudes – who monitors public 
attitudes, concerns and who responds to them
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• Governing the system – overall responsibility 
for achieving uptake, other actors involved and 
mechanisms to hold them accountable
• Evaluating progress – monitoring of uptake 
including identification of problems, including for 
disadvantaged groups
• Monitoring outcomes – monitoring adverse effects
We are not examining individual motivations or the 
role of social, cultural, and political factors, such as 
arguments about individual autonomy versus collective 
action, as these have been addressed in detail elsewhere. 
We have confined our review to Europe, ref lecting 
both the salience of concerns about low uptake in some 
European countries and the challenge of contextualising 
with confidence research from other settings.
Objectives
To conduct an overview of systematic reviews, 
supplemented by European reports and reviews, 
that evaluate health system components, barriers 
and facilitators to establishing effective childhood 
immunization and influenza vaccination programmes at 
health system and health service level. To identify gaps 
in the evidence and make recommendations for future 
research. 
Methodology
Search and selection
Our priority was to search for systematic reviews of 
health system factors affecting the implementation of 
immunization programmes, including barriers and 
facilitators. However, given the anticipated paucity of 
evidence for the system as a whole, we incorporated 
European reports and reviews (including non-Cochrane 
systematic reviews) to supplement the results of our 
search. A protocol was registered beforehand on 
PROSPERO, an international database of prospectively 
registered systematic reviews in health and social care 
(https://www.crd.york.ac.uk/prospero).
We searched electronic databases, including the 
Cochrane Database of Systematic Reviews (CDSR), Ovid 
Medline, Ovid Embase, Web of Science, PsychInfo and 
Google Scholar), using a pre-defined search strategy. 
European health organization websites were also searched 
and any relevant publications retrieved (for example: 
WHO Regional Office for Europe, ECDC (European 
Centre for Disease Prevention and Control), VENICE 
(Vaccine European New Integrated Collaboration Effort) 
Project, European Council, European Commission, 
VaccinesEurope.eu). We also searched the London 
School of Hygiene and Tropical Medicine database of 
all systematic reviews for vaccines, created for the WHO 
(www.nitag-resource.org) (reported in Fernandes et al 
2018 (24)). Reference lists of included reports and reviews 
were manually searched to identify any additional reviews 
from the grey literature. Papers with abstracts published 
in English, French and German between January 2000 
up to and including May 2018 were considered for 
inclusion in order to provide the most up to date evidence. 
One reviewer selected the studies to include according 
to the selection criteria in Box 1. Reasons for exclusion 
included studies not being about Europe, being about a 
single European country, not being a review or report, 
not related to immunization/vaccination, population 
not children or influenza (or about pandemic flu), no 
programme or policy specified, no health system factors, 
focus on personal or cultural behaviour, language other 
than English, French or German, no abstract available 
or duplicates.
Data extraction and synthesis
One author extracted data from each included review 
using a data extraction sheet. The original data extraction 
form summarized key information from each review, 
including authors, year of publication; objectives; 
population; information about the interventions assessed; 
outcome indicators and conclusions, focused on the 
information needed for the health systems framework. 
A formal assessment of the quality of the reviews was 
not conducted given the range of types of review and 
report to be included and because our goal was primarily 
to map potential factors. In view of the wide variety of 
evaluations and interventions likely to be included within 
the eligible reviews and reports, no subgroup analyses 
were planned.
A narrative synthesis of collected data was conducted. An 
overall description of included reviews (e.g. an ‘Overview 
of reviews’ table) and synthesis by health system domain 
related to according to the health systems framework, 
considering physical resources, human resources, 
intellectual resources, social resources, health system 
financing, governance and delivery. We allocated each 
systematic review to the most relevant sub-system 
although there is obviously some overlap with other sub-
systems within some of the reviews.  
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Box 1 Inclusion criteria
Types of study 
Cochrane systematic reviews and non-Cochrane systematic reviews supplemented by European reports and reviews including 
non-systematic reviews or reports from the grey literature covering countries in the EU that have a primary focus on childhood 
immunization or influenza vaccination. 
Condition or domain 
This review focuses on the health system factors that influence performance of population-level vaccination programmes in the 
relevant target population. 
Participants/ population
Children under school age – standard scheduled vaccinations including TB (BCG), Rotavirus, Diphtheria, Tetanus, Pertussis, 
Poliomyelitis, Haemophilis influenza type B infection, Hepatitis B, Pneumoccocal disease, Meningoccocal disease, Measles, 
Mumps, Rubella, Varicella and human papillomavirus (HPV) (although the latter is later we included it to maximize the evidence), 
older people (influenza only), at risk groups (influenza only) (seasonal not pandemic, bird, swine flu etc).
Intervention(s), exposure(s)
All types of national or regional immunization interventions including organized and non-organized programmes. These may 
include legislation, policies, guidelines, recommendations, mandatory vaccinations schedules, strategies, governance, surveillance 
and services. We also considered barriers and interventions to improve the effectiveness and efficiency of immunization 
programmes.
Comparator(s)/control
If relevant, no immunization intervention or alternative immunization interventions from the above.
Outcome(s)
The primary outcomes of interest relate to provider-level and system-level factors: legislation, policies, guidelines, 
recommendations, mandatory vaccinations schedules, strategies, governance, surveillance and services. We also considered 
barriers and interventions to improve the coverage, effectiveness and efficiency of immunization programmes. Contextual factors 
associated with the coverage, effectiveness and efficiency of immunization programmes: physical resources, human resources, 
intellectual resources, social resources, health system financing, governance and delivery
Results of the literature search
The results of the search and selection process are 
presented in Figure 8. 
Characteristics of included studies
The review identified 1425 publications of which 264 
were included for full text review, based on an initial 
assessment of titles and abstracts. After full text review, 
143 publications were included for data extraction, which 
included an additional 27 papers from manual searching. 
45 were systematic reviews, 6 were non-systematic 
literature reviews (reviews including a search strategy), 
32 were European reports and 51 were reviews (reviews 
with no reference to a search strategy). Given the more 
robust nature of systematic reviews, these were prioritized 
for data extraction. 
Summary of evidence from systematic reviews 
within the health systems framework
Most of the 45 systematic reviews covered various 
immunization topics (n=19), childhood immunization 
(n=17), influenza (n=5), HPV (n=3) or measles (n=1). 
An analysis of the included systematic reviews using 
the health systems framework showed that most of the 
available evidence is allocated within the monitoring 
public attitudes sub-system (n=23). A smaller number of 
reviews covered other sub-systems including generating 
the evidence (n=3), professional roles (n=3), registering 
the population (n=2), governing the system (n=6) and 
evaluating progress (n=7). There was some overlap 
between sub-systems for several of the reviews but one 
review in particular covered multiple sub-systems (24). 
Fernandes et al. (24) reviewed all systematic reviews 
relating to vaccination and so could not be categorized. 
Ryan et al (25) also covered several sub-systems but 
the focus was on public attitudes, also including the 
systematic reviews in this review (26–34). 
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Although the included systematic reviews, in their 
entirety, fitted the inclusion criteria for this review, many 
of the individual studies identified by those reviews 
were not relevant (based on information provided 
in the systematic review). For the most part, this was 
because the studies were not European studies, did 
not address health system factors, or did not relate to 
children’s immunization programmes or adult influenza 
vaccination.   
In 11 systematic reviews, none of the identified individual 
studies were relevant to the objective of this review (i.e. 
relating to health system factors, from Europe, relating 
to childhood or influenza vaccination programmes). In 
4 systematic reviews, there was insufficient information 
to establish the number of relevant studies and in 2 
systematic reviews, the number of relevant studies could 
be identified but not specifically referenced. There 
were 231 relevant individual studies (where sufficient 
information was available), of which 32 individual 
studies were duplicated in 46 cases, leaving 185 unique 
and relevant individual studies, of which 174 could be 
fully cited. 
Reflecting the focus of systematic reviews on public 
attitudes, the topics included in these studies primarily 
relate to understanding determinants of uptake and 
evaluating interventions to improve uptake. Interventions 
INITIAL DATABASE SEARCH RESULTS
Ovid (Medicine, Embase) = 1252 (1438–186 before year 200)
PsychInfo = 2
Web of Science = 48
Cochrane Library = 123
Total = 1425
PAPERS EXCLUDED BASED ON
ABSTRACT/TITLE = 1161
Not immunization/vaccination = 233
Intervention – not programme or policy = 146
Not health system factors = 279
Personal or cultural  = 1
Not children or influenza = 276
Not European = 98
Single Euro country = 118
Other/no abstract/NA = 10
EXCLUDED BASED ON FULL TEXT = 148
Not European = 4
Single European country = 6
Not review or report = 4
Not immunisation/vaccination  = 8
Population not children or influenza = 6
Not programme or policy = 2
Not health system factors = 72
Personal or cultural behaviour = 1
Other – language/no abstract = 9
Duplicates = 24
FINAL INCLUDED STUDIES FOR
DATA EXTRACTION
143
(including 45 systematic reviews)
INCLUDED BASED ON FULL TEXT
OVID Embase/Medicine = 95
(including 6 systematic reviews)
WoS  = 6 (including 2 systematic reviews)
Cochrane = 15
(including 15 systematic reviews)
Plus additional papers:
Internet sources = 5
Manual searching = 13
Bibliography searching = 9
Total = 143
FULL TEXT PAPERS FOR REVIEW
BASED ON TITLES AND ABSTRACTS
Ovid (Medicine, Embase) = 215 
PsychInfo = 0
Web of Science = 24
Cochrane Library = 25
Total = 264
Figure 8 Flow diagram of search and selection process
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ranged from increasing understanding of the factors 
affecting coverage, interventions to support, promote and 
inform both parents and health professionals, and more 
complex system-level, multi-factorial strategies to address 
level of uptake and inequalities. Other studies from other 
sub-systems evaluated decision-making processes and 
recommendations at national level, access to vaccination, 
financial incentives, information systems and the health 
system impact of vaccination programmes.
Summary of other evidence from non-systematic 
reviews and reports
Given the paucity of relevant European evidence on 
some sub-system factors from systematic reviews, we 
supplemented it with evidence from 6 non-systematic 
literature reviews and 32 European reports. The majority 
of reports are associated with European organizations 
relating to public health and vaccination (ECDC, WHO 
Regional Office for Europe, the ADVICE project and 
the VENICE project). Evidence for all health system 
factors is more wide-ranging when considering non-
systematic reviews and reports (8 compared to 6 sub-
systems covered) and these reports go some way to filling 
the gaps in the evidence from systematic reviews. There 
was no evidence of this type for the sub-systems relating 
to setting professional roles or supplying materials.
While covering more sub-systems, the level of evidence 
for reports and non-systematic reviews was inherently 
lower, with most references to health system factors 
being based on expert opinion, either the opinion of the 
authors themselves or surveys of individual experts on 
vaccination, rather than observational or interventional 
studies. Moreover, the limited information about study or 
article references provided in the non-systematic reviews 
made it more difficult to assess their particular relevance 
to this review. 
We also considered whether evidence from more general 
review articles could fill the gaps where evidence from 
literature reviews and reports was not available. We found 
that the information provided in reviews was generally 
the opinion of the author(s), with occasional reference to 
the literature, and did not add much to the information 
found in the systematic reviews, non-systematic reviews 
and reports. Given the general nature of this data and 
the availability of evidence from systematic reviews 
and reports we did not extract any data about the 
characteristics of the articles. 
Key health system factors highlighted by 
the evidence
Generating and applying evidence
The evidence shows the diversity of national-level 
recommendations for childhood and inf luenza 
vaccination within Europe. This may be due to 
differences in health systems, disease burden, and 
decision-making processes, but differences can also be 
seen where all of these are similar. Burchett et al. (35) 
highlight common categories of criteria that influence 
decisions about vaccine adoption across countries, albeit 
to varying degrees. The categories are: the importance 
of the health problem; vaccine characteristics; 
immunization programme considerations; acceptability; 
accessibility, equity and ethics; financial/economic issues; 
impact; alternative interventions; and the decision-
making process. Yet, recommendations can vary by their 
definition of risk groups (69) or recommended ages of 
vaccination, if recommended at all (70). A comparison 
of four similar Scandinavian health systems showed 
different interpretations of disease burden and approaches 
to data analysis when establishing vaccination policy 
(71). For example, burden can be considered in terms of 
number of cases, level of threat to health, mortality or 
number of healthcare visits. Inputs and assumptions used 
in economic evaluations can also vary widely.
There is scope for harmonization between European 
countries in terms of the process and methods for 
developing recommendations, including sharing of 
resources such as systematic reviews (to avoid duplicated 
effort) and agreeing common definitions. This would 
have many direct benefits, especially for families moving 
between countries, as well as indirect ones, such as 
reducing the scope for those opposed to immunization 
to portray differences negatively. Common European 
guidelines can be established (72) and, unlike across 
European countries where recommendations vary widely, 
more standardized strategies across US states have 
been shown to result in better coverage (73). Broader 
outcomes, such as economic analysis in immunization 
decision-making, are now widespread in Europe. While 
these analyses can assist modelling future effects of 
vaccines, comparing different strategies, identifying 
critical input parameter, estimating budget impact and 
cost-effectiveness, appraisals are generally informal 
and without the use of cost effectiveness thresholds or 
multiple-criteria decision making (36, 37). Systematic 
and harmonized development of recommendations 
within a formal framework may facilitate the successful 
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implementation and funding of vaccination programmes 
(74). However, some differences in process and 
recommendations are likely to remain due to varying 
national or regional priorities, systems and finance across 
Europe.
Funding
Funding mechanisms for vaccination vary across Europe 
and across vaccination types, including out-of-pocket, 
publicly funded, official health insurance and employer 
funding, either in full or in part. Recommendations 
that are not accompanied by the necessary funding may 
not achieve adequate uptake but different countries in 
Europe will have different public health priorities (14). 
The ability to fund vaccination programmes (including 
capacity, identification of and response to inequalities 
in uptake, monitoring and investment, as well as unit 
vaccination costs) can be frustrated by financial crises, 
although at such times concerted efforts to maintain 
vaccination coverage are most important (75). Some 
countries, such as those in Southern Europe with fewer 
resources available, may also be more sensitive to changes 
in funding than other high-income countries where 
parental hesitancy is more of an issue in vaccine refusal 
than resources available for funding (76). 
Enacting legislation
Vaccination programmes can be mandatory, based on 
recommendations alone, or a mix of both (77). This is 
essentially a political decision, reflecting views about 
the relationship between the individual and the state. 
However, the available evidence does not provide an 
answer to the question of which is best, perhaps because 
this will depend on context, while comparisons are 
hindered by different definitions of ‘recommended’ and 
whether mandatory approaches are consistently enforced, 
such as being accompanied by penalties or other 
measures to ensure compliance (77). 
Professional roles
While the role of professionals is often cited as an issue 
in monitoring and responding to public attitudes as part 
of their wider role in primary care (e.g. their attitudes 
and knowledge of the risks and benefits of vaccination 
and subsequent recommendation of vaccination during 
routine visits) (38), they may also play a more specific 
part in the implementation and administration of 
programmes. Employing lay workers for the purposes of 
improving coverage (28) or implementing programmes 
within the school system are examples of this, although 
the level of success varies by study (78).
Registering the population 
Ideally immunization registers should collect data on 
vaccines, generate reminders/recall notices, provide 
official vaccination forms on request, allow coverage 
assessments, be established from birth, linked to health 
outcomes (to monitor long term impact and performance), 
protect data, allow data sharing and be standardized, such 
as using bar coding on vaccines (79). However, not only 
do some countries lag behind in terms of establishing 
such comprehensive information systems, there are also 
certain under-vaccinated population groups (e.g. Roma, 
migrants and refugees) that have restricted access to 
healthcare and these groups also tend to be those who 
may be excluded from medical and population registers 
due to high mobility/migration, lack of appropriate 
information, fear of legal consequences, economic 
environment and insufficient coordination among public 
health authorities (39, 40). While improving information 
systems may increase overall coverage, more tailored 
approaches may be required to address the particular 
needs of vulnerable, under-vaccinated groups.
Monitoring public attitudes
There are challenges in terms of vaccination coverage 
for certain diseases, in certain countries and particularly 
among certain vulnerable population groups across 
Europe. This includes both disease outbreaks and 
general issues with achieving target coverage rates. In 
terms of health system factors, hard to reach groups 
can have limited access to healthcare but there are 
also geographical, cultural and socioeconomic factors 
influencing uptake (80). While there is considerable 
evidence on the determinants of vaccination uptake 
(41, 42, 44), there is still a need to better understand 
the barriers to achieving target rates, particularly for 
adults (81) and those from marginalized groups (82) so 
that health systems can better address the needs of those 
groups.
There are many studies, and systematic reviews of these 
studies, investigating interventions to improve uptake, 
primarily addressing the knowledge, attitudes and 
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decision-making process of parents or adults eligible 
for vaccination, be it directly or indirectly through 
health professionals or by increasing ease of access (25, 
29, 45–52, 57). This review did not aim to investigate 
how particular interventions might change behaviour 
or address differences due to personal beliefs, culture 
or socioeconomic factors, as this is covered elsewhere in 
the literature. However, facilitators focused on changes 
to the health system can include evidence-informed 
routine immunization schedules, political commitment 
(including resources), targeted, second-chance/
supplementary immunization strategies, and multi-
sectorial communication initiatives (80). Facilitators 
include raising awareness and better understanding the 
dynamics of practice (particularly for adults), but this 
needs to be accompanied by evidence-based up-to-date 
guidelines, national/international recommendations, 
surveillance of vaccination rates, opportunities to 
provide vaccines more readily, leadership at a European 
level and a firm research and action. Reasons for lack of 
uptake by adults of influenza vaccination can depend on 
perceptions and lack of information but recommendation 
by physicians can assist uptake (83). In particular, flexible 
vaccine delivery systems are increasingly required due 
to the movement of populations across borders, the 
existence of specific under-vaccinated populations and 
the influence of the anti-vaccination movement (84).
Governing the system
There is a need for political commitment and leadership, 
both nationally and internationally for implementation 
to be effective (80). There are multiple barriers to 
implementation that need to be overcome through 
a cohesive approach (85–88). Barriers range from 
inadequate funding (not just for the vaccination product 
itself but also resources for the implementation of 
programmes such as lab supplies, staff and training) to 
perceptions to insufficient monitoring (such as variable 
and under-reporting of coverage and cases and the quality 
or reliability of data). Subsequently, potential solutions 
include a combination of education, communication, 
funding and improved surveillance. 
The types of challenges and solutions may differ 
by vaccination programme. For example, there are 
particular challenges in terms of improving uptake 
of adult vaccination (89). The health system barriers 
and facilitators to the effectiveness of vaccination 
programmes may also differ according to the level of 
centralization and government control (90). The policies 
and practices underpinning vaccination programmes 
vary widely across Europe (91, 92). Thus, tailored, goal-
driven programmes, addressing the particular needs of 
the public and professionals, including local champions 
and experts with influence, and supplementary activities 
to address identified local barriers are required (93, 94). 
Other health system facilitators to optimal immunization 
programmes include surveillance, quality assessment, 
lab networks (95), indicators of lab performance (96), 
strengthening programmes (registry, reminder and recall 
systems, expert advocates) (94) and financial incentives 
(26, 59, 61, 97).
Evaluating progress
There is variability of coverage data and information 
systems (98) and coverage can be considered an indicator 
of success (99). Immunization information systems 
are key to the success of a programme (63) including 
monitoring and evaluating programmes (100), and 
reminder/recall interventions (30, 64, 65). There are 
multiple ways to evaluate the impact of new vaccines on 
health systems including experiences from a programme, 
effectiveness, incidence of disease, herd immunity, 
hospitalization and economic evaluation (68).
Monitoring outcomes
Systems to monitor vaccine safety, effectiveness and 
performance are key (101–103). The success depends on 
the comprehensiveness of the organization of surveillance 
schemes including population specific denominators 
(104), appropriate surveillance methodologies (105), 
serological/molecular surveillance (106) and laboratory 
capacity (107). Monitoring migrants is a challenge for 
some surveillance systems (108).
Overview of main findings
We identified 45 systematic reviews relating to health 
system factors and childhood or influenza vaccination 
programmes in Europe. While wide-ranging, they did 
not cover the entire health system and the focus of the 
evidence was on public attitudes, either understanding 
vaccine hesitancy, inequalities or interventions aimed at 
increasing coverage. This focus of evidence on uptake 
is even more dominant considering that we excluded 
14 articles which focused solely on personal or other 
reasons. Most of the overlap of the included systematic 
reviews occurred within this sub-system. Funding, 
enacting legislation, supply of materials and monitoring 
outcomes were not covered by any of the included 
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systematic reviews. Regarding the evidence included in 
these systematic reviews, only a minority of individual 
studies related to childhood or influenza vaccination 
programmes in Europe, with much of the cited evidence 
generated in the United States. Reports from European 
organizations (WHO Regional Office for Europe, 
ECDC, VENICE etc.) have gone some way to filling 
the gap, but these reports tend to be based on surveys or 
the collated opinions of experts rather than reviews of 
interventional or observational studies.
Conclusion 
While there is much evidence about the health system 
factors inf luencing the success of childhood and 
influenza vaccination programmes in Europe, there 
are still gaps that require further research. Much of the 
existing research is focused on the United States and 
addressing public attitudes. While this is important, 
public and professional attitudes are one part of a 
complex health system that must be investigated 
as a whole, given the interaction of so many of the 
influencing factors. Further systematic evidence on the 
specific roles of health professionals, supply and systems 
for monitoring outcomes of vaccination programmes in 
Europe is required.
4 
Comparative 
analysis of 
country fiches
Bernd Rechel
The comparative analysis is based on the information 
provided in the country fiches, where more detailed 
information can be found, including references and 
details for studies and data cited in the country fiches 
(see the Appendix). 
The comparative analysis aims to set out: 
• differences and commonalities in the governance 
approach, the financing of vaccination services and 
provider organizations involved;
• differences and commonalities in success factors and 
barriers to effective vaccination coverage.
Governance
In all EU Member States, there is a dedicated agency 
in charge of developing and overseeing implementation 
of national vaccination plans and programmes. This 
is usually the Ministry of Health or a subordinated 
agency, often supported by technical advisory groups or 
committees.
In all EU Member States, vaccination programmes are 
organized at the national level, whereas the regional level 
tends to be charged with overseeing implementation 
of vaccinations and monitoring vaccination coverage. 
Consequently, vaccination programmes or plans tend 
to apply to the whole country. In Italy, for example, a 
National Immunization Plan 2017–2019 was issued in 
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January 2017. Until then, Italy’s vaccination schedules 
had been a patchwork of 21 different regional vaccination 
schedules; the new plan helped to harmonize these 
diverse programmes. The plan sets targets for vaccine 
coverage, but also sets out actions to reduce disparities 
between Italian regions.
However, there are some countries where the regional 
level has latitude to modify national vaccination 
programmes and recommendations to local needs. 
This includes Denmark, Germany, Spain and Sweden. 
Yet, this potential for regional modifications typically 
concerns additional vaccinations that go beyond the set 
of vaccinations recommended for the whole country.
In 9 EU Member States (Bulgaria, Croatia, Czech 
Republic, France, Hungary, Italy, Poland, Slovakia and 
Slovenia), vaccinations against measles are mandatory for 
children, while in the remaining 19 countries they are 
voluntary, but recommended by the relevant authorities. 
Italy only added measles to the list of mandatory 
vaccinations for children in July 2017, while Romania is 
currently discussing whether vaccination should become 
mandatory.
However, the distinction between voluntary and 
mandatory immunization is not always clear-cut. In 
Greece, children require proof of immunization against 
measles when enrolling in kindergarten or primary 
school, so that the formally voluntary immunization is 
de facto mandatory. Similarly, in Germany, vaccinations 
are voluntary, but children will only be admitted to day-
care facilities or school if they have received the standard 
vaccinations. If the children are not vaccinated, the 
parents must prove that they have taken medical advice 
on vaccination. In case of a measles outbreak in a day-
care facility or school, the institution is allowed to exclude 
unvaccinated children from attendance. In Cyprus too 
vaccinations are voluntary, but a vaccination certificate is 
needed for enrolment in schools. An attempt to establish 
similar procedures in Lithuania failed in 2016. 
In contrast, vaccinations for adults against influenza 
are voluntary in almost all EU Member States. The 
sole exception is Slovakia, where vaccination against 
influenza is mandatory for any person living in social 
care facilities, as well as for any person at increased risk 
of infection due to living or working in an area with the 
presence of avian influenza. In the remaining countries, 
adult vaccinations against influenza are recommended for 
specified groups of the population, such as people aged 
65 years and older, pregnant women, people with chronic 
conditions or people with serious immunodeficiencies. 
The countries have embraced a mix of incentives and 
sanctions to improve vaccination coverage. These include 
awareness campaigns, financial rewards for parents or 
health care providers, and financial sanctions or refusal 
of school or kindergarten entry for those who refuse 
(mandatory or even voluntary) vaccinations.
Specific targeted measures for vulnerable groups of 
the population are adopted in a number of countries 
(including Croatia, Finland, Germany, Greece, Ireland, 
Luxembourg, Malta, the Netherlands, Portugal, Romania, 
the United Kingdom). In particular, these include actions 
for refuges and asylum-seekers, often as part of medical 
screening upon entry to the country. Other countries also 
offer targeted measures for ethnic minority groups, such 
as the Roma and Travellers. Examples include Croatia, 
Ireland, Romania, and the United Kingdom.
Only 12 EU Member States reported using a population 
register as the basis for their vaccination programmes: 
Croatia, Czech Republic, Denmark, Hungary, Ireland 
(for measles), Italy (in 90% of regions or local health 
services, with a national system being set up), Lithuania, 
Malta, the Netherlands (for measles), Portugal, Slovakia, 
Slovenia. 
In some of the other countries (e.g. Bulgaria, Estonia, the 
Netherlands in the case of influenza, Poland, Spain), the 
registries of health care providers (usually GPs) or health 
insurance funds are used to monitor vaccination uptake 
and invite patients for vaccinations. In Estonia, there is 
concern over the population registry including many who 
have moved abroad and a decision was made to use GP 
registries instead.
The methods used to estimate vaccination coverage 
rates also differ between countries. There are differences 
for both the numerator (the number of people being 
vaccinated) and the denominator (the number of people 
who should be vaccinated). Only some countries use 
population registries as the denominator for calculating 
rates. Others use the records of health care providers 
(patient lists) and lists of people covered by health 
insurance funds. Calculation of the numerator is based 
on a variety of sources, including data on reimbursements 
for providers, sales data and reports by health care 
providers. Some countries also use surveys to establish 
vaccination rates. 
Sometimes, methods differ even within countries. In 
Italy, calculation of the denominator differs across 
regions, with some using statistical population data, 
whereas others use the number of resident people in their 
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territory, and still others the number of people registered 
in the local health system register. In Spain, sources 
to determine the denominator (i.e. the populations of 
the corresponding sex and age groups) differ across the 
different Autonomous Communities and include official 
statistical bodies, population health registers and registers 
of the vaccination services. In Sweden too different 
methods are used to estimate the vaccination coverage 
rate at county council level, including data from regional 
vaccination registries (for about a third of the counties), 
financial systems, surveys of older people (65+), patient 
record systems, and doses distributed.
Provision
Measles vaccinations for children are provided in most 
EU Member States through primary care physicians or 
nurses. Depending on the organization of primary care 
in the country, this can include paediatricians, general 
practitioners (GPs), school physicians, and nurses in 
various settings, such as GP practices or school health 
services. Given that measles vaccinations for children are 
provided at different ages, with the first shot typically 
given at 12 months and a second shot often several 
years later (the timing of the second shot differs widely 
between countries), different types of providers and 
professionals can be involved. School health services play 
an important role for the second shot in a number of 
countries, whereas pharmacies and pharmacists do not 
tend to play a major role.
For adult vaccinations against influenza, the principal 
health care providers are physicians and nurses in primary 
health care, although with differences between countries 
as to whether this task is performed by physicians, nurses 
or both. In some countries, vaccinations are also offered 
by public health institutions. Occupational health 
services play an important role in several countries for 
those who receive influenza vaccinations to protect them 
against occupational health risks, such as health workers. 
Only six countries (Ireland, Latvia, Malta, Portugal, 
Sweden, and the United Kingdom) report the availability 
of influenza vaccinations in (some) pharmacies, although 
these are now also being introduced on a pilot basis in 
Estonia and France. 
Financing 
In all EU Member States, childhood vaccinations against 
measles are free of charge at the point of delivery. The 
only exception is the private sector in Cyprus, where 
patients pay the cost of the vaccine and of the vaccination 
when being vaccinated, unless they have private health 
insurance. It has been estimated that 42% of children in 
Cyprus are vaccinated in the public sector and 58% in the 
private sector, although with a higher share in the public 
sector in recent years. Systems in place for financing 
vaccinations against measles differ across countries, in 
line with the predominant systems for health financing 
and paying health care providers.
For adult vaccinations against influenza, most (21) EU 
Member States provide vaccinations free of charge at 
the point of delivery for those groups of the population 
targeted by the respective national vaccination 
programme, e.g. people aged 65 years and above. In only 
seven countries (Austria, Belgium, Bulgaria, Estonia, 
Latvia, Poland and Slovenia) targeted patients need to 
pay at least part of the costs for adult vaccinations against 
influenza (Table 2).
Table 2 Is adult vaccination against influenza free of charge at 
the point of delivery for targeted groups of the population?
Country Yes No
Austria X
Belgium X
Bulgaria X
Croatia X
Cyprus X
Czech Republic X
Denmark X
Estonia X
Finland X
France X
Germany X
Greece X
Hungary X
Ireland X
Italy X
Latvia X
Lithuania X
Luxembourg X
Malta X
Netherlands X
Poland X
Portugal X
Romania X
Slovakia X
Slovenia X
Spain X
Sweden (a) X
United Kingdom X
Note: (a) patient co-payment required in 4 of 21 regions
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Key barriers and facilitators
Barriers to effective vaccination coverage against 
measles
The country fiches identified a number of barriers to 
an effective vaccination coverage against measles, with 
only five countries (Cyprus, Denmark, Luxembourg, 
Portugal and Sweden) not reporting any major barriers. 
The factor mentioned in most fiches (20 countries) 
was vaccine hesitancy. Seven countries noted a failure 
to reach vulnerable groups of the population. Six 
of the reports mentioned a lack of awareness in the 
population as one of the barriers to effective vaccination 
coverage. Five countries reported insufficient training 
or vaccine hesitancy among health professionals. Factors 
related to the organization, provision and financing 
of vaccination services were only reported by very few 
countries, with two (Latvia and Romania) reporting 
short-term shortages of vaccines, two (Hungary and 
Lithuania) reporting a shortage of resources, and three 
(Greece, Ireland and Lithuania) reporting the lack of 
a vaccination register as barriers. Two countries also 
reported the voluntary character of vaccinations as a 
barrier to vaccination coverage (Table 3).
Table 3 Overview of key barriers to effective vaccination coverage of childhood vaccinations against measles
Country Vaccine hesitancy Voluntary 
character of 
vaccinations
Lack of awareness Failure to reach 
vulnerable groups
Lack of 
vaccination 
register
Austria X X X
Belgium X X
Bulgaria X X
Croatia X X
Cyprus
Czech Republic X X
Denmark
Estonia X
Finland X
France X X
Germany X
Greece X X X
Hungary X X
Ireland X X
Italy X
Latvia X
Lithuania X
Luxembourg
Malta X
Netherlands
Poland X
Portugal
Romania X X X
Slovakia X X
Slovenia X
Spain X X
Sweden
United Kingdom X X
Total 20 2 6 7 3
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Lack of resources Lack of training 
for health  
workers 
Vaccine  
shortages
Migration Unclear No major barriers
X
X
X
X
X
X X
X
X
X
X X X
X X
X
X
X
X
2 5 2 4 1 5
Facilitators of effective vaccination coverage 
against measles
Of the 28 EU Member States, 25 identified key 
facilitators for effective vaccination coverage against 
measles. The factor mentioned by most (14 countries) 
was the inclusion of measles vaccination in the health 
services that are publicly funded. This was followed by 
awareness-raising campaigns (mentioned in 8 country 
fiches) and a good health service delivery network (7 
country reports). Six mentioned public attitudes that 
were conducive to measles vaccinations, the role of 
health professionals and the existence of a monitoring 
system overseeing vaccinations, and five each mentioned 
the mandatory character of measles vaccinations and the 
existence of special incentive schemes (Table 4).
Barriers to effective vaccination coverage against 
influenza
22 of the 28 EU Member States identified barriers to 
effective vaccination coverage of adults against influenza. 
The most commonly mentioned barrier (described in 
15 of the country fiches) was lack of awareness among 
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Table 4 Overview of key facilitators of effective vaccination coverage of adult vaccinations against measles
Country Inclusion in 
vaccination plan
Health 
professionals
Mandatory 
character of 
vaccinations
Covered by public 
funds
Awareness-raising 
campaigns
Austria X X
Belgium X X
Bulgaria X X
Croatia X
Cyprus X X X
Czech Republic X
Denmark X
Estonia X X X
Finland
France X X
Germany
Greece X
Hungary
Ireland X X
Italy X X X
Latvia
Lithuania X X
Luxembourg X
Malta X
Netherlands
Poland X X
Portugal X X
Romania
Slovakia X X
Slovenia X X
Spain X X
Sweden
United Kingdom
Total 4 6 5 14 8
the general population, with people being unaware of 
the potentially serious consequences of the disease. The 
related issue of vaccine hesitancy was pointed out by 11 
of the countries, linking low vaccination coverage to 
anti-vaccination movements. Out-of-pocket payments 
as a barrier to higher coverage rates were also pointed 
out by 9 countries. Lack of training for health workers 
was noted in 7 of the countries, with the related issue 
of low vaccination coverage among health workers or 
difficulties in accessing vaccination services for them 
mentioned by 6 countries (Table 5).
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Facilitators of effective vaccination coverage 
against influenza
Only 14 EU Member States identified facilitators of 
effective vaccination coverage against influenza. These 
include media campaigns to raise awareness in the 
general population and among health workers, the 
involvement of employers and professional societies, 
outreach services, financial incentives for providers 
of immunizations, and the provision of inf luenza 
vaccinations in pharmacies.
Monitoring  
system
Incentive  
schemes
Public attitudes Recall system Health care 
delivery network 
Tailored 
interventions
X X X
X X X
X
X
X X
X
X
X X
X
X X
X X
X
X
X
X X
X X X
6 5 6 1 7 2
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Table 5 Overview of key barriers to effective vaccination coverage of adult vaccinations against influenza
Country Vaccine  
hesitancy
Voluntary 
character of 
vaccinations
Lack of  
awareness
Failure to reach 
vulnerable groups
Not part 
of national 
vaccination 
schedule
Austria X X
Belgium X
Bulgaria X X
Croatia
Cyprus X X
Czech Republic X
Denmark X
Estonia X
Finland X X
France X X
Germany X
Greece
Hungary
Ireland X
Italy X X
Latvia X X
Lithuania
Luxembourg X
Malta
Netherlands X X
Poland X
Portugal
Romania X
Slovakia
Slovenia X
Spain X
Sweden X X
United Kingdom X X X
Total 11 1 15 4 1
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Out-of-pocket 
payments
Lack of 
training  
for health 
workers
Complicated  
system
Migration Difficulties in 
access for or low 
coverage among 
health workers
Procurement; 
supply  
shortages
Low vaccine 
effectiveness
X X
X X X
X
X
X
X X
X
X
X X
X
X X
X X
X
X X X
X X
X X
X X
X X X
9 7 4 1 6 3 2
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Bernd Rechel, Jennifer Priaulx, Martin McKee
This report brings together key information from the 
umbrella review and country fiches (see Appendix) on 
the governance, organization, provision and financing of 
vaccination programmes in EU Member States, including 
perceived barriers and facilitators. The aim was to identify 
factors that could be considered in efforts to strengthen 
vaccination systems and increase vaccination coverage.
Limitations
Before delving into the findings of the report, it is 
important to highlight some of its limitations. The 
umbrella review was limited to what had been researched 
and included in previous systematic reviews. As noted, a 
considerable part of the evidence, particularly in terms 
of systematic reviews, focuses on vaccine hesitancy and 
reasons for under-vaccination, such as health literacy, lack 
of trust and socioeconomic or ethnic inequalities (21–23, 
109–112). In turn, there is also considerable evidence on 
interventions to address non-compliance and inequalities 
(51, 113, 114), including other reviews of reviews (115). 
In the comparative analysis of country fiches, questions 
in the template used for data collection were open-ended, 
which means that the issues identified by the country 
respondents should not be regarded as exclusive. This 
applies in particular to the barriers to and facilitators 
of effective vaccination coverage against measles and 
influenza, where many factors may have been identified 
in earlier parts of the country fiches and not repeated in 
the final section on barriers and facilitators, or without 
distinguishing clearly between those that apply to 
measles and those that apply to influenza. 
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The literature on health system related 
barriers
The literature review aimed to fill a gap in previous 
reviews, focusing on the importance of health 
system factors in implementing effective vaccination 
programmes. Although we had identified other umbrella 
reviews of systematic reviews in the field of vaccination, 
these reviews had different objectives to our review 
that focused on health system factors. Ryan et al. (25), 
aimed to synthesize evidence of consumers’ use of 
medicines, including interventions targeting consumers 
and promoting evidence-based prescribing and use. 
Fernandes et al. (24) aimed to collate a bibliographical 
resource of all vaccination-related systematic reviews. 
The health system approach to understanding the 
effectiveness of immunization programmes has been 
used elsewhere but the focus seems to have been mainly 
on middle- or low-income countries. For example, 
Burchett et al. evaluated case studies of the impact 
of introducing new vaccines into the health system 
in low- and middle-income countries (116). GAVI, 
the international Vaccine Alliance (www.gavi.org), 
proposes support for health system and immunization 
strengthening, including immunization supply chain, 
data, leadership/management/coordination, and demand 
promotion. There are multiple examples of health system 
strengthening efforts in low and middle income countries 
(117, 118) and it is by no means a new topic (119). 
Where health systems have been discussed in relation 
to immunization in Europe, much of the published 
literature is not based on systematic methods, but 
rather in the form of expert opinions or non-systematic 
reviews of the literature, which are less robust approaches 
to evidence review. Our review identified 98 non-
systematic reviews and reports covering health system 
factors. For example, McGuire et al. (120, 121) provide 
a comprehensive list of health system and vaccine policy 
making features which includes many of the factors that 
we identified. However, our systematic approach adds 
weight to the conclusions of their more iterative approach 
to evidence review.
Comparative analysis of country fiches
Governance
All EU Member States have a dedicated agency in 
charge of developing and overseeing implementation of 
national vaccination plans and programmes. Vaccination 
programmes are organized at the national level, whereas 
the regional level tends to be charged with overseeing 
implementation of vaccinations and monitoring 
vaccination coverage. 
Where there are major differences between countries is 
in whether childhood vaccinations against measles are 
mandatory or not. In 9 countries (Bulgaria, Croatia, 
Czech Republic, France, Hungary, Italy, Poland, 
Slovakia and Slovenia), vaccinations against measles 
are mandatory for children, while in the remaining 19 
countries they are voluntary, but recommended by the 
relevant authorities. However, the distinction between 
voluntary and mandatory immunization is not always 
clear-cut. In several countries (Bulgaria, Cyprus, Czech 
Republic, Germany, Greece and Spain) vaccinations 
are voluntary, but vaccination certificates are required 
for enrolment of children in schools or kindergartens. 
In contrast, vaccinations for adults against influenza 
are voluntary in almost all EU Member States. The 
sole exception is Slovakia, where vaccination against 
influenza is mandatory for any person living in social care 
facilities, as well as for any person having an increased 
risk to be infected due to living or working in an area 
with the presence of avian influenza. It is noteworthy 
that almost all of the countries that have opted for 
mandatory vaccinations (except Italy) are in Central 
and Eastern Europe. This points to the wider societal 
and cultural context that may be more or less accepting 
of the introduction of mandatory vaccinations. Even in 
countries with mandatory vaccinations, those who refuse 
vaccinations may prefer to pay fines rather than getting 
vaccinated. Yet, it is one of the policy options available.
Other options are additional incentives and sanctions; 
illustrations for many are given in the country fiches. 
They include awareness campaigns, financial rewards for 
parents or health care providers, and financial sanctions 
or refusal of school or kindergarten entry for those who 
refuse (mandatory or even voluntary) vaccinations.
Specific targeted measures for vulnerable groups 
of the population are adopted in several countries 
(including Croatia, Finland, Germany, Greece, Ireland, 
Luxembourg, Malta, the Netherlands, Portugal, Romania, 
the United Kingdom). These include in particular 
actions for refugees and asylum-seekers, often as part of 
the medical screening upon entry to the country. Other 
countries, such as Croatia, Ireland, Romania and the UK, 
also offer targeted measures for ethnic minorities, such as 
the Roma and Travellers. It would be important to know 
how successful these measures are and what more would 
need to be done to close gaps in vaccination coverage.
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The organization of vaccination programmes is another 
area where improvements seem possible. Only 12 
countries reported using a population register as the basis 
for their vaccination programmes. In some of the other 
countries (e.g. Bulgaria, Estonia, the Netherlands in the 
case of influenza, Poland, Spain), the registries of health 
care providers (usually GPs) or health insurance funds are 
used to monitor vaccination uptake and invite patients 
for vaccinations, but these may not always be complete.
The methods used to estimate vaccination coverage 
rates also differ between countries, with much scope 
for improvements. There are differences for both the 
numerator (the number of people being vaccinated) and 
the denominator (the number of people who should 
be vaccinated). Only some countries use population 
registries as the denominator for calculating rates. Others 
use records of health care providers (patient lists) and lists 
of people covered by health insurance funds. Calculation 
of the numerator is based on varied sources, including 
data on reimbursements for providers, sales data and 
reports by health care providers. Some countries also use 
surveys to establish vaccination rates.
Provision
Measles vaccinations for children are provided in most 
EU Member States through primary care physicians or 
nurses. Depending on the organization of primary care 
in the country, this can include paediatricians, general 
practitioners (GPs), school physicians, and nurses in 
various settings, such as GP practices or school health 
services. Given that measles vaccinations for children are 
provided at different ages, with the first shot typically 
given at 12 months and a second shot often several 
years later (the timing of the second shot differs widely 
between countries), different types of providers and 
professionals can be involved. School health services play 
an important role for the second shot in several countries, 
whereas pharmacies and pharmacists do not tend to play 
a role.
For adult vaccinations against influenza, the principal 
health care providers are physicians and nurses in primary 
health care, although with differences between countries 
as to whether this task is performed by physicians, nurses 
or both. In some countries, vaccinations are also offered 
by public health institutions. Occupational health 
services play an important role in a number of countries 
for those who receive influenza vaccinations to protect 
them against occupational health risks, such as health 
workers. Only six countries (Ireland, Latvia, Malta, 
Portugal, Sweden, and the United Kingdom) report 
the availability of influenza vaccinations in pharmacies, 
although these are now also being introduced on a pilot 
basis in Estonia and France.
While little can be changed about the organization and 
delivery of primary health care services in the countries 
covered with the sole purpose of improving vaccination 
services, there might be scope for involvement of a wider 
range of actors in some countries. Depending on the 
country and its organizational and regulatory context, 
this can include school health services for vaccinations 
against measles and pharmacies for adult vaccinations 
against influenza. 
Financing
In all EU Member States, childhood vaccinations against 
measles are free of charge at the point of delivery. The 
only exception is the private sector in Cyprus, where 
patients have to pay the cost of the vaccine and of the 
vaccination, if they do not have private health insurance. 
It has been estimated that 42% of children in Cyprus are 
vaccinated in the public sector and 58% in the private 
sector, although more recent estimates indicate a shift 
towards the public sector in the wake of the financial 
crisis. 
For adult vaccinations against influenza, most (21) EU 
Member States provide vaccinations free of charge at 
the point of delivery for those groups of the population 
targeted by the respective national vaccination 
programme, e.g. people aged 65 years and above. In only 
seven countries (Austria, Belgium, Bulgaria, Estonia, 
Latvia, Poland and Slovenia) targeted patients need to 
pay at least part of the costs for adult vaccinations against 
influenza. Improving public coverage of vaccinations 
against influenza and removing administrative barriers 
for getting reimbursed seem to be potential avenues for 
improving vaccination coverage.
Key barriers and facilitators
The country reports suggest that there are currently 
few factors related to the organization, provision and 
financing of vaccination services that are in the way of 
improved vaccination coverage. Two countries (Latvia and 
Romania) reporting short-term shortages of vaccines, two 
(Hungary and Lithuania) reported a shortage of resources, 
and three (Greece, Ireland and Lithuania) the lack of 
a vaccination register as barriers. The overwhelming 
majority of countries (20 countries) point to vaccine 
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hesitancy as of the main barriers for improved vaccination 
coverage against measles. Five countries also reported 
insufficient training or vaccine hesitancy among health 
professionals. It is clear that major efforts are required 
in many countries to address these concerns or lack of 
knowledge.
The key facilitator mentioned by most (14 countries) for 
effective vaccination coverage against measles was the 
inclusion of measles vaccination in the health services 
that are publicly funded. This was followed by awareness-
raising campaigns (mentioned in 8 country fiches) and a 
good health service delivery network (7 country fiches). 
For influenza, 15 countries pointed out that there is a lack 
of awareness among the general population, with people 
being unaware of the potentially serious consequences 
of the disease. The related issue of vaccine hesitancy 
was pointed out by 11 of the countries, linking low 
vaccination coverage to anti-vaccination movements. The 
existence of out-of-pocket payments as a barrier to higher 
coverage rates was pointed out by 9 countries.
Only 14 EU Member States identified facilitators for 
effective vaccination coverage against influenza. These 
include media campaigns to raise awareness in the general 
population and among health workers, the involvement 
of employers and professional societies, outreach services, 
financial incentives for providers of immunizations, and 
the provision of influenza vaccinations in community 
pharmacies.
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Bernd Rechel, Martin McKee
This report and the underlying country fiches provide a 
detailed overview of the measures taken by EU Member 
States to address vaccine-preventable diseases. They 
reveal a situation that is far from satisfactory. While 
some countries have achieved high levels of coverage 
with measles vaccine, others lag far behind, exposing 
their populations to avoidable disease and, in some 
cases, premature death. The situation is even worse 
for influenza vaccine coverage. This is an area where 
the scope for learning from the experience of others is 
obvious.
The material presented here should be read in 
conjunction with a new report published by the 
European Commission’s Expert Panel on Investing in 
Health, which has looked in detail at vaccine hesitancy 
in the EU (122), and which drew on some of the material 
assembled for this report. It complements the findings 
presented here but looks in more detail at the main 
factors (enablers and obstacles) influencing vaccination 
uptake, assessing measures that can be considered as 
means to improve vaccination coverage. 
Like this report, it highlights the importance of developing 
a systems approach to national vaccination programmes. 
Thus, it is important that the administration of vaccines 
to individuals should not be viewed in isolation but 
rather should be looked at within a wider perspective 
that includes legislative frameworks, governance 
arrangements, accuracy and completeness of registers of 
target populations, funding mechanisms, and monitoring 
systems. This makes it easier to identify the diverse range 
of obstacles and enablers of high rates of vaccination 
coverage. While this report has provided much detail 
The organization and delivery of vaccination services34
on the organization of vaccination programmes, there is 
considerable scope for more detailed evaluations of how 
these programmes work in practice. Thus, as the country 
fiches show, the scale and nature of monitoring the 
effectiveness of vaccination programmes varies greatly 
and information on how uptake varies among different 
groups in the population, and the reasons why, is often 
fragmentary.  
Both reports highlight the importance of vaccine hesitancy. 
The Expert Panel report looks at this in considerable 
detail, seeking to understand individuals’ and parents’ 
concerns or fears about vaccine safety and side effects, 
which are often based on lack of trust and exposure to 
myths that undermine confidence in vaccines. Yet, it 
reveals how healthcare providers do not always counter 
these myths with evidence-informed advice. Moreover, 
when they do, their messages may backfire. Thus, it is 
important to draw on the now extensive evidence from 
psychological research on how best to frame messages, 
recognising that this will be different for those who are 
merely uninformed, in that they lack information, and 
for those who are misinformed, believing information 
that is false to be correct. It is also necessary to address 
disinformation, when people are subject to information 
spread with the intention to deceive.  
Both reports note the continued existence of barriers 
to access, which can be financial or organizational. 
The continued existence of co-payments for influenza 
vaccine in some countries is an obvious barrier but, even 
though measles vaccination is free everywhere, there may 
be costs involved in accessing facilities. The insistence, 
in some countries, that only physicians can administer 
vaccines is a further barrier. There is no evidence to 
support such a restrictive policy and, in many countries, 
they are given entirely safely by nurses and pharmacists. 
However, all those involved in vaccination programmes 
should be supported with specific training to address 
concerns from hesitant individuals.
The fiches note how vaccination is mandatory in some 
countries but not in others. On the evidence available 
it is not possible to make a universal recommendation 
and much will depend on context as well as political 
preferences. If it is mandatory, there is a need for a 
well-designed communication strategy, addressing in 
particular the scope for such a decision to be exploited 
for political purposes unrelated to vaccination. Where 
mandatory vaccination is not considered acceptable, an 
alternative can be to require individuals to opt out but 
only subject to certain conditions, such as following a 
mandatory consultation with a healthcare worker who 
explore the risks involved. 
The continued toll of vaccine preventable disease in the 
EU is unacceptable. Those countries that have achieved 
high levels of coverage show what can be done. While 
the precise arrangements must be adapted to the precise 
circumstances prevailing in each country, this report, 
and the accompanying one by the Expert Panel, offer 
a basis to engage in discussion of how this continuing 
threat to the health of Europe’s citizens can be addressed.
35References
References
1. Kmietowicz Z. Measles: Europe sees record number 
of cases and 37 deaths so far this year. BMJ (Clinical 
research ed). 2018;362:k3596.
2. ECDC. Number of measles deaths by country, EU/
EEA, 1 July 2017–30 June 2018 [https://ecdc.europa.eu/
en/publications-data/number-measles-deaths-country-
eueea-1-july-2017-30-june-2018, accessed 28 August 
2018]. Stockholm: ECDC; 2018.
3. ECDC. Monthly measles and rubella monitoring 
report, August 2018 [https://ecdc.europa.eu/en/
publications-data/number-measles-cases-month-and-
notification-rate-million-population-country-0, accessed 
28 August 2018]. Stockholm: ECDC; 2018.
4. WHO. European Health Information Gateway 
[https://gateway.euro.who.int/en/hfa-explorer/, accessed 
6 July 2018]. Copenhagen: World Health Organization 
Regional Office for Europe; 2018.
5. ECDC. Summary of the influenza 2016–2017 
season in Europe [https://ecdc.europa.eu/en/publications-
data/summary-inf luenza-2016-2017-season-europe, 
accessed 28 August 2018]. Stockholm: ECDC; 2018.
6. ECDC. Seasonal influenza vaccination in Europe 
Vaccination recommendations and coverage rates in the 
EU Member States for eight influenza seasons, 2007–
2008 to 2014–2015. Stockholm: ECDC; 2017.
7. ECDC. Vaccine hesitancy among healthcare 
workers and their patients in Europe. A qualitative study. 
Stockholm: ECDC; 2015.
8. Carrillo-Santisteve P, Lopalco PL. Measles still 
spreads in Europe: who is responsible for the failure to 
vaccinate? Clin Microbiol Infect. 2012;18 Suppl 5:50–6.
9. ECDC. Catalogue of interventions addressing 
vaccine hesitancy. Stockholm: ECDC; 2017.
10. Nohynek H, Wichmann O, F DA, Gatekeepers 
VN. National Advisory Groups and their role in 
immunization policy-making processes in European 
countries. Clin Microbiol Infect. 2013;19(12):1096–105.
11. ECDC. Current practices in immunisation 
policymaking in European countries. Stockholm: 
ECDC; 2015.
12. Elfstrom KM, Dillner J, Arnheim-Dahlstrom L. 
Organization and quality of HPV vaccination programs 
in Europe. Vaccine. 2015;33(14):1673–81.
13. Parez N, Giaquinto C, Du Roure C, Martinon-
Torres F, Spoulou V, Van Damme P, et al. Rotavirus 
vaccination in Europe: drivers and barriers. Lancet Infect 
Dis. 2014;14(5):416–25.
14. Kanitz EE, Wu LA, Giambi C, Strikas RA, Levy-
Bruhl D, Stefanoff P, et al. Variation in adult vaccination 
policies across Europe: an overview from VENICE 
network on vaccine recommendations, funding and 
coverage. Vaccine. 2012;30(35):5222–8.
15. Mipatrini D, Stefanelli P, Severoni S, Rezza G. 
Vaccinations in migrants and refugees: a challenge for 
European health systems. A systematic review of current 
scientific evidence. Pathog Glob Health. 2017;111(2):59–
68.
16. WHO. Evaluation of the WHO Regional Office 
for Europe Tailoring Immunization Programmes (TIP) 
behavioural insights tool and approach. Final report. 
Copenhagen: World Health Organization Regional 
Office for Europe; 2016.
17. European Commission – Health and Consumers 
Directorate-General. Report on the Conference on 
childhood immunisation: progress, challenges and 
priorities for further action – Luxembourg, 16–17 
October 2012. European Commission; 2013.
18. Council of the European Union. Council 
conclusions on childhood immunisation: successes and 
challenges of European childhood immunisation and the 
way forward (2011/C 202/02). 2011 8.7.2011.
19. European Centre for Disease Prevention and 
Control (ECDC). Vaccine hesitancy 2018 [Available 
from: https://ecdc.europa.eu/en/immunisation-vaccines/
vaccine-hesitancy.
20. World Health Organization Regional Office 
for Europe. Vaccination and trust 2017 [Available 
from: http://www.euro.who.int/en/health-topics/
disease-prevention/vaccines-and-immunization/
publications/vaccination-and-trust.
21. Karafillakis E, Larson HJ. The benefit of the doubt 
or doubts over benefits? A systematic literature review 
of perceived risks of vaccines in European populations. 
Vaccine. 2017;35(37):4840–50.
22. Larson HJ, Clarke RM, Jarrett C, Eckersberger 
E, Levine Z, Schulz WS, et al. Measuring trust 
in vaccination: A systematic review. Hum Vaccin 
Immunother. 2018;14(7):1599–609.
The organization and delivery of vaccination services36
23. Larson HJ, Jarrett C, Eckersberger E, Smith DM, 
Paterson P. Understanding vaccine hesitancy around 
vaccines and vaccination from a global perspective: a 
systematic review of published literature, 2007–2012. 
Vaccine. 2014;32(19):2150–9.
24. Fernandes S, Jit M, Bozzani F, Griffiths UK, 
Scott JAG, Burchett HED. A bibliometric analysis of 
systematic reviews on vaccines and immunisation. 
Vaccine. 2018;36(17):2254–61.
25. Ryan R, Santesso N, Lowe D, Hill S, Grimshaw 
J, Prictor M, et al. Interventions to improve safe and 
effective medicines use by consumers: an overview 
of systematic reviews. Cochrane Database Syst Rev. 
2014(4):CD007768.
26. Giuffrida A, Gosden T, Forland F, Kristiansen 
IS, Sergison M, Leese B, et al. Target payments in 
primary care: effects on professional practice and 
health care outcomes. Cochrane Database Syst Rev. 
2000(3):CD000531.
27. Oyo-Ita A, Wiysonge CS, Oringanje C, 
Nwachukwu CE, Oduwole O, Meremikwu MM. 
Interventions for improving coverage of childhood 
immunisation in low- and middle-income countries. 
Cochrane Database Syst Rev. 2016;7:CD008145.
28. Lewin S, Munabi-Babigumira S, Glenton C, 
Daniels K, Bosch-Capblanch X, van Wyk BE, et al. 
Lay health workers in primary and community health 
care for maternal and child health and the management 
of infectious diseases. Cochrane Database Syst Rev. 
2010(3):CD004015.
29. Thomas RE, Lorenzetti DL. Interventions to 
increase influenza vaccination rates of those 60 years and 
older in the community. Cochrane Database Syst Rev. 
2018;5:CD005188.
30. Jacobson Vann JC, Jacobson RM, Coyne-Beasley T, 
Asafu-Adjei JK, Szilagyi PG. Patient reminder and recall 
interventions to improve immunization rates. Cochrane 
Database Syst Rev. 2018;1:CD003941.
31. Thomas RE, Russell ML, Lorenzetti DL. 
Systematic review of interventions to increase influenza 
vaccination rates of those 60 years and older. Vaccine. 
2010;28(7):1684–701.
32. Maglione MA, Stone EG, Shekelle PG. Mass 
mailings have little effect on utilization of influenza 
vaccine among Medicare beneficiaries. Am J Prev Med. 
2002;23(1):43–6.
33. Stone EG, Morton SC, Hulscher ME, Maglione 
MA, Roth EA, Grimshaw JM, et al. Interventions 
that increase use of adult immunization and cancer 
screening services: a meta-analysis. Ann Intern Med. 
2002;136(9):641–51.
34. Jacobson Vann JC, Szilagyi P. Patient reminder and 
patient recall systems to improve immunization rates. 
Cochrane Database Syst Rev. 2005(3):CD003941.
35. Burchett HE, Mounier-Jack S, Griffiths UK, Mills 
AJ. National decision-making on adopting new vaccines: 
a systematic review. Health Policy Plan. 2012;27 Suppl 
2:ii62–76.
36. Ultsch B, Damm O, Perleth M, Wichmann O. 
Health Economics In immunization decision-making 
– results from a systematic literature research and a 
stakeholder symposium In Germany. Value Health. 
2015;18(7):A569.
37. Beentjes K. A systematic review of the broader 
outcomes of routine childhood vaccination policies in 
the European Economic Area, Switzerland, Canada and 
the United States 2016.
38. Raak C, Schmidt-Troschke S, Ostermann T. Health 
care professionals’ attitudes and opinions regarding the 
vaccination of measles-A systematic review. European 
Journal of Integrative Medicine. 2010;2 (4):234.
39. Fournet N, Mollema L, Ruijs WL, Harmsen IA, 
Keck F, Durand JY, et al. Under-vaccinated groups in 
Europe and their beliefs, attitudes and reasons for non-
vaccination; two systematic reviews. BMC public health. 
2018;18(1):196.
40. Mipatrini D, Stefanelli P, Severoni S, Rezza G. 
Vaccinations in migrants and refugees: a challenge for 
European health systems. A systematic review of current 
scientific evidence. Pathogens and Global Health. 
2017;111(2):59–68.
41. Jain A, van Hoek AJ, Boccia D, Thomas SL. 
Lower vaccine uptake amongst older individuals 
living alone: A systematic review and meta-analysis 
of social determinants of vaccine uptake. Vaccine. 
2017;35(18):2315–28.
42. Malerba V, Costantino C, Napoli G, Marchese V, 
Casuccio A, Tabacchi G, et al. Antimeningococcal and 
antipneumococcal vaccination determinants: a European 
systematic literature review. Epidemiologia e prevenzione. 
2015;39(4 Supplement 1):59–64.
37References
43. Eilers R, Krabbe PF, de Melker HE. Factors 
affecting the uptake of vaccination by the elderly in 
Western society. Prev Med. 2014;69:224–34.
44. Smith LE, Amlot R, Weinman J, Yiend J, Rubin GJ. 
A systematic review of factors affecting vaccine uptake in 
young children. Vaccine. 2017;35(45):6059–69.
45. Fernandez de Casadevante V, Gil Cuesta J, 
Cantarero-Arevalo L. Determinants in the Uptake of the 
Human Papillomavirus Vaccine: A Systematic Review 
Based on European Studies. Front Oncol. 2015;5:141.
46. Falagas ME, Zarkadoulia E. Factors associated with 
suboptimal compliance to vaccinations in children in 
developed countries: a systematic review. Curr Med Res 
Opin. 2008;24(6):1719–41.
47. Ferrer HB, Trotter C, Hickman M, Audrey S. 
Barriers and facilitators to HPV vaccination of young 
women in high-income countries: a qualitative systematic 
review and evidence synthesis. BMC Public Health. 
2014;14:700.
48. Fu LY, Bonhomme LA, Cooper SC, Joseph JG, 
Zimet GD. Educational interventions to increase HPV 
vaccination acceptance: a systematic review. Vaccine. 
2014;32(17):1901–20.
49. Lau D, Hu J, Majumdar SR, Storie DA, Rees SE, 
Johnson JA. Interventions to improve influenza and 
pneumococcal vaccination rates among community-
dwelling adults: a systematic review and meta-analysis. 
Ann Fam Med. 2012;10(6):538–46.
50. Odone A, Ferrari A, Spagnoli F, Visciarelli S, Shefer 
A, Pasquarella C, et al. Effectiveness of interventions that 
apply new media to improve vaccine uptake and vaccine 
coverage. Hum Vaccin Immunother. 2015;11(1):72–82.
51. Sadaf A, Richards JL, Glanz J, Salmon DA, Omer 
SB. A systematic review of interventions for reducing 
parental vaccine refusal and vaccine hesitancy. Vaccine. 
2013;31(40):4293–304.
52. Williams N, Woodward H, Majeed A, Saxena 
S. Primary care strategies to improve childhood 
immunisation uptake in developed countries: systematic 
review. JRSM Short Rep. 2011;2(10):81.
53. Abdel-Aleem H, El-Gibaly OM, El-Gazzar AF, 
Al-Attar GS. Mobile clinics for women’s and children’s 
health. Cochrane Database Syst Rev. 2016(8):CD009677.
54. Turnbull C, Osborn DA. Home visits during 
pregnancy and after birth for women with an alcohol 
or drug problem. Cochrane Database Syst Rev. 
2012;1:CD004456.
55. Kaufman J, Ryan R, Walsh L, Horey D, Leask J, 
Robinson P, et al. Face-to-face interventions for informing 
or educating parents about early childhood vaccination. 
Cochrane Database Syst Rev. 2018;5:CD010038.
56. Saeterdal I, Lewin S, Austvoll-Dahlgren A, Glenton 
C, Munabi-Babigumira S. Interventions aimed at 
communities to inform and/or educate about early 
childhood vaccination. Cochrane Database Syst Rev. 
2014(11):CD010232.
57. Macdonald L, Cairns G, Angus K, de Andrade M. 
Promotional communications for influenza vaccination: 
a systematic review. Journal of health communication. 
2013;18(12):1523–49.
58. Crocker-Buque T, Edelstein M, Mounier-Jack S. 
Interventions to reduce inequalities in vaccine uptake 
in children and adolescents aged <19 years: a systematic 
review. Journal of epidemiology and community health. 
2017;71(1):87–97.
59. Scott A, Sivey P, Ait Ouakrim D, Willenberg 
L, Naccarella L, Furler J, et al. The effect of financial 
incentives on the quality of health care provided by 
primary care physicians. Cochrane Database Syst Rev. 
2011(9):CD008451.
60. Lagarde M, Haines A, Palmer N. The impact of 
conditional cash transfers on health outcomes and use 
of health services in low and middle income countries. 
Cochrane Database Syst Rev. 2009(4):CD008137.
61. Van Herck P, De Smedt D, Annemans L, Remmen 
R, Rosenthal MB, Sermeus W. Systematic review: Effects, 
design choices, and context of pay-for-performance in 
health care. BMC Health Serv Res. 2010;10:247.
62. Odendaal WA, Ward K, Uneke J, Uro-Chukwu 
H, Chitama D, Balakrishna Y, et al. Contracting out 
to improve the use of clinical health services and 
health outcomes in low- and middle-income countries. 
Cochrane Database Syst Rev. 2018;4:CD008133.
63. Groom H, Hopkins DP, Pabst LJ, Morgan JM, 
Patel M, Calonge N, et al. Immunization Information 
Systems to Increase Vaccination Rates: A Community 
Guide Systematic Review. J Public Health Man. 
2015;21(3):227–48.
64. Szilagyi PG, Bordley C, Vann JC, Chelminski A, 
Kraus RM, Margolis PA, et al. Effect of patient reminder/
The organization and delivery of vaccination services38
recall interventions on immunization rates: A review. 
JAMA. 2000;284(14):1820–7.
65. Harvey H, Reissland N, Mason J. Parental reminder, 
recall and educational interventions to improve early 
childhood immunisation uptake: A systematic review 
and meta-analysis. Vaccine. 2015;33(25):2862–80.
66. Arditi C, Rege-Walther M, Durieux P, Burnand 
B. Computer-generated reminders delivered on paper to 
healthcare professionals: effects on professional practice 
and healthcare outcomes. Cochrane Database Syst Rev. 
2017;7:CD001175.
67. Shojania KG, Jennings A, Mayhew A, Ramsay CR, 
Eccles MP, Grimshaw J. The effects of on-screen, point 
of care computer reminders on processes and outcomes of 
care. Cochrane Database Syst Rev. 2009(3):CD001096.
68. Hyde TB, Dentz H, Wang SA, Burchett HE, 
Mounier-Jack S, Mantel CF, et al. The impact of new 
vaccine introduction on immunization and health 
systems: a review of the published literature. Vaccine. 
2012;30(45):6347–58.
69. Pebody RG, Leino T, Nohynek H, Hellenbrand W, 
Salmaso S, Ruutu P. Pneumococcal vaccination policy 
in Europe. Euro surveillance : bulletin europeen sur 
les maladies transmissibles = European communicable 
disease bulletin. 2005;10(9):174–8.
70. Pinot de Moira A, Nardone A. Varicella zoster virus 
vaccination policies and surveillance strategies in Europe. 
Euro surveillance : bulletin europeen sur les maladies 
transmissibles = European communicable disease bulletin. 
2005;10(1):43–5.
71. St-Martin G, Lindstrand A, Sandbu S, Fischer 
TK. Selection and Interpretation of Scientific Evidence 
in Preparation for Policy Decisions: A Case Study 
Regarding Introduction of Rotavirus Vaccine Into 
National Immunization Programs in Sweden, Norway, 
Finland, and Denmark. Front Public Health. 2018;6:131.
72. Vesikari T. The role of scientific societies in the 
decision-making process to recommend new vaccines: 
The example of rotavirus in Europe. Journal of Public 
Health. 2008;16(4):287–90.
73. Rizzo C, Rezza G, Ricciardi W. Strategies in 
recommending inf luenza vaccination in Europe 
and US. Human Vaccines and Immunotherapeutics. 
2018;14(3):693–8.
74. Nohynek H, Wichmann O, Dancona F. National 
advisory groups and their role in immunization policy-
making processes in european countries. Clinical 
Microbiology and Infection. 2013;19(12):1096–105.
75. Maltezou HC, Lionis C. The financial crisis and the 
expected effects on vaccinations in Europe: A literature 
review. Infectious Diseases. 2015;47(7):437–46.
76. Moreira M, Castro O, Palmieri M, Efklidou 
S, Castagna S, Hoet B. A ref lection on invasive 
pneumococcal disease and pneumococcal conjugate 
vaccination coverage in children in Southern Europe 
(2009–2016). Human Vaccines and Immunotherapeutics. 
2017;13(6):1242–53.
77. Haverkate M, D’Ancona F, Giambi C, Johansen 
K, Lopalco PL, Cozza V, et al. Mandatory and 
recommended vaccination in the EU, Iceland and 
Norway: Results of the VENICE 2010 survey on the 
ways of implementing national vaccination programmes. 
Eurosurveillance. 2012;17(22):20120531.
78. Perman S, Turner S, Ramsay AI, Baim-Lance 
A, Utley M, Fulop NJ. School-based vaccination 
programmes: a systematic review of the evidence on 
organisation and delivery in high income countries. 
BMC Public Health. 2017;17(1):252.
79. Johansen K, Lopalco PL, Giesecke J. Immunisation 
registers – important for vaccinated individuals, 
vaccinators and public health. Euro Surveill. 2012;17(16).
80. Martin R, Wassilak S, Emiroglu N, Uzicanin 
A, Deshesvoi S, Jankovic D, et al. What will it take 
to achieve measles elimination in the World Health 
Organization European Region: Progress from 2003–
2009 and essential accelerated actions. Journal of 
Infectious Diseases. 2011;204(SUPPL. 1):S325–S34.
81. Ozisik L, Tanriover MD, Rigby S, Unal S. ADVICE 
for a healthier life: Adult Vaccination Campaign 
in Europe. European Journal of Internal Medicine. 
2016;33:14–20.
82. Duval L, Wolff FC, McKee M, Roberts B. 
The Roma vaccination gap: Evidence from twelve 
countries in Central and South-East Europe. Vaccine. 
2016;34(46):5524–30.
83. Szucs TD, Muller D. Influenza vaccination coverage 
rates in five European countries – A population-based 
cross-sectional analysis of two consecutive influenza 
seasons. Vaccine. 2005;23(43):5055–63.
84. Wicker S, Maltezou HC. Vaccine-preventable 
diseases in Europe: Where do we stand? Expert Review 
of Vaccines. 2014;13(8):979–87.
39References
85. Anonymous. Progress toward measles elimination – 
European Region, 2005–2008. Mmwr. 2009;Morbidity 
and mortality weekly report. 58(6):142–5.
86. Anonymous. Progress toward elimination of 
measles and prevention of congenital rubella infection 
– European region, 1990–2004. Mmwr. 2005;Morbidity 
and mortality weekly report. 54(7):175–8.
87. de Hoog MLA, Vesikari T, Giaquinto C, Huppertz 
HI, Martinon-Torres F, Bruijning-Verhagen P. Report 
of the 5th European expert meeting on rotavirus 
vaccination (EEROVAC). Hum Vacc Immunother. 
2018;14(4):1027–34.
88. Villani ER, Colloca G, Valente S, Bernabei R. 
Vaccination among the elderly: European state of art and 
the need for a culture shift. Journal of Gerontology and 
Geriatrics. 2017;65(3):154–60.
89. Holm MV, Blank PR, Szucs TD. Inf luenza 
vaccination coverage rates in Europe – covering five 
consecutive seasons (2001–2006) in five countries. 
Influenza and other respiratory viruses. 2007;1(5–6):215–
21.
90. Schmitt HJ, Booy R, Weil-Olivier C, Van Damme 
P, Cohen R, Peltola H. Child vaccination policies in 
Europe: A report from the summits of independent 
European vaccination experts. Lancet Infectious Diseases. 
2003;3(2):103–8.
91. Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, 
Ferro A, Tridente G, et al. National seasonal influenza 
vaccination survey in Europe, 2008. Euro surveillance 
: bulletin europeen sur les maladies transmissibles = 
European communicable disease bulletin. 2008;13(43).
92. Mereckiene J, Cotter S, Weber JT, Nicoll A, Levy-
Bruhl D, Ferro A, et al. Low coverage of seasonal 
influenza vaccination in the elderly in many European 
countries. Euro surveillance : bulletin europeen sur les 
maladies transmissibles = European communicable 
disease bulletin. 2008;13(41).
93. Muscat M. Who gets measles in Europe? Journal of 
Infectious Diseases. 2011;204(SUPPL. 1):S353–S65.
94. Muscat M, Ben Mamou M, Shefer A, Jankovic D, 
Deshevoy S, Butler R. The State of Measles and Rubella 
in the WHO European region. Revista espanola de salud 
publica. 2015;89(4):345–51.
95. Centers for Disease C, Prevention. Progress toward 
control of rubella and prevention of congenital rubella 
syndrome – worldwide, 2009. Mmwr. 2010;Morbidity 
and mortality weekly report. 59(40):1307–10.
96. Anonymous. Global Measles and Rubella 
Laboratory Network, January 2004–June 2005. 
Mmwr. 2005;Morbidity and mortality weekly report. 
54(43):1100–4.
97. Kroneman M, Paget WJ, van Essen GA. Influenza 
vaccination in Europe: an inventory of strategies to reach 
target populations and optimise vaccination uptake. 
Euro surveillance : bulletin europeen sur les maladies 
transmissibles = European communicable disease bulletin. 
2003;8(6):130–8.
98. Haverkate M, D’Ancona F, Johansen K, Van Der 
Velden K, Giesecke J, Lopalco PL. Assessing vaccination 
coverage in the European Union: Is it still a challenge? 
Expert Review of Vaccines. 2011;10(8):1195–205.
99. Mereckiene J, Nicoll A, Lopalco P, Noori T, Weber 
JT, Dematte L, et al. Seasonal influenza immunisation in 
Europe. Overview of recommendations and vaccination 
coverage for three seasons: Pre-pandemic (2008/09), 
pandemic (2009/10) and post-pandemic (2010/11). 
Eurosurveillance. 2014;19(16).
100. Olssen KG, V, Derrough, T. Immunisation 
information systems in the EU and EEA Results of a 
survey on implementation and system characteristics. 
European Centre for Disease Prevention and Control 
(ECDC); 2017.
101. Valenciano M, Ciancio B, Moren A. First steps in 
the design of a system to monitor vaccine effectiveness 
during seasonal and pandemic influenza in EU/EEA 
Member States. Euro surveillance : bulletin europeen sur 
les maladies transmissibles = European communicable 
disease bulletin. 2008;13(43).
102. Valenciano M, Ciancio BC. I-MOVE: A European 
network to measure the effectiveness of inf luenza 
vaccines. Eurosurveillance. 2012;17(39).
103. Chabanon AL, Bricout H, Ballandras C, Souverain 
A, Caroe TD, Butler KM. Report from enhanced safety 
surveillance of two influenza vaccines (Vaxigrip and 
Intanza 15 mug) in two European countries during 
influenza season 2016/17 and comparison with 2015/16 
season. Human Vaccines and Immunotherapeutics. 
2018;14(2):378–85.
104. Fleming DM, van der Velden J, Paget WJ. 
The evolution of inf luenza surveillance in Europe 
and prospects for the next 10 years. Vaccine. 
2003;21(16):1749–53.
The organization and delivery of vaccination services40
105. Guiso N, Liese J, Plotkin S. The global pertussis 
initiative: Meeting report from the fourth regional 
roundtable meeting, France, April 14–15, 2010 – 
Commentary. Human Vaccines. 2011;7(4).
106. Santibanez S, Mankertz A, Hubschen JM, 
Muller CP, Ben Mamou MC, Muscat M, et al. 
Molecular surveillance of measles and rubella in 
the WHO European Region: new challenges in the 
elimination phase. Clinical Microbiology and Infection. 
2017;23(8):516–23.
107. Williams CJ, Gray J, Pebody RG, Lobanov A. 
Survey of rotavirus surveillance, laboratory capacity and 
disease burden in the eastern part of the WHO European 
Region. Euro surveillance : bulletin europeen sur les 
maladies transmissibles = European communicable 
disease bulletin. 2008;13(34).
108. Williams GA, Bacci S, Shadwick R, Tillmann T, 
Rechel B, Noori T, et al. Measles among migrants in 
the European Union and the European Economic Area. 
Scandinavian journal of public health. 2016;44(1):6–13.
109. Rainey JJ, Watkins M, Ryman TK, Sandhu P, 
Bo A, Banerjee K. Reasons related to non-vaccination 
and under-vaccination of children in low and middle 
income countries: findings from a systematic review 
of the published literature, 1999–2009. Vaccine. 
2011;29(46):8215–21.
110. Brown KF, Kroll JS, Hudson MJ, Ramsay M, Green 
J, Long SJ, et al. Factors underlying parental decisions 
about combination childhood vaccinations including 
MMR: a systematic review. Vaccine. 2010;28(26):4235–
48.
111. Bosch-Capblanch X, Zuske MK, Auer C. Research 
on subgroups is not research on equity attributes: 
Evidence from an overview of systematic reviews on 
vaccination. Int J Equity Health. 2017;16(1):95.
112. Lorini C, Santomauro F, Donzellini M, Capecchi 
L, Bechini A, Boccalini S, et al. Health literacy 
and vaccination: A systematic review. Hum Vaccin 
Immunother. 2018;14(2):478–88.
113. Jarrett C, Wilson R, O’Leary M, Eckersberger E, 
Larson HJ, Hesitancy SWGoV. Strategies for addressing 
vaccine hesitancy – A systematic review. Vaccine. 
2015;33(34):4180–90.
114. Das JK, Salam RA, Arshad A, Lassi ZS, Bhutta ZA. 
Systematic Review and Meta-Analysis of Interventions 
to Improve Access and Coverage of Adolescent 
Immunizations. J Adolesc Health. 2016;59(4S):S40–S8.
115. Dube E, Gagnon D, MacDonald NE, Hesitancy 
SWGoV. Strategies intended to address vaccine hesitancy: 
Review of published reviews. Vaccine. 2015;33(34):4191–
203.
116. Burchett HE, Mounier-Jack S, Torres-Rueda 
S, Griffiths UK, Ongolo-Zogo P, Rulisa S, et al. The 
impact of introducing new vaccines on the health system: 
case studies from six low- and middle-income countries. 
Vaccine. 2014;32(48):6505–12.
117. Ozawa S, Paina L, Qiu M. Exploring pathways for 
building trust in vaccination and strengthening health 
system resilience. BMC Health Serv Res. 2016;16(Suppl 
7):639.
118. Wigle J, Coast E, Watson-Jones D. Human 
papillomavirus (HPV) vaccine implementation in low 
and middle-income countries (LMICs): health system 
experiences and prospects. Vaccine. 2013;31(37):3811–7.
119. Travis P, Bennett S, Haines A, Pang T, Bhutta Z, 
Hyder AA, et al. Overcoming health-systems constraints 
to achieve the Millennium Development Goals. Lancet. 
2004;364(9437):900–6.
120. Prof Alistair McGuire, Professor Mike Drummond, 
Sam Keeping. Childhood & Adolescent Inf luenza 
Vaccination in Europe: A Review of the Evidence. 
London; 2015.
121. McGuire A, Drummond M, Keeping S. Childhood 
and adolescent influenza vaccination in Europe: A review 
of current policies and recommendations for the future. 
Expert Review of Vaccines. 2016;15(5):659–70. 
122. Expert Panel on Effective Ways of Investing in 
Health. Vaccination Programmes and Health Systems in 
the European Union. Brussels: European Commission, 
2018.
Appendix
Country fiches

Austria
Katharina Habimana
Governance
In Austria the Federal Ministry of Labour, Social Affairs, 
Health and Consumer Protection (Bundesministerium 
für Arbeit, Soziales, Gesundheit und Konsumentenschutz, 
BMASGK) is responsible for procurement of vaccines 
in the national vaccination programme. In close collab-
oration with the National Vaccination Board (Nationales 
Impfgremium)1 and based on its scientific advice, the 
Federal Ministry of Labour, Social Affairs, Health and 
Consumer Protection annually issues national recom-
mendations for vaccinations (BMASGK, 2018a), which 
include information on available and recommended vac-
cinations and are designed mainly for doctors, phar-
macists and health professionals. The Austrian recom-
mendations are developed and published at the national 
level. At the regional level, counselling and vaccination 
centres2 are in place, which carry out vaccinations, pro-
vide information on vaccinations and also advise other 
providers. Vaccinations in Austria are voluntary, and 
population registries do not serve as a basis for vaccina-
tion programmes. However, selected infectious diseases 
such as measles have to be reported to a national registry 
(Epidemiologisches Meldesystem) to ensure containment of 
the disease (BMASGK, 2018b).
1 The NIG consists of national experts, For more information 
please refer to: https://www.bmgf.gv.at/home/Gesundheit/
Gesundheitsfoerderung_Praevention/Impfen/Expertinnen_
und_Experten_des_Nationalen_Impfgremiums.
2 For more information on the regional counselling and 
vaccination centres please refer to: https://www.gesundheit.
gv.at/service/beratungsstellen/impfen.
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measles in refugee homes) and persons working in refugee 
care (BMASGK, 2018c).
About 5–15% of the population in Austria are infected 
with influenza each year and many of them suffer from 
the disease. Vaccinations against influenza are not cov-
ered by the free national immunization programme but 
are recommended in Austria for all children (starting 
from the age of six months) and all adults. A special rec-
ommendation is in place for several groups at high risk, 
e.g. health workers, persons above the age of 50 years or 
persons affected by chronic disease. Vaccinations are not 
documented in a central register in Austria. Therefore, 
there are no detailed data available on the number of 
administered vaccines or vaccination coverage rates. 
Data from the pharmaceutical industry (the Austrian 
Association of Vaccine Manufacturers, ÖVIH) indicate 
that the vaccination coverage rate against seasonal influ-
enza is below 10%. The influenza situation in Austria is 
monitored by an Influenza Surveillance System. These 
data are reported to the European Surveillance System 
operated by the European Centre for Disease Prevention 
and Control (ECDC) (AGES, 2018).
Provision
Provider organizations and professionals involved in 
administering childhood vaccinations against measles 
in Austria include:
• Physicians. Only physicians can prescribe 
vaccinations.
• The national immunization programme is imple-
mented by the nine federal states and organized 
differently at the federal state level, involving 
mainly paediatricians, general practitioners and 
public health officers.
• The national immunization programme is also 
implemented in schools, involving public health 
officers, school physicians, paediatricians and gen-
eral practitioners.
• There are also ambulances and vaccination centres 
that administer MMR vaccines.
According to the national recommendations, the first dose 
of the MMR-vaccine should be administered at the age of 
9 months, followed by a second dose three months later. 
Several of the vaccinations included in the national vac-
cination plan are provided free of charge for children 
under the age of 15 years, in line with the free national 
immunization programme. This programme covers dis-
eases occurring very frequently, as well as more rare but 
severe diseases (BMGF, 2017a). The following vaccines 
are included in the national immunization programme for 
children at defined age groups: vaccines against measles, 
mumps and rubella (MMR), diphtheria, Haemophilus 
influenza type B, hepatitis B, human papillomavirus 
(HPV), meningococci of groups A, C, W135 and Y 
(MEC-4), pertussis, pneumococcal, poliomyelitis, rota-
virus and tetanus (BMASGK, 2018a).
In the context of the global measles and rubella elimi-
nation programme of the World Health Organization 
(WHO), vaccinations against measles (as part of the 
combined vaccination against MMR) are free of charge 
for all persons above the age of 9 months (BMASGK, 
2018a). However, between 2012 and 2014 the vaccine 
was available free of charge until the age of 45 years only. 
Since 2014 there have been no upper age limits for the 
free measles vaccine any more. In 2014 the then Ministry 
of Health initiated a public awareness campaign (keine-
masern.at), which was described by outside observers as 
creative and innovative, seeking to encourage vaccination 
among both infants and unimmunized adults (WHO, 
2016). However, in 2015 Austria still had the second 
highest rate of measles cases per one million inhabitants 
(35.3) in the EU (ECDC, 2016).
In 2016 measles vaccination rates were analysed in 
depth using a population-based mathematical model 
at the national level (BMGF, 2016). According to the 
results of these calculations, in 2015, in children aged 
between 2 and 5 years, measles vaccination coverage 
rates for the first dose reached 92% and were about 
10% lower for the second dose. In particular, children 
born between 2008 and 2010 and young adults born 
in the 1990s had lower immunization rates. It was esti-
mated that about half a million persons aged between 
15 and 30 years were not protected against measles. 
Measles incidence stood at 10.4 cases per one million 
population in 2017.
In addition to the awareness campaign, the Federal 
Ministry of Labour, Social Affairs, Health and Consumer 
Protection provides a national action plan on MMR-
elimination, information leaflets in German, English, 
Arabic, Turkish, Croatian and Slovak, and recommen-
dations for refugees (high priority to immunize against 
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measles and influenza. All vaccinations in Austria are vol-
untary and authorities are often limited to making recom-
mendations. Scepticism about vaccinations in Austria has 
some sort of “tradition” and is often based on “personal 
philosophy or groundless fears about side effects […] and, 
there are even quite a number of health workers who are 
anti-vaccine” (WHO, 2016). There are also vaccination 
critics strongly opposing vaccinations.
Regarding childhood vaccinations against measles, 
sometimes parents of young children are not aware of the 
importance of having their children vaccinated. However, 
vaccine hesitancy also seems to play a role. In young adults 
it can be assumed that many of them are simply not aware 
of the fact that they are not protected against measles. 
This is why authorities initiated a broad awareness-raising 
campaign on measles in 2014, promoting free-of-charge 
vaccinations for all age groups. To further reduce vaccine 
hesitancy, the annual European Immunization Week cam-
paign is used to raise awareness (Kreidl & de Kat, 2017). 
Having the MMR-vaccine free of charge in Austria and 
strongly recommending it in the national recommendations 
are two key facilitators of its uptake. Paediatricians who are 
close to the patients and participate in the programme are 
another crucial element for achieving effective vaccination 
coverage rates among children in Austria.
Coverage of adult vaccinations against influenza in 
Austria is low, mainly due to lack of awareness and vac-
cine hesitancy. Kunze & Kunze (2015) further suggest 
the “most extensive recommendations for influenza vaccina-
tion worldwide” are not adequately implemented due to 
“ignorance, lack of social marketing and the predominance 
of a distinct discordance within the health system in general, 
and the Austrian medical fraternity in particular”. Kunze, 
Böhm & Groman (2013) even describe Austria as a coun-
try that is “resistant to influenza vaccination”, as the impact 
of influenza on public health seems to be misjudged 
by the population and even the opinion of health care 
workers is divided. Furthermore, there is no vaccination 
reminder system for adults in place.
Even where contributions by employers or social health 
insurance funds reduce the costs of vaccinations against 
influenza, the remaining financial barriers, with patients 
generally having to pay for the vaccination out of pocket, 
can reduce access (Hoffmann et al., 2016). Hoffmann et 
al. (2016) also suggest involving and incentivizing general 
practitioners to support vaccinations against influenza, as 
they are often more trusted by the patients than the media 
or the internet.
When the first vaccination is carried out at the age of one 
year or later, the second dose should be administered in 
an interval of at least four weeks, but as soon as possible 
(BMASGK, 2018a).
Provider organizations and professionals involved in 
administering vaccinations against influenza in Austria 
include:
• Primary health care providers, such as general prac-
titioners, paediatricians, occupational health physi-
cians, public health officers, and internists, as well 
as regional and local counselling and vaccination 
centres. In some provinces, outpatient clinics may 
also provide vaccinations against influenza or pro-
vide vaccinations bought by patients at pharmacies.
Relevant professional standards and guidelines are detailed 
in the national recommendations, as different types of 
vaccines against influenza should be chosen according to 
different age or risk groups.
Financing
Childhood vaccinations against measles are free of 
charge in Austria. Patients do not need to cover any costs 
at the point of delivery. Vaccinations provided in the 
national immunization programme are covered by the 
federal government (two thirds) and by provinces and 
social health insurance funds (one sixth each). Vaccines 
in the national immunization programme, including 
vaccines against MMR, are procured by tenders covering 
several years.
Vaccinations against influenza are not publicly covered 
and have to be paid by patients out of pocket. Influenza 
vaccines are only available on prescription, and doctors 
carrying out the vaccination charge a fee. Social health 
insurance funds may promote influenza vaccinations by 
covering part of the costs, such as in annual promo-
tion periods when vaccines are available in pharmacies 
at a reduced price. Some employers and health insurance 
funds also cover the costs for the vaccinations, such as 
employers of health care workers (BMASGK, 2018a).
Key barriers and facilitators
The current epidemiological situation in Austria points 
to the need for a higher immunization coverage for both 
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Governance
Vaccine governance and agencies involved
Belgium’s vaccination programmes are organized at the 
subnational level. Indeed, disease prevention in health 
care, and hence immunization policy, is a duty and 
responsibility of the Communities and the Regions. These 
authorities are responsible for vaccine strategy including 
vaccine schedule, public tenders for choice of vaccine, 
vaccine promotion (including awareness campaigns), 
cost evaluations, vaccine coverage assessment, etc. As a 
result, the vaccination programmes differ slightly between 
Belgium’s Communities (see Figures 1 and 2).
For the Flemish-speaking community (in Flanders and 
Brussels) the Agency for Care and Health (Agentschap 
Zorg en Gezondheid1) is responsible for vaccine policy and 
a subnational vaccination plan is available online.2 The 
plan covers various topics including communication to 
the population, training of health care workers, vaccine 
1 https://www.zorg-en-gezondheid.be/
2 https://www.zorg-en-gezondheid.be/vlaams-actieplan-
vaccinaties-2012-2020
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strongly advised based on the individual responsibility for 
community health.
At the national level the Superior Health Council (SHC) 
permanent vaccine working-group (Belgium’s National 
Immunization Technical Advisory Group, NITAG)8 of 
the Federal Public Service (FPS) of Health, Food Chain 
Safety and Environment9 provides independent scientific 
advice on vaccinations and formulates recommendations. 
These recommendations serve as a basis for the vaccina-
tion programmes set up by the three Belgian regions.
In addition to the basic vaccination schedule for children, 
which includes vaccination against measles, Superior 
Health Council recommendations are available for preg-
nant woman (e.g. pertussis), adolescents and adults (e.g. 
booster vaccines), older people (e.g. yearly flu vaccina-
tions) and other specific risk groups (e.g. immunocom-
promised), as found on their website.10 These recommen-
dations and further documentation on vaccination are 
also available on the community websites11 and several 
others like SSMG/Domus Medica.
The vaccine schedule for measles vaccination and the 
target populations for influenza vaccination are the same 
across the country. Considering influenza, the groups at 
risk for whom vaccination is strongly recommended are 
pregnant women, people aged 65 years and more, health 
care workers, and those with an underlying risk or mor-
bidity aged 6 months and older. There is an additional 
recommendation for those aged 50–65 years because of a 
higher risk of hospitalization after contracting influenza.12
Targeted measures
For children of refugees and asylum-seekers under the age of 
5 months, vaccination must be carried out according to the 
basic vaccination calendar recommended in Belgium. From 
the age of 5 months, vaccination follows the principles of 
catch-up vaccinations for which specific recommendations 
are available.13 Asylum-seekers are offered a first vaccina-
8 https://www.health.belgium.be/en/superior-health-council
9 https://www.health.belgium.be/en/health
10 https://www.health.belgium.be/fr/vaccination
11 http://www.vaccination-info.be/; https://www.zorg-en-
gezondheid.be/infectieziekten-en-vaccinatie; http://www.
ostbelgienlive.be/desktopdefault.aspx/tabid-420
12 https://www.health.belgium.be/nl/advies-9488-vaccinatie-
griep#article
13 https://www.health.belgium.be/fr/avis-9111-vaccination-de-
rattrapage-fiche
schedules for children and adults, registry for vaccine 
administration, etc. In the French-speaking community 
(in Wallonia and Brussels) the responsibilities regard-
ing vaccine policy are shared between several agencies 
(ONE3; COCOF4; AviQ5) based on location and/or pop-
ulation age-group. The German-speaking community 
(Deutschsprachige Gemeinschaft) is responsible for its own 
vaccine programme, but uses the French-speaking com-
munity platform (e.g. for public tenders).
In addition, Belgium’s federal authorities remain the 
competent authority for specific components of vaccine 
governance. Polio vaccination, for example, falls within 
the federal jurisdiction, as the mandatory vaccination of 
infants against polio (see next section) is based upon fed-
eral legislation.6 Being responsible for foreign affairs and 
national health, the federal authorities are also the com-
petent authority for Belgium’s international commitments 
such as the ‘Measles & Rubella WHO elimination global 
strategic plan’, in cooperation with the subnational level.
Recommendations, mandatory vaccination, 
incentives, sanctions
In Belgium only vaccination against polio is mandatory 
by law. Vaccination against poliomyelitis was first recom-
mended in Belgium in 1958 and became implemented as 
mandatory in 1967 under the Royal decree of 26 October 
1966. In case of non-immunization against polio, the par-
ents or guardian of the child concerned can be prosecuted 
by the Federal health inspector.
In the French community vaccination against poliomyeli-
tis, diphtheria, whooping cough, Haemophilus influenzae 
type b, measles, rubella and mumps are mandatory in 
order for children to attend a public childcare centre, 
whilst vaccination against pneumococcal disease, menin-
gococcal disease type C and hepatitis B are strongly rec-
ommended.7 By contrast, in the Flemish community 
there is no legal obligation for vaccination in order for 
children to attend a childcare centre, although vaccination 
following the Flemish Community Vaccine Calendar is 
3 http://www.one.be/
4 http://be.brussels/a-propos-de-la-region/les-institutions-
communautaires-a-bruxelles/cocof
5 https://www.aviq.be/
6 Royal decree of 26 October 1966: http://www.ejustice.just.
fgov.be/doc/rech_f.htm
7 Article 31 of the French Government’s Decree of 27 February 
2003: http://www.ejustice.just.fgov.be/doc/rech_f.htm
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The organization and provision of vacci-
nation services
Childhood vaccination against measles
Provision of infant immunization services (including 
first dose of MMR at 12 months) is mainly undertaken 
by Well-Baby Clinics (Coordinators: Kind en Gezin for 
the Flemish-speaking community, ONE for the French-
speaking community, Kaleido-Ostbelgien for the German-
speaking community). There is a large number of such 
consultation rooms all over Belgium which facilitates 
access. General practitioners, paediatricians and hospital-
based physicians cover the remaining part of infant 
immunization.
Vaccines for school children (including the second dose of 
MMR at 11–12 years) are offered through school health 
services, general practitioners and paediatricians.
Adult vaccination against influenza
For adult immunizations, the general practitioner is usually 
the key vaccinator. This is particularly the case for adult 
influenza vaccination. In homes for older people, often the 
responsible medical doctor will take care of the influenza 
vaccination programme. Chronic disease patients (lung, 
renal or cardiac insufficiency, haematological patients, 
people living with HIV, etc.) may also be vaccinated by 
their treating specialist. Occupational medicine services are 
vaccinators for exposed professionals, including influenza 
vaccination of health care workers. In addition, since April 
2016 nurses have been allowed to administer physician-
prescribed vaccines without the presence of a doctor.
Financing
Childhood vaccination against measles
All vaccines, including MMR, that are included in the 
basic vaccination schedule for children, with the excep-
tion of rotavirus vaccine16, are provided free of charge, 
being fully covered by the respective Communities. 
Manufacturers have to follow a public tender procedure 
set up by the respective Communities on average every 
three to four years.
16 Partial reimbursement by the national health insurance
tion when applying for asylum, and further vaccinations 
are given at reception facilities (coordinated by Fedasil) 
or at well-baby clinics (for children under 6 years of age). 
Vaccinations offered include polio (depending of country 
of origin), tetanus, diphtheria, whooping cough, measles, 
mumps, rubella and influenza (depending on season 
and a person’s risk factors). In the Flemish Community 
a mobile vaccination team started a few years ago with 
catch-up immunization plans in schools without school 
health services, and in populations with lower vaccination 
coverage (e.g. Roma communities).
Vaccination coverage
Two main population registries on vaccine status exist: 
Vaccinnet14 (Flemish Community based) and E-Vax15 
(French Community and German Community based). 
These are automatic ordering systems used by doctors that 
also collect information on vaccine administration. In 
Flanders, for example, all vaccinations with free-of-charge 
vaccines should be registered in the database. Although 
the aim is the exhaustive recording of vaccinations, these 
population registries are currently incomplete, particu-
larly for adults and for the French-speaking community, 
for which recordings are essentially completed by school 
health services. Hence, for estimating vaccination cov-
erage, regular vaccination coverage studies are set up, 
using the cluster sampling method. These studies are 
conducted for the three regions by the Communities 
almost every three to four years, from which national 
weighted averages are estimated. According to the most 
recent surveys, vaccination coverage for the first dose of 
MMR (measles, mumps, rubella) is 95.6% in Wallonia, 
94.1% in Brussels and 96.2% in Flanders (Vermeulen et 
al., 2017; Robert E, Swennen B & Provac-ULB - École 
de Santé Publique, 2015). Coverage of the MMR second 
dose is 93.4% in Flanders and 78.0% for Wallonia and 
Brussels. Vaccination coverage for two documented doses 
of MMR is 87.4% in Flanders and 75.0% in Wallonia 
and Brussels (Vermeulen et al., 2017; Grammens et al., 
2016). For influenza, vaccination coverage is based on 
surveys in specific risk groups (40–50% in health care 
workers (Vermeulen et al., 2017) and pregnant women 
(Maertens et al., 2016), or in the over 15 years old cat-
egory by the Health Interview Survey (e.g. 60–70% in 
people aged 65 years and over (Gezondheidsenquete, 
2013).
14 www.vaccinnet.be
15 https://www.e-vax.be
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80% in Wallonia and Brussels. The lower vaccination cov-
erage in Wallonia and Brussels is related to various factors, 
such as vaccine hesitancy and commodity issues (e.g. paren-
tal authorization not available), lower catch-up modalities 
(e.g. no mobile team available), higher rate of vaccinations 
in private practices, and lower use of vaccination in public 
health services. Moreover, the vaccination coverage for the 
second MMR dose is probably underestimated in these two 
regions, being estimated from school-based surveys that 
do not take into account all the vaccinations performed by 
paediatricians or general practitioners. In Flanders popu-
lation groups that are difficult to access, such as the Roma 
population and Jewish children in private Jewish schools 
(Asnong et al., 2011), are approached through a mobile 
vaccination team, so that these groups of the population 
are offered vaccines (e.g. measles catch-up vaccination) in 
a tailored way. With the increased number of measles cases 
in Europe, since September 2018 in Flanders the vaccines 
from the public tender (free or charged) may be used for 
catch-up vaccination in adults.
It remains very difficult to improve vaccination coverage 
against influenza, in particular among health care work-
ers. Barriers include misinformation and misperceptions 
on influenza and influenza vaccination among this group, 
and a lack of awareness about the role health profes-
sionals may play in disease transmission. The weak vac-
cine effectiveness is probably also playing a role. General 
vaccine campaigns to inform and increase awareness 
(brochures, press-releases, etc) are organized by all three 
Communities. In Flanders a campaign is running to 
improve influenza vaccination in health care workers, 
especially in hospitals and nursing homes.18
Although population registries of administered vaccines 
exist, recording vaccine administration is not obligatory 
for all vaccines and is particularly incomplete for adults 
and the French-speaking community as mentioned above. 
These registries could, however, become an excellent tool 
to collect data on vaccines administered and real-time 
vaccination coverage. At the same time, pockets of under-
vaccination can be identified by the Communities and 
physicians, so that more specific actions can be taken.
Finally, most physicians are exposed during their medical 
education to a teaching module on vaccinology, although 
more efforts are needed to extend this training to all uni-
versities and nursing schools.
18 http://www.laatjevaccineren.be/campagnes
For vaccinations of infants against measles, the services 
provided by Well-Baby Clinics and school health services 
are also free of charge. Vaccinations provided to infants 
or children by general practitioners and paediatricians 
operate through a fee-for-service system (vaccines are free 
of charge, but a consultation fee has to be paid).
Adult vaccination against influenza
For healthy adults over 65 years of age, pregnant women 
and at-risk population groups, influenza vaccines are 
partially reimbursed by the National Health Insurance 
(INAMI/RIZIV), as are the medical consultations. 
In Flanders all residents at elderly nursing homes and 
institutions for disabled people and chronic psychiatric 
patients are offered influenza vaccination free of charge.
Certain vaccines indicated for professional risks and 
offered by occupational medicine services are reimbursed 
by the Federal Agency for Occupational Risks (Fedris). 
These include hepatitis A, hepatitis B, and yellow fever 
vaccines, but not influenza vaccines.
The vaccines used for the vaccination of asylum seekers 
in Belgium (including measles and influenza vaccines as 
aforementioned) at entry are provided by the Flemish 
Community, and reimbursed by the federal authorities.17 
Once asylum-seekers are appointed to an asylum centre, 
vaccination is supported by the regional vaccination ser-
vices, as for the general population.
Key barriers and facilitators
As mentioned above, the coverage rate for the first dose 
of MMR is close to or above 95% according to the most 
recent vaccination coverage studies. One main reason for 
this high coverage rate is the organization of MMR vacci-
nation through public health services and primary health 
care providers, as well as paediatricians. These services are 
easily accessible, geographically well distributed across the 
country and mostly free of charge. In addition, the teams 
in Well-Baby Clinics and school health services are well 
trained and receive regular scientific and practical training.
The vaccination uptake for the second MMR dose is, how-
ever, still below 95% in the three regions, and lower than 
17 https://www.zorg-en-gezondheid.be/vaccinatie-vluchtelingen-
vanaf-nu-bij-aankomst-in-belgi%C3%AB
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Figure 1: Immunisation schedule in the Flemish community
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Figure 1 Immunization schedule in the Flemish community
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Bulgaria
Maria Rohova
Governance
The Health Act (2004) regulates general principles for 
the control of communicable diseases and epidemic out-
breaks, including immunizations. The Minister of Health 
determines by ordinance who is subject to immunizations 
(mainly in terms of age or risk groups), as well as the 
methods and the terms for carrying out vaccinations.
The Ministry of Health is responsible for developing 
vaccination plans and programmes and overseeing imple-
mentation at the national level. An Expert Advisory 
Council on Surveillance of Immunoprophylaxis is estab-
lished under the Minister of Health, and functions as a 
consultative body on the planning and implementation 
of vaccination programmes. The immunization policy is 
a part of the state health policy and is carried out by the 
Ministry of Health. The Ministry also coordinates the 
activities of other institutions involved.
The 28 Regional Health Inspectorates, which represent 
the Ministry of Health in every district of the country, are 
responsible for the organization of vaccination plans and 
programmes at the regional level. Their functions include 
supervising vaccination activities in their respective dis-
tricts, planning mandatory and targeted immunization 
for the next year (number of persons to be vaccinated), 
and providing information on vaccination coverage, etc. 
The National Centre of Public Health and Analysis sum-
marizes the Regional Health Inspectorates’ reports on the 
number of performed vaccinations and provides informa-
tion for the whole country to the Ministry of Health and 
the National Centre of Infectious and Parasitic Diseases. 
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sanctioned in this way rather than having their children 
vaccinated. Information about immunizations is availa-
ble on the Ministry of Health website, and many other 
agencies and nongovernmental organizations provide 
such information as well. In 2017 several nongovernmen-
tal organizations together with the Ministry of Health 
started an awareness campaign in response to growing 
anti-vaccination movements. Every year the media pro-
vide information about influenza, risk groups and recom-
mended vaccinations.
In emergency epidemic situations, or where there are sig-
nificant declines in immunization coverage, the Minister 
of Health can order additional mandatory vaccination 
and revaccination against measles (outside those planned 
in the Immunization Calendar) for specific groups, as well 
as organizing immunization campaigns, on-site immu-
nizations, and temporary immunization points, etc. For 
recommended vaccinations (such as influenza) there are 
only information campaigns. In addition, general prac-
titioners should inform risk groups about vaccination 
against influenza.
For mandatory immunizations, vaccination coverage is 
measured by administrative reports (e.g. reports of per-
formed vaccinations by general practitioners and other 
providers). The registers of infants and children sub-
ject to mandatory vaccination against measles (at the 
required age) are used as the denominator in calculat-
ing the vaccination coverage rate. The Regional Health 
Inspectorates maintain these registers at the regional level. 
At the national level the vaccination coverage rate is 
analysed annually by the National Centre of Infectious 
and Parasitic Diseases. However, not all the performed 
vaccinations against influenza are fully recorded by health 
facilities. Moreover, there are no specific requirements 
on reporting vaccinations against influenza by age or risk 
groups. Thus, vaccination coverage estimates are often 
inaccurate, or data are insufficient for calculating cov-
erage rates (National Centre of Infectious and Parasitic 
Diseases, 2017).
Provision
General practitioners provide vaccination against measles 
for all children enrolled on their lists. For children not 
registered with a general practitioner, mandatory vaccina-
tions can be provided by health professionals in so-called 
immunization offices established by the 28 Regional 
Health Inspectorates. Exceptionally, vaccination can also 
The latter prepares annual analyses of immunoprophylaxis 
in Bulgaria for the Ministry of Health.
According to the Health Act, there are three types of 
immunization in Bulgaria: mandatory, targeted and rec-
ommended. All kinds of vaccination (whether mandatory, 
targeted or recommended) are specified in the ordinance 
mentioned above. Mandatory planned immunizations 
and re-immunizations are scheduled by age group in the 
Bulgarian Immunization Calendar, as regulated by the 
Ministry of Health. Some of the non-mandatory vac-
cinations recommended by the Ministry of Health for 
specific high-risk populations are included in national 
programmes for prophylaxis and prevention (such as 
vaccines against rotavirus and human papillomavirus).
Vaccination against measles is mandatory for children, 
in accordance with the Bulgarian Immunization Calendar. 
Vaccinations are performed as a combined vaccine against 
measles, mumps and rubella (MMR), with two doses, 
the first for infants over 13 months and the second for 
children aged 12. Vaccination against influenza is rec-
ommended for several target groups (older people, people 
with certain chronic conditions, and certain employees 
such as medical personnel, etc.). Participation in this 
vaccination is voluntary.
General practitioners maintain registers of children 
(enrolled on their lists) who are subject to mandatory 
planned vaccinations against measles. They are obliged 
to record all the immunizations performed. The general 
practitioners notify the parents about upcoming immu-
nizations in the Calendar. Regional Health Inspectorates 
summarize the information from general practitioners’ 
registers at the regional level and monitor the uptake of 
vaccines in their respective districts. Planning mandatory 
immunizations for the next year, based on general practi-
tioners’ annual plans and population registers maintained 
by the National Statistical Institute, is also the respon-
sibility of the Regional Health Inspectorates. However, 
this is not the case for recommended vaccinations against 
influenza – all health care establishments should only 
report the number of immunizations performed to the 
Regional Health Inspectorates.
Participation in vaccinations against measles is manda-
tory for all children. There are sanctions for parents who 
refuse to have their children vaccinated, as regulated 
by the Health Act. Unvaccinated children cannot go to 
kindergarten, and the parents must pay fines. However, 
the fines are not very high and some parents prefer to be 
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infection. In 2009 an outbreak of measles was detected, 
following an eight-year period without any indigenous 
measles transmission. In 2017 several cases of measles 
were identified among the Roma community living in 
the second largest city in Bulgaria. In recent years vac-
cination rates have been falling because of both growing 
anti-vaccination movements among parents and nega-
tive perceptions among vulnerable groups of individu-
als. According to the National Centre of Infectious and 
Parasitic Diseases (2017), there is currently a real risk of 
an outbreak of measles and rubella, especially among the 
Roma community and migrants.
The low uptake of influenza immunization is a result of 
popular underestimation of the severity of the disease and 
its complications in Bulgaria. Out-of-pocket payments 
and the low health literacy of some patients (especially 
risk groups) are key barriers to effective coverage.
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be delivered through other health care establishments 
or medical offices in schools, kindergartens and social 
institutions for children, but only under the supervision 
of the relevant Regional Health Inspectorate. Generally, 
professional standards and guidelines for mandatory vac-
cinations (medical contraindications, for instance) are 
regulated by the ordinance on immunizations; further-
more, the Regional Health Inspectorates provide consul-
tations and expertise in the field of immunoprophylaxis 
in specific cases.
Adult vaccinations against influenza can be provided by 
health care establishments (primary or specialist health 
care providers) and by immunization offices under the 
Regional Health Inspectorates. Such vaccinations can 
be requested by patients and the patients choose the 
provider.
All health care providers involved in vaccination are 
accountable to the relevant Regional Health Inspectorate.
Financing
All children in Bulgaria are entitled to free access to man-
datory immunization programmes (including vaccination 
against measles). Vaccines are paid for by the Ministry of 
Health and vaccination services provided by general prac-
titioners are covered by social health insurance. Services 
provided in immunization offices under the Regional 
Health Inspectorates are also free of charge for children. 
All children in Bulgaria are insured and contributions for 
them are paid from the state budget.
Adult vaccinations against influenza are paid for by the 
patients. Although vaccines and vaccination services are 
not expensive, out-of-pocket payments create barriers to 
access for some risk groups, such as older people with 
low incomes.
Key barriers and facilitators
Bulgaria has a long tradition of childhood vaccination 
against measles and a well-established system for man-
datory immunization regulated by several legislative acts. 
Moreover, vaccination is covered entirely from public 
sources without financial barriers to access for patients. 
Despite these positive factors, which could be consid-
ered facilitators for effective coverage, there are groups 
of vulnerable individuals who are still susceptible to 

Croatia
Aleksandar Džakula
Governance
In Croatia childhood vaccination is mandatory. For years 
vaccination coverage for all the vaccines in the immuni-
zation programme was very high, over 95%, but in the 
last few years there has been a decrease of coverage in the 
whole country, and in some counties coverage is very low. 
This situation is of major concern, particularly in regard 
to measles outbreaks in Europe. The Ministry of Health, 
together with the public health institutes, is continuously 
working to increase vaccination coverage.
Information about the type of mandatory vaccinations 
for different age groups is set out in the immunization 
programme (Figure 1).
The vaccination of pre-school and school-aged children, 
travellers, sailors, health workers and others is regulated 
under the Law on the Protection of the Population 
against Communicable Diseases and the Ordinance 
on the Method of Implementation of Immunization, 
Seroprophylaxis and Chemoprophylaxis against Infectious 
Diseases. In an emergency, the Law states that the 
Ministry of Health, upon a proposal from the Croatian 
Institute of Public Health, declares an infectious disease 
epidemic, or a danger of an infectious disease epidemic, 
and determines an infected or endangered area.
There are three categories of vaccine: mandatory (for 
example, vaccination against measles), recommended 
(for example, influenza vaccination for older people) and 
additional (for example, vaccination against hepatitis A 
for travellers).
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the Croatian Institute of Public Health. The main body 
responsible for implementation of the mandatory vac-
cination programme and its monitoring, as defined by 
laws and regulations at the national level, is the Croatian 
Institute of Public Health. The Institute receives man-
datory vaccination reports from family doctors, primary 
care paediatricians and the school medical service that 
are collected by the County Public Health Institutes 
(Croatian Institute of Public Health, 2018). The annual 
review report is regularly published in the Croatian 
Health Statistical Yearbook of the Croatian Institute of 
Public Health.
The Agency for Medicinal Products and Medical 
Devices (HALMED) is a stakeholder which actively 
The national level mandatory vaccination programme is 
the most important and most successful preventive health 
programme in the country. The local County Public 
Health Institutes are responsible for its implementation 
and monitoring. The Croatian state plays a significant role 
in the protection of its citizens, and the Croatian Institute 
of Public Health, using the population register, is respon-
sible for monitoring and controlling the vaccination rate 
among children and adults. Vaccination coverage shows 
the percentage of the population or of a specific age or 
risk group who have received a particular vaccination 
(www.hzjz.hr).
Each year the Ministry of Health announces the immu-
nization programme, based on the recommendations of 
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Figure 1: Vaccination calendar for 2018i re 1 Immunizati programme for 2018
1  Infants born from HBsAg-positive mothers are vaccinated right after birth,  
using immunoglobulin according to the post-exposure scheme
2 only for children who have missed re-vaccination according to previous programmes
3 diphtheria, tetanus, pertussis 
4 measles, mumps, rubella
*  Check the number of vaccinations and provide missed vaccinations, if necessary
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Vaccination coverage
The 2017 report on the vaccination programme suggests 
that vaccination coverage has declined since 2012, with 
large variations in vaccination coverage across counties. 
Table 1 shows the vaccine coverage for measles, mumps 
and rubella (MMR) according to primary vaccination and 
revaccination by county.
Provision
Primary care doctors (family doctors and primary care 
paediatricians) and the school medical service (a service 
within County Public Health Institutes) carry out the 
mandatory vaccination programme for school-aged chil-
dren. Family doctors or County Public Health Institutes 
contributes to the protection and promotion of public 
health through the regulation of medicines and vaccines 
by monitoring their quality, effectiveness and safety on 
the Croatian market. In coordination with the Croatian 
Institute of Public Health, HALMED also monitors the 
side-effects of medicines/vaccines and the side-effects 
reported in clinical trials. After the United Kingdom 
and the Netherlands, Croatia was the third country 
in the European Union to start using a mobile appli-
cation for reporting suspected adverse drug reactions 
(HALMED, 2016). Once approved by HALMED, the 
Croatian Institute of Public Health assesses the quantity 
of vaccines required and distributes them to the County 
Public Health Institutes, which then distribute them 
further to the primary care doctors (family doctors, 
primary care paediatricians and school and adolescent 
medicine doctors).
Table 1 MMR vaccination by county, Croatia, 2017
Primary vaccination Revaccination
County Scheduled Vaccinated % Scheduled Vaccinated %
Bjelovarsko-bilogorska 1 010 974 96.44 1 076 1 038 96.47
Koprivničko-križevačka 1 011 993 98.22 1 074 1 051 97.86
Karlovačka 996 956 95.98 1 034 1 027 99.32
Ličko-senjska 308 257 83.44 391 380 97.19
Osječko-baranjska 2 520 2 191 86.94 2 364 2 221 93.95
Virovitičko-podravska 700 674 96.29 861 842 97.79
Brodsko-posavska 619 593 95.8 629 621 98.73
Požeško-slavonska 1 216 1 171 96.3 1 298 1 270 97.84
Vukovarsko-srijemska 1 442 1 366 94.73 1 513 1 463 96.7
Istarska 1 642 1 445 88 1 920 1 756 91.46
Primorsko-goranska 2 636 2 110 80.05 2 604 2 499 95.97
Sisačko-moslavačka 1 317 1 268 96.28 1 324 1 290 97.43
Zadarska 1 695 1 485 87.61 1 642 1 566 95.37
Splitsko-dalmatinska 5 237 4 110 78.48 4 739 4 414 93.14
Dubrovačko-neretvanska 1 268 708 55.84 1 283 1 060 82.62
Šibensko-kninska 882 826 93.65 1 045 980 93.78
Međimurska 1 173 1 136 96.85 1 110 1 091 98.29
Varaždinska 1 337 1 286 96.19 1 474 1 405 95.32
Krapinsko-zagorska 949 914 96.31 1 239 1 223 98.71
Grad/City of Zagreb 7 859 7 319 93.13 8 015 7 620 95.07
Zagrebačka 2 883 2 648 91.85 2 995 2 886 96.36
CROATIA 38 700 34 430 88.97 39 630 37 703 95.14
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active pro-vaccination programme, ignorance about the 
benefits of vaccination and the release of false information 
about vaccination through the mass media are some of 
the factors which affect citizens’ attitudes. They contribute 
to falling vaccination rates, with potential serious conse-
quences for health.
In Croatia risk groups recommended to be vaccinated 
against influenza include people whose health status or 
medical condition increases the risk of influenza com-
plications. Preference is given to people suffering from 
chronic conditions, people over the age of 65 and other 
vulnerable groups.
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are in charge of the recommended vaccination pro-
grammes. County Public Health Institutes also provide 
additional vaccination, on request.
Based on the Health Care Act, the Croatian Public Health 
Institute also monitors the health status and implemen-
tation of health care for vulnerable populations. There 
are specific programmes for refugees and the Roma 
population.
There are no incentives for patients or vaccinators under 
the mandatory vaccination programme, but some “pro-
vaccination” programmes are financed at county level.
Financing
All mandatory vaccines and vaccines recommended 
for specific vulnerable groups are covered by compul-
sory health insurance, provided by the Croatian Health 
Insurance Fund. Additional vaccines are paid for 
out-of-pocket.
Barriers and facilitators
In recent years Croatia has faced a strong anti-vaccination 
movement, leading to hesitancy towards vaccination 
among both parents and health professionals. A study 
published in 2016 explored attitudes regarding vaccina-
tion in a nationally representative sample of 1000 people. 
Over two thirds of participants reported vaccine accept-
ance (69.9%; 95% CI = 66.2–73.3), about one fifth 
(19.5%; 95% CI = 16.9–22.5) reported vaccine hesitancy 
(i.e. they would accept some but not all vaccines), while 
10.6% (95% CI = 8.4–13.3) would refuse all vaccinations 
(Repalust et al., 2016).
So far, there is no clear national strategy for dealing with 
the anti-vaccination movement. Croatia is trying to 
raise public awareness of the importance and benefits of 
vaccination through various public health actions, such 
as holding professional meetings, creating posters and 
flyers, and organizing workshops and lectures. Individuals 
within some local communities are also seeking to intro-
duce changes. There is particular concern in the area 
of Dubrovnik and its surroundings, where the County 
Public Health Institute conducts various interventions, 
such as educational brochures, infographics and short 
videos, trying to educate the population. The shortage 
of health workers in primary health care, the lack of an 
Cyprus
Chrystala Charalambous, Mamas Theodorou
Governance
The Child and Adult Immunization Programme in 
Cyprus is set out at the national level by the Ministry 
of Health of the Republic of Cyprus, following recom-
mendations from the National Advisory Committee 
on Immunizations. The aim of the immunization pro-
gramme is to maintain and increase the already high levels 
of immunization of all children at the appropriate age 
and recommended doses. To achieve this, the Ministry of 
Health and, more specifically, the Directorate of Medical 
and Public Health Services, which is the responsible body, 
has adopted the Expanded Programme on Immunization 
and closely adheres to WHO recommendations. The 
immunization programme is an ongoing process, modi-
fied and updated according to changes in epidemiological 
data and international scientific knowledge and recom-
mendations. Based on these recommendations, and in an 
effort to ensure a unified approach to the administering 
of vaccines, the Ministry of Health has published a vac-
cination booklet with the recommended programme, as 
well as background information on the vaccines, their 
side-effects and contraindications, which is disseminated 
to all health workers involved in the administering of vac-
cines (both in the public and private sectors) (Figure 1).
In addition to the vaccines shown in Figure 1, for the last 
three years the HPV vaccine has also been introduced 
and is given free to all girls in the first class of secondary 
school (11–12 year olds).
Although vaccinations are not mandatory in Cyprus, 
immunization coverage is very high. According to 2017 
data, 97% of children were covered with DTP3 (Figure 2) 
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Figure 1 Immunization scheme
Source: Ministry of Health, 2016
Vaccines that are given special findings
Adult Vaccination
1. Td Adults – given if recommended doses were missed and as a booster dose every 10 years
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4. Influenza – given to high risk groups and for other specific indications
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Figure 2 DTP3 coverage in Cyprus, 2005–2017
Source: WHO, 2018
parents’ private health insurance.
• Cooperation between the public and private sectors 
to promote vaccination. Every year a campaign is 
organized to inform not only health professionals 
but also children and their parents about the ben-
efits of vaccination. The campaign includes news-
letters and messages in radio and TV programmes 
and the distribution of leaflets.
• The Vaccination Coverage Intervention Action is 
undertaken annually to ensure that all children at 
primary schools (public and private) are vaccinated 
according to the recommended programme. More 
specifically, at the beginning of each school year 
health visitors check all pupils’ vaccination cards 
to ensure that they are vaccinated according to the 
recommended programme; in cases of incomplete 
vaccinations, they inform the parents or guardians 
of the importance of, and the necessity to proceed 
with, the vaccination of their children. In April 
of the same school year the vaccination cards are 
rechecked in order to assess the result of this inter-
vention. Results are usually quite good. Children 
can also be vaccinated at schools.
Regarding adult vaccination against influenza, the 
Ministry of Health, following recommendations from 
and 90% were covered against MMR (WHO, 2018). 
These data are derived from national surveys conducted 
by the Ministry of Health, covering children of 17–24 
months of age. These surveys are repeated every three 
years and are carried out according to WHO recommen-
dations and guidelines.
As a result of the high immunization coverage, no measles 
cases were reported during 2015 and 2016 in Cyprus and 
only eight cases during the period from February 2017 
to January 2018.
The high immunization coverage is mainly due to several 
incentive schemes, including:
• Provision of vaccines free of charge to all children 
in the public sector, regardless of their nationality 
or socioeconomic status. Children who are asylum-
seekers or refugees living in government-organized 
accommodation are also vaccinated free of charge 
by the Ministry’s medical and public health ser-
vices. Newly arriving refugees are immunized with 
some basic vaccines such as DTaP and IPV within 
48 hours of their arrival.
• A significant percentage of children are also immu-
nized by their private paediatrician. In this case 
the cost is paid out-of-pocket or covered by the 
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Provision
Children can go to either the public or the private sector 
for vaccination. Immunization in the public sector is 
carried out at hospitals and health centres by health vis-
itors or nurses, as well as at schools by the school health 
services, under the guidance of public health doctors and 
after receiving written consent from the parents. In the 
private sector vaccinations are carried out by paediatri-
cians or, for adults, by general practitioners. In the public 
sector the responsibility for calling and follow-up lies with 
local health visitors, while in the private sector it lies with 
primary care paediatricians.
Financing
The vaccines used in the public sector are centrally pur-
chased through a tender by the pharmaceutical services 
of the Ministry of Health and are provided free of charge 
to all children regardless of income, socioeconomic status 
and nationality. The seasonal influenza vaccine is also 
provided free of charge to all persons over 65 who apply 
to public hospitals. These people, regardless of whether 
they are entitled to free medical care or not, can apply 
for vaccination directly at hospitals or health centres, 
using their identity card to confirm their age. For other 
age groups, vaccination against influenza is provided free 
of charge only to those people who are eligible for free 
health care in the public sector. The total cost of vaccines 
and vaccination services provided by the public sector is 
borne exclusively by the Ministry of Health.
For vaccinations carried out in the private sector, doc-
tors purchase vaccines from pharmacies and are then 
reimbursed directly by the patients or by private health 
insurance. According to the price list issued by the Cyprus 
Pharmaceutical Services in March 2018, the maximum 
retail price (i.e. the maximum price pharmacies can 
charge when selling medications) was set at €14.23 for 
the MMR vaccine and at €25.93 for the vaccine against 
seasonal influenza (Pharmaceutical Services Cyprus, 
2018). However, patients pay paediatricians or general 
practitioners much more for vaccination in the private 
sector.
It is estimated that 42% of children are vaccinated in the 
public sector and 58% in the private sector. However, 
more recent estimates indicate that during the financial 
crisis more children were vaccinated in the public sector 
than in the private sector.
WHO and the European Centre for Disease Prevention 
and Control, recommends vaccination of those belonging 
to the following high-risk groups, in order to reduce the 
number of patients, the severity of infection, and the 
number of deaths:
• citizens over 65 years;
• residents in nursing homes and patients in long-
term care institutions;
• children and adults with chronic lung disease or 
cardiovascular disease;
• people with chronic kidney disease;
• people with chronic metabolic disease, including 
diabetes mellitus;
• people with HIV infection;
• people with neurological disease;
• immunosuppressed individuals;
• people with sickle cell anaemia or other 
haemoglobinopathies;
• children and adolescents who require long-term 
aspirin therapy;
• pregnant women after the first trimester of 
pregnancy;
• people working or living in places where the afore-
mentioned high-risk groups live; and
• health workers.
There are no complete data for adult vaccination against 
influenza, except for those who have been vaccinated in the 
public sector. According to Health and Hospital Statistics 
(Cyprus Statistical Service, 2015), around 13 000 adults 
(belonging to the above-mentioned high-risk groups) are 
vaccinated every year in the public sector. Influenza activity 
in Cyprus is monitored through three systems: syndromic 
surveillance in primary care, virological surveillance, and 
surveillance of severe illness and deaths. Recent data show 
that influenza intensity is low in Cyprus compared to most 
other EU/EEA countries (European Centre for Disease 
Prevention and Control, 2018b).
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WHO (2018). WHO vaccine-preventable diseases: mon-
itoring system. 2018 global summary. Online at: http://
apps.who.int/immunization_monitoring/globalsummary/
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CYP, accessed 17 September 2018.
Key barriers and facilitators
The financial incentives mentioned above, and because 
all children and certain categories of adults can be 
vaccinated free of charge in the public sector, as well as 
the monitoring of the vaccination coverage of children, 
have contributed to the high vaccination coverage in 
Cyprus.
There are no serious barriers that make it difficult for 
children to have access to vaccinations. According to a 
survey conducted in 2015 (Ministry of Health, 2016), 
the main reasons reported by parents for not vaccinating 
their children were “child’s sickness” (67%), followed by 
“lack of vaccine” (9.8%), “lack of time” (7.6%), “lack 
of interest” (6.5%), “limited information” (3.3%), and 
“other reasons” (8.7%). Despite the high rates of vacci-
nation, there is still room for improvement. According to 
the 2015 national vaccination survey, approximately 2% 
of the population rejects vaccination.
For influenza vaccination, there is no evidence on barriers 
or facilitators. However, barriers might include possible 
ignorance of the existence of the vaccine and the impor-
tance of vaccination against influenza, particularly for 
older people, as well as misinformation and the anti-
vaccination movement. Facilitators are likely to include 
the free-of-charge provision of the vaccine and the infor-
mation provided for the population by the services of the 
Ministry of Health and private doctors.
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Czech Republic
Lucie Bryndová
Governance
Legislation on vaccination
The act on public health protection (Act No. 258/2000 
Coll.) defines the obligation to undergo specified manda-
tory vaccinations for all people with permanent residence 
in the Czech Republic as well as for those with a residence 
permit for 90 days and above. Types of mandatory vac-
cination (whether regular, specific or exceptional) and 
vaccination schedules are defined in implementing regu-
lations (Ministry of Health’s Decree No. 537/2006 Coll., 
on vaccination against infectious diseases, last amended 
by Ministry of Health’s Decree No. 355/2017 Coll.). 
These include vaccination against diphtheria, tetanus, per-
tussis, poliomyelitis, hepatitis B, Haemophilus influenzae 
type B, measles, mumps and rubella (MMR) for all, and 
vaccination against tuberculosis, pneumococcal diseases 
and rabies only in defined cases.
In addition to mandatory vaccination, there are vacci-
nations that are not mandatory but are still covered by 
social health insurance (Act No. 48/1997 Coll., on social 
health insurance). These include vaccines against human 
papillomavirus (for girls and boys aged 13 to 14 years), 
influenza and pneumococcal diseases for defined groups 
(i.e. seniors aged 65 years and older), pneumococcal and 
meningococcal diseases and influenza for patients with 
immunity disorders.
Additionally, health insurance funds operate individual 
prevention programmes that provide full or partial reim-
bursement to their insured members for vaccinations 
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Apart from fines, there is another factor that encourages 
parents to follow the vaccination schedule with their 
children. Children without proper vaccination, if not 
exempted for medical reasons or due to lifelong immu-
nity, cannot be, according to the law, accepted into pre-
school facilities. This does not apply to mandatory school 
education. Providers of preschool services can be fined 
up to CZK 500 000 (€20 000) if they accept an unvac-
cinated child. There has been a wide public debate on 
this topic in recent years. However, the findings of the 
Czech Constitutional Court supported this legal provi-
sion, based on the argument that it would be “an act of 
social injustice if nonvaccinated children without serious 
medical reasons were accepted into a preschool facility, 
thus benefiting from the willingness of others to take the 
minor risk of being vaccinated” (JUD282605CZ).
Estimation of vaccination coverage
By law the health insurance funds are required to report 
to the Ministry of Health the number of vaccinated chil-
dren by age cohorts according to the mandatory vaccina-
tion schedule. The denominator is the total number of 
children in the given age cohort based on the population 
registry. Reporting is due at the end of April for the 
preceding calendar year.
Since January 2018 vaccination against measles is also 
listed in the mandatory specific vaccinations, applying to 
people taking up new jobs at infection or dermatovenere-
ology departments.
Influenza
Vaccination against influenza is not mandatory in the 
Czech Republic. Nevertheless, for defined groups it is 
covered by the social health insurance system. According 
to the Act No. 48/1997 Coll., on social health insurance, 
these groups are as follows:
1. people aged 65 and over,
2. people with pharmacology treatment due to 
chronic cardiovascular, pulmonary, renal or dia-
betes conditions,
3. people after splenectomy or after blood formation 
cells transplantation,
against other diseases such as tick-borne encephalitis or 
meningococcal disease or influenza.
Measles
Vaccination against measles is part of the mandatory 
regular vaccination scheme. All people with permanent 
residence in the Czech Republic or having a residence 
permit for 90 days and above are obliged to be vaccinated 
against measles.
The vaccination programme is organized at national level, 
with the Ministry of Health publishing the vaccination 
schedule in its decree. Currently, vaccination against mea-
sles is given together with vaccination against mumps and 
rubella, and should be provided as follows: the first dose 
to children aged 13 to 18 months and the second dose to 
children aged 5 to 6 years. If there are medical reasons, a 
child can be exempted from vaccination or the vaccina-
tion can be postponed, but this fact must be recorded in 
the child’s medical record, as otherwise not undergoing a 
vaccination is viewed as a violation of the law.
The main state authorities in charge of controlling 
observance of the law are the Regional Public Health 
Authorities. There are 14 of them, one in each region. 
These authorities control vaccination coverage by birth 
year of the respective cohorts.
In practice, the authorities check, on a continuous basis, 
children by the first letter of their family name, based 
on the population registry. In administrative procedures 
parents are responsible for their children up to the age of 
15. They can be fined up to CZK 10 000 (€400) if their 
child has not followed the vaccination schedule. The 
Regional Public Health Authorities impose a fine, and, if 
it is not paid, the customs office enforces it. The fines are 
state budget income.
If a person does not undergo a mandatory vaccination 
and is not registered with any general practitioner (see 
below), the Regional Public Health Authority decides in 
an administrative procedure which general practitioner 
will provide the vaccination and the person must receive it.
There are no specific targeted measures in the national 
vaccination plan regarding specific groups of the pop-
ulation (e.g. refugees, religious objectors), since measles 
vaccination is mandatory for all residents, including these 
groups (although financing differs – see below).
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practitioners may ask the Ministry of Health to provide 
them with contact details for their registered children 
from the population registry. If a child is not registered 
with any general practitioner, the Regional Public Health 
Authority decides which general practitioner will provide 
the vaccination and the person must receive it.
State monitoring and control is based on children’s med-
ical records in general practice offices, and is intended to 
ensure high vaccination coverage. General practitioners 
are obliged to provide the authorities with the necessary 
information and medical records or face a fine.
Influenza
Adult vaccination against influenza is provided by pri-
mary health care providers, namely general practitioners 
for adults, or by physicians in long-term health or social 
care facilities. If a vaccination is offered by employers, 
it is provided by an occupational medicine provider. It 
can be also provided by the Regional Institutes of Public 
Health (but not by the National Institute of Public 
Health).
Financing
Measles
Vaccination against measles is covered by social health 
insurance and is free of charge at the point of delivery. 
Primary care doctors receive the vaccines directly from 
distributors, who are reimbursed directly by the health 
insurance funds. Reimbursement for vaccine provision is 
included in general practitioners’ capitation payments or 
paid fee-for-service in the case of an unregistered patient.
For people not covered by the social health insurance 
system, such as refugees, the state pays for vaccines and 
their provision directly, because vaccination is also man-
datory for these people. Payment to providers is chan-
nelled through regional budgets.
Influenza
Vaccination against influenza is covered by social 
health insurance for defined groups of people (see the 
Governance section above). For these people, vaccination 
(i.e. the vaccine and its provision) is free of charge at the 
4. people living in long-term care facilities, or in 
homes for older people, facilities for people with 
physical disabilities, or social care facilities with 
special regimes (i.e. facilities for people with 
dementia or Alzheimer’s disease),
5. people with limited spleen functionality, or with 
serious immunodeficiencies requiring long-term 
follow-up treatment at specialized departments, 
or after invasive meningococcal or pneumococcal 
disease.
Until 2010 vaccination against influenza was part of the 
mandatory vaccination schedule. As a mandatory specific 
vaccination, it applied to people working at places with 
higher risk of infectious disease, namely long-term care 
facilities, homes for older people, facilities for people 
with physical disabilities, and social care facilities with 
special regimes.
The 2010 legislative changes moved the influenza vacci-
nation from the mandatory (which was free for eligible 
people) to the voluntary schedule, but at the same time 
explicitly, by law, covered it under social health insurance, 
dropping the group of employees but broadening the 
categories of eligible patients.
Estimation of vaccination coverage
Health insurance funds are, by law, required to report 
to the Ministry of Health the number of people vacci-
nated against seasonal influenza. The denominator is the 
total number of people based on the population registry. 
Reporting is due at the end of April for the preceding 
calendar year.
Provision
Measles
Providers responsible for vaccination against measles are 
primary health care providers, namely general practition-
ers for children and adolescents. They are legally obliged 
to ensure and provide mandatory vaccination to their 
registered children. In practice, general practitioners fulfil 
their duty by inviting children for regular vaccination 
according to the vaccination schedule. No case has been 
reported where a health care provider has been fined 
for “not ensuring” the vaccination of a child. General 
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point of delivery for the cheapest vaccine. Otherwise the 
patient has to co-pay.
If a vaccination is offered by employers, and is provided 
by an occupational medicine provider, it is usually also 
free of charge for the patient.
For all the others, it is a paid service, both for the 
vaccine and its provision. However, all health insurance 
funds have special prevention programmes for their 
insured, above the statutory insurance coverage. They 
contribute to (i.e. reimburse) their insured members 
for any kinds of vaccines that are not covered by stat-
utory health insurance, up to a certain financial limit. 
Usually, only vaccines are covered, not their provision, 
and a claim for reimbursement must be made to the 
health insurance fund (i.e. the patient pays first and is 
then reimbursed).
Key barriers and facilitators
Measles
Key barriers: false stories among new parents regarding 
the side-effects of mandatory vaccination. The National 
Institute of Public Health and the Ministry of Health 
are responsible for health literacy and the dissemination 
of public health-related information. Their outreach is, 
however, limited.
Facilitators: fines and the vaccination requirement for 
preschool facility admission, as described above.
Influenza
Since vaccination against influenza is voluntary and free 
of charge only for some people, it is not too widely used. 
Promoting free-of-charge vaccination by more employers 
would help to increase coverage rates. However, simply 
including it as part of employment benefit packages does 
not increase coverage, because people compromise over 
different benefits and often choose other ones (such as 
contributions towards a vacation).
Denmark
Peter Henrik Andersen
Governance
For vaccination against both measles and rubella, the 
Danish Health Authority (Sundhedsstyrelsen) is in charge 
of developing and overseeing the implementation of 
national vaccination plans and programmes. It recom-
mends to the Ministry of Health a vaccine for use in a 
publicly financed programme. Ultimately, financing is 
secured via legislation passed in the Danish Parliament. 
When considering vaccine candidates, the Danish Health 
Authority prioritizes according to the seriousness of the 
disease to be prevented. The agency has a vaccination 
committee with members drawn from the relevant med-
ical specialties (paediatrics, infectious diseases, general 
medicine and public health) and from the Statens Serum 
Institut, the Danish Medicines Agency and the Danish 
Patient Safety Authority.
The Danish Medicines Agency is responsible for approval 
if no central European Medicines Agency (EMA) approval 
exists (which is the case for almost all new vaccines). It is 
also responsible for pharmacovigilance, passively receiving 
reports on suspected adverse events from both health care 
personnel and private persons (patients/family members, 
etc.).
The Statens Serum Institut provides vaccines for use in 
public tenders. They also advise health care personnel on 
the use of vaccines and monitor the uptake of vaccine 
programmes, as well as monitoring the diseases prevented 
by the vaccine. For influenza, they also monitor day-by-
day all-cause mortality as a proxy for influenza-related 
mortality during the influenza season.
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Measles
In practice, the majority of measles vaccines are given 
by primary health care providers (general practitioners/
nurses in general practitioner clinics). School vaccination 
is normally not done in Denmark but is currently being 
considered for certain vaccines.
Influenza
Most influenza vaccines for adults are given by primary 
health care providers (general practitioners/nurses in gen-
eral practitioner clinics), but dedicated vaccination clinics 
(including mobile units/in homes for older people/in 
pharmacies) also perform vaccinations (provided they 
report their activity to the vaccination registry).
Financing
Measles
Childhood MMR vaccination is free of charge for all 
residents (two doses recommended at 15 months and 4 
years of age; the offer ends when the child turns 18 years 
of age).
The cost (vaccine and vaccination fee) is covered by the 
National Health Service. The five regions tax their citizens 
and are responsible for regional health costs, including 
costs for vaccination. There is no patient payment. In 
asylum centres children are offered MMR vaccination 
free of charge, covered by the Danish Red Cross, which 
is responsible for the centres.
Influenza
Vaccination is free of charge for defined risk groups 
(those with a number of medical conditions, those aged 
65 and over, and pregnant women in the 2nd and 3rd 
trimesters).
The doctors (general practitioners and vaccination clin-
ics) buy the influenza vaccines from the Statens Serum 
Institut and are reimbursed by the National Health 
Service at a fixed price. For defined risk groups there is 
no patient payment. Employers may choose to pay for 
vaccination of employees not in the risk groups.
The Danish Patient Safety Authority monitors safe prac-
tices among health care personnel and is responsible for 
contact tracing.
Vaccination programmes are almost always organized 
nationally. An exception would be the Capital Region, 
which offers free hepatitis B vaccination to men who have 
sex with men (MSM).
There is no national vaccination plan. All vaccines are 
recommended, but no vaccine is mandatory.
In Denmark all residents are assigned a unique personal 
identification number which is used for registration of the 
vaccine. Since November 2015 all vaccinations are required 
to be reported to the Danish Vaccination Registry. It is 
also possible to register previously administered vaccines in 
this registry. The vaccination registry is run by the Danish 
Health Data Authority. Since May 2014 reminders are 
sent (from the Statens Serum Institut) to parents whose 
children are recorded as missing at least one childhood 
vaccine (including MMR). Electronic letters are sent out 
when the child is 2, 6½ and 14 years of age.
There are no targeted measures for specific groups in the 
population. Asylum seekers (children) are offered vaccina-
tions in the asylum centres run by the Danish Red Cross 
and some municipalities.
The main incentive for general practitioners to vacci-
nate is driven by their reimbursement for the activity 
by the National Health Service. The cost per vaccina-
tion has been agreed between the Medical Practitioners 
Organization and the National Health Service.
Vaccination coverage is calculated by birth cohort. The 
numerator is the number of individuals registered with an 
administered vaccine and the denominator is the number 
of individuals of that age residing in Denmark at the time 
of calculation. Real-time data on coverage is shown on the 
website of the Statens Serum Institut. For influenza, the 
coverage is calculated for all risk groups (number of doses 
given per season) and by age groups, e.g. for persons aged 
65 years and above (proportion vaccinated per season).
Provision
In principle, any medical doctor can administer vaccines. 
Doctors with type B authorization can delegate to assist-
ing personnel, i.e. nurses.
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Despite free vaccination, the uptake of influenza vaccines 
for people aged 65 years and above is only around 50%. 
No precise data on coverage exists for the other medical 
risk groups.
Key barriers and facilitators
Current MMR coverage in the childhood vaccination 
programme is around 95% for MMR1 and around 90% 
for MMR2, giving only minor room for improvement 
(Denmark obtained WHO measles elimination status in 
2017). However, coverage was lower in previous cohorts, 
which is why the government decided to offer free MMR 
vaccination for all non-immune residents as of 1 April 
2018 (one dose, unlimited offer).
For adult influenza vaccination, fewer than half of the 
defined risk groups are currently vaccinated. There is a 
great variety in the ways people can get vaccinated, and 
organizational aspects, financing and delivery of services 
do not appear to be important barriers to vaccination. 
However, it seems the public perception of influenza as a 
potentially serious disease is missing.
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Estonia
Kaija Kasekamp
Governance
The Ministry of Social Affairs is responsible for develop-
ing and overseeing implementation of the national immu-
nization schedule and programmes. It is also responsible 
for developing and implementing the national immuni-
zation policy, and organizes the procurement of vaccines 
and immunoglobulins to fulfil the immunization sched-
ule. Furthermore, it coordinates the implementation of 
the immunization schedule, immunization pursuant to 
emergency care, and immunization necessary for the 
prevention of an epidemic of a communicable disease.
The Ministry of Social Affairs also coordinates the activ-
ities of the Health Board and the Medicines Agency. The 
Health Board organizes the distribution of vaccines and 
immunoglobulins, carries out immunization surveillance 
and monitors immunization coverage. The Medicines 
Agency issues marketing authorizations for medicines 
(including vaccines and immunoglobulins) and carries 
out their safety and quality monitoring.
The national health insurance fund (Estonian Health 
Insurance Fund) is involved in immunization mainly 
through the financing of primary health care and school 
nursing. From 2019 it is planned that the Estonian 
Health Insurance Fund will take over the Ministry 
of Social Affairs’ responsibility for organizing vaccine 
procurement.
The Communicable Diseases Prevention and Control 
Act regulates immunization in Estonia. Vaccines that 
are included in the national immunization schedule and 
emergency vaccinations are nationally organized and 
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Vaccinations can only be carried out by a medical pro-
fessional (doctor, nurse or midwife) who has completed 
special training. National guidelines for medical profes-
sionals have been developed to ensure safe vaccinations.
Newborns are vaccinated at the hospital after delivery 
according to the national immunization schedule. The 
family doctor or nurse is responsible for vaccinating per-
sons on their patient list according to the immunization 
schedule. School-aged children and adolescents receive 
vaccinations at school and the school nurse carries out 
these vaccinations according to the national immuniza-
tion schedule. Post-traumatic anti-tetanus immunizations 
are carried out in the emergency medical departments in 
hospitals. Other immunizations are provided by outpa-
tient clinics for infectious and travel medicine, women’s 
clinics and/or private practices.
Before each vaccination in the school, the school nurse 
must ask for written consent from the parent of the child 
even if it has already been granted for the child’s admis-
sion to the school. Parental consent helps to avoid any 
contraindications. If the family does not want to vaccinate 
their children, this must be confirmed in writing. This 
is also mandatory when vaccinations conducted by the 
primary care provider are rejected.
There are no sanctions for parents or people who have 
decided to reject vaccination according to the immuniza-
tion schedule. Nevertheless, there is a continuous media 
monitoring and communication strategy on increasing 
vaccination coverage among the population.
The Health Board supervises health care providers. The 
purpose of supervision is to ensure:
(a) the quality, effectiveness and safety of immunolog-
ical products at all stages of their handling;
(b) compliance with the immunization procedure 
(safety) requirements; and
(c) completion of the immunization programme.
The Health Board monitors vaccination coverage and 
is responsible for overseeing the level of coverage in the 
country. The vaccination programmes are not based on 
population registries. All health care providers need to 
report vaccinations to the Health Board (including mea-
sles and influenza). For vaccines that are included in the 
national immunization schedule (measles), the health care 
publicly funded. Vaccinations that are not included in 
the immunization schedule are governed by the same 
legislation, but the state does not organize or finance 
these vaccines.
The national immunization schedule includes vaccines 
for children against 12 diseases: tuberculosis, hepatitis B, 
rotavirus, diphtheria, tetanus, whooping cough, measles, 
mumps, rubella, polio and Haemophilus influenza type B 
(Hib); the HPV vaccine has also been added to the state 
vaccine schedule for girls starting from 2018. For adults, 
a diphtheria and tetanus vaccine is included in the immu-
nization schedule every ten years.
Adult vaccination against influenza has not been added 
to the immunization schedule; nevertheless, a health 
technology assessment (HTA) was conducted in 2014 
by the Tartu University Department of Public Health 
to evaluate the impact of seasonal influenza vaccination 
by analysing the costs and cost-effectiveness of a nation-
wide vaccination of population-based target groups in 
Estonia. The analysis concluded that a national influenza 
vaccination programme for population-based risk groups 
would reduce both the number of influenza cases, includ-
ing severe cases requiring hospitalization, and illness-
related costs in both young children and older adults. 
Nevertheless, as of 2018, political commitments have not 
been made to add adult influenza vaccines to the national 
immunization schedule.
A National Immunization Technical Advisory Group 
advises the Ministry of Social Affairs on issues and deci-
sions concerning state immunoprophylaxis. The expert 
group consists of representatives of the Ministry of 
Social Affairs, the Health Board, the State Agency of 
Medicines, the Estonian Health Insurance Fund, the 
Estonian Society of Family Physicians, the Estonian 
Society for Infectious Diseases, the Estonian Society 
of Paediatricians, the Union for Child Protection, the 
Estonian Nursing Association and the Immunologists 
and Allergists Society.
Vaccination is voluntary in Estonia. The parent or legal 
guardian of a child or a person with restricted legal capac-
ity decides about the vaccination of that person. Before 
performing the vaccination, the health care professional 
checks the health of the patient and finds out whether or 
not they have permanent or temporary contraindications 
for vaccinations. In case of contraindications, vaccination 
is not performed or is temporarily postponed.
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monitoring of medicinal products is subject to adverse 
reaction reports from health care professionals. Health 
care professionals carrying out vaccinations are required 
to submit a notification to the State Agency of Medicines 
regarding all serious adverse reactions. In addition, 
every person can report an adverse reaction to the State 
Agency of Medicines. All non-serious adverse reactions 
are reported to the Marketing Authorization holder of 
the vaccine. All alert notifications received by the State 
Agency of Medicines are registered, identified and entered 
into the database. Information on adverse reactions is 
analysed, forwarded to the Marketing Authorization 
holder, the World Health Organization and the European 
Medicines Agency. The State Agency of Medicines pub-
lishes an overview of adverse drug reactions, including 
vaccines, on its website annually.
Provision
Childhood vaccinations against measles are provided at 
the ages of 1 and 13 years. It is a combined vaccine for 
measles, mumps and rubella. The first vaccine is most 
commonly provided by the primary care provider during 
a child’s regular health check-ups. Family doctors are 
motivated to actively invite parents for child check-ups, 
including vaccinations, because they are a part of the 
quality bonus system. Health check-ups for children are 
mandatory for certain age groups (at 1 month, 3 months, 
12 months, 2 years and pre-school) and these mostly align 
with the immunization schedule. School nurses mostly 
provide the second vaccination at the age of 13.
Since influenza vaccinations are not included in the 
national immunization schedule, these vaccinations are 
not organized at a national level. Any health care provider 
that has medical professionals with appropriate training 
can perform the vaccinations. Primary care providers or 
ambulatory clinics specializing in infectious and travel 
medicine mostly perform the influenza vaccinations.
It is mandatory for the health care provider to register all 
immunizations in writing or in the electronically stored 
immunization booklet and enter them on the health 
record, which, according to the most recent develop-
ments, automatically adds the data to the digital immu-
nization booklet. An immunization certificate is issued to 
newborn babies on the maternity ward; for other persons 
the family physician or other health care provider issues 
the certificate. The written consent or refusal of the parent 
or legal representative is kept on the patient’s health 
provider needs to report to the Health Board the number 
of persons in the target group and the number of persons 
vaccinated. This means that health care providers, such 
as  primary care providers and school nurses, use their 
own patient lists as the basis to define the target groups. 
The coverage of the national health schedule vaccines is 
not calculated based on the national population registry, 
because of the quality of the data in the national popu-
lation registry; it is assumed that it includes people who 
are not actually resident in Estonia. Nevertheless, for 
calculating influenza vaccine coverage, the Health Board 
uses the population registry. There are no specific target 
measures for population groups other than the threshold 
of covering 95% of children with vaccinations included in 
the immunization schedule. By the end of 2017, 95% of 
children aged 1–14 years were vaccinated against measles. 
Around 50 000 persons were reported to have received an 
influenza vaccine during 2017, out of a total population 
of approximately 1.3 million.
The Health Board provides a statistical overview of all 
immunizations and reports on the vaccination schedule 
four times a year. An overview of vaccination coverage is 
published annually on the Health Board’s website and on 
the official national website for vaccinations: vaktsineeri.
ee. On the basis of the reports, the Health Board draws up 
and reports data on immunization to the World Health 
Organization and to the European Commission. Based on 
these reports, the Health Board monitors immunization 
trends and assesses their impact on the epidemiological 
situation in the country. If necessary, the Health Board 
submits proposals for changes to the immunoprophylaxis 
programmes or for new activities.
The Health Board monitors the storage, distribution and 
transportation of immunological products in accordance 
with the requirements of the cold chain. Supervision of 
health care professionals includes, for example, a check 
on whether the medical professionals who are providing 
the vaccinations have received appropriate training and 
whether all vaccinations have been provided, recorded 
and documented in an accurate and timely manner. The 
Health Board also checks whether the immunizations 
are conducted according to the national immunization 
schedule, especially whether they are provided in a timely 
manner.
The State Agency of Medicines carries out safety and 
quality monitoring of medicines, including immuno-
logical products, to ensure that they meet quality and 
safety requirements. Post-marketing safety and quality 
The organization and delivery of vaccination services78
immunization and prophylactic treatment necessary for 
the protection of their health in those occupations where 
they are at risk of infection (including placement, foreign 
missions of military and civil structures, etc.).
The municipalities can finance the prevention and con-
trol of communicable diseases (including vaccinations), 
but this is rather rare. The Communicable Diseases 
Prevention and Control Act makes it possible for the 
Estonian Health Insurance Fund to finance vaccines, but 
so far this option has not been used.
Key barriers and facilitators
The main facilitator of vaccination coverage against 
measles is its inclusion in the national immunization 
schedule, which enables access to vaccination for all 
children free of charge. Vaccination is part of primary 
health care and health care provided at schools, which 
means that it is easily accessible. Primary care providers 
are interested in high coverage rates, because it is part 
of their quality bonus system. Furthermore, since there 
is a surveillance system in place for monitoring cover-
age, it is possible to take immediate action if coverage 
starts to decrease.
A barrier in the current system is the increase in the 
number of patients or their representatives who decline 
vaccination because of unfounded concerns. Although 
there is continuous communication on a national level 
explaining the need for vaccinations, the number of 
children under 2 years receiving measles vaccination is 
decreasing. Greater stakeholder involvement including 
primary care providers and other medical personnel might 
increase trust in vaccinations.
Adult influenza vaccination coverage is extremely low in 
Estonia. Although population-based vaccination of risk 
groups has been assessed as cost-efficient, no political 
commitments have been made to add adult influenza 
vaccines to the national immunization schedule. The high 
vaccination service charge might be an additional barrier 
for increasing coverage.
records. Since Estonia has National Health Records, this 
information is then accessible for all health care providers 
in the country.
Pharmacies have not participated in vaccination pro-
grammes in the past. They are allowed to sell vaccines but, 
generally, pharmacies have not been allowed to vaccinate. 
However, in the autumn of 2018, a pilot programme was 
launched, allowing to provide influenza vaccinations in 
pharmacies during a one-month period.
Financing
All vaccinations included in the national immunization 
schedule, including measles, are free of charge at the point 
of delivery. Vaccinations not included in the immuni-
zation schedule and performed at the person’s request 
(or on the recommendation of a doctor) are paid for 
out-of-pocket.
Vaccines are procured at the national level and distrib-
uted to the service providers. Until 2018, the Ministry 
of Social Affairs has financed vaccines from the state 
budget. From 2019 the Estonian Health Insurance Fund 
will be responsible for covering the costs of vaccines. 
The Estonian Health Insurance Fund is funded through 
social health insurance contributions in the form of an 
earmarked social payroll tax. Since all children are enti-
tled to health insurance, there are no gaps in vaccination 
coverage as a result of having no health insurance.
Primary care and school health care are also free of 
charge for insured people in Estonia, which means that 
there is also no co-payment at the point of service deliv-
ery when receiving vaccinations. Vaccination costs are 
included in the capitation payment for primary care 
and school nursing. In primary care the providers are 
also incentivized with a quality bonus system to increase 
vaccination coverage.
Vaccines that are not included in the national immuni-
zation schedule, such as influenza, need to be paid fully 
out-of-pocket. The person would need to purchase the 
vaccine and, if the vaccination is not done by the primary 
care provider, might need to pay for the immunization 
as well. Vaccination in the outpatient centres providing 
immunization services are carried out on the basis of a 
price list set by the provider.
Employers are responsible for financing their employees’ 
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Finland
Ilmo Keskimäki
Governance
The following agencies are in charge of developing and 
overseeing the implementation of the national vaccination 
plans and programmes:
• The Ministry of Social Affairs and Health1 is 
responsible for legislation on vaccines and the 
national vaccination programme. In addition, the 
Ministry makes proposals to the government and 
the Parliament on including new vaccines in the 
national vaccination programme and decides on 
the purchase of vaccines used in the national vac-
cination programme.
• The vaccines in the national vaccination pro-
gramme are purchased by the state for use in 
municipal health services. The municipalities/
municipal health authorities are responsible for the 
practical organization of vaccinations included in 
the national vaccination programme. For children, 
vaccinations are provided according to the national 
vaccination programme by maternity and child 
health clinics and school health care.
• The National Institute for Health and Welfare2 
is the expert agency on infectious disease pro-
tection and vaccinations. It monitors, evaluates 
and develops the national vaccination programme 
in order to maintain high vaccination coverage. 
The National Institute for Health and Welfare 
1 Ministry of Social Affairs and Health: www.stm.fi
2 National Institute for Health and Welfare: www.thl.fi
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Vaccination programme for children and 
adolescents
• In Finland vaccinations against eleven diseases, their 
sequelae and their long-term complications are 
available to all children and adolescents. Girls are 
additionally offered HPV vaccine against cervical 
cancer. Vaccinations under the national vaccination 
programme are free of charge. According to current 
legislation, data on vaccinations given are entered 
into the patient information system and transferred 
to the National Patient Data Repository. Citizens 
can access their own vaccination details in the online 
service.3 Vaccination details are also entered into 
the Well-Baby Clinic health card given to parents/
guardians of each child vaccinated.
• If a child has not received a particular vaccina-
tion at a child care clinic, this can be remedied in 
school health care, student health care, the army 
or adult health care (for example, checking the 
measles vaccine status of having received two doses 
or being ill with the disease is instructed to be done 
in the army and in occupational health care). In 
addition, there are specific instructions for children 
and adolescents in at-risk groups for BCG, pneu-
mococcal conjugate, TBE and hepatitis vaccines, 
seasonal influenza vaccinations and vaccinations 
for patients receiving stem cell transplants.
Vaccination programme for adults
• Vaccines that are part of the national vaccina-
tion programme are free of charge for adults 
and administered at the local health centre. 
Vaccinations are entered into the patient infor-
mation system and transferred into the National 
Patient Data Repository. Citizens can access their 
own vaccination details online (Omakanta).
• Vaccination details should also be entered on a 
health card given to the person vaccinated. This 
card will remind the person when he or she has 
received vaccinations and when boosters are 
required. As normally no reminder system exists, 
it is important for adults to be updated on the 
need of boosters for vaccinations administered in 
childhood and adolescence.
3 Omakanta: http://www.kanta.fi/en/omakanta
also hosts expert groups supporting decision-
making on the national vaccination programme. 
These are the National Immunization Technical 
Advisory Group and expert groups nominated 
by the National Institute for Health and Welfare 
for evaluating individual vaccines and vaccination 
strategies.
• The National Institute for Health and Welfare 
makes its proposals on national vaccination pro-
gramme vaccines and vaccination strategies to 
the Ministry of Social Affairs and Health. The 
Ministry’s Advisory Board on Communicable 
Diseases acts as an expert body for infectious dis-
ease protection and supervises the general trends 
regarding communicable diseases, and supports 
protection activities.
• The Ministry of Social Affairs and Health Working 
Group on Vaccination Purchasing prepares the 
financial aspects of purchases of national vaccina-
tion programme vaccines. The National Institute 
for Health and Welfare takes care of implementing 
Ministry of Social Affairs and Health decisions on 
purchasing vaccines, the distribution of vaccines 
to the municipal health authorities, and guidance 
on the implementation of the national vaccination 
programme.
Organization of vaccination programmes
• In Finland the vaccination programme is financed 
by the government; it is uniform and national. The 
local primary care authorities organize national 
vaccination programme vaccinations. The National 
Institute for Health and Welfare has issued detailed 
guidance on the implementation of the national 
vaccination programme and the practical organi-
zation of vaccinations.
• Due to a high risk of tick-borne encephalitis (TBE) 
in some parts of the country, the government has 
recently supplemented the national vaccination 
programme with TBE vaccination for residents in 
certain municipalities or areas, or for those who 
stay at least four weeks in summer time in the 
municipalities at risk. The decision was imple-
mented in 2018.
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Table 2 National Vaccination Programme in 
Finland for adults
Vaccine For whom and when?
Diphtheria and tetanus 
vaccine, DT
Persons who have received the basic series are 
given a booster at 25 years (DTaP), thereafter 
every 20 years up to the age of 65 years (dT), 
and then every 10 years (dT)
Polio vaccine, IPV The basic series generally requires no boosters 
in adulthood. 
A booster is recommended for persons arriving 
from or departing for longer than four weeks in 
areas classified as at-risk by the World Health 
Organization.
Measles, mumps and 
rubella vaccine, MMR
Every adult must be protected against measles, 
mumps and rubella, either by having had the 
diseases or by having had two doses of MMR 
vaccine. If this is not the case, missing vaccine 
doses are given.
Influenza vaccine For persons aged 65 years and over, those 
belonging to medical risk groups, pregnant 
women, and those taking care of adults 
for whom influenza might be severe and 
life-threatening.
• In addition, certain adults in risk groups are enti-
tled to free tick-borne encephalitis and hepatitis 
vaccines, seasonal influenza vaccinations and vacci-
nations for patients receiving stem cell transplants.
Vaccinations are not mandatory in Finland but in 2017 
the Law on Communicable Diseases (1227/2016 ) was 
amended and since 1 March 2018 health and social care 
employers have to ensure employees, including trainees 
and students, caring for patients and clients with a risk 
of negative consequences of communicable diseases have 
received adequate vaccinations (i.e. pertussis vaccination 
if taking care of children under 1 year of age, influenza 
vaccination if taking care of vulnerable individuals, hep-
atitis B vaccination for all, measles and varicella protec-
tion by disease or two vaccination doses). The regulation 
applies to both public and private health and social care 
providers. The National Institute for Health and Welfare 
has provided detailed instructions on the implementation 
of this legal provision for employers and health and social 
care providers. However, this regulation has met some 
resistance and led to unwanted litigation cases and the 
termination of some work contracts.
The vaccination programme for children is provided by 
child health clinics and school health care and adminis-
tered during the children’s regular health visits to these 
Table 1 National Vaccination Programme in 
Finland for children and adolescents
Age Disease Vaccine
2 months Rotavirus diarrhoea Rotavirus
3 months Meningitis, pneumonia, sepsis and 
ear infection
Pneumococcal 
conjugate (PCV)
3 months Rotavirus diarrhoea Rotavirus
3 months Diphtheria, tetanus, pertussis, 
polio and Hib diseases, such as 
meningitis, epiglottitis and sepsis
5-in-1 vaccine 
(DTaP-IPV-Hib)
5 months Meningitis, pneumonia, sepsis and 
ear infection
Pneumococcal 
conjugate (PCV)
5 months Rotavirus diarrhoea Rotavirus
5 months Diphtheria, tetanus, pertussis, 
polio and Hib diseases, such as 
meningitis, epiglottitis and sepsis
5-in-1 vaccine 
(DTaP-IPV-Hib)
12 months Meningitis, pneumonia, sepsis and 
ear infection
Pneumococcal 
conjugate (PCV)
12 months Diphtheria, tetanus, pertussis, 
polio and Hib diseases, such as 
meningitis, epiglottitis and sepsis
5-in-1 vaccine 
(DTaP-IPV-Hib)
12–18 months* Measles, mumps, rubella MMR
6 months to 6 
years
Seasonal influenza (annually) and 
its complications
Influenza
1.5 to 11 years Chickenpox Chickenpox**
4 years Diphtheria, tetanus, pertussis, polio 4-in-1 vaccine 
DTaP-IPV
6 years Measles, mumps, rubella MMR
6 or 12 years Chickenpox Chickenpox***
girls aged 11 to 
12 years
Cervical cancer HPV
14 to 15 years Diphtheria, tetanus, pertussis 
(whooping cough)
DTaP
* The National Institute for Health and Welfare recommends 
that the first MMR vaccine dose be given at the age of 12 
months.
** For children who have not had chickenpox.
*** According to the instructions issued by the National 
Institute for Health and Welfare
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The following methods are used to estimate vaccination 
coverage rates at the national and subnational level:
• The National Institute for Health and Welfare 
maintains the National Vaccination Register 
(NVR) which is used to monitor and evaluate the 
coverage of the national vaccination programme.4 
The data are collected continuously and coverage 
can be estimated on a real-time basis. The results 
on vaccination coverage are made available on the 
National Institute for Health and Welfare website 
for national, regional and primary care authority 
levels.
• Vaccination details are obtained electronically 
directly from patient information systems. At 
the moment, the National Vaccination Register 
includes vaccinations given in public primary 
health care. Details of vaccinations administered 
in specialist medical care and private health care 
are planned to be added in the near future, once 
data transfer problems have been resolved.
• The National Vaccination Register also allows the 
evaluation of the benefits and safety of the national 
vaccination programme. By combining data from 
the National Vaccination Register and other health 
registers, information such as the effectiveness of 
influenza vaccines can be obtained almost in real 
time. The denominator figures are obtained from 
the national population registries which are con-
sidered accurate enough for this purpose.
Provision
According to the national vaccination programme, vac-
cinations against measles are administered at the age of 
12–18 months and at the age of 6 years. Measles vac-
cination is combined with vaccinations against mumps 
and rubella. The vaccinations are provided by child 
health clinics organized by the municipal primary care 
authorities.
Seasonal influenza vaccine is included in the national vac-
cination programme only for those over 65 years of age 
and for those to whom influenza poses a substantial threat 
to health. Since 2012 seasonal influenza vaccines have also 
been offered to family members of persons vulnerable to 
4 www.thl.fi/en/web/vaccination/vaccination-coverage
services. These public providers monitor the uptake of 
the vaccinations according to the national vaccination 
programme. Vaccinations are not mandatory, but families 
very rarely refuse childhood vaccinations. The vaccination 
coverage in Finland under the vaccination programme 
is excellent for many vaccines such as DTaP-IPV-Hib 
(over 97% coverage), good for some such as HPV (70% 
coverage), but not nearly as good for influenza (34% 
coverage). For adults there is no similar follow-up and call 
system. In principle, occupational health care should have 
this responsibility, but usually adults themselves need to 
ensure that they have received at least a basic series of 
three vaccination doses each for tetanus, diphtheria and 
polio, and two doses of MMR.
It is advised that the vaccinations in the national vac-
cination programme are offered to migrants, including 
(1) children and pregnant women applying for asylum, 
(2) quota refugees, (3) persons who have been granted 
asylum, (4) adopted children, (5) foreign students using 
student health care, and (6) persons immigrating perma-
nently to Finland. The National Institute for Health and 
Welfare has also issued detailed instructions for health 
care providers and professionals regarding the assessment 
of each migrant’s existing vaccination protection and 
the cases where there is a need to complete the national 
vaccination programme vaccinations. The latter applies to 
vaccinations against polio, hepatitis A and B, influenza 
and tuberculosis. As detailed above, another targeted 
group for vaccinations is health and social care workers.
There are no monetary incentives or sanctions for vacci-
nations. The National Institute for Health and Welfare 
has run several campaigns on vaccinations directed at the 
general public. There is an ongoing seasonal campaign for 
seasonal influenza vaccination called “Stop influenza – 
take the vaccination”. When the HPV vaccination was 
introduced into the national vaccination programme, the 
National Institute for Health and Welfare ran a campaign 
directed at adolescent girls about HPV infection, cervi-
cal cancer and HPV vaccination. The websites of these 
campaigns are continuously maintained by the National 
Institute for Health and Welfare.
The health care authorities also inform residents about 
vaccinations. Employers are obliged to offer vaccines to 
their employees if their work puts them at risk of com-
municable disease. Some other employers (i.e. beyond 
health and social care work) also offer vaccinations against 
seasonal influenza to their employees.
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vaccination programme are purchased by the state and 
vaccination services are organized and funded by the 
municipal primary care authorities. The vaccinations 
provided by employers are funded primarily by them, but 
the costs are partly reimbursed by the Social Insurance 
Institution. Those who are not in the above groups have 
to cover at least the cost of the vaccine but if the vacci-
nation is given at a public health care, it is usually free 
of charge.
Key barriers and facilitators
In Finland the coverage of MMR vaccination is quite 
high, reaching 94% among children born in 2015, and 
has somewhat improved during recent years. However, 
the coverage is slightly lower than 95% which is con-
sidered to be the level necessary to prevent outbreaks 
of measles. In addition, there are areas with coverage 
below 90%. The inadequate coverage is probably not so 
much related to the vaccination system which in general 
is considered to operate well but to the health beliefs of 
the parents. According to some anecdotal evidence, this 
is also an explanation for low local vaccination coverage 
in some areas of the country with higher support for 
vaccine-sceptic opinions.
The coverage of seasonal influenza vaccine has improved 
but is still relatively poor in Finland even in the large 
groups eligible for free-of-charge vaccines; in the 2017/18 
season coverage among those aged over 65 years was 
47.6% and for children aged 6-35 months it was 34.5%. 
Among the working-age population, coverage is even 
lower: 30.1–34.6% in women and 23.2–25.9% in men 
aged 30–59. The out-of-pocket pharmacy cost of influ-
enza vaccines (€10–14) is probably not the main reason 
for low coverage but the complicated system for getting 
vaccinations when the person is not eligible for free-of-
charge vaccination might be a factor. These complica-
tions include time costs related to requesting the vaccine 
prescription from a physician, purchasing the vaccine 
at a pharmacy, and visiting a health centre for vaccina-
tion. In addition, influenza is not generally understood 
to be a serious illness. However, the public campaigns 
for increasing coverage have improved the situation to 
some extent.
An additional factor influencing public attitudes to influ-
enza vaccination is the fact that Finland was one of the 
countries affected by several cases of narcolepsy as a conse-
quence of the mass vaccinations for Influenza A (H1N1) 
a serious case of influenza. This includes family members 
of older persons, newborn infants, pregnant women and 
persons with immunodeficiencies. Informal carers are also 
given the shot free of charge. These vaccines are regularly 
provided by the municipal primary care authorities at 
local health centres. In cases where the employer provides 
seasonal influenza vaccines to their employees, vaccina-
tion takes place at occupational health services.
Persons not belonging to the groups listed above can 
request a prescription for the vaccine from a medical 
doctor, buy the vaccine at the pharmacy and visit the local 
health centre, occupational health service or a private 
clinic to be vaccinated. Guidelines on vaccinations are 
issued by the National Institute for Health and Welfare.
Financing
All vaccinations in the national vaccination programme, 
including against measles, are free of charge for the patient.
The purchasing of the national vaccination programme 
vaccines is funded from the state budget. The vaccina-
tion services are organized by the municipal primary 
care authorities and funded by the municipalities. The 
municipalities have the right to levy taxes and they also 
receive state subsidies.
The main gaps in financing vaccination services apply to 
undocumented migrants and EU and ETA citizens who 
are not covered by health insurance in their home coun-
try. Some large municipalities, such as Helsinki, Espoo 
and Turku, have decided to provide health services not 
granted by national legislation to these groups. These 
services include childhood vaccinations.
As a general rule, vaccinations included in the national 
vaccination programme are free of charge for the patient. 
The national vaccination programme covers vaccination 
against influenza for those over 65 years of age and for 
those to whom influenza poses a substantial threat to 
health as well as their family members. Other specific 
groups for whom influenza vaccination is provided free 
of charge are personnel in health and social care and 
pharmacy services, pregnant women, children aged 6–35 
months, and men and women starting their conscript or 
voluntary service in the army.
The financing of adult influenza vaccinations comes from 
multiple sources. The vaccinations under the national 
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in 2009/10. These adverse effects resulted in public debate 
and raised concern regarding the safety and effectiveness 
of influenza vaccines.
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France
Karine Chevreul
Governance
The Ministry of Health is responsible for developing and 
overseeing the implementation of national vaccination 
plans and programmes. Each year the national immuni-
zation programme is set out by the Minister of Health on 
the basis of proposals made by the Technical Commission 
on Immunization of the French National Authority for 
Health (Haute Autorité de Santé). Implementation is the 
responsibility of regional health agencies (Agences region-
ales de santé) that are charged with ensuring that the 
provision of health services meets the needs of the popu-
lation and with implementing regional health policies in 
relation to mother and child health (protection maternelle 
et infantile). Health care providers are obliged to report 
cases of measles to the relevant regional health agency.
The French National Public Health Agency (Santé publique 
France), created through the merger of two key public 
health bodies, the French Institute for Public Health 
Surveillance (Institut de Veille Sanitaire) and the National 
Institute for Prevention and Health Education (Institut 
national de prévention et d’éducation pour la santé), mon-
itors the implementation of the immunization plan. It 
provides statistics on the share of the targeted population 
that has been immunized and on the number of cases of 
vaccine-preventable diseases. Infant vaccination coverage is 
mainly calculated through the returns of mandatory health 
certificates when a child reaches their second birthday. 
More recently, and for older children, vaccine coverage 
is also measured through the databases of the statutory 
health insurance about health care utilization. All health 
services that are reimbursed through the statutory health 
insurance are registered in these databases (see for instance: 
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for individuals with certain chronic conditions (such as 
lung diseases, cardiovascular diseases, neurological dis-
eases, kidney and liver diseases, diabetes, cancers and 
immunity disorders), pregnant women, obese people, 
relatives of particularly vulnerable newborns (such as 
premature newborns, newborns with congenital heart 
disease, immune deficits, lung disease, or neurological 
disease). Immunization against influenza is also recom-
mended for residents of nursing homes irrespective of 
their age, as well as for health professionals, including 
pharmacists, and people working in the travel sector (e.g. 
on ships and planes).
Provision
Childhood vaccinations against measles
Most childhood vaccinations against measles are admin-
istered by self-employed general practitioners. However, 
they can also be administered by hospital doctors, nurses 
(if prescribed by a doctor), in public vaccination centres, 
in mother and child health services, and by midwives for 
pregnant women, cohabitating relatives, and relatives of 
newborns under the age of eight weeks.
When the vaccination is to be administered by a self-
employed health professional, it is first prescribed by a 
physician; the parents then have to obtain the vaccine from 
a pharmacy and return with it to the health professional 
who administers the vaccination. When administered in 
a public vaccination centre, or a mother and child health 
service, the prescription, delivery and administration of 
the vaccine are usually done by the health care provider.
Adult vaccinations against influenza
Most adult vaccinations against influenza are also per-
formed by self-employed general practitioners. However, 
they can also be administered by hospital doctors, nurses 
(for at-risk adults for whom vaccination is indicated), in a 
public vaccination centre, in a medical centre managed by 
the statutory health insurance, by a midwife (for women 
and relatives of a newborn at high risk), and by mother 
and child health services for children below 7 years and 
pregnant women.
For individuals who are not at increased risk, when the 
vaccination is to be administered by a self-employed 
health professional, it is first prescribed by a physician, 
http://invs.santepubliquefrance.fr/Dossiers-thematiques/
Maladies-infectieuses/Maladies-a-prevention-vaccinale/
Couverture-vaccinale/Donnees/Grippe). Statutory health 
insurance is the single public payer for health services in 
France, and through various schemes it covers more than 
99% of the resident population.
The National Public Health Agency is also in charge 
of raising the awareness of the population about the 
importance of immunizations against vaccine-preventable 
diseases such as measles and influenza. It produces infor-
mation materials for patients, parents and health pro-
fessionals, including leaflets, flyers and posters, as well 
as vaccination campaigns through the media and the 
Internet. Many of these documents are also available 
online. A website managed by the National Public Health 
Agency provides comprehensive information on immuni-
zation programmes and vaccines.1 It aims to increase the 
trust of the population in publicly organized vaccination 
programmes and to provide all the information needed 
about vaccination. A version for health professionals has 
also been launched in 2018.
Since January 2018 there have been 11 mandatory immu-
nizations for children before the age of two. These are 
against tetanus, diphtheria, poliomyelitis, Haemophilus 
influenzae type b, pertussis, Streptococcus pneumoniae 
(pneumococcal vaccine), group C Neisseria meningitidis 
(meningococcal C vaccine), hepatitis B, rubella, measles 
and mumps.
Vaccination against measles is thus compulsory for 
children who must receive two injections between the 
ages of 1 and 2 years for all children born since January 
2018. In order to extend immunization coverage, children 
born after 1980 should also have received two doses. 
Unvaccinated children are not admitted to any kind of 
social life (day nurseries, crèches, schools, leisure activi-
ties, holidays camps, etc.). There is no further sanction 
or fine for parents who do not have their children vacci-
nated, but they could be legally pursued for compromis-
ing their child’s health.
Immunization against measles is recommended for health 
professionals and professionals working with young 
children.
Immunization against seasonal influenza is recom-
mended for all people aged 65 years and over, as well as 
1 https://vaccination-info-service.fr
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insurance. Patients have to pay 70% of the service fee for 
the visit to the health professional who administers the 
vaccine. The remaining 30% of the service fee is covered 
for about 95% of the population by complementary vol-
untary health insurance.
When the vaccines are administered in public vaccination 
centres, or mother and child health services, they are usu-
ally free at the point of delivery and no payment has to 
be made out of pocket for the vaccines or their adminis-
tration. The costs of the vaccines are covered by statutory 
health insurance. Vaccination centres are financed by the 
state, and mother and child health protection services by 
local government at department level.
Adult vaccinations against influenza
Vaccines for immunizations against influenza are also fully 
covered by statutory health insurance for the targeted pop-
ulation and there are no out-of-pocket payments. When 
immunizations against influenza are administered by a 
self-employed health professional, people can obtain the 
vaccine for free from the pharmacy if they belong to the 
targeted population groups and provide their invitation 
letter from the statutory health insurance or the specific 
form for prescription. Patients then have to pay 70% of 
the service fee for the visit to the health professional who 
administers the vaccine. The remaining 30% of the service 
fee is covered for about 95% of the population by com-
plementary voluntary health insurance cover. When the 
vaccines are administered in a public vaccination centre, 
or by a mother and child health service, they are free at 
the point of delivery and no payment has to be made.
Key barriers and facilitators
The main barriers for effective immunization coverage 
in France are public (mis)perceptions on immunization 
and the safety of vaccines, oversight and negligence. 
According to the regular Health Barometer survey, favour-
able attitudes towards vaccination declined markedly 
between 2000 and 2017 (Figure 1). In 2010 almost 40% 
of respondents had negative attitudes towards immuni-
zation. This was mainly due to the failure of the H1N1 
campaign, with negative media reports, lack of involve-
ment of private physicians, concerns over the safety of 
vaccines, and sometimes beliefs that immunization is 
recommended under the pressure of pharmaceutical com-
panies for vested financial interests.
then the patient has to obtain the vaccine from a phar-
macy and return with it to the health professional who 
administers the vaccination.
Every year in the autumn the statutory health insurance 
sends a personal invitation to be vaccinated against influ-
enza to all insured people covered by the recommenda-
tions (with the exception of pregnant women and obese 
people, who are difficult to identify as such in the data-
base). The person will be given the vaccine for free from 
a pharmacist when showing the invitation letter, and will 
then visit a health professional (doctor, nurse or midwife) 
to receive the vaccination.
If a person of the targeted population does not receive 
an invitation (e.g. pregnant women and obese people), 
a physician can prescribe the vaccine on a specific form 
and the patient will receive the vaccine for free from the 
pharmacist.
Since October 2017 pharmacists have been allowed 
to vaccinate against influenza, on a voluntary basis. A 
pilot was conducted in two regions (Auvergne-Rhône-
Alpes and Nouvelle Aquitaine) for the influenza season 
2017/18. For the next season (2018/19) the pilot will be 
extended to two additional regions (Occitanie and Hauts-
de-France). It is foreseen that all pharmacists in all the 
regions of France, including overseas departments, will 
be allowed (if they want to) to vaccinate against influenza 
from October 2019 onwards.
Financing
Childhood vaccinations against measles
In France vaccines used in both mandatory and recom-
mended immunizations are covered by statutory health 
insurance.
When immunization against measles is administered by a 
self-employed health professional, patients can receive the 
vaccine for free from a pharmacy (on production of their 
statutory health insurance card) when they are between 
1 and 17 years of age. If they are 18 years or older, the 
costs are covered by statutory health insurance at a rate 
of 65%, with the remaining costs covered for about 95% 
of the population by complementary voluntary health 
insurance. In practice, the vast majority of the popula-
tion receives the vaccine for free and the pharmacist is 
reimbursed by the statutory and complementary health 
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Figure 1 Attitudes towards vaccination (in %) among 18–75 year-olds in France, 2000–2017
Sources: Baromètres santé, 2000, 2005, 2010, 2014, 2016, 2017, Santé publique France
Reference
Gautier A et al. (2017). Adhésion à la vaccination en 
France: résultats du Baromètre santé 2016. Bulletin 
Epidémiologique Hebdomadaire, Hors-série Vaccination, 
21–7.
Although attitudes towards vaccination have again 
improved (with only 2.2% of the population against all 
types of immunizations), distrust towards some vaccines 
persists. Immunization against influenza shows the high-
est rate of distrust (nearly 15% of people aged 18 to 75 
years in 2017), with people aged between 25 and 49 years 
having the most negative attitudes.
In the 2016 Health Barometer survey (Gautier et al., 
2017), parents of children aged between 1 and 15 years 
were more in favour of immunization than any other 
groups of the population (i.e. people without children 
or with children below 1 or above 15 years; OR adjusted 
by age, gender, level of education, income and region = 
1.2; p<0.01). However, one quarter of parents surveyed 
in 2016 reported that they had refused a recommended 
vaccination because they thought the vaccines were not 
safe or useful; 17% reported that they had postponed 
an immunization recommended by their doctor because 
they were unsure; and over a quarter reported that they 
had accepted an immunization despite having had doubts 
about its efficacy.
The main facilitators of effective vaccination coverage 
in France are excellent access to immunization services, 
public coverage of the costs of vaccinations, and informa-
tion and education campaigns.
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Germany
Miriam Blümel
Governance
In 2001 the “German Protection against Infectious 
Diseases Act” (the law on prevention and control of infec-
tious diseases in humans) came into force and defined 
the basics for vaccinations with the aim of protecting the 
population from communicable diseases. The Federal 
Institute for Infectious and Non-Communicable Diseases 
(Robert Koch Institute) is a subordinated agency of the 
Federal Ministry of Health. It is the government’s central 
scientific institution in the field of biomedicine and an 
important body for the safeguarding of public health in 
Germany. Among other tasks, the Robert Koch Institute 
is charged with identification, surveillance and preven-
tion of infectious diseases. The tasks of the Robert Koch 
Institute are specified in § 4 of the German Protection 
against Infectious Diseases Act (2001).
The Robert Koch Institute is advised in its technical 
and regulatory tasks by several committees, including 
the Standing Committee on Vaccinations. The Standing 
Committee on Vaccinations is an independent advisory 
group that develops national recommendations for the 
use of licensed vaccines. It consists of 12 to 18 unpaid 
members representing different expert fields who are 
appointed by the Federal Ministry of Health for a period 
of three years.
Vaccination recommendations by the Standing Com-
mittee on Vaccinations apply nationally and are based 
on the criteria of evidence-based medicine. While the 
Federal Institute for Vaccines and Biomedicines (Paul 
Ehrlich Institute) is responsible for licensing vaccines with 
regard to product-specific efficacy, safety and quality, the 
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vaccination in Germany. Adults can therefore decide 
for themselves and parents can decide for their children 
which vaccinations they receive.
In 2015 the Act to Strengthen Health Promotion and 
Prevention came into force with the aim to improve 
disease prevention and health promotion by regulating 
vaccination policy through a range of legal measures. 
For instance, children will only be admitted to day-
care facilities if the parents can prove that they have 
taken medical advice from a physician. If this proof is 
not provided, the responsible health authority will be 
informed. Parents who refuse the counselling can be fined 
up to €2500. In case of a measles outbreak in a day-care 
facility or school, the institution is allowed to exclude 
unvaccinated children from attendance. Furthermore, 
the recruitment of employees in medical facilities can 
be made dependent on their vaccination coverage and 
immunization status.
According to the “German Health Interview and 
Examination Survey for Children and Adolescents” 
(KiGGS) conducted by the Robert Koch Institute, ado-
lescents with a migration background from both parents 
represent a population group with a relatively low vaccina-
tion rate. Various welfare services and non-governmental 
organizations have developed primary prevention projects 
in collaboration with the responsible health authorities, 
the Robert Koch Institute and the Federal Ministry of 
Health in order to better reach this group. For example, 
the university medical centre Charité Berlin has launched 
the Impfbus (“vaccination bus”) project. This mobile vac-
cination centre drives to schools, informs pupils about 
necessary vaccinations, and conducts them (with parental 
consent). The vaccination bus also supports the medical 
care of refugees.
In Germany a national immunization register does not 
exist. However, nationwide and continuous surveil-
lance of vaccination coverage is available from school 
entrance examinations since 2001. As a second pillar 
for the nationwide monitoring of vaccine uptake, the 
Robert Koch Institute coordinates KV-Impfsurveillance 
(KV-Vaccination Surveillance) in cooperation with the 
17 Regional Associations of SHI-Accredited Physicians 
(KV) to monitor vaccination coverage in all age groups, 
in specific risk groups and at district level. All 17 Regional 
Physicians’ Associations send anonymized payroll data 
on vaccination services, child and adolescent health 
check-ups and diagnoses of vaccine-preventable diseases 
from ambulatory care physicians to the Robert Koch 
Standing Committee on Vaccinations analyses the indi-
vidual benefit-risk ratio, but also studies epidemiology at 
the population level and the effects of a nationwide vac-
cination strategy for Germany. In addition, the Standing 
Committee on Vaccinations develops criteria to delin-
eate a common vaccine response from a health impair-
ment beyond the usual extent of a vaccine response. The 
Committee’s recommendations are considered medical 
standard. While the Committee’s recommendations are 
not binding, they provide the basis for the vaccination 
guidelines of the Federal Joint Committee. After publi-
cation of a new Committee recommendation, the Federal 
Joint Committee has three months to decide if they will 
include this recommendation in the vaccination guide-
lines. If they decide against it, they must provide the 
arguments that led to the rejection. Once a vaccination 
is included in the guidelines, it is covered under statu-
tory health insurance. As already mentioned, the recom-
mendations of the Standing Committee on Vaccinations 
apply nationally. However, the German Protection against 
Infectious Diseases Act gives the federal states the oppor-
tunity to make special arrangements for their own federal 
state. The federal state recommendations are relevant for 
the vaccine injury compensation programme.
The Standing Committee on Vaccinations’ recom-
mendations are usually published once a year in the 
Epidemiological Bulletin and on the websites of the Robert 
Koch Institute. Since 2004 detailed explanations of the 
recommendations have also been published. The recom-
mendations include a vaccination schedule of standard 
vaccinations for infants, toddlers, children, adolescents 
and adults, and a table of indication and booster doses 
with explanatory notes. According to the vaccination 
schedule, infants receive primary immunization for tet-
anus, diphtheria, pertussis, poliomyelitis, hepatitis B, 
Haemophilus influenzae type B, pneumococcal disease and 
rotaviruses. Toddlers should receive primary immuniza-
tion for meningococcal disease (Serogroup C), measles, 
mumps, rubella and varicella. Human papillomavirus 
(HPV) is a standard vaccination for girls and boys aged 
between 9 and 14 years. The Standing Committee on 
Vaccinations also recommends an annual vaccination 
against influenza and pneumococcal vaccination from 
the age of 60 (see Table 1).
The Standing Committee on Vaccinations gives recom-
mendations for the use of vaccinations for infants, tod-
dlers, children, adolescents, adults, adults older than 60 
years and for certain high-risk groups (e.g. patients with 
chronic conditions). However, there is no mandatory 
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Table 1: Vaccination recommendations 2017/18
Source: German Standing Committee on Vaccination (STIKO) recommendations, 2017/18 
Weeks
INFANTS
Months
TODDLERS CHILDREN
Years
ADOLESCENTS ADULTS
6 2 3 4 11-14 15-23 2-4 5-6 7-8 9-14 15-16 17 from 18 from 60
Tetanus G1 G2 G3 G4 N A1 N A2 N A
Diphtheria G1 G2 G3 G4 N A1 N A2 N A
Whooping cough 
Pertussis G1 G2 G3 G4 N A1 N A2 N A
Polio 
Poliomyelitis G1 G2 G3 G4 N A1 N N (if required)
Hepatitis Β G1 G2 G3 G4 N
Hib Haemophilus  
influezae type b G1 G2 G3 G4 N
Pneumococcal 
disease G1 G2 G3 N S
Rotaviruses G1 G2 G3
Meningococcal 
disease 
Serogroup C
G1 
From 12 months N
Measles G1 G2 N S
Mumps  
Rubella G1 G2 N
Chicken Pox 
Varicella G1 G2 N
Flu 
Influenza
S 
(annually)
HPV Human  
papillomaviruses N
AGE 
VACCINE U6 U7 U9 U10 J1U7A/8U4
 b
 a
 a
 a
f
f
f
c
d
e
G1 G2
ee
g
G
S
A
N
PRIMARY IMMUNISATION  
(up to 4 doses of vaccine G1-G4)
STANDARD VACCINATION
BOOSTER VACCINATION
CATCH-UP VACCINATION  
(primary immunisation of persons not yet vaccinated 
or completion of an incomplete vaccination series)
Well-child visit
Well-adolescent visit
(J1 aged 12-14 years)
This dose is not required if a monovalent vaccine is administered.
The 1st vaccine dose should be administered from the age of 6 weeks. Depending on 
the type of vaccine, 2 or 3 doses are required at intervals of a minimum of 4 weeks.
Vaccination with polysaccharide vaccine, booster vaccination only recommended for 
specific indications.
Single dose vaccinations for all individuals ≥ 18 years with unclear vaccination status 
and who were born after 1970, who have not been vaccinated or only received one 
vaccination as a child. Preferably with an MMR vaccine.
Standard vaccination for girls ages 9-14. For catch-up vaccinations and number of 
vaccine doses see the summary of product characteristics.
Td booster vaccination every 10 years. The next Td vaccination that is due is to be 
administered as a single dose vaccination in the form of Tdap or, if indicated, in the 
form of a Tdap-IPV combination vaccination.
Premature infants receive an additional dose of vaccine at the age of three months, 
i.e. a total of 4 doses.
a
b
c
d
e
f
g
U
J
Table 1 Vaccination recommendations 2018/19
Source: German Standing Committee on Vaccination recommendations, 2018/19
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facilities; and (3) other federal states have opted for cov-
erage of medical services under the statutory health insur-
ance scheme. Irrespective of the means of access, vacci-
nations for refugees, as well as other medical treatments, 
are all financed through the federal state governments. 
Also nongovernmental organizations play a pivotal role in 
providing measles vaccinations to migrants and to other 
children without health insurance coverage.
For adult vaccinations against influenza, the same rules 
apply as in the case of measles vaccination. Vaccination is 
a mandatory statutory health insurance benefit and free 
of charge at the point of delivery for those population 
groups listed in the vaccination guidelines of the Federal 
Joint Committee. Listed groups include adults aged 60 
years and older, pregnant women and all people with 
an increased health risk due to an underlying disease. 
Numerous sickness funds offer a range of vaccinations 
beyond those listed in the guidelines as a voluntary ben-
efit, e.g. vaccination against influenza for insured persons 
who are not included in the risk groups.
For the upcoming influenza season (2018/19), the Standing 
Committee on Vaccinations is changing its recommenda-
tion on influenza vaccination. According to its assessment 
published in January 2018, the Committee sees an added 
benefit of a quadrivalent vaccine compared to a trivalent 
one. For the 2018/19 season the Joint Federal Committee 
has included the recommendation in the vaccination 
guidelines and thus created the conditions for allowing 
those with statutory health insurance to be vaccinated 
against seasonal influenza with a quadrivalent vaccine.
People who are not eligible for vaccination against influ-
enza have to pay the physician out-of-pocket. However, 
many companies provide free-of-charge vaccinations for 
their employees.
Key barriers and facilitators
Although vaccination is not mandatory in Germany, 
measles immunization coverage among 3-year-olds with 
one vaccine dose has been at about 97%, which is above 
the EU average. Immunization uptake and paediatric 
immunization rates have been steadily rising over the last 
decade. However, gaps still persist in the second dose of 
measles vaccine. About every third person among people 
older than 60 years is vaccinated against seasonal influ-
enza, which is close to the EU average (OECD/European 
Observatory on Health Systems and Policies, 2017).
Institute, covering all age groups. Based on these data, 
vaccination coverage rates can be assessed in a represent-
ative manner for different age groups (at least for people 
who are insured through statutory health insurance, i.e. 
around 87% of the German population) and at district 
level. Some of the regionalized data (measles and rotavirus 
vaccination) are made publicly available online.2
Provision
Every physician in ambulatory care is allowed to provide 
vaccination services, irrespective of their specialization. 
Childhood vaccination against measles is usually under-
taken by paediatricians as part of routine health check-
ups for children. Adult vaccinations against influenza 
can also be provided by any physician, not only general 
practitioners. Company physicians are also allowed to 
conduct general vaccinations, such as against influenza. 
In addition, vaccinations are also organized and carried 
out by the health authorities.
Financing
Childhood vaccination against measles is free of charge 
at the point of delivery and there are no co-payments. 
Vaccination against measles is included in the vaccination 
guidelines of the Federal Joint Committee and is therefore 
a mandatory benefit under statutory health insurance. 
The statutory health insurance funds cover the costs of 
vaccinations against measles for children and all adults 
born after 1970, and for all other vaccinations listed in 
the guidelines. According to the Association of Private 
Health Insurance Companies, vaccination coverage is 
regulated individually by every health insurance com-
pany. As a rule, private health insurance companies cover 
the costs of vaccinations recommended by the Standing 
Committee on Vaccinations. Health authorities, which 
also provide vaccination against measles, are financed 
through the federal state government.
Refugees are also entitled to (childhood and young adult) 
vaccination against measles, but the regulations are com-
plex and access to health care varies between the federal 
states. During the first fifteen months of stay (1) some 
states require prior authorization for any medical treat-
ment beyond emergency treatment (i.e. also for vacci-
nation); (2) some states offer vaccinations in designated 
2 http://www.vacmap.de/
Germany 95
A facilitator for measles vaccination was the harmoniza-
tion of the immunization schedule with routine health 
check-ups for children, and moving the second measles 
vaccine dose from age 6 into the second year of life. After 
this change in the immunization schedule, second dose 
coverage especially increased dramatically. A barrier to 
improved vaccination coverage against measles is the low 
coverage achieved 20 years ago and earlier, and the lack 
of a systematic catch-up for these age groups. The decen-
tralized and privatized vaccination system in Germany 
has problems in actively reaching out to these age groups 
of adolescents and young adults and in systematically 
closing the remaining gaps. There is a routine adolescent 
check-up, but it is only taken up by approximately 50% 
of adolescent children.
For influenza, important barriers to improved vaccination 
coverage are the perceptions of the adult population in 
respect to the need for the vaccine and the severity of 
the disease, and mistrust in the vaccine and its perceived 
safety and effectiveness (Bödeker et al., 2015).
To give physicians in ambulatory care a financial incentive 
to provide vaccinations (or at least not to prevent vacci-
nation for financial reasons), there is a separate remuner-
ation mechanism for all listed vaccinations. Unlike many 
other primary care services, vaccinations are not tied to 
budget restrictions.
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Greece
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Governance
Key agencies
According to the decision of the Ministry of Health 
(Υ1/ΓΠ 161682/2008), the National Immunization 
Committee is the body of the Ministry of Health and 
Social Solidarity that is responsible for advising on recom-
mended vaccines. The Ministry determines the national 
vaccination programme, after the issuance of a joint min-
isterial decision by the Minister of Finance, the Minister 
of Labour and Social Security and the Minister of Health 
and Welfare.
The National Immunization Committee is responsible 
for recommendations on the drafting and updating of the 
national vaccination programme and vaccination recom-
mendations for the general public. It is also responsible 
for providing vaccination recommendations regarding 
specific population groups and health professionals; for 
providing vaccination recommendations in the event of 
epidemics, pandemics and public health emergencies, 
including the setting of vaccination priorities; for the 
drafting of proposals for the development of population 
vaccination programmes in the country or for subgroups, 
and for the monitoring of their implementation; for the 
monitoring of epidemiological data on diseases prevented 
by vaccination; for taking measures to ensure the ade-
quacy of vaccines and sera; and finally for the identifi-
cation or modification of the technical specifications for 
vaccines and sera according to the specifications of the 
World Health Organization (WHO).
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according to its progress, guidelines are issued based 
on the current data and the opinion of the competent 
scientific bodies.
A circular for influenza vaccination is issued by the 
above-mentioned agencies on an annual basis. Influenza 
vaccination includes only one vaccine dose and is rec-
ommended for all people aged over 6 months, if they 
wish to have it. Particular emphasis is placed on the 
importance of influenza vaccination for individuals 
belonging to the so-called high-risk groups. The Health 
District Governors, the General Directors for Public 
Health and Social Welfare of the Districts and the Public 
Health and Social Care Directors of the Regional Units, 
as well as the mayors of the Kallikratis Municipalities 
of the country, collaborate with the Centre for Disease 
Control and Prevention in organizing joint actions to 
inform the public and special populations (e.g. schools) 
about both influenza and the importance of influenza 
vaccination through the distribution of printed mate-
rial, speeches, social messages in the media, etc. The 
National Organization for Medicines (EOF) is responsi-
ble for the adequacy of the vaccine in the Greek market 
throughout the transmission period of the influenza 
virus. The activity of influenza and the circulating virus 
strains are monitored through the Centre for Disease 
Control and Prevention’s supervision networks, with 
laboratory supervision in the Greek Influenza Report 
Centres. The notification of each laboratory-confirmed 
influenza case is made at the Centre for Disease Control 
and Prevention, which sends the annual epidemiological 
surveillance report on influenza to the Public Health 
Directorate of the Ministry of Health. An epidemiological 
surveillance bulletin on influenza is issued on a weekly 
basis, including information on the vaccination status of 
severe laboratory-confirmed influenza cases hospitalized 
in intensive care units, as well as on the vaccination 
status of those who died. There is no dedicated official 
responsibility for call and follow-up for those who have 
not been vaccinated against measles or influenza. The 
vaccine and the vaccination performed are recorded in 
the personal Booklet of Child Health (in writing) and 
in the national electronic database that is linked to the 
National Register of Social Insurance for both children 
and adults.
Special programmes
To address the health needs of refugees, asylum-seekers 
and irregular immigrants in Greece, a relevant circular has 
Vaccination programmes
In Greece, on the basis of systematic scientific docu-
mentation, epidemiological data and economic weight-
ing, and taking into account the guidelines of WHO 
and the European Centre for Disease Prevention and 
Control (ECDC), the child and adolescent vaccination 
programme and the adult vaccination programme are 
drawn up at the national level, and include and explain 
the timetable for all vaccines recommended to the general 
public and to groups at high risk. The national vaccina-
tion programme includes the vaccination plan for measles 
for children and for influenza for adults.
Vaccines included in the national vaccination programme 
are recommended but, in accordance with current legisla-
tion, sanctions are not imposed on those who do not want 
to be vaccinated or vaccinate their children. However, 
enrolment of pupils in kindergarten and primary school 
requires vaccination in accordance with the national vac-
cination programme, as shown on each pupil’s health 
card (No. Φ.6/451/115136/Γ1/16-9-2010 circular of the 
Ministry of Education, Research and Religious Affairs). 
Therefore the vaccination of children is becoming in 
a sense mandatory, with adult vaccination remaining 
recommended.
For measles, due to the recent epidemic outbreak in 
Greece, the National Immunization Committee, under 
the auspices of the Ministry of Health, has drawn up 
a circular recommending the immediate vaccination 
of children, adolescents and adults who have not been 
vaccinated. According to the national vaccination pro-
gramme, children, adolescents and adults born after 
1970 who have no history of the disease should be 
vaccinated with two doses of measles vaccine in the 
form of a monovalent measles vaccine or a trivalent 
MMR vaccine. In addition, it is recommended that the 
first dose of the MMR vaccine is administered at the 
age of 12 months and the second dose three months 
after the first dose or as soon as possible thereafter. In 
high-risk cases the second dose may be administered a 
minimum of four weeks after the first dose. These recom-
mendations apply for as long as the epidemic outbreak 
of measles is in progress and until a new Committee 
decision is issued. The Centre for Disease Control and 
Prevention carries out activities to inform the public, as 
well as vaccination interventions for vulnerable popula-
tion groups. The evolution of the epidemic in Greece 
is systematically monitored by the Ministry of Health 
and the Centre for Disease Control and Prevention and, 
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or not, including asylum-seekers. Vaccines are covered 
through the Greek National Health Service Organization 
(EOPYY) and by extension from the state budget. There 
are no charges at the point of delivery for vaccinations 
included in the national vaccination programme.
Key barriers and facilitators
Obstacles and facilitators of effective vaccination coverage 
for measles and influenza are common. The development 
and extent of the anti-vaccination movement constitute 
a major obstacle to increasing the rate of vaccinations. At 
present, vaccinations are not mandatory and sanctions 
are not imposed. In addition, a large percentage of Greek 
citizens are unaware of the existence of adult vaccination 
and consider vaccinations to be an issue only for children. 
The absence of a national vaccination archive also inhibits 
the search for those who refuse vaccination or those who 
need to update their vaccination status. The free provi-
sion to everyone of the vaccines included in the national 
vaccination programme is, however, a major facilitator of 
vaccination coverage in Greece.
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been issued, according to which they should be vaccinated 
as a matter of priority against measles, rubella, mumps, 
diphtheria, tetanus, pertussis and poliomyelitis, and new-
borns against tuberculosis. If epidemiological supervision 
reveals a series of cases, meningococcal and influenza 
vaccination is recommended during the virus circulation 
period, at the age of ≥ 6 months. In the second year, and 
if their stay in the country is prolonged, vaccinations 
are supplemented according to the national vaccination 
programme and a tuberculin-reaction check is performed. 
The above recommendations are updated depending on 
epidemiological data and the availability of vaccines.
Vaccination coverage
Vaccination coverage of the population is researched at the 
national level through studies conducted by the National 
School of Public Health, by the country’s universities, 
by the Centre for Disease Control and Prevention, and 
by the Hellenic Statistical Authority, in collaboration 
with the Ministry of Health. Vaccination coverage of 
children in Greece against measles is maintained at a 
high level. However, vulnerable social groups such as the 
Roma have a low level of vaccination coverage. As far as 
adult influenza vaccination is concerned, there has been 
an increase, but it is still at low levels compared to the 
European goal.
Provision
Vaccines are provided to the Health Centres of the 
Health Districts of the country and to the Public Health 
Directorates of the Regional Units. The health profes-
sionals who administer the vaccines are mostly nurses 
and physicians in the public and private sectors. Special 
cases, such as mobile populations (e.g. refugees, asylum 
applicants) with no National Register of Social Insurance, 
are being vaccinated by organizations such as nongov-
ernmental organizations or the National Red Cross fol-
lowing the Centre for Disease Control and Prevention’s 
guidelines.
Financing
Vaccines included in the national vaccination pro-
gramme, including those against measles for children and 
against influenza for adults, are provided free of charge 
to all legal residents in the country, whether insured 
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No.Δ1α/Γ.Π.οικ. 75890/5-9-2018 circular of Hellenic 
Ministry of Health “Guidelines for the influenza 2018-
2019 – Influenza vaccination” .
No.Γ1α/Γ.Π.οικ.66202/04-10-2018 circular of Hellenic 
Ministry of Health “National Programme of vaccination 
for adults 2018–2019”.
Hungary
Györgyi Tokodi, Péter Gaál
Governance
In Hungary vaccination programmes are regulated by 
Decree No. 18/1998 (VI. 3.) NM of the Minister of 
Welfare on the Prevention and Control of Infectious 
Diseases and Epidemics. The Decree specifies a so-called 
vaccination guideline,1 which has, since 2017, been 
issued by the Ministry of Human Capacities, to update 
all the necessary knowledge on vaccination, including 
the practical tasks regarding the implementation of the 
vaccination programmes, general and specific indica-
tions and contraindications of vaccines, the storage and 
use of vaccines, registration and reporting requirements, 
as well as other provisions and recommendations on a 
yearly basis.
The Decree categorizes vaccinations into five main groups:
1. Mandatory, free-of-charge routine childhood 
immunizations (tuberculosis, diphtheria, per-
tussis, tetanus, poliomyelitis, measles, rubella, 
mumps, Haemophilus influenzae type B, hepatitis 
B, Streptococcus pneumoniae);
2. Mandatory, free-of-charge immunization where 
there is risk of infection (people living in the 
vicinity of typhoid, diphtheria, pertussis, measles, 
rubella, mumps; hepatitis A patients; people at risk 
of tetanus or rabies infection; newborns of hepati-
tis B carrier mothers; health workers and students);
1 Article 4, section (2). Before 2017 the vaccination guideline 
was issued by the National Centre of Epidemiology, which was 
integrated into the National Public Health Institute.
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Health Visitor Service is organized on a territorial basis. 
Each health visitor is responsible for a district and is 
charged with the preventive care of inhabitants, includ-
ing pregnant women, post-partum women and children 
under the age of 6 in their homes, and school children 
aged 6+ years in schools. The health visitor keeps track of 
those who are obliged to be vaccinated and maintains a 
vaccination register for them. If there is a missed vaccina-
tion, the health visitor sends a written notification. After 
three failed attempts, the health visitor is obliged to report 
the case to the District Government Office.
The health visitor has to report completed vaccinations, 
failed vaccinations over two months, and the emigration 
and immigration of persons liable for vaccination.
The District Government Offices integrate and electron-
ically transfer the data provided by health visitors to 
the electronic epidemiological surveillance register of 
the Ministry for Human Capacities, in particular to the 
Department of Hospital Hygiene and Communicable 
Disease Control. This means that vaccination coverage 
data are up-to-date and available at every level (national, 
county and district).
The same process applies to communicable disease sur-
veillance, the only difference being that patients are 
reported by the medical doctors who detect the disease. 
The list of communicable diseases, the reporting of which 
is mandatory, is determined by the same decree.6
Given that the system is mandatory and based on the 
place of residence, there are no targeted measures for 
specific groups of the population and no special incentive 
schemes in place. Parents who fail to vaccinate their chil-
dren can be fined. The fine or the implementation of the 
mandatory vaccination can be enforced by the Hungarian 
tax authority.
For mandatory childhood immunization, the vaccination 
coverage rates are calculated using administrative infor-
mation, mainly the data reported by health visitors to 
the electronic epidemiological surveillance database. The 
denominator is the total number of children obliged to 
be vaccinated in the given year, because they reached the 
vaccination age.
6 Decree No. 18/1998 (VI. 3.) NM of the Minister of Welfare, 
Article 16/A, Annex 1.
3. Voluntary, free-of-charge immunization where 
there is risk of infection (diphtheria; hepatitis B 
(e.g. family members of people with hepatitis B 
infection; patients on dialysis; oncology patients; 
IV drug users); influenza; HPV for girls aged 
12+);
4. Mandatory (e.g. yellow fever) and optional (e.g. 
hepatitis A) vaccination for travellers; and
5. Occupation-related mandatory vaccination (e.g. 
tetanus, tick-borne encephalitis, hepatitis B).
The minister responsible for health (the Minister for 
Human Capacities) is assigned the power to control and 
supervise the prevention and elimination of communi-
cable diseases, which is delegated to the national chief 
medical officer.2 The national chief medical officer is 
authorized to act on their own where there is a risk of 
epidemics.3 Local official activities are under the scope of 
authority of County and District Government Offices.4 
The deputy state secretary for the affairs of the chief 
medical officer is responsible for the development of 
national immunization programmes, and the coordi-
nation and supervision of implementation via the 
Communicable Diseases Prevention and Surveillance 
Unit under the Department of Hospital Hygiene and 
Communicable Disease Control, as well as the Clinical 
and Epidemiological Microbiology Directorate of the 
National Public Health Institute.5
In Hungary all vaccination programmes are nationwide, 
but their implementation is organized on a territorial 
basis through the public health departments and units 
of County and District Government Offices. However, 
the immunization calendar applies nationwide and the 
same vaccine schedule and vaccines are used in the whole 
country.
The electronic epidemiological surveillance database is 
maintained by the Department of Hospital Hygiene 
and Communicable Disease Control of the Ministry of 
Human Capacities, and updated with data from the field. 
For mandatory childhood vaccination, the most impor-
tant actor, responsible for preparing the monthly reports, 
is the health visitor (mother and child health nurse). The 
2 Article 2, section (1).
3 Article 2, section (2).
4 Article 3, section (1).
5 Order No. 51/2017 (X. 25.) EMMI of the Minister of Human 
Capacities.
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●	 workers where influenza is an occupational hazard, 
such as health and social care workers, people 
working in stock-raising, people working with 
immigrants, and people working in public educa-
tion institutions.
In addition to the national programmes, pharmacies offer 
several other vaccines that can be purchased by non-target 
groups.
In the 2017/18 influenza season the utilization of free-of-
charge vaccines was 65.2%.7 In 2017, 1.2 million vaccine 
doses were distributed among the target groups.
The Department of Hospital Hygiene and Communicable 
Disease Control of the Ministry of Human Capacities 
operates and maintains Influenza Sentinel Surveillance, 
which publishes the number of reported influenza-like 
illness consultations per 100 000 population and the 
number of virus detections. Influenza-like illness cases are 
reported by Sentinel general practitioners (roughly 20% 
of the total, and numbering 1351 in the 2017/18 season), 
on a weekly basis, by age groups. Of these family doctors, 
100 regularly take samples from patients to identify the 
virus strain. Figure 1 shows an example of the weekly 
number of influenza-like illness cases and the number 
of specimens testing positive for influenza viruses for the 
2017/18 influenza season.
7 Epinfo 20/19.
Vaccination coverage
In Hungary mandatory, free-of-charge vaccination against 
measles (group 1 vaccination) was introduced in 1969, as 
a result of which most persons aged under 47 years have 
received at least one shot. Since 1989, to achieve long-
term protection, children have received two shots, the first 
at the age of 15 months and the second at the age of 11 
years. Thanks to the mandatory vaccination programmes, 
the territory-based Health Visitor Service, and the strict 
reporting system, immunization coverage is excellent in 
Hungary (see Table 1), and measles cases are extremely rare.
Table 2 shows the trend regarding the number of measles 
cases. Between 2006 and 2016 there were no indigenous 
cases in Hungary, and only imported cases occurred. In 
2017 a small outbreak took place in a small hospital near 
the border, where a foreign measles patient was treated 
and a few health workers and patients contracted the 
disease. In 2018, 18 imported, or import-related, cases 
were reported.
Under the national influenza vaccination programme, 
vaccination is accessible free of charge for certain target 
groups on a voluntary basis (group 3 vaccination), 
including:
●	 High-risk populations, including people over the 
age of 60, pregnant women, chronic patients, such 
as patients with immune deficiency, chronic res-
piratory, cardiovascular and kidney diseases, and 
long-term care patients,
Table 1 Coverage of the second dose of the measles vaccine, 2010–2017
2010 2011 2012 2013 2014 2015 2016 2017
Coverage (%) 99.5 99.5 99.4 99.3 99.4 99.6 99.7 99.7
Source: Department of Hospital Hygiene and Communicable Disease Control, Ministry of Human Capacities
Table 2 Measles cases, 2006–2017
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Cases 1 0 0 1 0 0 1 1 0 0 0 36
Source: http://www.who.int/immunization/monitoring_surveillance/ 
burden/vpd/surveillance_type/Country_slides_measles.pdf?ua=1
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of Hospital Hygiene and Communicable Disease Control 
of the Ministry of Human Capacities.
Financing
With the exception of occupation-related mandatory vac-
cination, which has to be covered by employers, vaccines 
for mandatory vaccinations are free of charge. They are 
covered from the central government budget under the 
Ministry of Human Capacities.8 With the exception of 
vaccination against influenza, HPV and pneumococcus,9 
voluntary vaccinations are excluded from the publicly 
funded benefit package, and the clients have to pay for 
them out-of-pocket, both for the vaccine and the vac-
cination service.10 The service fee for administering the 
shot is set at HUF 2000, while it is free of charge for 
mandatory vaccinations. Publicly financed health service 
providers are paid for by the NHIFA depending on the 
type of service, e.g. primary care is capitated and out-
patient specialist services are paid for by fee-for-service 
points.
Vaccines are procured centrally and distributed to the 
District Government Offices, which further distributes 
them among the relevant health service providers, such 
8 Act CLIV of 1997, Article 142, section (2).
9 Government Decree No. 284/1997 (XII. 23.) Korm, Annex 
2, item 16.
10 Act LXXXIII of 1997, Article 18, section (6), point (t).
Provision
The provision of immunization is based on the vaccina-
tion guideline, which incorporates the professional guide-
lines according to which vaccination should be adminis-
tered. The health service providers who administer the 
vaccines are supervised by and accountable to the District 
Government Offices.
Measles
Mandatory childhood vaccination for the entire child 
population between the ages of 0 and 6 years are admin-
istered by family paediatricians or family doctors, while 
childhood vaccinations for children over the age of 6 
years are organized through the so-called school cam-
paign vaccinations, which are administered by school 
health doctors. Contraindications are considered by the 
administering doctor.
Influenza
Influenza vaccines are administered by family doctors in 
primary care, or by occupational health doctors in the 
workplace, where influenza is an occupational hazard. 
They are obliged to report the utilization of free-of-charge 
influenza vaccines to the Government District Offices, 
which aggregate and transfer the data to the Department 
Figure 1 The number of patients with influenza-like illness who sought medical attention, per 100 000 popu-
lation, and the number of influenza positive samples in Hungary, week 40 of 2017 – week 20, 2018
Source: Department of Hospital Hygiene and Communicable Disease Control
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important problem, and it is difficult for doctors 
to diagnose the disease because most of them have 
not encountered a single case for decades. On 
the other hand, outbreaks in neighbouring coun-
tries and in Hungary usually facilitate population 
awareness, because of the media coverage of such 
events.
as family paediatricians, family doctors or occupational 
health doctors. Family doctors usually pick up the vac-
cines in person from their local District Government 
Office.
Key barriers and facilitators
Hungary has a good immunization record, which is 
attributable to the well-organized system of addressing 
communicable diseases and the generally favourable 
attitude of the population towards vaccination and the 
prevention of infections. Nevertheless there are some 
threats to the existing system of public health, which can 
erode its firm organizational basis and might jeopardize 
current achievements:
●	 Since its establishment in 1991 the National Public 
Health and Medical Officer Service has undergone 
several reorganizations, the most recent of which 
was the organizational integration of its territorial 
units into the Government Office System and of 
the Office of the National Chief Medical Officer 
into the Ministry of Human Capacities. In con-
trast, the new Minister for Human Capacities 
has announced the re-establishment of the Office 
of the National Chief Medical Officer. Frequent 
major reorganizations are a risk for the disinte-
gration of established processes and the loss of 
competent public health specialists.
●	 Despite recent improvements, Hungary is still 
facing a human resource crisis due to the emigra-
tion of qualified health workers. Shortages mostly 
affect the population in disadvantaged regions.
●	 In the case of mandatory childhood vaccination, 
coverage gaps are related to particular groups, such 
as children with anti-vaccination parents.11 For this 
group, fines do not seem to be an effective correc-
tive measure, and there are suspicions that certain 
anti-vaccination parents can obtain fake vaccination 
certificates from certain family paediatricians.12
●	 In terms of measles, imported cases (such as 
from Romania or Ukraine) seem to be the most 
11 www.ajbh.hu/documents/10180/2500969/Jelentés+az+óvodai+ 
felvétel+védőoltások+elmaradása+miatti+elutasításáról+ 
361_2016/c4de3125-7ec7-4fd8-8aba-2d0fe77421ae?version=1.0.
12 https://www.nlcafe.hu/csalad/20161105/gyermekorvos-
kotelezo-vedooltas/.

Ireland
Maebh Ní Fhallúin
Governance
The Health Service Executive1 is Ireland’s publicly 
funded national health service, delivering health and 
social care services to the population of Ireland. It is 
responsible for the operational side of health and social 
care, implementing health and social care policy and leg-
islation. The Department of Health has responsibility for 
developing policy and legislative frameworks for public 
health and for funding. The Health Service Executive is 
accountable to the Minister for Health.
The National Immunisation Office, established in 2005 
under the Health Service Executive, serves as a coordinat-
ing unit for immunization to ensure high-quality, stand-
ardized implementation of all publicly funded immuniza-
tion programmes (The Role of the National Immunisation 
Office 2005–2011). The Office’s main responsibilities 
include:
•	 preparation of options papers for the imple-
mentation of changes, and the introduction of 
new vaccines, to the national immunization pro-
grammes. Health Service Executive management 
and the Department of Health determine the 
most appropriate implementation option and the 
National Immunisation Office then prepares a 
detailed implementation plan and project man-
ages the implementation of the programme or 
campaign;
1 Health Service Executive: https://www.hse.ie/eng/health/
immunisation/whoweare/. 
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Measles (Children) Flu (Adults)
Policy/
Decision-Making
Nationally (Health Service 
Executive, Department 
of Health, National 
Immunisation Advisory 
Committee)
Nationally (Health 
Service Executive, 
Department of Health, 
National Immunisation 
Advisory Committee)
Coordination/
Promotion
Nationally (Health Service 
Executive, National 
Immunisation Office)
Nationally (Health 
Service Executive, 
National Immunisation 
Office)
Implementation Nationally (Health Service 
Executive, National 
Immunisation Office)
Nationally (Health 
Service Executive, 
National Immunisation 
Office)
Vaccinations are not mandatory in Ireland but are 
strongly recommended by the state, including for both 
measles and influenza.
Measles (Children) Influenza (Adults)
There are two measles vaccination 
programmes for children, one delivered to 
children at 12 months through primary care 
and the other delivered at 4–5 years of age 
through Health Service Executive school 
immunization teams that go to primary 
schools (although in one Health Service 
Executive area children go to their primary 
care provider).
The database for children in the primary 
immunization programme is populated 
predominantly by birth notification data. The 
school programme targets children attending 
school.
For the primary childhood immunization pro-
gramme there are eight separate immuniza-
tion registries for eight of the Health Service 
Executive regions (based on former health 
boards/administrative areas). For the measles 
vaccine at 4–5 years of age, immunization 
information should be entered into the 
national Schools Immunisation Information 
System. (There is no single registry in Ireland 
that merges all immunization data.) The local 
Health Service Executive immunization office 
is responsible for calls and follow-up.
Follow-up and recall of defaulters is per-
formed at the local level by Health Service 
Executive immunization staff.
Local immunization offices are responsible 
for the local immunization registry. The 
National Immunisation Office is responsi-
ble for setting standards that are imple-
mented locally. It is also responsible for the 
governance of the Schools Immunisation 
Information System which is managed locally.
The influenza immunization 
programme for older people 
(>65 years) is a voluntary 
programme. No population 
register is used to identify 
and target individuals. There 
is a an annual Health Service 
Executive -funded public 
campaign (on radio and 
sometimes TV, as well as 
through posters and leaflets) 
to encourage vaccine uptake 
among this age group and 
other risk groups. Individuals 
are recommended to attend 
their primary care provider or 
pharmacist for vaccination. 
There is no call or follow-up 
for individuals who do not 
attend for vaccination.
There is no register of people 
younger than 65 years or for 
health care workers. However, 
individuals at risk in younger 
age groups and health care 
workers are also targeted in 
the annual public campaign.
•	 coordinating immunization programmes through 
collaboration with all stakeholders involved in 
their delivery and support;
•	 managing vaccine supply chains;
•	 developing educational, training and communi-
cation materials for health professionals and the 
public; and
•	 developing and implementing national standards 
in various aspects of immunization including 
training and education, consent forms, medica-
tion protocols and Health Service Executive staff 
immunization guidelines.
All information on immunization provided by 
the National Immunisation Office is based on the 
‘Immunisation Guidelines for Ireland’, developed by the 
National Immunisation Advisory Committee2 in the 
Royal College of Physicians of Ireland, which contain 
recommendations on the appropriate use of licensed vac-
cines. In addition to advising the Chief Medical Officer in 
the Department of Health on specific vaccine recommen-
dations for use in Ireland, the National Immunisation 
Advisory Committee also helps develop national immu-
nization strategies. Furthermore, it provides recommen-
dations on which groups of the population should receive 
the seasonal influenza vaccine.
The Health Protection Surveillance Centre3 is the 
specialist agency for the surveillance of communicable 
diseases and is part of the Health Service Executive. It 
provides policy advice and public information on the con-
trol and prevention of infectious diseases, and also carries 
out disease surveillance and epidemiological investigations 
and does research and training.
The Health Products Regulatory Authority4 is an inde-
pendent statutory body that provides an up-to-date list of 
licensed vaccines. It is the body responsible for pharmacov-
igilance and monitors adverse events following vaccination.
All vaccination programmes are organized nationally by 
the Health Service Executive.
2 National Immunisation Advisory Committee: https://www.
rcpi.ie/policy-and-advocacy/national-immunisation-advisory-
committee/.
3 Health Protection Surveillance Centre: https://www.hpsc.ie/
abouthpsc/.
4 Health Products Regulatory Authority: www.hpra.ie.
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Adult vaccinations against influenza are provided by gen-
eral practitioners or practice nurses in primary care or by 
community pharmacists. Vaccinations are provided to 
health care workers primarily by Occupational Health 
departments. In recent years peer vaccinators (nurses) 
have been trained in many health care settings to provide 
vaccination. Health care workers can also obtain vaccina-
tions from their own primary care provider or pharmacist.
General practitioners are private providers contracted by 
the Health Service Executive to deliver vaccinations. For 
administering vaccinations, they are accountable to both 
the Health Service Executive and the Irish Medical Council, 
which is the regulator of the medical profession in Ireland.
Practice nurses are privately employed by general practi-
tioners and are responsible for adhering to the standards 
and guidance provided by the Nursing and Midwifery 
Board of Ireland.
Peer vaccinators in health care settings are nurses 
employed by the health care facility. They are responsible 
for adhering to the standards and guidance provided by 
the Nursing and Midwifery Board of Ireland.
Pharmacists are private providers contracted by the Health 
Service Executive to deliver vaccinations. For administering 
vaccinations, they are accountable to the Health Service 
Executive and the Pharmaceutical Society of Ireland, 
which regulates the professional practice of pharmacists.
Financing
Childhood vaccinations against measles are provided free 
at the point of delivery. The costs of vaccines and vacci-
nation services are covered from the statutory financing 
system via taxation.
Adult vaccinations against influenza are provided free 
of charge by the Health Service Executive to all those 
in at-risk groups with a medical card (i.e. those from 
low-income households). The vaccine is free for every-
one, but for those without a medical card, doctors and 
pharmacists may charge a consultation/administration fee 
(Ireland does not have universal primary care so a general 
practitioner consultation fee of €50–€60 is standard).
The statutory financing system (taxation) covers the cost 
of the vaccine for everyone. For medical card holders, the 
statutory financing system (taxation) also covers the cost 
Targeted measures for specific groups of the population.
Measles (Children) Flu (Adults)
There are Health Service Executive 
promotional materials specifically for 
members of the Traveller and Roma 
communities.
None.
Incentive schemes for citizens/parents or vaccinators.
Measles (Children) Flu (Adults)
The Health Service Executive runs 
awareness campaigns for the 
public and for vaccinators. There 
are no sanctions.
The Health Service Executive runs 
awareness campaigns for the 
public and for vaccinators. There 
are no sanctions.
The methods used to estimate vaccination coverage rates 
at national/subnational level.
Measles (Children) Flu (Adults)
Administrative method based on 
the numbers vaccinated through 
the Health Service Executive’ s two 
programmes (at 12 months and at 
5 years) divided by the number of 
eligible children in the population. 
Health Service Executive birth 
registration data is used for the 
primary immunization register (plus 
any children who moved in, minus 
children who moved out or died).
For the school immunization 
system each child vaccinated 
is entered into the system. The 
denominator used at school level 
is the school class population at 
the beginning of the school year. 
Uptake is reported by area, region 
and nationally.
• Administrative method for those 
aged ≥65 - - Primary Care 
Reimbursement Scheme data
- On a monthly basis from 
September to August, Monthly/
Annual reports
• Survey method for health care 
workers
- Hospitals and long-term care 
facilities
- Mid/end season
• Telephone/omnibus surveys 
representative of the adult 
population
- Approximately every three years
- Comparison is made with 
Primary Care Reimbursement 
Scheme data for the >65 years 
age group
- Collecting data for population 
groups not routinely monitored
(Source: https://www.hse.ie/eng/health/ 
immunisation/hcpinfo/fluinfo/dr-j-mereckiene.pdf )
Provision
Childhood vaccinations against measles are administered 
by general practitioners or practice nurses in primary care 
(at 12 months) or in schools by public health/community 
nurses (at 4–5 years). For the primary immunization 
programme children are registered with one general prac-
titioner practice for the delivery of the recommended 
vaccines.
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Facilitators for childhood vaccination against 
measles
• There is no cost for individuals if vaccination is 
obtained before 12 years of age
• Supportive approach by health care professionals
• The Health Service Executive’s active recall system 
for the primary immunization programme. 
Mop-up clinics for the school immunization pro-
gramme are held over the summer for those chil-
dren who may have missed vaccination day
Barriers to adult vaccination against influenza
• Cost for members of the public without medical cards
• Some vaccine hesitancy due to the perception of 
harmful effects associated with the vaccine
• Availability/access issues for some health care 
professionals (e.g. those working in small rural 
communities)
• For health care workers, access to vaccination, if 
delivered in clinics, can be particularly difficult 
if they have to travel to a site off-work to obtain 
vaccination
Facilitators for adult vaccination against influenza
• Increasing informed media coverage and medical 
advice for the public
• Promotional/awareness campaigns
• Local champions
• Pharmacist delivery provides additional venues in 
the community
• Peer vaccinators
Reference
Interview with Dr Kevin Kelleher, Assistant National 
Director for Public and Child Health.
of the vaccine administration. People without a medical 
card pay out-of-pocket for vaccine administration, which 
may or may not be included in the general practitioner 
consultation fee. Payment is not a barrier to uptake of 
vaccination for measles but could be for influenza.
Key barriers and facilitators
Barriers for childhood vaccination against 
measles
• Vaccine hesitancy because of social media, mistrust 
in vaccines and belief in potential harmful effects. 
This impacts on the level of vaccine uptake.
• Absence of a national primary immunization infor-
mation system negatively impacts on the ability 
to identify children who miss their first dose of 
measles vaccine if they move to another area. In 
addition, general practitioners do not have access 
to the immunization registry to review vaccines 
received if a child has moved to another practice.
• Children born outside Ireland who come to the 
country in their first or second year of life may not 
be entered onto the local immunization register, 
unless they are picked up by a general practitioner 
or the parents seek registration themselves.
• Migrant parents may have language or health liter-
acy challenges. Even if their child is on the register 
they may not understand the invitation letters sent 
by the Health Service Executive to attend for vac-
cination. Some marginalized groups (e.g. migrants 
and homeless families) may move home frequently 
and Health Service Executive correspondence/invi-
tations to vaccination may not be received.
• Children older than 12 years of age who have 
missed the measles vaccine doses at the recom-
mended age have to pay for vaccination (but not 
for the vaccine).
• General practitioners and nurses have difficulty 
identifying older children who have missed measles 
vaccinations if they are new to the practice, as there 
is no web-based system to interrogate at the time 
of consultation and many parents are not sure of 
the vaccine status of their older children.
Italy
Walter Ricciardi, Giovanni Rezza, Fortunato Paolo 
D’Ancona, Stefania Iannazzo, Maria Cristina Rota
Governance
Key agencies
The Italian Ministry of Health is charged with defining 
the national immunization plan. This document is ratified 
with an agreement at the State-Regions conference. Since 
the Italian national health system is decentralized, the 21 
regions (19 Regions and two Autonomous Provinces) 
have the task of establishing their own regional immuni-
zation plan and implementing it, based on the national 
recommendations.
The Italian Ministry of Health has established that all 
the vaccines included in the national immunization plan 
should be considered part of the so-called “minimum 
level of healthcare services” (LEA) that the regional 
authorities must provide to citizens free of charge. The 
national immunization plan outlines the objectives of 
the national immunization strategy for different age and 
risk groups, and it is ratified by an agreement with the 
regional authorities (the State-Regions Conference) who 
are responsible for the implementation of vaccination 
programmes in their respective regions. Childhood vac-
cines are usually administered by local vaccination cen-
tres, and in some cases by family paediatricians and/or 
general practitioners.
For influenza vaccination, the Ministry of Health’s 
Directorate-General for Health Prevention provides an 
annual update of a document (“Circular letter for pre-
vention and control of influenza”), signed by the Minister 
of Health, shared and agreed with the regions, indicating 
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Organization of vaccination programmes
The Regions are in charge of implementing the national 
immunization plan, and the organization of vaccina-
tion programmes differs across regions. The national 
immunization plan requires regions to guarantee free 
and easy access to all vaccines included in the sched-
ule, in order to achieve individual and population-level 
protection from vaccine-preventable diseases in line 
with national objectives. Furthermore, it requires the 
regions to organize training for health care workers, 
communication campaigns and the evaluation of their 
vaccination strategies.
A national electronic immunization register will start to 
be implemented in the second half of 2018. It will allow 
vaccination coverage to be evaluated with extreme pre-
cision, recalling individuals not yet immunized. So far, 
there are regional or local electronic immunization regis-
ters in more than 90% of Italian Regions and local health 
services, and they are used for the entire immunization 
process, from call-out to vaccination, to calculating the 
vaccination coverage. Regional aggregated coverage data 
are sent to the Ministry of Health to estimate the national 
vaccination coverage.
Targeted measures
Specific groups of people benefit from targeted vaccina-
tion measures, such as child-bearing women, individuals 
with specific health conditions at high risk of vaccine-
preventable disease, individuals at high risk of professional 
exposure, individuals at high risk from specific behaviours 
(e.g. men who have sex with men), or individuals living 
in specific conditions (living with an immunosuppressed 
person in the same household).
The objectives of the national immunization plan include 
the reduction of inequalities through the promotion of 
vaccination interventions in marginalized or particu-
larly vulnerable groups of the population, including 
irregular migrants, refugees and asylum-seekers, who 
may experience difficulties in accessing prevention ser-
vices. The national immunization plan recommends 
close collaboration between vaccination services, health 
care workers, cultural mediators and nongovernmental 
organizations.
the new vaccines’ composition and reporting recom-
mendations for the prevention of influenza through vac-
cination and other measures of hygiene and personal 
protection. As the influenza vaccine is included in the 
LEA, it is free of charge for selected target populations. 
It is administered mainly in vaccination centres and by 
general practitioners.
The main target of the influenza vaccination campaign 
is all individuals aged 65 years and over, with a vaccina-
tion coverage target of at least 75% and the aim of 95% 
coverage. Influenza vaccination is also recommended for 
high-risk individuals aged under 65, with the same target 
coverage rate.
National and regional level
The Regions are responsible for planning, financing, 
organizing and implementing health care services, includ-
ing vaccination services following the national immuni-
zation plan recommendations.
Vaccination plan
The current National Immunization Plan 2017–2019 
was issued in January 2017. In the past Italy’s vaccination 
schedules had been a patchwork of 21 different regional 
vaccination schedules; the new plan helped to harmonize 
the diverse programmes. The plan recommends vaccina-
tion for people throughout the entire life-course and sets 
clear targets for vaccination coverage, but it also identifies 
the main priorities (e.g. measles and rubella elimination, 
polio eradication) and considers many actions to reduce 
disparities among Italian regions.
Mandatory and recommended vaccinations
Until June 2017 there were only four mandatory vacci-
nations: polio, diphtheria, tetanus and hepatitis B. At the 
end of July 2017 a new law was approved increasing to 
10 the number of mandatory vaccinations for children 
aged 0–16 years: the previous four plus Hib, pertussis, 
measles, mumps, rubella and varicella. Regional authori-
ties are required to promote and actively offer all vaccines 
indicated in the national immunization plan, including 
mandatory and non-mandatory vaccinations.
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for non-vaccination; however, further surveys are not 
planned.
Provision
All vaccinations, except against influenza, are mainly 
administered by the vaccination services in the local 
health units. Involvement of family paediatricians is being 
piloted in some regions.
Adult vaccinations against influenza are administered in 
almost all regions by general practitioners. Each region 
is free to decide on its own organization and is in charge 
of vaccine procurement, although in some cases vac-
cine procurement is further decentralized, to the level of 
local health services. Data are collected by public health 
services.
Financing
All compulsory and recommended vaccinations included 
in the National Immunization Plan 2017–19 are offered 
to the target population free of charge. The costs of vac-
cines and vaccination services are covered by the National 
Health Fund, which is a statutory financing system (via 
taxation) which covers the entire resident population.
Influenza vaccination is offered free of charge to all risk 
groups for which it is recommended, including:
•	 all individuals aged 65 years and above;
•	 clinical risk groups, such as individuals with 
treatment-induced and/or disease-induced immu-
nosuppression, metabolic disorders, chronic pul-
monary, cardiovascular or renal disease, hepatic 
disease, people living with HIV/AIDS, individuals 
with morbid obesity defined as body mass index 
>= 30kg/m2;
•	 all pregnant women in the second and third tri-
mesters of pregnancy;
•	 all health care workers; for them vaccination is 
voluntary – it is an individual choice, and there is 
no penalty for not being vaccinated;
•	 selected occupational groups, such as military ser-
vice personnel and poultry industry workers; staff 
Incentive schemes
No monetary incentives exist for vaccinators, except for 
general practitioners in the case of influenza vaccina-
tion. Since September 2017 proof of vaccination has 
been required for children up to 6 years of age to attend 
kindergarten and nurseries. Lack of vaccination in older 
children does not impede their access to school, but 
financial sanctions are applied to parents refusing vacci-
nation (with a maximum fine of €500 if all vaccinations 
are missing). The financial sanctions are also applied to 
parents of children up to 6 years of age if their parents 
refuse vaccinations.
Vaccination coverage
Vaccination coverage for all childhood vaccinations 
included in the national immunization schedule is meas-
ured annually for the following categories:
•	 at 24, 36 and 48 months old (for all vaccines);
•	 children in their 7th year of life and those in their 
8th year of life (booster: DTP, polio; second dose: 
MMR, Var);
•	 adolescents aged 11–18 years (first dose and full 
course of HPV vaccine);
•	 adolescents aged 16 and 18 years (DTP, IPV, 
MMR, Men C, Men ACWT);
•	 individuals aged 65 years and over, pregnant 
women and general population (only for influenza)
•	 individuals aged 65 years (Zoster and pneumococ-
cal vaccines).
Vaccination coverage for each vaccine is calculated by the 
Ministry of Health dividing the number of persons fully 
vaccinated by age in the target population by the total 
number of persons in the target population. The denom-
inator is the critical point: some regions provide statistical 
population data, whereas others provide the number of 
people resident in their territory, and others the number 
of people registered in the local health system register.
In addition, epi-cluster surveys were conducted in 
1998, 2003 and 2008 to validate administrative cover-
age data and to collect information regarding reasons 
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working in laboratories, e.g. in the non-medical 
academic or environmental sector; police and fire-
fighters; veterinary service workers; and
•	 residents of long-term care facilities and household 
members of immunosuppressed individuals.
The system covers the entire resident population, includ-
ing non-EU citizens with a regular residence permit and 
their dependent family members legally residing in Italy. 
Irregular immigrants are also entitled to receive vaccina-
tions free of charge.
Key barriers and facilitators
Concerns about adverse events following immunization 
(e.g. autism or other chronic conditions) and underesti-
mation of the potential severity of vaccine-preventable 
diseases are the main barriers to effective vaccination 
coverage against measles. Facilitators include targeted 
education and communication campaigns, training for 
health care workers, identification and vaccination of 
the most susceptible, and the update of the measles and 
rubella elimination plan.
The measles outbreak that started in Italy in 2017, with 
more than 7,000 cases and eight deaths in less than two 
years, has contributed to raising awareness among the 
population on the importance of vaccination.
With regard to influenza, concerns about perceived vac-
cine safety and effectiveness and the perceived low severity 
of influenza are the most commonly reported barriers to 
vaccination. Low influenza vaccination coverage among 
health care workers is also considered an obstacle.
Targeted education and communication campaigns and 
training for health care workers can facilitate influenza 
vaccination uptake.
Latvia
Daiga Behmane, Oksana Martinuka
Governance
Childhood vaccination against measles – 
agencies and roles
According to Cabinet Regulation No. 330 ‘Vaccination 
Regulations’ (2000),1 the following public agencies are 
responsible for organizing and providing the vaccina-
tion programme: the Centre for Disease Prevention and 
Control2, the National Health Service3 and the State 
Agency of Medicines4. The agencies are under the juris-
diction of the Ministry of Health.
The Centre for Disease Prevention and Control is respon-
sible for planning, coordinating and monitoring the 
implementation of the state immunization programme, 
and also plans the total number of vaccines necessary for 
implementation of the vaccination calendar, and coor-
dinates it with the Ministry of Health. In addition, the 
Centre for Disease Prevention and Control analyses the 
immunization indicators and morbidity of inhabitants 
and the use of vaccines. Each month the Centre com-
piles data on the vaccine orders by institutions and sub-
mits the total order for vaccines to the drug wholesaler. 
Drug wholesalers ensure storage and supply of vaccines 
to vaccination institutions according to the list of vacci-
nation institutions submitted by the Centre for Disease 
Prevention and Control.
1 https://likumi.lv/ta/en/en/id/11215-vaccination-regulations.
2 https://www.spkc.gov.lv/lv/.
3 http://www.vmnvd.gov.lv/.
4 https://www.zva.gov.lv/.
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Character of vaccinations
According to Cabinet Regulation No. 330 ‘Vaccination 
Regulations’ (2000), vaccination is mandatory for state 
institutions and vaccination providers but voluntary for 
the general public. There are no sanctions for vaccinators, 
parents or other citizens who refuse vaccinations.
Patients or parents can refuse vaccinations without any 
legal consequences. If a patient or their legal representa-
tive declines vaccination, a medical practitioner explains 
the health consequences and then draws up a refusal in 
writing which has to be signed by the person who has 
refused to be vaccinated.
Vaccination against influenza for those classified as 
belonging to the health risk groups, persons aged over 
65 years of age and occupational target groups (e.g. health 
care professionals) is recommended, but vaccination is 
voluntary.
System for call and recall
Latvia does not have a computerized immunization regis-
try or other computerized record systems with the capac-
ity to issue reminders or recall notifications to patients. 
However, medical practitioners or vaccinating institutions 
are responsible for monitoring patients and they have to 
notify patients regarding the necessity for vaccination.
An electronic immunization register within e-health is 
under development.
Targeted measures
There are no asylum-seeker or refugee-specific vaccination 
policy documents. In accordance with the Asylum Law, 
asylum-seekers receive state-funded emergency medical 
assistance and primary health care (including vaccina-
tion), taking into account the special reception needs of 
asylum-seekers. Also, there are no special districts for ref-
ugees and no territorial vaccination strategy documents. 
In Latvia there are no data on vaccination coverage for 
special risk groups (migrants, refugees, ethnic minorities, 
or socially and economically disadvantaged people).
There is an annual information campaign to raise aware-
ness among the general public and health professionals 
regarding vaccination against seasonal influenza.
The National Health Service is responsible for tendering 
and purchasing vaccines used in the state immunization 
programme in the country and for the reimbursement of 
drug wholesalers for vaccines. Together with the Centre 
for Disease Prevention and Control, the National Health 
Service evaluates the results of vaccinations and the use 
of vaccines, and works to maximize vaccination coverage 
rates.
The State Agency of Medicines ensures drug certification 
by issuing permits and licences to drug wholesalers. Only 
vaccines registered in the Medicinal Product Register of 
Latvia can be used.
The Ministry of Health has established the State 
Immunization Advisory Council to professionally eval-
uate issues related to vaccination and the state immuni-
zation programme, provide proposals for solutions, and 
evaluate the demand for vaccines.
According to Cabinet Regulation No. 330 ‘Vaccination 
Regulations’ (2000), the implementation of immuniza-
tion policy is organized nationally.
Vaccination is organized and implemented by vaccinat-
ing institutions (medical treatment institutions, mostly 
general practitioners) which conform to the mandatory 
requirements for performing vaccinations.
The National Public Health Strategy 2014–2010 defines 
key elements of the state immunization policy, and mon-
itors performance indicators and actions to achieve these 
indicators.
Childhood vaccination against measles – vac-
cination plans
Childhood vaccination against measles is voluntary. A 
routine two-dose measles vaccination is included in the 
vaccination schedule.
Adult vaccinations against influenza – vacci-
nation plans
There is a public health strategy to improve vaccination 
coverage for seasonal influenza vaccination, and respective 
seasonal influenza vaccination recommendations have 
been developed (e.g. recommendations for age groups, 
risk groups and target groups).
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Provision
In Latvia measles vaccination is routinely provided to 
all children. Routine vaccinations are organized and 
implemented by vaccinating institutions, mostly general 
practitioner practices, which conform to the mandatory 
requirements laid down in laws and regulations for med-
ical treatment institutions and their units and with the 
basic requirements for hygiene and infection control in a 
medical treatment institution. General practice personnel 
also provide vaccinations in the event of an outbreak (e.g. 
measles). Each month vaccination institutions prepare the 
vaccine order, taking into account the number of persons 
to be vaccinated and the current amount of vaccines left 
in stock. Vaccine stock should be kept to a minimum by 
ordering monthly only the quantity of vaccine required 
until the next delivery.
Inhabitants have the right to choose a vaccinating institu-
tion or a medical practitioner to perform the vaccination.
In Latvia there has been no routine vaccination in school-
based health services since 2008.
Drug wholesalers are responsible for the procurement 
and distribution of vaccines to vaccination services and 
also to pharmacies for some vaccines (for example against 
seasonal influenza).
Primary health care providers are responsible for iden-
tifying adults in high-risk groups and prescribing the 
influenza vaccine for them.
Healthy adults usually receive their seasonal influenza 
vaccine in the vaccination services room.
Financing
All expenditures related to routine vaccinations, their 
organization, supervision and monitoring, the acquisition 
of vaccines, drawing-up of medical documentation, vac-
cine injection, as well as the treatment of any side-effects 
caused by vaccination, which have been included in the 
minimum package of services provided for inhabitants 
specified in laws and regulations, are funded from the 
state budget.
If an outbreak or epidemic of measles is recorded in 
Latvia, the primary care physician has to collect informa-
tion on the vaccination status of affected people and their 
Childhood vaccination against mea-
sles – coverage
In Latvia immunization coverage is analysed at two 
administrative levels, regional and national. It uses an 
administrative method based on monthly reports from 
all vaccination providers to the regional level and from 
there to the national level. Vaccinating institutions submit 
aggregated data on the number of vaccinated individ-
uals in the reporting month, broken down by vaccine-
preventable disease and whether it was the first or second 
vaccination. The number of vaccinated individuals is used 
as the numerator.
For children of 12–15 months of age receiving their first 
dose of measles vaccine, the number of children in that 
age group is used as the denominator.
For 7-year-old children receiving their second dose of 
measles vaccine, the total number of 7-year-old children 
reported by the Central Statistical Bureau of Latvia5 is 
used as the denominator.
Latvia assesses vaccination coverage for measles quarterly 
and annually.
Adult vaccinations against influ-
enza – coverage
National Health Service data on reimbursed vaccine doses 
(for children aged 6–23 months, persons aged 65 years 
or more, persons with chronic diseases and pregnant 
women) are used for influenza vaccination coverage esti-
mates. Immunization of health care workers is not reim-
bursed and not reported separately, and the total number 
of pregnant women and persons with certain chronic 
diseases is unknown.
In addition, vaccination providers report monthly the 
number of patients vaccinated against influenza, cover-
ing both the total number and the number of children. 
Denominators to assess coverage are the size of the pop-
ulation and the number of children aged from 6 months 
to 18 years.
Latvia assesses vaccination coverage for influenza both 
monthly and by season.
5 https://www.csb.gov.lv/en/statistika/db.
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not among the reasons given by respondents for missing 
vaccinations. Economic barriers for childhood vaccina-
tion were also rarely reported. Insufficient vaccination 
coverage is likely to be related to the attitudes or other 
commitments of parents. A possible reason for low mea-
sles vaccination coverage rates among 7-year-old children 
is parental forgetfulness. Some parents also did not con-
sider vaccination necessary for older children.
Potential barriers for low seasonal influenza vacci-
nation coverage among adults might be the financial 
burden of vaccine costs and vaccine administration fees. 
Furthermore, receiving the vaccine can be difficult for 
those adult groups for whom influenza vaccination is 
recommended but for whom vaccine costs are only par-
tially reimbursed.
Potential barriers to influenza vaccination related to 
patients might include lack of awareness about the health 
threats posed by influenza and the benefits of vaccina-
tion, misperceptions about vaccine safety, fears of adverse 
effects, inconsistent advice or health care providers not 
recommending vaccination.
Potential barriers to influenza vaccination related to 
health care providers might include medical practition-
ers’ negative attitudes towards influenza vaccination and 
influenza vaccine hesitancy among health care workers.
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contacts (adults and children who have not had measles 
and who have not been vaccinated against measles; people 
who have not had measles and have been only partially 
vaccinated, people whose vaccination against measles is 
not recorded), and must vaccinate non-immunized indi-
viduals. Expenses for these vaccinations are covered from 
the state budget.
In case of an epidemic or threat, the Minister of Health is 
entitled to issue an order for the mandatory vaccination 
of specific groups of inhabitants in extraordinary cases 
and to purchase supplementary vaccines within the scope 
of budgetary resources allocated in the budget of the 
Ministry of Health.
For persons classified as belonging to one of the risk 
groups (persons suffering from chronic respiratory dis-
eases, chronic cardiovascular diseases, chronic metabolic 
disorders, chronic kidney diseases, immunodeficiency, 
or undergoing immunosuppression therapy), persons 
aged 65 years and more, and pregnant women (at any 
stage of pregnancy), the National Health Service covers 
50% of the cost of the influenza vaccine from the state 
budget. For the remaining cost of the vaccine (50%) 
and its administration, individuals need to pay out-of-
pocket, unless costs are covered by their employer or 
health insurance.
For healthy adults, the vaccine cost and vaccine adminis-
tration fees are not covered from the state budget.
Key barriers and facilitators
Immunization data show that vaccination coverage of the 
first measles, mumps and rubella (MMR) dose is above 
the target level (>95%). By the end of 2017, 96.4% of 
children aged 12–15 months had received the first dose 
of measles vaccine. However, the measles vaccination 
coverage among eligible schoolchildren is below the target 
level. By the end of 2017, 88.9% of 7-year-old children 
had received the second dose of measles vaccine.
Latvia saw a short-term (September–December 2017) 
shortage in MMR vaccine, probably due to manufacturer 
production problems.
In 2015 the Latvian Centre for Disease Prevention and 
Control conducted a survey on missed opportunities for 
childhood vaccination. The survey showed that lack of 
availability of vaccines and accessibility problems were 
Lithuania
Liubove Murauskiene
Governance
The Ministry of Health has overall responsibility for 
health policy in Lithuania. The main policy document 
in the vaccination field is the national immunization 
programme. Currently, the 2014–2018 programme is 
ongoing (Lietuvos Respublikos sveikatos apsaugos min-
istro, 2014). It comprises a situation analysis, objectives, 
tasks and targets, and outlines its implementation. The 
main objectives are: to control, eliminate or eradicate 
vaccine-preventable diseases (polio, measles, rubella); to 
decrease the risk of outbreaks; and to ensure the safety, 
effectiveness and accessibility of vaccination. The targets 
include immunization coverage for children of 90–95% 
in each municipality and the whole country, the eradi-
cation of measles in Lithuania, and the introduction of 
new vaccines.
The national organizational framework is set out by a 
Ministry of Health decree (amended in 2017) (Lietuvos 
Respublikos sveikatos apsaugos ministras, 2017), which 
describes the functions regarding immunizations and 
the coordination of all stakeholders (primary health care 
institutions, public health institutions, etc.). Two public 
health institutions under the Ministry of Health, namely 
the Centre for Communicable Disease and AIDS (at 
national level) and the National Public Health Centre1 
(at regional level, a network of 10 regional departments), 
are involved in the prevention of communicable diseases 
and are in charge of coordinating vaccination, moni-
toring vaccination coverage and surveillance of vaccine-
preventable diseases.
1 https://nvsc.lrv.lt, accessed 1 June 2018.
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Seasonal influenza vaccinations are recommended for 
groups at risk, such as older people, pregnant women 
and health workers. Revaccinations for adults, as well 
as the pneumococcal vaccine for groups at risk, are free 
of charge for patients (Lietuvos Respublikos sveikatos 
apsaugos ministro, 2015). Responsibilities and procedures 
are similar to vaccination services for children, except that 
the timing is linked to the influenza season (Lietuvos 
Respublikos sveikatos apsaugos ministro, 2012).
Regular public awareness campaigns on the impor-
tance and availability of vaccines, as well as professional 
training, are components of the national vaccination 
programme.
Provision
In general, primary health care providers provide vacci-
nation services for the registered population. They iden-
tify target groups from their records, plan the coverage, 
request and pick up vaccines, vaccinate and report on 
vaccinations, and perform other related functions.
Licensed physicians identify and vaccinate populations, and 
licensed nurses and midwives can also administer vaccines.
An official guide to procedures is used as the basis for the 
mandatory documentation of health care facilities.
Usually, vaccination services are available at primary 
health care clinics, as well as in a few other health care 
facilities, e.g. in specialized hospitals with the exception 
of privately funded vaccinations, including those paid 
for by employers and provided at the workplace if all 
requirements for safe vaccination are met.
The prescription of vaccines and their sale in pharmacies 
are legally forbidden.
Financing
All vaccinations included in the national immunization 
schedule are free of charge at the point of delivery. The 
same could be said about vaccination against seasonal 
influenza and pneumococcal infection for the groups at 
risk, for post-exposure prophylaxis, as well as revaccina-
tions once per decade (diphtheria and tetanus) for adults 
over 25 years old. Other vaccinations are funded privately 
or by employers.
The Centre for Communicable Disease and AIDS over-
sees the demand for vaccines and coordinates vaccina-
tion services; it provides expertise and consultations. 
The National Health Insurance Fund procures vaccines 
through centralized public purchasing. Vaccines are dis-
tributed to health care providers from the warehouse of 
the Centre for Communicable Disease and AIDS (the 
central vaccine store).
Licensed health care providers (mainly primary health 
care institutions) are in charge of the provision of vac-
cination services. They have to report to public health 
institutions all cases of vaccine-preventable diseases, the 
numbers of vaccinations and population coverage, as well 
as adverse events following immunization. The National 
Public Health Centre shares the reported information 
with the Lithuanian Centre for Communicable Disease 
and AIDS. Public health institutions collect and report 
aggregated immunization data.
The National Public Health Centre monitors health care 
providers at least once a year through a publicly available 
questionnaire which allows monitoring of their compli-
ance with national legislation on vaccination. The mon-
itoring mostly involves a review of medical documenta-
tion, including patient medical records.
A national immunization schedule for children has been 
drawn up, with the latest update in 2018. Pneumococcal 
vaccine (PCV), human papilloma virus vaccine (HPV), 
rotavirus vaccine (RV) and B type meningococcal vaccine 
(Men B) have been introduced in the national immu-
nization schedule during the 2014–2018 programme 
(Lietuvos Respublikos sveikatos apsaugos ministro, 2018). 
For instance, the first MMR vaccination is given at the 
age of 15–16.5 months, the second within 6–7 years.
According to the Law on human communicable disease 
prevention and control, vaccinations in Lithuania are not 
mandatory, but they are recommended. The attempt by 
the Ministry of Health in 2014 to keep non-vaccinated 
children away from public nurseries and kindergartens 
was deemed to fail after the 2016 decision of the Supreme 
Administrative Court of Lithuania.2 The Court ruled that 
the approach taken by the authorities, which included the 
recording of personal data about vaccinations, contra-
vened the right to privacy.
2 https://www.lvat.lt, accessed 30 May 2018. 
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provider caps the total estimate of annual expenditure at 
no more than 70 fee-for-service payments altogether. As 
a result it is hard to assess the actual incentives created by 
the fee-for-service payments scheme.
The Centre for Communicable Disease and AIDS pro-
cures and distributes cold boxes for health care facilities.3 
More than half of about 500 health care providers have 
been equipped with modern cold boxes to ensure safe 
transportation of vaccines.
Key barriers and facilitators
A number of key barriers to and facilitators of effective 
vaccination coverage for measles and influenza can be 
identified (see Table 1).
3 https://www.ulac.lt, accessed 29 May 2018.
The National Health Insurance Fund, as the statu-
tory financing scheme, centrally procures vaccines and 
syringes. This expenditure of around €17 million per year 
is covered by state budget subsidies. The subsidies are 
allocated in accordance with the national immunization 
programme. Currently, the programme also funds aware-
ness campaigns and professional training, each costing 
around €30 000 per year. However, after the procure-
ment of vaccines, the second largest explicit allocation 
under the programme is the annual €800 000 expenditure 
on additional fee-for-service payments for the influenza 
vaccination service under the incentive scheme for pri-
mary health care providers; this supplements the major 
capitation payment. Currently, there are four fee-for-
service payments (of about €2 each) related to vaccina-
tion, namely, the vaccination of children performed by a 
physician or nurse, as well as vaccination against influenza 
performed by a physician or nurse for people from the 
risk group. However, the contract between the National 
Health Insurance Fund and each primary health care 
Table 1 Key barriers and facilitators
Barriers Facilitators
Organization It is likely that the routine historic system does not meet new 
challenges like increasingly negative attitudes towards vaccination 
in society and the increasing mobility of the population.
There are advantages to the historic system with explicit roles and 
well known mechanisms.
Prioritization of vaccination services is on the health policy agenda.
Independent evaluation of approaches and tools.
More analytical reviews of the actual situation regarding communi-
cable diseases.
Shift from monitoring by “checking papers” to a more advisory 
approach.
Targeted efficient information campaigns.
Delivery Opportunistic approach to delivery when activities are predomi-
nantly carried out inside a health care facility for its visitors during 
limited working hours.
Misbalance in logistics while health care providers have to take 
care of proper transportation (return travel to the capital (Vilnius) at 
least four times per year).
Some gaps in updated knowledge, communication skills and 
attitudes of health workers, e.g. general practitioners who replaced 
paediatricians are less well informed about child vaccination issues
Vaccination services delivered outside health care facilities.
Tailored training for health professionals and professionals working 
in the community, e.g. social workers, personnel in nurseries and 
kindergartens, etc.
Improved logistics.
Financing Substantial additional costs of transportation and equipment on the 
side of providers.
Payment arrangements with proven efficient incentives.
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Nr.355 “Dėl užkrečiamųjų ligų profilaktikos ir kontrolės 
priemonių, priskiriamų būtinosioms visuomenės sveikatos 
priežiūros priemonėms ir finansuojamoms iš Lietuvos 
respublikos valstybės biudžeto” [Resolution 355 on the 
necessary public health protection against communicable 
diseases measures financed by the State Budget]. Vilnius, 
Government of the Republic of Lithuania.
Lietuvos Respublikos Žmonių [Parliament of the 
Republic of Lithuania] (1996) užkrečiamųjų ligų pro-
filaktikos ir kontrolės įstatymas. m. Rugsėjo 25 d. Nr. 
I-1553 [Law on prevention and control of communicable 
diseases. No. I-1553]. Vilnius, Parliament of the Republic 
of Lithuania.
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Nr.V-955 “Dėl Lietuvos respublikos vaikų profilaktinių 
skiepijimų kalendoriaus patvirtinimo” [National immu-
niztion schedule for children. Order No.V-955]. Vilnius, 
Ministry of Health.
Lietuvos Respublikos Vyriausybės [Government of the 
Republic of Lithuania] (1999) m. kovo 30 d. nutarimas 
Luxembourg
Guillaume Campagné, Françoise Berthet, 
Nathalie de Rekeneire, Diane Pivot
Governance
In Luxembourg the Ministry of Health is the main agency 
in charge of developing and overseeing the implementa-
tion of national vaccination policies. The Ministry follows 
the advice and recommendations of a national immuni-
zation technical advisory group, formally established in 
2011, called the Conseil supérieur des maladies infectieuses 
(CSMI). Composed of civil servants and experts from 
several scientific societies, this committee enjoys a high 
level of independence in the choice and the conduct of 
its mission, despite being attached to the Ministry of 
Health, and is in charge of setting out and editing vaccine 
recommendations. The committee has published recom-
mendations for measles and influenza vaccination, but 
these recommendations are not legally binding.
Relating to the organization and delivery of vaccination 
services, the Ministry delegates to the Directorate of 
Health three main functions:
1. Communication
2. Pharmacovigilance
3. Vaccine supply
The first two functions of communication and pharma-
covigilance are similar for measles and influenza. The 
Directorate of Health communicates to health care pro-
fessionals any amendment to vaccine recommendations 
published by the Conseil supérieur des maladies infectieuses. 
Professionals are also regularly informed through national 
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therefore applies to everyone. Official guidelines from the 
Conseil supérieur des maladies infectieuses mention that the 
first vaccine dose against measles should be administered 
at the age of 12 months, with a booster administered 
at the age of 15–23 months. Catch-up immunization 
applies to every individual born after 1970 who is not (or 
not fully) vaccinated against measles.
For influenza vaccines, recommendations take into 
account risk. Influenza vaccination is recommended for 
people aged 65 years and older, pregnant women, people 
with chronic cardiac and lung conditions, people with 
metabolic pathologies, people with immunodeficiency, 
and people with certain blood diseases, among others. 
Hence, not everyone should be given the influenza vac-
cine but only people in defined risk groups. In terms of 
cost coverage, people not included in the risk groups 
are not covered under the third-party payment system 
nor under reimbursement from the statutory health 
insurance.
Population registries are currently not used to support 
vaccination programmes against measles or influenza.
Targeted measures are in place for measles among refu-
gees. Within three days of their registration, refugees are 
seen by a medical doctor and those for whom no proof 
can be found of previous vaccination against measles will 
receive a dose of the measles vaccine.
Several incentive schemes are in place in Luxembourg 
for vaccination against influenza and measles. Overall, 
the general public is informed about all vaccinations 
from birth (an information brochure about childhood 
vaccines is distributed to all parents) as well as yearly 
during the European Immunization Week. For this, the 
Directorate of Health organizes a yearly national cam-
paign under the auspices of the Ministry and different 
methods and media are mobilized to inform the public. 
For measles, there are also financial incentive schemes. 
Notably, parents are incentivized (family allowance of 
€580) to visit medical doctors six times during the first 
two years following their child’s birth. These consulta-
tions are scheduled around the time of the first measles 
vaccine dose (9–12 months) and of the booster dose (at 
21–24 months). Paediatricians performing these consul-
tations are also financially incentivized, as the tariff of 
these consultations is higher than a normal one. In the 
end, parents and professionals are encouraged to achieve 
optimal vaccination status.
campaigns about vaccination. Furthermore, raising aware-
ness of measles and influenza vaccines among the general 
public is part of the Ministry’s mandate. The Ministry’s 
website includes all information and updates pertaining 
to vaccine recommendations.
Pharmacovigilance is the second function devolved to the 
Directorate of Health. Any serious adverse event occur-
ring with measles or influenza vaccines has to be notified 
to its pharmacy department. Collected data are then ana-
lysed and sent to international agencies when appropriate.
For the third function, vaccine supply, the Ministry’s role 
differs for measles and influenza.
For the supply of measles vaccines, the Directorate of 
Health has several tasks. It is in charge of the public 
tender for the acquisition of measles vaccines and des-
ignates the pharmaceutical wholesaler for vaccine stock 
logistics. The Directorate then organizes and oversees 
the vaccine supply. It collects orders from health care 
providers (professionals and hospital pharmacies) for any 
vaccines they need, and transmits these orders to the 
pharmaceutical wholesaler that will dispatch the vaccines 
to providers. The procedure is completely free of charge 
for health care professionals and hospital pharmacies, as 
the Directorate pays the manufacturer for all supplied 
vaccines according to the contract. Consequently, the 
vaccine is available at the point of care free of charge.
The organization for the supply of influenza vaccines 
differs. Indeed, pharmacies contract directly with phar-
maceutical wholesalers to buy influenza vaccines (from 
several manufacturers). Individuals belonging to risk 
groups entitled to free influenza vaccines need a medical 
prescription to obtain the flu vaccine from their local 
pharmacist, where the vaccine is subjected to full reim-
bursement according to the third-party payment system. 
A regular convention with the national health insurance 
system (Caisse nationale de santé) establishes the Ministry 
of Health’s contribution to the costs of the influenza 
vaccines.
In Luxembourg policy design and the implementation 
of vaccination programmes take place at the national 
level. There is, however, no written national multi-year 
vaccination plan.
There are no mandatory vaccinations in Luxembourg but 
measles and influenza vaccines are recommended. For 
measles vaccination, the recommendation is universal and 
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vaccinations against influenza. These professionals have 
several similar roles to paediatricians involved in admin-
istering vaccine against measles:
1) informing and counselling patients;
2) prescribing the vaccine against influenza;
3) administering the influenza vaccine (fully covered 
for patients of certain risk groups through the 
third-party payment system);
4) documenting the given vaccine in the patient’s 
vaccination record; and
5) reporting any serious adverse event occurring with 
the influenza vaccine to the pharmacy department 
of the Directorate of Health – Pharmacovigilance.
General practitioners are the mainly private practice pro-
fessionals involved in influenza vaccination. Their compli-
ance with the recommendations and guidelines published 
by the Conseil supérieur des maladies infectieuses is variable, 
and 80% of the cost of a visit to the general practitioner 
or specialist is reimbursed.
Financing
Childhood vaccinations against measles are free of charge 
at the point of delivery.
The state budget covers 100% of the cost of measles 
vaccines; the state budget and statutory health insurance 
together cover 100% of the cost of influenza vaccines; 
and vaccination services costs are covered by statutory 
health insurance at their usual rates: 100% for children 
and adolescents up to 18 years, 80% for adults.
The Ministry of Health has not identified any major gap 
in population coverage for the statutory financing system.
Vaccines against influenza are free of charge for some 
risk groups (notably people aged 65 years and older, 
pregnant women and people with chronic conditions, 
among others). Some employers also provide vaccines and 
vaccination services to their employees, all free of charge.
For high-risk groups covered by social health insurance, 
vaccine costs are partially covered by the state budget 
(from the Ministry of Health). For the general population 
For the influenza vaccine, the Ministry of Health organ-
izes a national campaign every year incentivizing target 
groups to get vaccinated.
To estimate the measles vaccination coverage rate, a 
national survey is organized by the Directorate of Health 
every five years, based on a representative sample of 
25–30-month-old children.
To estimate the influenza vaccination coverage rate, the 
Directorate of Health uses administrative data provided 
by the national health insurance system. Administrative 
reimbursement data from people over 65 years old, living 
and insured in Luxembourg, are collected and analysed 
for every season.
Provision
In Luxembourg public health services, school health ser-
vices, community nurses and pharmacies are not involved 
in administering vaccinations against measles. Primary 
health care professionals such as paediatricians are the 
principal providers involved in administering childhood 
vaccinations against measles. These professionals have 
several roles:
1) informing and counselling patients;
2) administering the measles vaccine (supplied for 
free by the Directorate of Health);
3) documenting the given vaccine in the patient’s 
vaccination record; and
4) reporting any serious adverse event occurring with 
the measles vaccine to the pharmacy department 
of the Directorate of Health – Pharmacovigilance.
Paediatricians are the principal private practice profes-
sionals involved in childhood vaccinations. They use and 
comply with recommendations and guidelines published 
by the Conseil supérieur des maladies infectieuses. The cost 
of the visit is fully reimbursed for all children up to 18 
years old.
In Luxembourg public health services, school health ser-
vices, community nurses and pharmacies are not involved 
in administering vaccinations against influenza. Primary 
health care professionals, mainly general practitioners, are 
the principal providers involved in administering adult 
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and for all risk groups, vaccination service costs are cov-
ered by the statutory financing system (social health 
insurance).
The situation is different for employees if their employers 
provide vaccines and vaccination services free of charge.
Barriers and facilitators
The Ministry of Health has not identified any major gap 
in population coverage for the statutory financing system.
In Luxembourg the key facilitators for achieving an effec-
tive vaccination coverage of childhood vaccinations 
against measles are as follows:
1) a family allowance of €580 for parents whose child 
attends the six planned medical consultations – 
each of these visits being an opportunity to inform, 
counsel and answer questions about immuniza-
tion, and two of these visits being set according to 
the measles vaccination schedule;
2) medical doctors are financially incentivized to 
perform these six planned medical consultations 
thanks to a special tariff higher than the standard 
one; and
3) measles vaccines are available free of charge for 
patients and medical doctors at the point of 
delivery.
In Luxembourg no key facilitators have been identified 
for achieving effective vaccination coverage of adult vac-
cinations against influenza. Moreover, several key bar-
riers are present:
1) unlike measles vaccines, influenza vaccines are 
not available at the point of service and must 
be collected from a pharmacy by patients with a 
prescription;
2) the amount to be paid by every covered adult 
patient after a medical consultation is roughly 20% 
of the consultation’s normal tariff; and
3) some risk groups do not get free of charge influ-
enza vaccines.
Malta
Natasha Azzopardi Muscat
Governance
The Primary Child Health and Immunization Unit is 
responsible for primary health care and prevention of 
illness in children within the community. Its services 
include Well-Baby Clinics, the National Immunization 
Service and the School Health Service. It forms part of 
the Primary Health Care Service within the Ministry 
for Health. The Minister for Health also appoints an 
Advisory Committee on Immunization whose remit 
it is to advise on immunization schedules and the 
inclusion of vaccines in the public health service. The 
Communicable Diseases Unit within the Directorate for 
Health Promotion and Disease Prevention is responsible 
for surveillance, including the surveillance of vaccine-
preventable disease.
Vaccination programmes are organized at a national 
level. In the public health services, vaccines are centrally 
procured and distributed. Immunizations are delivered 
within primary care health centres distributed throughout 
the country. In specific immunization campaigns, local 
councils may also be involved as sites for immunization 
delivery.
It should be noted that in Malta there is a significant 
private health sector in primary care and community 
paediatrics. Several immunizations are delivered through 
these providers and are paid for out-of-pocket or via 
private health insurance. Vaccines which are not covered 
by the public health sector may be obtained privately. 
Under-reporting of immunization from the private sector 
remains an issue.
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care sector, MMR vaccines tend to be administered by 
general practitioners or private community paediatri-
cians. Nurses are regulated by the Council for Midwives 
and Nurses under the Health Care Professions Act. The 
immunization service is accountable to the Primary Care 
Management team which includes the Chief Nursing 
Manager in primary care. Private general practitioners are 
regulated by the Medical Council under the Health Care 
Professions Act. They are not managerially accountable 
and are self-employed.
The public health service may be involved in the coordi-
nation of specific vaccination efforts with groups such as 
refugees and irregular immigrants. The public health ser-
vice does not offer a parallel service to that offered by the 
public primary care facilities. The communicable disease 
surveillance unit is accountable to the Superintendent of 
Public Health.
The School Health Service consists of a team of doctors 
and nurses who provide monitoring of primary child 
health and well-being as well as preventive care services 
in all State and Church Schools in Malta and Gozo. 
The emphasis is on the early detection of develop-
mental, growth, sensory and learning problems, as well 
as physical disorders. To this end, pre-school develop-
mental assessments are carried out before school entry, 
i.e. at pre-kindergarten level. These assessments, which 
are carried out in the parents’ presence, involve taking 
a medical and family history, conducting a language, 
physical and social development assessment, height and 
weight measurement, as well as checking vaccination 
records.
Throughout the school year, the school doctors and nurses 
carry out a number of procedures with the following 
being of relevance to vaccination:
• rechecking and updating vaccination records for 
all Year 1 pupils;
• checking of vaccination records and TB screening 
of all non-Maltese pupils; and
• the administration of diphtheria, tetanus and polio 
vaccine (booster) to Year 10 pupils, along with an 
MMR catch-up campaign running in parallel. 
The team works in close collaboration with the 
National Immunization Service through regular updat-
ing and inputting of vaccines in the central national 
There is no national vaccination plan. Vaccination is 
guided by the public immunization schedule (http://dep-
utyprimeminister.gov.mt/en/phc/pchyhi/Pages/National-
Immunization-Schedule.aspx).
Vaccination is regulated through the Prevention 
of Disease Ordinance, Chapter 36 of the Laws of 
Malta, Articles 54–67 (http://www.justiceservices.gov.
mt/DownloadDocument.aspx?app=lom&itemid=8595). 
Diphtheria, tetanus and polio vaccination are manda-
tory. There is a legal notice that still refers to man-
datory immunization of girls against rubella by the 
time they are 13 years old. However, this refers to 
the period when girls were immunized against rubella 
between the ages of 10 and 13 and in practice this has 
been superseded by the MMR vaccine in line with the 
national immunization schedule. Under the Prevention 
of Disease Ordinance, the Minister has the power to 
prescribe mandatory vaccination as follows: “any disease 
as the Minister may prescribe until such time as full 
and continued protection of the child against these 
diseases is ensured”.
Public vaccination programmes are based on the 
Common database (CdB) which is maintained by the 
Public Registry. The immunization service has access to 
the government common database and is responsible for 
call and follow-up.
Specific active immunization programmes are carried 
out with refugees and irregular immigrants. Usually this 
is part of the medical screening that takes place upon 
arrival in the country. There are no religious objectors but 
persons who object to vaccination are being encountered 
increasingly frequently.
There are no incentive schemes or sanctions currently 
in place. Parents are strongly encouraged to have their 
children vaccinated prior to school entry.
Vaccination coverage is calculated at the national level.
Provision
Measles
Childhood vaccinations against measles are delivered 
as part of the MMR in the vaccination schedule. In the 
public primary care sector these are delivered by nurses 
who run the immunization clinics. In the private primary 
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Financing
Childhood vaccinations against measles are free of charge 
at the point of delivery. The cost is covered through 
the statutory financing system via the general govern-
ment budget. Vaccines are procured through the Central 
Procurement Supplies Unit.
If patients choose to have the MMR vaccination privately, 
then they formally pay the full cost out-of-pocket unless 
they have a private insurance scheme which partly or fully 
covers childhood vaccinations.
The seasonal influenza vaccine for the year 2017/18 was 
available free of charge from all health centres. In the first 
week the campaign was launched, priority was given to:
•	 All persons aged 55 years and over
•	 Children between 6 months and 59 months of age
•	 Persons of any age suffering from chronic diseases 
of the lungs, heart, liver or kidneys, diabetes, and 
any immunodeficiency conditions, including HIV 
and AIDS - in these cases, the Schedule V Control 
Card or a recent medical certificate stating the 
person’s medical condition should be presented.
After the first week the influenza vaccine was available free 
of charge for all persons over the age of 6 months while 
stocks lasted. It is likely that the same or highly similar 
criteria will continue to apply in future.
The costs of vaccines and vaccine services are covered 
under the statutory financing system via taxation from 
the general government budget, and through the Central 
Procurement and Supplies Unit.
Those persons who opt to take the influenza vaccine 
privately usually order it at the local pharmacy and pay 
for the full cost out-of-pocket. As government coverage 
has widened, the number of persons opting to pay for the 
vaccine privately appears to be coming down.
Over the past decade the government has widened the 
criteria for influenza vaccination with practically all those 
wishing to have the vaccine being able to access it free of 
charge after the first week while stocks are available. It is 
not reported that stocks have been totally depleted and 
that demand has not been met.
immunization database, administration of some vacci-
nations in schools and catch-up campaigns for missed 
vaccinations. The School Health Service is accountable 
to the management of Primary Health Care but works 
closely with the Department of Paediatrics, which is based 
at the main hospital.
Community nurses based in the health centres and the 
School Health Service play an important role in the 
implementation of the immunization programme since 
they issue the call/recall, administer the immunizations 
and carry out the data entry. Community nurses work 
within the immunization service.
Pharmacies sell vaccines from community retail phar-
macies. Vaccines may be administered in the pharmacy 
setting in the private sector by general practitioners or 
paediatricians normally carrying out a private clinic adja-
cent to (or embedded within) the pharmacy premises. 
Pharmacists do not administer immunizations routinely, 
but may do so under supervision.
Influenza
In the public primary care sector vaccinations against 
influenza are delivered by nurses who run the immuniza-
tion clinics. In the private primary care sector influenza 
vaccines tend to be administered by general practitioners.
Public health services organize and coordinate the influ-
enza vaccination campaign, including advising on spec-
ifications, procurement, etc., but the public health ser-
vice is not directly involved in administering influenza 
vaccinations.
Adult influenza vaccination is primarily carried out 
through immunization clinics at health centres by com-
munity nurses working in the immunization service. 
Persons caring for housebound relatives can phone for a 
special arrangement to be made such that the housebound 
person is given the influenza vaccine by the community 
domiciliary nursing service.
Pharmacies sell influenza vaccines from community retail 
pharmacies. Vaccines may be administered in the phar-
macy setting in the private sector by general practitioners 
normally carrying out a private clinic adjacent to (or 
embedded within) the pharmacy premises. Pharmacists 
do not administer immunizations.
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Key barriers and facilitators
Measles
Childhood vaccination against measles is widely available 
through the immunization clinics in the health centres. 
There are no financial barriers to access and vaccination 
is provided to all children in the country irrespective of 
nationality, etc. The main barriers being encountered are 
rising vaccine scepticism and ‘fake news’ on social media 
which requires constant rebuttal by health professionals.
Influenza
Adult vaccinations against influenza are widely avail-
able and promoted heavily. Over the years the criteria 
for vaccination have been extensively widened and one 
cannot really talk of unmet need in this area. For house-
bound and bedbound persons, domiciliary vaccination 
through the community nursing service is also availa-
ble. Occasionally, difficulties have been encountered in 
the past in procuring stock at national level in a timely 
manner.
Netherlands
Madelon Kroneman
Governance
For measles, the vaccination programme is part of the 
national immunization programme (Rijksvaccinatie-
programma), under the responsibility of the Ministry of 
Health, Welfare and Sport, to protect children against 
infectious diseases. To execute the programme, the Minis-
try of Health, Welfare and Sport delegated the task to the 
National Institute for Public Health and the Environment 
(Rijksinstituut voor Volksgezondheid en Milieu), which 
monitors and registers the vaccinations. The Minister of 
Health, Welfare and Sport decides which vaccinations will 
be part of the national immunization programme (Kro-
neman et al., 2016; National Institute for Public Health 
and the Environment, 2018a), based on the advice of the 
Health Council of the Netherlands, an independent advi-
sory body for the government. Childhood vaccinations 
are recommended in the Netherlands. Measles vaccina-
tions are provided to children at the age of 14 months 
and the age of 9 years. Childhood vaccinations are free 
of charge. Parents receive invitations for their child/ren 
from the National Institute for Public Health and the 
Environment, which uses the National Population Reg-
istry (Basisregistratie Personen) as the information source 
for these invitations. A reminder is sent if parents do not 
make use of the invitation.
Children who live in an asylum shelter receive an invi-
tation for a meeting with Youth Health Care Services. A 
vaccination plan is tailor-made for them, based on the 
vaccinations they have already had. There is a small group 
of religious objectors and a growing group of people who 
do not believe in vaccinations. There are no special pro-
grammes or policies for them.
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a vaccination certificate and a set of call-up cards for the 
different vaccinations up to the age of 4 years. Parental 
consent for vaccination is asked before the first vaccina-
tion and registered in the electronic registry of the Youth 
Health Care Services (Jeugdgezondheidszorg). For the vac-
cination at 9 years old, parents receive a new invitation.
Adult vaccinations against influenza are provided by 
general practitioners. They invite eligible persons based 
on the information in their information system. General 
practitioners mostly organize special vaccination hours, 
but they are free to organize the actual administration 
as they wish. The professional organization of general 
practitioners provides a guide on how the influenza vac-
cination campaign is organized and implemented (Vrieze 
et al., 2017).
Financing
Childhood vaccinations, including measles vaccination, 
are free of charge at the point of delivery. The national 
immunization programme is financed through general 
taxation.
Influenza vaccination is free of charge at the point of 
delivery for persons at high risk of complications from 
influenza infection. The groups for which vaccination is 
recommended are (as of 2018):
•	 persons aged 60 or over
•	 children and adults with certain conditions, 
namely:
– patients with abnormalities and functional 
disorders of the airways and lungs
– patients with a chronic heart disorder
– patients with diabetes mellitus
– patients with a chronic kidney disease
– patients who recently underwent a bone 
marrow transplant
– persons living with HIV
– persons with a reduced resistance to infec-
tion (e.g. because of (functional) asplenia, 
autoimmune disease, liver cirrhosis, chemo-
therapy or immunosuppressive medication)
•	 children aged between 6 months and 18 years who 
are long-term salicylate users
Vaccination uptake is calculated based on data from the 
National Population Registry and the number of adminis-
tered vaccinations (Schurink-van ’t Klooster & de Melker, 
2017; van Lier et al., 2018).
Influenza vaccination is part of the National Influenza 
Prevention Programme coordinated by the National 
Influenza Prevention Programme Foundation (Stichting 
Nationaal Programma Grieppreventie). The National 
Institute for Public Health and the Environment over-
sees the quality and effectiveness of the programme and 
purchases the vaccines through European tenders. The 
Minister of Health decides which risk groups are eli-
gible for influenza vaccination, based on advice of the 
Health Council of the Netherlands. Vaccination for risk 
groups is free of charge. Selection and invitation of per-
sons at risk of complications associated with influenza are 
done by general practitioners, based on their electronic 
patient records. Influenza vaccination is recommended, 
not mandatory.
Some employers offer influenza vaccination through their 
occupational health services. The number of persons vac-
cinated in this way are not included in the uptake figures, 
but previous research revealed that this number is rather 
low (Kroneman & Verheij, 2003).
Vaccination uptake figures are based on the Nivel Primary 
Care Database (Nivel Zorgregistraties eerste lijn). This data-
base uses routinely recorded data from health care pro-
viders to monitor health and utilization of health services 
in a representative sample of the Dutch population. The 
database contains data on approximately 800 000 patients 
from 211 general practitioner practices.
Side-effects of vaccinations (for both measles and influ-
enza) are registered and monitored by the Netherlands 
Pharmacovigilance Centre Lareb.
Provision
Childhood vaccinations against measles at the age 
of 14 months are administered by physicians at Child 
Health Centres (Consultatiebureaus), where parents go 
with (healthy) babies for regular health check-ups. At the 
age of 9 years vaccination is provided by municipal public 
health services.
Soon after a baby’s birth the parents receive an invitation. 
This invitation includes a letter, an information brochure, 
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National Influenza Prevention Programme Foundation 
pays about €10 per vaccinated person belonging to one 
of the target groups.
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•	 persons with an intellectual disability living in 
residential homes (National Institute for Public 
Health and the Environment, 2018b).
The influenza vaccination programme is financed through 
general taxation. General practitioners order vaccines 
from the National Influenza Prevention Programme 
Foundation. A spillage of 5% is allowed. Larger spillage 
will be at the expense of the general practitioner. General 
practitioners receive a fee for each vaccinated person from 
the target groups. People who do not belong to the target 
groups have to pay out-of-pocket. Sometimes employers 
pay for these vaccinations, which are then administered 
through their occupational health service.
Key barriers and facilitators
Childhood vaccinations against measles are provided 
during the regular health check-ups of babies at the age of 
14 months. For those parents who visit the Child Health 
Centres, the vaccination does not require an extra visit. 
The invitation contains an information leaflet. Parents 
receive a baby book at their first visit to the Child Health 
Centre, in which they can register the developments of 
their children and in which the vaccination schedule is 
indicated. Vaccination uptake, although still high, has 
been slowly decreasing over the years. It is not yet clear 
why this is the case. Since January 2018 more time has 
been made available for professionals to discuss parents’ 
worries concerning vaccinations. A number of other 
activities to increase vaccination uptake are currently 
being discussed or initiated, including a dialogue with 
anti-vaccination movements, and the establishment of a 
website with patient stories.
Vaccine uptake of adults against influenza is also decreas-
ing. This trend started in 2008 and the latest figures 
available indicate uptake was still falling in 2016. Vaccine 
uptake decreased from over 75% at the beginning of the 
century to 53% in 2016 (Heins et al., 2016). Research 
revealed that among older people their willingness to 
accept vaccination is influenced by their judgement of 
the effectiveness of the vaccine, the risk of contracting the 
disease and the risk of dying as a result of influenza (Eilers 
et al., 2017). This information can be useful in designing 
information campaigns. Previous research revealed that 
a personal invitation from a general practitioner was a 
facilitator for influenza vaccination uptake (Kroneman, 
Paget & van Essen, 2003). As an incentive for general 
practitioners to organize and administer the vaccines, the 
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Vrieze HA et al. (2017). NHG/SNPG-Handleiding 
Griepvaccinatie, Herziening 2017, De organisatie, uitvo-
ering en achtergrond van de griepvaccinatie in de huisart-
senpraktijk [NHG/SNPG manual influenza vaccination, 
revised version 2017, The organization, implementation 
and background of the influenza vaccination in GP prac-
tice]. Utrecht: Nederlands Huisartsen Genootschap.
Poland
Iwona Kowalska-Bobko, Katarzyna Badora-Musiał
Governance
Recommendations for the implementation of vaccina-
tions in Poland are prepared by:
1. the Paediatric Team of Experts on the Protective 
Vaccination Programme at the Ministry of Health, 
and
2. the Sanitary-Epidemiology Group at the Chief 
Sanitary Inspectorate.
Recommendations result from the analysis of national 
data on the incidence of specific infectious diseases 
and infections. They also take into account the recom-
mendations and reports of the Advisory Committee 
on Vaccination of the European Centre for Disease 
Prevention and Control (ECDC) and the recommenda-
tions of the World Health Organization (WHO).
Entities that carry out vaccinations keep medical records 
regarding mandatory vaccinations, including storing 
immunization cards and making entries confirming the 
vaccination, and prepare reports on mandatory vaccina-
tions and reports on the vaccination status of persons 
covered by preventive health care, which they provide 
to the state county (powiat – the middle level of Polish 
territorial self-government) sanitary inspector.
The National Institute of Public Health–National 
Institute of Hygiene (Narodowy Instytut Zdrowia 
Publicznego–Państwowy Zakład Higieny (NIZP-PZH)), 
the health research and expert advisory institution in 
Poland prepares annual reports.
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According to the Law dated 5 December 2008 on the 
prevention and control of infections and communicable 
diseases in humans (OJ L 2008 No. 234 item 1570):
1. Persons issuing a live birth certificate are obliged 
to attach an immunization card and a vaccination 
booklet for the child;
2. Persons carrying out vaccinations, e.g. primary 
care physicians, must (a) maintain medical records 
concerning mandatory vaccination, including 
keeping immunization cards and making entries 
confirming the completion of vaccination; (b) 
prepare reports on the mandatory vaccinations 
carried out and reports on the vaccination status 
of persons covered by preventive health care, and 
provide the State County Sanitary Inspector with 
such reports.
3. The Chief Sanitary Inspector shall announce in a 
communiqué, in the official journal of the Minister 
of Health, the Protective Vaccination Programme 
for a given year, with detailed indications con-
cerning the use of particular vaccines, resulting 
from the current epidemiological situation, not 
later than 31 October of the year preceding the 
implementation of the programme.
4. The health-epidemiological stations (at the state 
county level) shall determine the annual demand 
for vaccines, store the vaccines and supply the vac-
cinating service providers with them. The entities 
obliged to prepare the quantitative demand for 
vaccines used for the performance of the manda-
tory vaccination, together with the schedule of 
vaccine deliveries, and to prepare reports on the 
types, numbers, serial numbers and validity dates 
of vaccines, are the authorities of the State Sanitary 
Inspectorate. The entity responsible for reporting 
on the implementation of vaccine delivery sched-
ules is the central distributor appointed by the 
Minister of Health.
5. The Minister of Health determines by way of 
an executive regulation the entities obliged to 
draw up a quantitative demand for vaccines 
used for mandatory vaccinations, together with 
a schedule of supplies of vaccines, their storage 
and distribution.
There are no acts addressed exclusively at migrants living 
in Poland. Legal regulations apply to the general popu-
lation in Poland and, where appropriate, they also take 
into account the needs and/or obligations of migrants 
(Sakowski, 2012).
The obligation to vaccinate according to the immuniza-
tion programme applies to everyone who stays in Poland 
for more than three months. The Act on preventing and 
combating infections and infectious diseases does not 
provide an exception for any specific population group 
(e.g. refugees, religious objectors, etc.).
If non-citizens are legally resident in Poland and registered 
with a general practitioner, regardless of health insur-
ance cover, they can receive free vaccinations under the 
immunization programme up to the age of 19. Indeed, 
such immunizations might be mandatory. For persons 
who do not have health insurance entitlements, the 
costs of mandatory vaccinations, medical qualification 
tests or specialist consultations are financed from the 
state budget (from the part managed by the Minister 
of Health).
Primary care physicians are the primary source of infor-
mation about vaccinations. The facilities of the State 
Sanitary Inspectorate are in constant contact with vac-
cination points, providing them with refunded vaccines, 
monitoring reporting and publishing information mate-
rials on websites. However, there are no standard proce-
dures in this area and the quality of information available 
in individual facilities is very variable. The Chief Sanitary 
Inspector conducts the campaign “Vaccinating the will-
ingness to vaccinate” (Zaszczep w sobie chęć szczepienia) 
and publishes legal acts regarding this issue.
A nationwide campaign, “Vaccinate yourself with knowl-
edge!” (Zaszczep się wiedzą!), which promotes reliable 
information and sources of vaccination information, has 
been under way since 2015. The campaign emphasizes 
the need for a responsible approach to the idea of vac-
cinations. The main tool is the website www.zaszczep-
siewiedza.pl, where people looking for answers to the 
question “why is it worth it to vaccinate?” will find the 
most important information.
Another important source of information is the portal 
szczepienia.info, created in 2007 and run by the National 
Institute of Public Health–National Institute of Hygiene, 
which is accredited by Vaccine Safety Net WHO.
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The Polish immunization programme includes:
1. The mandatory immunization programme,
2. The mandatory immunization programme for risk 
groups,
3. The recommended immunization programme.
Since 2013 the National Programme for Fighting 
Influenza has been educating the public and building 
awareness of the risks associated with influenza and its 
complications. This is a social initiative by independent 
medical experts. The assumptions of the programme were 
created in cooperation between experts of the Working 
Group on Influenza, the National Institute of Public 
Health–National Institute of Hygiene and the Polish 
Society of Health Education. In 2016, 205 territorial 
self-government units financed older people’s vaccination 
against influenza.5
Vaccination coverage
The average coverage with the MMR vaccine in Poland 
in 2015 was 96.7% (for children having two doses of 
MMR). In 2017, 63 cases of measles were registered. 
The last death due to measles in Poland was recorded in 
the 1990s.6
Of all the infectious diseases covered by epidemiological 
surveillance in Poland, most cases are caused by influenza. 
Every year during the peak influenza season, which in 
Poland most often runs from January to March, influ-
enza and influenza-like illness result in an overloading 
of the primary health care system and become a lead-
ing cause of sickness absence, generating significant eco-
nomic and social costs (Wojtyniak & Goryński, 2016). 
In the 2016/17 season a record number of influenza and 
influenza-like cases were recorded. In total, 4 919 110 
people fell ill, 20% more than for the same period of the 
previous influenza season. There have also been 25 deaths 
due to influenza and its complications. Most often they 
occurred in people over 65 who are the most vulnera-
ble to influenza complications (Wojtyniak & Goryński, 
2016).
5 Szczepienia, Ogólnopolski Program Zwalczania Grypy, http://
opzg.pl/szczepienia.
6 http://szczepienia.pzh.gov.pl/szczepionki/odra/6/#szczepionki-
przeciw-odrze-w-programie-szczepien-ochronnych.
Key agencies
The immunization programme is established as a national 
policy by the Ministry of Health and the General 
Sanitary Inspectorate, in cooperation with the Sanitary-
Epidemiology Board (Rada Sanitarno-Epidemiologiczna) 
and the Paediatric Group of Experts for Vaccination 
(Pediatryczny Zespół Ekspertów ds Szczepień Ochronnych). 
The Board is an advisory group and consists of: epide-
miologists, paediatricians, infectious disease physicians, 
microbiologists and sanitary inspection members. The 
programme is published before 31 October in the year 
preceding the implementation of the programme as a 
Ministry of Health directive approved by the General 
Sanitary Inspectorate.
Immunization programmes
In Poland vaccinations included in the immunization 
schedule are mandatory for children and adolescents 
(0–19 years old). This means that every child residing 
in Poland can receive vaccines refunded by the state, 
but it also means that parents are obliged to show up to 
vaccination visits (Article 5 of the Act on preventing and 
combating infections and infectious diseases – Journal 
of Laws, Dz. U. 2008, No. 234, Item 1570). Refusal to 
vaccinate usually means triggering an administrative pro-
cedure, which typically involves a monetary fine.
Mandatory vaccinations are set by Polish law and per-
tain to all children residing in Poland for longer than 
three months. Each child at birth receives an immuni-
zation card which is stored at the general practitioner’s 
office and is used to monitor progress through the 
immunization schedule. Based on this card, the gen-
eral practitioner calls parents for Well-Baby visits and 
administers scheduled vaccines as part of developmental 
monitoring. The current immunization schedule (2018) 
includes 11 mandatory vaccines, against tuberculosis, 
hepatitis B, diphtheria, tetanus, pertussis, poliomyelitis, 
Haemophilus influenzae type b, pneumococci, measles, 
mumps and rubella (MMR). The immunization sched-
ule also includes a separate section describing which 
additional vaccines are recommended, but their cost 
has to be met by parents4 (e.g. rotavirus vaccines or 
meningococcal vaccines).
4 Mandatory vaccinations in Poland, http://szczepienia.pzh.gov.
pl/en/stories/mandatory-vaccinations-in-poland/.
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It is not recommended to administer the vaccine during 
pregnancy, and women should not become pregnant in 
the first month after vaccination.
Vaccination against influenza belongs to the recom-
mended set of vaccinations, which means that the vac-
cinated person covers the cost of the vaccine. More and 
more territorial self-government units are active in influ-
enza prevention, so that in these territories older people 
have the opportunity to access influenza vaccination free 
at the point of delivery.
Provision
In Poland vaccinations are carried out in therapeutic enti-
ties by doctors in individual medical practices, individual 
specialist medical practices or group medical practices, or 
by nurses and midwives in individual medical practices, 
individual specialist practices or group practices of nurses 
and midwives.
Mandatory vaccination is performed exclusively by health 
care providers under agreements concluded with the 
National Health Fund for the provision of basic health 
care or other scope of services, if so provided by the agree-
ment. Only vaccine preparations registered and available 
on the Polish market may be used in the implementa-
tion of the mandatory and recommended vaccination 
programmes.
Compliance with the scope of services and dates of vac-
cination are supervised by the State Sanitary Inspectorate 
in accordance with Article 5 (3) of the Act on the State 
Sanitary Inspection.
According to data collected by sanitary-epidemiological 
stations, a total of 799 958 people in 2015 were vacci-
nated against influenza in the whole of Poland, i.e. 2.1% 
of the population. Compared to 2014, the number of 
vaccinated patients decreased by 7.6%. Most people who 
were vaccinated were aged over 65 (with a coverage in this 
age group of about 7%) (Wojtyniak & Goryński, 2016).
Financing
Vaccines listed as mandatory are paid for by the Ministry 
of Health, and the costs of the immunizations are paid 
by the National Health Fund (the third-party payer 
of health services in Poland). Mandatory vaccines are 
given in practices/hospitals/clinics that contract with 
the National Health Fund (patients do not need to pay 
for it directly). However, recommended vaccines and 
immunizations need to be paid for either by patients 
individually, by employers or from individual private 
insurance funds. Vaccines are also available on the pri-
vate market (where costs are fully covered by patients)7. 
Sanitary-epidemiological stations determine the annual 
need for vaccines, store the vaccines and supply them to 
vaccination service providers.
The measles vaccine is given in a combined form as a 
measles, mumps and rubella (MMR) vaccine. Vaccination 
against measles belongs to the mandatory (free) set of vac-
cinations given to children in Poland aged 13–14 months 
and 10 years of age. They are financed from the budget of 
the Ministry of Health.
Children over 10 years of age who have not received two 
doses of MMR vaccine should be given the missing vac-
cine not later than by the age of 19 years. Vaccinations 
against measles, mumps and rubella are recommended 
(but not financed from the budget of the Ministry of 
Health) to persons:
-	 not vaccinated against measles, mumps and rubella 
as part of the mandatory vaccination, who receive 
two doses of vaccine at least four weeks apart, and
-	 young women, especially those working in chil-
dren’s environments (kindergartens, schools, hospi-
tals, clinics), and young men to prevent congenital 
rubella, especially those not vaccinated as part of 
the mandatory vaccination.
7 Poland, http://venice.cineca.org/documents/poland_ip.pdf.
Box 1 Mandatory vaccinations in Poland
Mandatory vaccinations are carried out by doctors, nurses, 
midwives and school hygienists. In practice, the vacci-
nation system is based on primary health care. General 
practitioners qualify for vaccination and constitute the 
main source of information. Nurses also perform vacci-
nations and record the administration of each vaccine on 
paper vaccination cards.
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Key barriers and facilitators
The state very clearly supports vaccination against measles 
by financing it from public funds and making it manda-
tory, but in 2017 almost 30 000 people in Poland evaded 
vaccination.
The very active anti-vaccination movement in Poland is a 
barrier to vaccination. Proponents of the anti-vaccination 
movement believe that the substances contained in vac-
cines are more harmful to health than the diseases against 
which they protect. It is argued that vaccines contain 
mercury, aluminium and formaldehyde, substances with 
toxic effects and many negative side-effects on health.
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Portugal
Jorge Simões, Inês Fronteira, Gonçalo Augusto
Governance
According to Ordinance No. 248/2017 of 4 August 
2017 the Directorate-General of Health (Direção-Geral 
da Saúde) is responsible at the national level for devel-
oping and overseeing implementation of the national 
immunization programme and other vaccination strat-
egies to protect public health and groups at risk or in 
special circumstances, such as free vaccination against 
seasonal influenza. At the regional level, Public Health 
Departments in each Regional Health Administration 
(Administração Regional de Saúde) are in charge of coordi-
nating the implementation of the national immunization 
programme and the free vaccination against influenza. At 
the local level those functions are carried out by Public 
Health Units, which are part of the Groups of Healthcare 
Centres (Agrupamentos de Centros de Saúde). Vaccines 
included in the national immunization programme and 
the vaccine against influenza are available free of charge 
in all primary health care units belonging to the National 
Health Service. Nurses are responsible for administering 
the vaccines.
The seasonal influenza vaccine is also available at com-
munity pharmacies and can be administered by pharma-
cists. However, if bought in a pharmacy, with a medical 
prescription, patients have to partially pay for the vaccine 
(37% of the price is covered by the National Health 
Service) (Guideline No. 018/2017 from the Directorate-
General of Health, published on 26 September 2017).
The governance of the Portuguese national immunization 
programme was strengthened in 2017 by a new regulation 
(Ordinance No. 248/2017, of 4 August 2017). The national 
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Figure 1 The national vaccination scheme in Portugal
 
Source: Directorate-General of Health
laboratory (National Institute of Health Dr Ricardo 
Jorge, Instituto Nacional de Saúde Dr Ricardo Jorge). At the 
regional level Public Health Departments are responsible 
for overseeing the national immunization programme’s 
implementation on a regular basis. At the local level 
Public Health Units coordinate the implementation of 
the national immunization programme.
The national immunization programme was established 
in Portugal in 1965. Several vaccines have been included 
under the national immunization programme since its 
inception. Currently, the Portuguese national immuniza-
tion programme includes vaccines against hepatitis B, diph-
theria, tetanus, pertussis, H. influenzae type b, poliomyeli-
tis, pneumococcal disease, meningococcal disease, measles, 
mumps, rubella and human papilloma virus (Figure 1).
immunization programme is organized and coordinated 
nationally by the Directorate-General of Health, which 
is responsible for proposing new or revised vaccination 
strategies to the Ministry of Health, issuing normative 
documents and guidance where appropriate, conducting 
monitoring and evaluation of both the vaccination process 
and the impact of vaccination strategies, guaranteeing the 
implementation of the national immunization programme 
and other vaccines offered through coordination with the 
procurement body (Shared Services of the Ministry of 
Health, Serviços Partilhados do Ministério da Saúde), the 
financing body (Central Administration of the Health 
System, Administração Central do Sistema de Saúde), 
the national medicines agency (National Authority of 
Medicines and Health Products, Autoridade Nacional do 
Medicamento e Produtos de Saúde) and the public health 
Birth HepB 1
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DTP – tetanus, diphteria and pertussis vaccine; Hib – Haemophilus influenzae type b vaccine; HPV – Human 
Papillomavirus vaccine; MenC – serogroup C meningococcal vaccine; PCV13 – 13-valent pneumococcal 
conjugate vaccine; Td – tetanus and diphtheria toxoids; Tdpa – tetanus toxoid, reduced diphtheria toxoid, and 
pertussis vaccine (reduced doses); MMR – measles, mumps and rubella vaccine; HepB – Hepatitis B vaccine 
Source: Directorate-General of Health
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•	 Refugees and migrants have access to the national 
immunization programme for free, under the same 
conditions as every Portuguese citizen;
•	 Other situations: during outbreaks (e.g. the hepa-
titis A outbreak in 2016/17), groups at higher risk 
are offered vaccination for free (even if the vac-
cine is not included in the national immunization 
programme).
Awareness-raising communication campaigns are organ-
ized regularly, and when new vaccines are included in the 
national immunization programme.
There are no specific incentives or sanctions for 
vaccinations.
Vaccination coverage is calculated in each National 
Health Service primary health care unit. The population 
(denominator) used is the total number of individuals 
who are registered in each National Health Service pri-
mary health care unit. As the National Health Service is 
universal, every citizen is a National Health Service user 
and is registered at a National Health Service primary 
health care unit.
National immunization programme vaccines: Vaccination 
coverage (of vaccine Y) in a given primary health care 
unit = Number of registered individuals born in year X 
vaccinated with vaccine Y / Total number of registered 
individuals born in the year X
Influenza vaccine: mixed method:
•	 administrative and survey (for ≥ 65 years old);
•	 records for institutional coverage;
•	 survey for clinical risk groups;
•	 Occupational Health for health care workers in the 
National Health Service.
Each National Health Service primary health care unit 
performs regular monitoring (at least yearly) and sends 
the information to the Public Health Unit of its juris-
diction. All Public Health Units communicate data 
to the respective Regional Public Health Department, 
and then each Regional Public Health Department 
sends the information to the Directorate-General of 
Health, which assembles national level information 
Vaccinations in Portugal are recommended. Portugal 
has achieved high immunization rates based on volun-
tary vaccination. However, according to Ordinance No. 
19058/1962 of 3 March 1962 and Decree-Law No. 
45198/62 of 20 February 1962, tetanus and diphtheria 
vaccines are mandatory for all people attending schools 
(up to the age of 7 years). Tetanus is also mandatory 
for certain professional groups, including civil servants. 
These laws are not enforced because these single vaccines 
do not exist and the Portuguese national immunization 
programme is not mandatory.
Individual information records based on population reg-
istries have existed since the inception of the national 
immunization programme in 1965, first on paper and, 
since 2003, in a computerized electronic system (in con-
tinental Portugal). This system was upgraded to an online 
system in 2017, which is still under development (in 
continental Portugal). Reminders and follow-up messages 
are generated automatically by the information system 
(since 2003) and managed by nurses in primary health 
care units. Catch-up with the schedules is done regularly.
Currently, in the national immunization programme 
specific groups of the population are targeted with specific 
measures and free vaccinations:
•	 Pertussis vaccine: All pregnant women should 
be vaccinated against pertussis (TDaP – tetanus, 
diphtheria and pertussis vaccine – reduced doses);
•	 BCG: Children at higher risk of TB (risk groups) 
should get BCG at birth or during childhood (<6 
years old);
•	 Pneumococcal vaccines: Children and adults 
with certain chronic illnesses (risk groups) can 
get the 23-valent and 13-valent pneumococcal 
vaccines free of charge, according to their doctor’s 
recommendation;
•	 Meningococcal B vaccine: Children and adults 
with certain chronic illnesses (risk groups) can get 
the MenB vaccine free of charge, according to their 
doctor’s recommendation;
•	 Hepatitis B vaccine: Health professionals and other 
risk groups can get HepB vaccine free of charge;
•	 Polio and MMR vaccines: Travellers and health pro-
fessionals can get polio and MMR vaccines for free;
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Table 2 Adult influenza vaccination coverage
Season Adult influenza vaccination 
coverage (>=65 years old)
Source
2010/11 48% Ecos, National Institute of 
Health Dr Ricardo Jorge
2011/12 43% Ecos, National Institute of 
Health Dr Ricardo Jorge
2012/13 55% Directorate-General of Health 
estimate
2013/14 57% Directorate-General of Health 
estimate
2014/15 55%  Directorate-General of Health 
estimate
2015/16 60% Directorate-General of Health 
estimate
2016/17 60%  Directorate-General of Health 
estimate
Provision
Vaccines included in the national immunization pro-
gramme (such as the MMR vaccine) are mainly pro-
vided at National Health Service primary health care 
units. Alternatively, private health care units can also 
offer national immunization programme vaccines, accord-
ing to specific agreements with the Regional Health 
Administrations, which are responsible for providing the 
vaccines for those private units. Nurses are the health care 
workers involved in the implementation of the national 
immunization programme, by administering vaccines and 
maintaining vaccination records.
Private market vaccines are bought in community phar-
macies, with a medical prescription, and can be admin-
istered at a health care unit (National Health Service 
or private). Alternatively, some private market vaccines 
(mainly influenza vaccination) can also be administered 
in pharmacies.
Adult vaccination against influenza is given for free to all 
citizens aged 65 years or older, health care workers, and 
specific groups of patients with chronic conditions. All 
other groups must have a medical prescription and buy 
the vaccine at any community pharmacy (the National 
Health Service covers 37% of the cost of the vaccine). 
For citizens eligible for free vaccination, the influenza 
on vaccination coverage, including the Autonomous 
Regions of Azores and Madeira. In the Autonomous 
Regions there are different records and information 
systems, but the same methodology for calculating 
coverage applies.
Table 1 Measles vaccination coverage
Cohort (of 
birth)
Measles vaccination 
coverage (latest data 
available)
Dose
Evaluation 
year
1997 96.6 MMR 2 2015
1998 96.6 MMR 2 2016
1999 97.6 MMR 2 2017
2000 97.9 MMR 2 2017
2001 98.0 MMR 2 2017
2002 98.0 MMR 2 2017
2003 98.0 MMR 2 2017
2004 97.7 MMR 2 2017
2005 97.7 MMR 2 2017
2006 97.6 MMR 2 2017
2007 97.2 MMR 2 2017
2008 96.7 MMR 2 2017
2009 96.7 MMR 2 2017
2010 96.5 MMR 2 2017
2011 95.0 MMR 2 2017
2012 97.8 MMR 1 2014
2013 98.0 MMR 1 2015
2014 97.8 MMR 1 2016
2015 98.4 MMR 1 2017
Note: According to the Portuguese national immu-
nization programme, Cohorts 1997–2011: children 
and adolescents aged 7–20 years old: 2 MMR doses; 
Cohorts 2011–2015: children aged 1–5 years old: 1 
MMR dose.
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o People hospitalized in the National Health 
Service, who have chronic conditions eligi-
ble for the influenza vaccine
•	 All people with the following chronic conditions, 
irrespective of their age:
o Diabetes
o Dialysis
o Down syndrome (Trisomy 21)
o Awaiting cell or organ transplant
o Submitted to cell or organ transplant
o On chemotherapy
o Cystic fibrosis
o With alfa-1 antitripsin deficit under therapy
o With Pulmonary interstitial disease under 
therapy
o Chronic disease with respiratory 
impairment
•	 National Health Service health care workers, who 
have contact with patients with chronic conditions
•	 Firemen who have contact with patients with 
chronic conditions
For those eligible for free influenza vaccination, the 
National Health Service covers the costs. For those who 
are not eligible for free influenza vaccination, but for 
whom vaccination is recommended, employers (if it is a 
professional group, e.g. those working in homes and insti-
tutions) or patients (e.g. pregnant women, older people 
aged 60–64 years) are responsible for buying the vaccines, 
with a medical prescription. The National Health Service 
covers 37% of the cost of the vaccine (the total cost at the 
pharmacy is around €6.00 and the citizen pays €3.80).
Key barriers and facilitators
Vaccination coverage in Portugal has been very high 
for several years. Primary health care services are well 
vaccine is mainly given at primary health care units. 
Also, primary health care units are in close touch with 
homes and residential structures for older people and the 
vaccines are provided to those institutions to be offered to 
all eligible patients (and administered there). People not 
eligible for free vaccination can have the influenza vaccine 
administered at a community pharmacy by a pharmacist 
or at National Health Service health care units.
Financing
Measles vaccine, like all vaccines included in the national 
immunization programme, is free of charge at the point 
of delivery.
The National Health Service, including vaccines and the 
national immunization programme, is funded from the 
government budget and therefore general taxation is the 
main source of national immunization programme fund-
ing. The Central Administration of the Health System 
(Administração Central do Sistema de Saúde) is the body 
responsible for financing the vaccines. Costs associated 
with physical and human resources to implement the 
national immunization programme are mainly supported 
by the National Health Service. As national immuniza-
tion programme vaccines can also be administered at 
some private health care units, there are some costs with 
physical and human resources that can be supported by 
private health care institutions, but all national immu-
nization programme vaccines are entirely funded by the 
National Health Service.
According to the latest guidance from the Directorate 
General of Health (guidance for influenza vaccina-
tion is issued annually) (Guidance No. 18/2017, of 26 
September 2017), influenza vaccination is free of charge 
at the point of delivery for the following groups:
•	 People aged 65 years or older
•	 All people with the following conditions, irrespec-
tive of their age:
o Living in institutions, including homes and 
other structures to support older people
o People who are recovering in the National 
Network for Integrated Care
o People with home support
The organization and delivery of vaccination services146
distributed across the country. Since the national immu-
nization programme is offered in primary health care 
units, this facilitates access to vaccines.
The good results obtained with vaccination since the 
1960s have built trust among citizens. Recently, the pro-
vision of vaccination services by some private providers 
has contributed to facilitating access for those children 
who are followed-up in the private sector. In addition, as 
all children are exempt from service fees, there are no eco-
nomic barriers to the national immunization programme.
Efforts have been made to increase awareness of the 
importance of vaccinating children with large media cam-
paigns and public discussions on the matter.
Eligible population groups have access to free influenza 
vaccines in primary health care units, which are well 
spread across the country. In addition, outreach activities 
at primary health care units also contribute to increased 
coverage of influenza vaccine, allowing for those who are 
housebound or institutionalized and unable to access 
primary health care units to be vaccinated.
Every year there is a large campaign in the media and in 
health care units to inform citizens that the vaccine is 
available free of charge for those eligible, as well as how 
the vaccine should be administered, and how patients 
should proceed to obtain vaccination.
Vaccination in community pharmacies since 2007 has 
facilitated access to vaccine administration for those 
not eligible for free influenza vaccination. In this case, 
patients must have a medical prescription and pay part 
of the costs for the vaccine (37%) and its administration.
Romania
Silvia Gabriela Scîntee
Governance
The agency in charge of developing and overseeing imple-
mentation of national vaccination plans and programmes 
is the Ministry of Health. The Ministry of Health estab-
lishes the national vaccination schedule, approves the 
national immunization programme and organizes the 
centralized procurement of vaccines. The National Centre 
for Communicable Diseases Surveillance and Control 
of the National Institute of Public Health coordinates 
the programme implementation and is responsible for 
the epidemiological surveillance of vaccine-preventable 
diseases, and the evaluation of vaccine coverage and vac-
cine supply; it also coordinates the surveillance of post-
vaccination adverse reactions. The District Public Health 
Authorities (the representatives of the Ministry of Health 
at district level, 41 districts plus the Bucharest Public 
Health Authority) are responsible for the local imple-
mentation of the national immunization programme, 
ensuring that the vaccines are distributed to the family 
medicine physicians and reimbursing doctors for pro-
viding the service. They are also in charge of promoting 
vaccination.
The national immunization programme is developed at 
the national level. Its implementation is supervised at 
district level by the District Public Health Authorities. 
Vaccination is performed by family doctors (except for 
those vaccines administered at birth in neonatal depart-
ments, in tuberculosis outpatient clinics, in health units 
hosting abandoned children, and in vaccination centres 
where vaccinations are performed on request or in case 
of epidemics).
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Vaccinations are recommended but not mandatory for 
all types of vaccines. A draft Vaccination Law to make 
vaccination mandatory (by checking the vaccination his-
tory of children when they start school) was issued in 
2017 and generated intense public debate. At the time 
of writing, the Law has been withdrawn from parliamen-
tary debate with the intention of being included in the 
new Health Code that the current government wants 
to promote.
Childhood vaccinations are recorded in the National 
Electronic Vaccination Registry introduced in 2011. 
The Registry is administered by the National Centre for 
Communicable Diseases Surveillance and Control of 
the National Institute of Public Health. The database is 
updated monthly by maternity departments and family 
doctors. The reports generated by the system are sub-
mitted by the physicians to the District Public Health 
Authorities in order to obtain reimbursement for the 
services provided. The District Public Health Authorities 
have access to the National Electronic Vaccination 
Registry in order to verify the physicians’ reports, as well 
as to generate analyses of immunization coverage in their 
districts.
Since 2001 a Migrant Health Department at the 
Romanian office of the International Organization for 
Migration has provided health assessments for transiting 
refugees upon their arrival, and pre-departure health 
assessments as required by the countries of resettlement, 
with the purpose of prevention and control of communi-
cable diseases. Foreigners who have obtained a protection 
form in Romania and foreigners who have acquired a 
right of residence in Romania have the same rights to 
health care as Romanian citizens.
From 2002 so-called health mediators have been intro-
duced within the national “Promotion of Mother 
and Child Health at Community Level” programme 
to enhance access to health care services among the 
Roma population. Health mediators are mainly women 
recruited from the Roma community, who receive spe-
cific training and are employed by the local authorities to 
facilitate communication between medical staff and the 
Roma community.
There are no other specific measures for objectors to vac-
cination, except the general information campaigns and 
the information and medical advice provided for each 
patient by family physicians or any other medical staff.
A national immunization programme is usually developed 
and updated every two years. The programme includes 
two sections: vaccination of the population at specific 
ages, according to a national vaccination schedule (Table 
1), and vaccination of risk groups (Table 2).
Table 1 Vaccination of the population at spe-
cific ages, according to the national 
vaccination schedule
Recommended 
age
Vaccine Administered by
within first  
24 hours
Hepatitis B vaccine
Maternity 
departments
2–7 days BCG
2 months DTPa-VPI-Hib-Hep. B
Pneumococcal conjugate vaccine
Family doctor
4 months DTPa-VPI-Hib-Hep. B
Pneumococcal conjugate vaccine
Family doctor
11 months DTPa-VPI-Hib-Hep. B
Pneumococcal conjugate vaccine
Family doctor
12 months Measles, Mumps and Rubella 
Vaccine
Family doctor
5 years Measles, Mumps and Rubella 
Vaccine
Family doctor
6 years DTPa-VPI Family doctor
14 years Vaccine against diphtheria, tetanus, 
and acellular pertussis (Tdap) for adults
Family doctor
Table 2 Vaccination of risk groups
Vaccine Groups at risk
Vaccine against diphtheria and 
tetanus for adults (Td) or adsorbed 
Tetanus toxoid if Td is not available
Pregnant women
Vaccines against influenza In accordance with WHO 
methodology
Measles, Mumps and Rubella 
Vaccine
People exposed by close contact
Other vaccines approved by the 
Ministry of Health for specific 
outbreak situations
People with increased risk
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Provision
Measles
Family doctors provide all immunizations included in 
the national immunization programme (except for those 
vaccines administered at birth in neonatal departments), 
including measles, mumps and rubella (MMR) vaccines, 
following a general health status evaluation of the patient 
to ensure that the vaccine can be safely provided.
Public health services elaborate, implement and evaluate 
the national immunization programme and organize the 
centralized procurement of the vaccines and vaccine dis-
tribution. Community nurses provide information on 
vaccination. If the vaccines provided under the national 
immunization programme are missing or insufficient (e.g. 
due to delays in centralized procurement), pharmacies sell 
these vaccines, as well as other vaccines not included in 
the national immunization programme.
Influenza
Family doctors provide immunization to the people at 
risk on their list, or to anybody else at their request, fol-
lowing a general health status evaluation of the patient to 
ensure that the vaccine can be safely provided.
Public health services conduct vaccination awareness 
campaigns and organize the centralized procurement of 
vaccines and their distribution for some of the groups at 
risk. Pharmacies sell vaccines to defined groups at risk or 
anyone else who wants to get vaccinated against influenza.
Financing
Measles vaccines are free of charge at the point of deliv-
ery. Vaccines against measles are provided under the 
national immunization programme and covered by the 
state budget allocated to the Ministry of Health. Vaccines 
under the national immunization programme are pro-
cured by the Ministry of Health through a centralized 
procedure and distributed to the District Public Health 
Authorities. In addition, the Ministry of Health dis-
tributes the other funds for the national immunization 
programme to the District Public Health Authorities or 
other implementing entities (e.g. health units hosting 
abandoned children, vaccination centres).
The draft of the Vaccination Law does not allow religious 
or other exemptions from vaccination, except for medi-
cal conditions that are certified by a special vaccination 
committee.
The current legislation does not include any explicit 
sanction for citizens or parents related to vaccination. 
Government Decision no. 857/2011 regarding sanctions 
for non-compliance with the public health regulations 
states that “non-compliance […] with measures for pre-
vention and tackling of communicable diseases, laid down 
in the existing norms” is sanctioned with fines between 
5000 and 10,000 lei (over €1000–2000). Considering 
immunization is a measure for “prevention of and fighting 
communicable diseases”, this article might count as an 
existing sanction.
Different drafts of the Vaccination Law included either 
sanctions for parents refusing vaccination or sanctions for 
parents refusing to receive information on vaccination. 
Both versions were highly contested by adherents to the 
anti-vaccination movement.
Vaccination coverage is calculated as the percentage of 
children enrolled at all family doctors vaccinated in 
accordance with the vaccination schedule, of all the chil-
dren enrolled at all family doctors. Data are collected at 
district level (by the District Public Health Authorities) 
twice a year: in February, for children aged 18 months, 
and for other children as foreseen by the national vac-
cination schedule, and in August, for children aged 
12 months and 24 months, and for other children as 
foreseen by the national vaccination schedule. Data are 
collected actively by reviewing documents at the offices 
of at least 30% of family doctors, and passively for the 
rest, through the documents reported by family doctors 
to the District Public Health Authorities. Data are com-
pared by random sampling with data in the National 
Electronic Vaccination Registry. Data from the District 
Public Health Authorities are sent in a specific reporting 
form to the National Centre for Communicable Diseases 
Surveillance and Control of the National Institute of 
Public Health. Vaccination coverage is calculated for 
BCG, Hep B, DTPa, Hib, VPI, MMR and Td for 
the total population of children, and per rural/urban 
residence, at district, regional and national level. The 
methodology was published by the National Centre 
for Communicable Diseases Surveillance and Control 
of the National Institute of Public Health on their site 
in 2016.
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insufficient information among the population, con-
cern of family doctors about providing vaccinations, 
and the increase in the number of seasonal cross-border 
migrants – children of these migrants may not follow the 
same vaccination schedule as Romanian-born children 
because they come from countries that may have differ-
ent epidemiological profiles and/or different vaccination 
schedules.
The last epidemiological report, for 2016, showed that the 
measles outbreak also affected many children under one 
year old (408 cases out of 2435) who were not eligible 
for MMR vaccination. The coverage rate of vaccination 
against measles was 87.1% for the first dose and 74.5% 
for the second dose.
A survey on the public perception of vaccination con-
ducted by the Romanian Institute for Evaluation and 
Strategy in 2017 showed that only 67% of those inter-
viewed did not agree with the statement “adverse reac-
tions post vaccinations outweigh the benefit of vaccina-
tion”; these were mainly adults between 36 and 50 years 
of age and from rural areas. Of those interviewed, 92% 
were aware of the measles outbreak in Romania, but only 
43% of them considered the lack of vaccination to be the 
main cause.
Adult vaccinations against influenza
Gaps in adult vaccinations against influenza might be 
due to the non-compliance of people with medical rec-
ommendations, insufficient information among the pop-
ulation or concerns of family doctors about providing 
vaccinations, and vaccine shortages. In 2016 the Ministry 
of Health distributed 500 000 doses of vaccine against 
influenza and 499 650 persons were vaccinated. As only 
the population at risk is included in the national immu-
nization programme, while the rest of the population 
is supposed to pay for their own influenza vaccine, the 
coverage is very low – 2.5% in 2016. For the population 
at risk, the coverage was 2.9% for pregnant women, 8.2% 
for persons over 65 years old, 17.8% for patients with 
chronic diseases, 31% for medical personnel, and 47.5% 
for institutionalized persons.
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Governance
There are several institutions that are involved in the 
process of developing, implementing and following up 
on the national immunization programme:
•	 the Ministry of Health
•	 the National Public Health Authority
•	 the Regional Public Health Authorities
•	 health insurance companies
•	 the State Institute for Drug Control
•	 health care providers (general practitioners for 
children and adolescents, general practitioners for 
adults) and pharmacies
The Ministry of Health is responsible for health policy, 
including drug policy, i.e. setting rules for the reimburse-
ment of vaccines. For the purpose of vaccines reimburse-
ment, the Ministry of Health Categorization Committee 
prepares recommendations for the Minister to make a 
decision. Recommendations are based on an evaluation 
and on statements of experts from the field of public 
health and pharmacoeconomy. In the case of a positive 
decision, the vaccine is included in the list of reimbursed 
drugs.
The implementation of the national vaccination policy is 
the responsibility of the National Public Health Authority. 
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Vaccination programmes
Vaccination programmes are organized nationally for 
entire cohorts of a certain age or for cohorts described 
in Regulation 585/2008 and the vaccination calendar. 
If an individual needs changes to the scheme defined for 
the entire cohort, there are special procedures according 
to which general practitioners might send patients to 
centres for persons with contraindications against vacci-
nation. There is also guidance for health workers on how 
to proceed with the vaccination of people in different 
age groups.
The national immunization programme consists of two 
parts. The first part is a mandatory vaccination pro-
gramme, setting out types of vaccinations within cohorts 
of the same age or groups of people at an increased risk 
of being infected. In Slovakia vaccination is mandatory 
against diphtheria, tetanus, pertussis, poliomyelitis, 
Haemophilus influenza type B, viral hepatitis type B, 
pneumococcal infections, measles, mumps and rubella. 
Mandatory vaccination programmes are based on regis-
tries of defined cohorts. The vaccination is defined by age, 
and general practitioners for children and adolescents are 
responsible for call and follow-up. When patients or par-
ents of children refuse the mandatory vaccination, health 
care providers are obliged to inform the Regional Public 
Health Authorities who then issue a penalty. Vaccination 
based on professional risk is provided by general prac-
titioners. Recommended vaccinations are not based on 
population registries.
Vaccination against measles was introduced in 1969. 
Today it is part of the MMR triple vaccine and con-
sists of two shots. The first, basic, one is mandatory for 
every child aged between 15 months and 18 months. The 
second, booster, shot is mandatory for every child during 
their 11th year of age. There are expert discussions under 
way regarding moving the second dose to an earlier age, 
so that children would be completely vaccinated before 
entering school. Two vaccines against MMR are currently 
available in Slovakia (Priorix, M-M-RVAXPRO). Both 
are fully reimbursed by the health insurance compa-
nies without any co-payment by patients. The choice of 
vaccine is based on the recommendation of the general 
practitioner. The provision of vaccinations is also fully 
reimbursed by health insurance companies. Vaccination 
against measles is provided by general practitioners for 
children and adolescents who call children based on the 
registry of children in their outpatient facility. There is 
no unified system; every general practitioner for children 
Vaccination policy is governed by Act No. 355/2007 Coll 
on the Protection, Support and Development of Public 
Health and on the Amendment and Supplementation of 
Certain Acts (Act 355/2007) and specifically by Ministry 
of Health Regulation 585/2008 on the prevention and 
control of communicable diseases (Regulation 585/2008). 
The National Public Health Authority issues annually a 
vaccination calendar with details on population groups, 
vaccination age and conditions to be fulfilled (type of 
vaccine by general description; no specific vaccine is men-
tioned by name). The National Public Health Authority 
has prepared an action plan for measles and rubella 
that is regularly updated, most recently in June 2017. 
Influenza has a specific position in terms of surveillance. 
The National Public Health Authority provides weekly 
updates on the epidemiological situation of acute res-
piratory infections and influenza. During the influenza 
season attention is dedicated to the communication of the 
epidemiological situation. Information on the incidence 
of influenza is published weekly on the National Public 
Health Authority website and sent to the media.
Regional Public Health Authorities are the primary point 
of contact for general practitioners for children and ado-
lescents and for general practitioners for adults. They 
conduct the yearly assessment of vaccination coverage 
in their respective districts, and monitor regional epide-
miological data. They are particularly important during 
local epidemics, as they take protective anti-epidemic 
measures when searching for the primary source of infec-
tious diseases, determine preventive steps and coordinate 
a regional approach. In case of a localized epidemic, for 
example of influenza or measles, they oversee implemen-
tation of specified procedures and monitor health care 
providers (including hospitals) in the area of infectious 
and preventable diseases. When it comes to vaccina-
tion during the epidemic, the Regional Public Health 
Authorities might order additional vaccinations. In this 
case they communicate with other responsible bodies 
and with the general practitioners who provide the vac-
cination. Regional Public Health Authorities also play 
an important role in the surveillance of influenza, as they 
coordinate regional sentinel surveillance systems. They 
also inspect health care facilities once a year.
The State Institute for Drug Control receives and analyses 
notices about adverse reactions to vaccines. It is responsi-
ble for the national registration of vaccines in the Slovak 
Republic. Health care providers are responsible for the 
delivery of vaccination programmes. Pharmacies supply 
health care providers with the vaccines.
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national level by the National Public Health Authority. 
As mentioned above, the coverage rate is derived from 
yearly inspections of health care providers undertaken by 
the Regional Public Health Authorities. They also collect 
information about vaccination refusal (full – completely 
refused vaccination, and partial – refusal of some vacci-
nations) and this is sent to the National Public Health 
Authority, which summarizes all relevant information 
about vaccination coverage and vaccination refusal. This 
information is published annually as the report “Evaluation 
of administrative inspection of vaccination coverage”.
The denominator for vaccination coverage against infec-
tious diseases with mandatory vaccination comes from 
health care providers’ data obtained during the annual 
inspection. Since the introduction of the national immu-
nization programme and mandatory vaccinations, the 
vaccination rate for decades was almost 100%, until the 
last five or ten years when the anti-vaccination movement 
found its followers also in Slovakia; the vaccination cov-
erage against measles is slightly decreasing (Figure 1). The 
highest rate of vaccination refusal is for the MMR vaccine 
and amounted to 3.1% in 2017. The decreasing vaccina-
tion coverage might lead to local epidemics of measles, 
which occurred for example in 2018 in the eastern part 
of Slovakia.
Calculation of the coverage rate for vaccination against 
influenza is based on the number of vaccines sold and 
the number of vaccines against influenza reimbursed by 
health insurance companies. This information is sum-
marized by the National Public Health Authority. The 
denominator is based on data from the Statistical Office 
of the Slovak Republic on the size of the resident popu-
lation in three age groups: 0–15 years, 16–58 years and 
59 years and over.
Provision
As stipulated by the law and the national immuniza-
tion programme, childhood vaccination against measles 
is provided by general practitioners for children and 
adolescents. There are about 1200 practices of general 
practitioners for children and adolescents; their network 
covers the entire country. Every newborn child should 
be registered with a general practitioner for children and 
adolescents, and there is free choice of provider.
Vaccination against measles for children with specific 
health conditions or children not in the national insurance 
and adolescents makes their own system, some using the 
postal service and others using electronic mailing or text 
messages.
For influenza, vaccination is mandatory for:
•	 people living in social care facilities, and
•	 people with an increased risk of infection due to 
living or working in an area where avian influenza 
is present; this vaccination should be provided 
based on a decision of the Regional Public Health 
Authorities.
Vaccination against influenza is recommended, based on 
a recommendation of a health care provider, for:
•	 children aged between 6 months and 12 years,
•	 people older than 59 years, and
•	 people with chronic respiratory disease, or cardio-
vascular, metabolic, renal and immune disorders.
In addition, vaccination against influenza is recom-
mended for people at increased risk of infection based 
on their profession:
•	 professional soldiers, or soldiers recalled for service, 
and
•	 health care professionals who are directly in contact 
with infected patients or with the source of influ-
enza outbreaks.
There are two influenza vaccines available in Slovakia, 
both containing strains recommended by WHO. Both 
types of vaccine are fully reimbursed by health insurance 
companies for mandatory vaccinations, as well as for 
recommended vaccinations against influenza based on 
age or specific health conditions. The health insurance 
companies also fully reimburse the vaccines and vacci-
nation against influenza for the entire population during 
the influenza season. No quadrivalent vaccine is available.
Vaccination coverage
The coverage rate for mandatory vaccinations of children 
(including against measles) is assessed at the subnational 
level by the Regional Public Health Authorities and at the 
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or patients can also choose a categorized vaccine that is 
not fully reimbursed and pay the difference. The list of 
reimbursed drugs is updated every month.
Up to the age of 18 years, health insurance contributions 
are paid by the state and the basic benefit package covers 
practically all provided services. The mandatory vaccina-
tion against diseases included in the national immuniza-
tion programme is fully reimbursed by health insurance 
funds. Health insurance companies reimburse a fee to 
physicians for performing vaccinations and the costs of 
vaccines to pharmacies. Representatives of health insur-
ance companies participate in the categorization commit-
tee responsible for the recommendations with regard to 
which vaccines are reimbursed.
Vaccination against measles, including fees to the gen-
eral practitioners for children and adolescents, is fully 
reimbursed by health insurance companies for cohorts 
defined in the mandatory vaccination programme. It is 
also fully reimbursed for cohorts defined in the recom-
mended vaccination programme (i.e. for influenza), if the 
vaccination is recommended by a health care provider. 
The only exception are people recommended for vacci-
nation against influenza due to professional risk. They 
are reimbursed by their employer for both vaccines and 
the vaccination.
scheme (e.g. foreigners staying long term in Slovakia) is 
provided by regional specialized paediatricians.
Vaccination against influenza is provided for children 
by general practitioners for children and adolescents and 
for adults by general practitioners for adults. Every year 
the Ministry of Health decides about the level of reim-
bursement for seasonal influenza vaccines; in recent years 
this level has consistently been 100%, with the aim of 
increasing vaccination coverage.
Both general practitioners for children and adolescents 
and general practitioners for adults follow guidelines 
issued by the National Public Health Authority. They are 
monitored by the Regional Public Health Authorities at 
regular (annual) intervals.
Vaccines are provided by pharmacies following cold 
chain principles, or any principles defined by product 
characteristics.
Financing
At least one vaccine against every communicable disease 
included in the national immunization programme is 
fully reimbursed by the health insurance system. Parents 
Figure 1 Measles vaccination coverage and cases per 100 000 population, 1953–2017
Source: Public Health Authority, personal communication
Source: PHA SR, 2016
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groups that may become active in vaccine controversies. 
The Internet and social media provide a means of organ-
ization for anti-vaccine and pro-vaccine groups and make 
it easier to disseminate information and misinformation. 
Health workers might sometimes insufficiently inform 
the parents who have doubts about vaccination. Given 
the increasing source of alternative treatments, immuni-
zation services must now put more effort into addressing 
inaccuracies and misinformation that may circulate about 
vaccines. Information about outbreaks in neighbouring 
countries helps to persuade parents to vaccinate their 
children.
Problems might occur with marginalized groups of the 
population, such as homeless people, the Roma minority, 
or drug users. They require special attention and proactive 
outreach to provide vaccination. There are special projects 
aimed at these groups of the population by the state, the 
private sector and non-governmental organizations.
One new feature in Slovakia that has been observed 
recently is the in- and outmigration of people because of 
study, work, family reasons, etc. This can interrupt the 
vaccination schemes when the vaccination is initiated in 
Slovakia but not completed, due to travel abroad.
Key barriers and facilitators
One of the main efforts of institutions involved in vacci-
nation is effective communication with the public. There 
are no disease-specific vaccination campaigns established 
by the state (i.e. by the Ministry of Health).
Each year Slovakia participates in the WHO European 
Immunization Week. Activities are realized by the 
National Public Health Authority and by the Regional 
Public Health Authorities. They are focused on the lay 
public, health workers, and groups of the population 
at risk, such as the Roma minority living in remote set-
tlements. For increasing awareness among the Roma, 
health mediators play an important role. They help Roma 
with following the vaccination schedule and facilitate 
communication between the Roma and health workers. 
Media coverage and dissemination of information are 
quite satisfactory, with input from experts from WHO, 
the National Public Health Authority, the Slovak epide-
miologic and vaccination associations, and the field.
In the Regional Public Health Authorities there are 
Health Protection and Promotion Counselling Centres, 
which provide the public with advisory services including 
on vaccination. Parents with doubts or questions can 
come and take advice on vaccination. The National Public 
Health Authority prepares annually a vaccination calendar 
for the public (mostly parents) and the vaccination strat-
egy is available on its website. Within the post-partum 
packet, mothers in hospitals are given an interactive tool 
of the vaccination calendar showing in a simple and clear 
way the dates when their newborn should be vaccinated. 
This interactive vaccination calendar is a reliable source 
of basic information on individual types of vaccination in 
the Slovak Republic. In addition, vaccination calendars 
are also distributed to paediatric outpatient departments. 
The aim is to build the public’s trust in vaccination and 
to persuade parents that vaccination is the best, simplest 
and fastest way of protecting their children against serious 
infectious diseases.
Factors that can cause public concern about vaccination 
comprise fears of adverse events after immunizations, 
publication of research papers that contradict established 
opinion about vaccine safety, new recommendations or 
changes in policies, and the introduction of new vaccine 
products. Once a concern has been raised, it can be sus-
tained by the spread of rumours, media reports, histori-
cal events that caused lingering doubts, marginalization 
of certain populations, and self-organized community 

Slovenia
Maja Sočan
Governance
Slovenia runs a comprehensive and accessible system 
for administering and recording immunizations. The 
National Institute of Public Health provides centrally pro-
cured vaccines with effective distribution chains, an ade-
quate cold chain and ongoing quality control. National 
funding is available for central vaccine procurement to 
ensure vaccines for all children.
The following vaccine-preventable diseases are covered 
by the programme:
•	 Mandatory vaccinations of children against diph-
theria, tetanus, pertussis, Hib, polio, measles, 
mumps, rubella and hepatitis B
•	 Recommended vaccination against pneumococcal 
infection for children
•	 Recommended vaccination against HPV for girls
•	 Selective immunization against tuberculosis for 
newborns/children with the following epidemi-
ological indications: newborns whose parents 
immigrated from countries with a high inci-
dence of tuberculosis in the five years before 
the infant’s birth; children whose mothers are 
being treated for tuberculosis; and children who, 
in the first years of life, lived permanently in, 
or frequently visited, countries with a higher 
incidence of tuberculosis
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The Vaccination and Chemoprophylaxis Programme is 
published in the Official Gazette and is available on the 
internet (http://www.nijz.si/sl/program-cepljenja-in-
zascite-z-zdravili-za-leto-2018, in Slovene). Instructions 
for the implementation of the programme are available 
at: http://www.nijz.si/sites/www.nijz.si/files/uploaded/
navodila_za_izvajanje_ip_2018.pdf, in Slovene.
More extensive changes to the Vaccination and 
Chemoprophylaxis Programme (including those with 
financial consequences, e.g. the introduction of a new 
vaccination) must be approved by the Health Council, a 
consultative body of the Ministry of Health.
Role of the national and regional level
Drafting the vaccination programme, planning, vaccine 
procurement, vaccine distribution, reporting of adverse 
events and reporting of errors in the vaccination proce-
dure are all done at the national level. Data on vaccina-
tion coverage are collected regionally and forwarded to 
the national level.
Regional vaccination coordinators are in charge of imple-
menting the vaccination programme at the regional level. 
They are located in nine Slovenian regions and belong 
organizationally to the National Institute of Public 
Health. The main functions of regional coordinators are 
to support the vaccination programme in their region, 
advise and inform the local medical and lay community, 
recognize the challenges in everyday vaccination practice, 
and provide vaccination coverage data.
Vaccination plan
Measles: There is no special national plan addressing 
measles vaccination in children or adults. Vaccination 
against measles is mandatory for some population groups 
and recommended for others (see below for more details).
Influenza: Vaccination coverage for influenza is very 
low in Slovenia (one of the lowest in the EU). A draft 
national strategic plan aiming to raise vaccination cov-
erage has been prepared but has not yet been made 
public, as it has to be approved by the Ministry of 
Health with short- and long-term goals set in concert 
with all stakeholders.
Agency in charge
According to current legislation, the Centre for 
Communicable Diseases, located at the National Institute 
of Public Health, is responsible for preparing the annual 
national Vaccination and Chemoprophylaxis Programme 
(Program cepljenja in zaščite z zdravili). Vaccination issues 
are covered by the Law on Infectious Diseases (https://
www.uradni-list.si/glasilo-uradni-list-rs/vsebina/72546, 
in Slovene) and details are described in the Regulations 
on certificates, record keeping and provision of vacci-
nation data, vaccine adverse reactions and vaccination 
errors (https://www.uradni-list.si/glasilo-uradni-list-rs/
vsebina/2017-01-1269/pravilnik-o-potrdilih-vodenju-
evidenc-in-zagotavljanju-podatkov-o-cepljenju-nezelenih-
ucinkih-po-cepljenju-in-zdravstvenih-napakah-pri-
cepljenju, in Slovene). The annual national vaccination 
programme covers vaccination target groups, vaccine 
types and mandatory or recommended vaccination 
schemes.
Before publication, the draft annual Vaccination and 
Chemoprophylaxis Programme is discussed with the 
regional vaccination coordinators and professional asso-
ciations of doctors who are the most important actors in 
the implementation of the vaccination programme (i.e. 
pediatricians and doctors of school medicine, infectious 
diseases specialists and epidemiologists). The comments 
made by health professionals are discussed at the Centre 
for Communicable Diseases and, if relevant, changes are 
made.
The annual Vaccination and Chemoprophylaxis 
Programme is also discussed within the National Advisory 
Committee on Immunization, which acts as an advisory 
body of the National Institute of Public Health. The 
appointed members and minutes of the meetings are 
publicly available (in Slovene) on the internet (http://
www.nijz.si/sl/posvetovalna-skupina-za-cepljenje). The 
National Advisory Committee on Immunization meets 
four times a year and discusses the challenges of the 
programme’s progress, adherence to the programme, and 
information from the Adverse Event Monitoring Register. 
It also discusses initiatives from health care professionals 
and other stakeholders.
The Centre for Communicable Diseases prepares the final 
version of the annual Vaccination and Chemoprophylaxis 
Programme, taking into account suggestions and com-
ments. The final version is sent to decision-makers at 
the Ministry of Health, Directorate of Public Health. 
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The paediatrician follows up on adherence to the vacci-
nation programme and sends additional invitations when 
children do not come to their scheduled appointments.
According to recently implemented regulations, all vacci-
nations are recorded in the vaccination registry, including 
mandatory and non-mandatory vaccinations. This new 
registry is not yet operational, but is expected to be so in 
2019. The vaccination registry is located at (and main-
tained by) the National Institute of Public Health.
Influenza is a non-mandatory vaccination. Before the 
influenza season, the National Institute of Public Health 
provides information through the media about the avail-
ability of influenza vaccines, and distributes the vaccines 
to public and private health centres. An individual can 
choose to be vaccinated in their family doctor’s outpa-
tient clinic or can go to one of the nine regional units of 
the National Institute of Public Health which also offer 
influenza vaccinations. Data about influenza vaccinations 
are entered into the vaccination registry.
Targeted measures
Refugees under 18 years of age are vaccinated free of 
charge with the same vaccines and following the same 
vaccination scheme as Slovenian citizens. The number of 
refugees in Slovenia is still low and most are located in 
refugee centres. The health care workers (nurses) working 
in refugee centres identify those who need vaccinations 
and refer them usually to a nearby outpatient clinic which 
is responsible for providing health care for refugees.
There are no targeted measures to reach religious objec-
tors in Slovenia. If parents object to mandatory vacci-
nations, according to the Law on Infectious Diseases 
and Regulations the child’s paediatrician must send 
a notification to the Health Inspectorate of Slovenia. 
Health inspectors then contact the parents and, if they 
still object, a legal process starts that ends with a penalty 
being paid by the parents.
Incentive schemes
Measles: There is no formal continuous campaign for 
measles vaccination. Every parent receives information 
about vaccinations in the so-called “parents’ school”, 
along with other information, and more than half of 
parents-to-be attend these “schools” before the child is 
Mandatory and voluntary programmes
According to the annual Vaccination and 
Chemoprophylaxis Programme, vaccination against mea-
sles is mandatory for children. Children are required to be 
vaccinated with a first dose of measles vaccine at the age 
of 12–18 months and with the second dose at the age of 
6 years, before entering primary school.
The obligation for measles vaccination ends at the age of 
18 years, except for students, for whom the requirement 
continues until 26 years of age (or earlier if they complete 
their studies before that age). Vaccination against measles 
for pre-school children, adolescents and students is free 
of charge.
Health care workers are required to receive two doses 
of measles vaccine, if not vaccinated according to the 
national programme before starting work. This obliga-
tion does not apply to those who have natural immunity 
having had measles earlier in life (it must be recorded in 
their medical records), or to those who have tested posi-
tive for measles-specific IgG antibodies.
Vaccination against influenza is not mandatory for 
anyone in Slovenia. The recommendations are in accord-
ance with WHO recommendations and are available 
on the internet (http://www.nijz.si/sites/www.nijz.si/
files/uploaded/cepljenje_proti_gripi_2018_19.pdf, in 
Slovene).
Population and vaccination registry
Measles: The vaccination programme for measles (and 
other vaccine-preventable diseases) is based on a popu-
lation registry, the Central Registry of the Population, 
which is a responsibility of the Ministry for Internal 
Affairs. Every child at birth is given a citizenship number 
(or identity number) that is also used in the vaccination 
registry.
Soon after a baby’s birth, parents choose a paediatrician 
who becomes responsible for the preventive and cura-
tive aspects of their child’s health. The newborn child 
is invited for the first screening at the age of 2 months 
and then regularly thereafter (according to the Law on 
Preventive Programmes for Children), including on the 
dates when vaccines are scheduled.
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Provision
Measles: Primary care physicians (primary care paedi-
atricians, doctors of school medicine and family physi-
cians) are the main vaccinators of pre-school and school 
children. Primary care physicians work in the public or 
private sector, in the latter case with a concession to pro-
vide publicly funded services. For mandatory vaccinations 
private doctors with a concession are paid by the National 
Health Insurance Institute and have the same obligation 
as those working in the public sector.
Doctors of school medicine check pupils’ vaccination 
records during regular preventive check-ups. If pupils 
have not yet been vaccinated, further action depends 
on the situation. If the doctor of school medicine is also 
the curative doctor of the pupil, and parents refuse the 
vaccination against measles, the doctor has to inform 
the Health Inspectorate. If the school medicine doctor 
is required only to carry out the preventive health check, 
they send a notice to the child’s paediatrician.
Nurses are entitled to take care of the vaccines (procure-
ment of vaccines, regular checks of the cold chain) and 
record-keeping, along with other administrative work. 
Pharmacies have no role in the measles vaccination 
process.
Influenza: Primary care physicians working in the public 
sector or private outpatient clinics with a concession are 
the main vaccinators for influenza. Nine regional insti-
tutes of public health also provide vaccinations with the 
influenza vaccine, but their vaccination clinics are mainly 
orientated towards travel medicine.
Nurses are entitled to take care of the vaccines (procure-
ment of vaccines, regular checks of the cold chain) and 
record-keeping, along with other administrative work. In 
addition, nurses can vaccinate with the influenza vaccine, 
but not without a physician’s permission. Pharmacies have 
no role in the influenza vaccination process.
Financing
The National Health Insurance Institute of Slovenia is 
the key payer of publicly funded health services, and, 
with the support of the Ministry of Health, provides the 
financial resources for the implementation of the vacci-
nation programme. Local governments have no role in 
the financing process.
born. At birth, in the maternity ward, every parent is 
given information material about the importance of vac-
cination. Before offering the measles vaccine, during the 
appointment parents are briefly informed (by a nurse or 
a paediatrician) why the child has to be given the vaccine. 
If parents refuse to have their child vaccinated, they face 
fines.
Influenza: Extensive information is given through the 
media before and during the influenza season. The 
National Institute of Public Health and the Ministry of 
Health use a variety of communication channels, includ-
ing TV spots, the internet and social media (e.g. Twitter).
There are no incentive schemes for vaccinators or patients.
Methods to estimate vaccination coverage
Measles: Vaccinators (paediatricians) are required to 
report the number of vaccinated children and the number 
of children who should be vaccinated according to the 
schedule. The data from public and private outpatient 
clinics are sent to regional units of the National Institute 
of Public Health once per year. The data are then com-
piled at the national level and presented in a yearly report 
that is made available on the internet (http://www.nijz.si/
sl/spremljanje-precepljenosti-deleza-cepljenih).
Influenza vaccine: Vaccinators (primary care physicians) 
and regional institutes of public health have to report 
the number of vaccinated individuals, stratified by age 
and risk groups. The data are collected at the national 
level and a report prepared by the National Institute of 
Public Health. The report is published on the internet 
(http://www.nijz.si/sites/www.nijz.si/files/uploaded/poro-
cilo_cepljenje2016.pdf ).
Measles vaccination coverage was 93% in 2017. Most 
children are vaccinated against measles for the first time 
aged 12–18 months and receive a second dose at the age 
of 5–6 years.
The Roma population is estimated to amount to 7000–
12 000 people in Slovenia. Some (mostly living in the 
northern and eastern parts of Slovenia) are more inte-
grated in society, while others (mostly living in the south-
eastern part of Slovenia) are keen to keep their traditions. 
In the south-eastern group vaccination coverage is lower 
than for the rest of the population.
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•	 Vaccination free of charge for children and 
students
•	 A more positive attitude in the media in 2017
•	 Changing perceptions of measles, due to measles 
outbreaks and deaths in neighbouring countries 
(e.g. Serbia and Italy)
A key barrier to improved influenza vaccination coverage 
is the general perception that influenza cannot lead to a 
life-threatening situation. This also applies to health care 
workers, for whom influenza is not an important topic 
in the professional curriculum. Paying for the influenza 
vaccine is an additional barrier, not only for patients in 
high-risk groups but also for health professionals, as they 
have to handle the payment, creating additional work, in 
particular in the public sector.
All mandatory vaccinations (including for measles vaccine 
and vaccination) and some non-mandatory childhood 
vaccinations (e.g. pneumococcal and HPV vaccine) are 
free of charge at the point of delivery. For families with 
no parent working, there are social compensations that 
enable families in need to obtain mandatory vaccinations 
free of charge along with other basic health services.
Vaccination of irregular migrants is not covered by the 
public financing scheme, but their numbers are likely to 
be small.
Vaccination against influenza is not completely free of 
charge for anyone in Slovenia. If a person is at least 65 
years of age, has a chronic condition, is pregnant or falls 
into another specified category, they have to pay for the 
vaccination but not for the vaccine, which is covered by 
the National Health Insurance Institute. Vaccination 
costs in the season 2017/18 were €7. Individuals who 
are not considered to be at high risk pay the full price 
for both vaccine and vaccination, which amounted to 
€14 for the quadrivalent influenza vaccine in the season 
2017/18. The trivalent vaccine was no longer available in 
2017/18 in Slovenia, except for children under 3 years of 
age (paediatric form).
Some employers provide influenza vaccinations for their 
employees free of charge. Hospitals and primary care 
clinics also offer influenza vaccinations free of charge for 
their health care workers, but coverage among health care 
workers remains low.
Key barriers and facilitators
Key barriers to reaching 95% measles coverage are:
•	 Vaccine hesitancy and refusal because of a strong 
anti-vaccine movement, usually in combination with 
alternative medicine and “natural” health lifestyles
•	 Lack of knowledge even among health care profes-
sionals, as measles is a rare disease in Slovenia and 
most health care workers do not have any personal 
experience of caring for patients with measles
•	 Negative messages in the media (until recently)
Facilitators of a high coverage of measles vaccinations are:
•	 Mandatory vaccination

Spain
Andreu Segura Benedicto1
Governance
The vaccination policy in Spain is determined by the laws 
that regulate health interventions, although the decentral-
ized model of public administrations (general or central, 
regional and local) modulates its application in practice.
The responsibility for establishing the basic lines of 
health and health care policies falls to the Ministry of 
Health, Consumption and Social Welfare of the General 
Administration. The General Directorate of Public 
Health, Quality and Innovation of this Ministry is the 
body directly in charge of vaccination policies.
The Spanish Agency for Medicines and Health Products, 
an autonomous body attached to the Ministry, is respon-
sible for the authorization of medicines, including vac-
cines, and their distribution, as well as the coordination 
of the pharmacovigilance network in the country.
The responsibility for implementation of vaccination 
policies, and for reaching the established objectives, lies 
with the 17 regions, known as autonomous communities 
(CCAA), and, where appropriate, the autonomous cities 
of Ceuta and Melilla.
1 Thanks are expressed for suggestions and comments on the 
Spanish country fiche by Aurora Limia (Spanish Ministry 
of Health, Consumption and Social Welfare); Amós García 
(Spanish Vaccines Society); Montse Martinez; Carmen Cabezas 
and Luís Urbiztondo (Catalan Department of Health); and 
the data from Angel Plans (Catalan Society of Occupational 
Health). The responsibility for possible errors is exclusively that 
of the author.
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d) Determining, where appropriate, specific objectives 
for immunization programmes, such as the elimination 
of measles.
e) Evaluating the immunization programme, including 
the collection and analysis of data on vaccination coverage 
provided by the regions.
f ) Other initiatives to promote vaccination (improvement 
of transparency in the operation of the presentation of 
vaccines, collaboration in vaccination campaigns, coor-
dination of joint procurement of vaccines at a better 
price, etc.).
g) Coordination of travel health, including International 
Immunization Centres. Some of them depend on the 
Ministry of Health, Consumption and Social Welfare, 
and are distributed across the country, while others are 
the responsibility of the regions.
The public health authorities of the regions are respon-
sible for:
a) Establishing the vaccination schedule for their territory.
In general, the schedule is the one recommended by the 
Inter-territorial Council of the National Health System. 
However, some differences persist in some regions (e.g. 
vaccination against Hepatitis A in Catalonia and Ceuta 
and Melilla cities).
b) Organizing the implementation of the vaccination 
schedule for the population of their territory.
In some regions advisory bodies have been created, 
involving scientific societies in vaccination strategies (in 
Catalonia, for instance: El Consell Assessor de Vacunes).
c) Buying the recommended vaccines.
In general, the vaccines are bought by the regional health 
services. The regions can benefit from a joint procurement 
framework to select the supplies of vaccines, signed by the 
Ministry of Health, Consumption and Social Welfare and 
the regions that want to participate.
d) Accrediting the vaccination centres from where the rec-
ommended vaccines are administered to the population.
In general, the accredited vaccination centres are the 
primary care centres of the public health care network, 
The coordination between central and regional levels 
is done by the Inter-territorial Council of the National 
Health System (CISNS), which has various commissions. 
The Commission of Public Health is the one in charge of 
public health matters. The Immunization Programme and 
Registry Committee and the Surveillance Committee are 
technical advisory groups of the Commission of Public 
Health on immunization and vaccines, and surveillance 
of diseases respectively. All the regions and autonomous 
cities and the Ministry of Health, Consumption and 
Social Welfare are represented in the Inter-territorial 
Council of the National Health System. The Council, the 
commissions and the working groups are coordinated by 
the Ministry of Health, Consumption and Social Welfare. 
There is also an Influenza Surveillance Working Group 
coordinated by the National Centre for Epidemiology 
(Institute of Health Carlos III).
The Public Health Commission of the Inter-territorial 
Council of the National Health System, coordinated by 
the General Directorate of Public Health, Quality and 
Innovation, is the key body in the development of vacci-
nation policies in Spain.
In summary, the role of the Inter-territorial Council of 
the National Health System includes:
a) Agreeing on the diseases that should be prevented by 
immunization, and the common schedule for systematic 
immunization.
Currently there are thirteen diseases subject to vaccination 
in addition to influenza vaccination. Vaccination against 
influenza is not part of the systematic childhood immu-
nization schedule, but is formally recommended for those 
aged over 65 years and other groups of the population 
(risk groups, health care professionals, pregnant women, 
etc.). However, this is going to change as a new lifelong 
schedule has been recently approved.
b) Designing a common official vaccination schedule for 
Spain.
Although the regions are responsible for establishing the 
vaccination schedule and the management of the pro-
gramme in their territory, the current trend is towards 
homogenization for the entire National Health System.
c) Establishing the risk indications for annual vaccines 
(influenza) or for vaccines not recommended systemati-
cally (e.g. meningitis B).
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maintenance corresponds to the regional health services. 
However, this is variable across regions, with some having 
registries or immunization information systems in place. 
Most of them are linked to health care records. In general, 
people are not systematically called when they should be 
vaccinated.
There are some protocols from the Ministry of Labour, 
Migration and Social Security directed at specific groups 
of the population such as refugees. The regions are respon-
sible for immunization programmes for these groups of 
the population.
Although the authorities are obliged to respect the deci-
sions of parents who do not authorize the vaccination of 
their children, in some regions these parents are asked to 
sign an official document stating their refusal. There is an 
agreement at the Inter-territorial Council of the National 
Health System to register vaccine hesitancy and this is 
implemented in most registries at the regional level.
The parents of vaccinated children have documents that 
certify the immunization status of their children. These 
documents can be requested in day care centres, schools 
and other children’s facilities, but schools cannot refuse 
to admit children who are not vaccinated.
The doses of vaccines administered in the official vacci-
nation services are used to calculate vaccination coverage. 
The small proportion of vaccines acquired in pharmacies 
and administered through the private health sector is 
generally not included, although some regions do col-
lect this information. The Autonomous Communities 
provide the information to the General Directorate of 
Public Health, Quality and Innovation of the Ministry 
of Health, Consumption and Social Welfare, as agreed 
by the Inter-territorial Council of the National Health 
System.
While the numerator used to calculate vaccination cover-
age is the number of administered doses of vaccines (i.e. 
the number of vaccinated persons), the sources used to 
determine the denominators (i.e. the populations of the 
corresponding population groups) vary between the dif-
ferent regions. In some cases they come from the official 
statistical bodies, in others from the population health 
registers or even from the registers of the vaccination 
services.
To diminish the possible differences in the procedures 
for calculating vaccination coverage between the regions, 
including paediatric services, family health care, and 
family and community nursing, as well as hospitals in 
the public network, but private centres are also accredited.
e) Distributing the recommended vaccines to the accred-
ited centres so they can be administered.
f ) Designing the procedures for calculating the vaccina-
tion coverage of the recommended vaccines, including 
the indicators agreed by the Inter-territorial Council of 
the National Health System, collecting the data, analysing 
the information, using it where appropriate to modify 
strategies and programmes and sending it to the General 
Directorate of Public Health of the Ministry of Health, 
Consumption and Social Welfare.
g) Other activities include: collaboration with surveil-
lance services for pharmacovigilance for the detection of 
possible adverse effects; vaccination campaigns for the 
population; awareness campaigns for health professionals; 
sero-epidemiological studies.
Local administrations collaborate with regional admin-
istrations and health services. Although some municipal 
school health programmes continue to exist in some 
Autonomous Communities, in most cases the general 
health services (basically the staff of the primary care 
centres and particularly the community nurses) carry 
out health promotion activities and disease prevention at 
schools. This includes the administration of some vaccines 
such as HPV and Hepatitis B and varicella. However, 
immunization programmes in schools do not exist in 
every region in Spain and there is also variability in the 
programmes and their coordination.
Other relevant agents could include the occupational 
risk prevention services (see the section on barriers and 
facilitators).
Scheduled vaccination is recommended and not man-
datory. The current schedule is available at: http://www.
msssi.gob.es/profesionales/saludPublica/prevPromocion/
vacunaciones/docs/CalendarioVacunacion2018.pdf, and 
also at https://vaccine-schedule.ecdc.europa.eu. However, 
the competent health authorities can order the mandatory 
administration of vaccines if there is risk of epidemic 
spread. The judicial authority can also order it.
The official vaccination programmes usually use the pop-
ulation records of the public assistance services based 
on the individual health cards whose management and 
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forces and the administration of justice – is affiliated with 
public insurers other than the National Health System. 
There are some 2.2 million people who have the right to 
choose a publicly reimbursed private health care provider. 
These providers also have accredited vaccination centres 
that can administer free of charge the recommended 
vaccines, which are also provided free of charge by the 
public health services of the respective Autonomous 
Communities.
In any case, measles and influenza vaccines can be pur-
chased at the community pharmacies at the publicly 
authorized price. There is no co-payment for these vac-
cines. Either they are received for free or they are paid 
for in full.
Key barriers and facilitators
Measles
There is no monovalent vaccine authorized in Spain, but 
the combined product with rubella and mumps (MMR) 
is used. Current vaccination coverage against measles 
is high, in particular for the first dose; coverage with 
the second dose is lower and varies more across regions 
(between 88.1% in Murcia and 99.6% in Madrid in 
2016).
Although active vaccine hesitancy seems quite limited, 
the concentration of parents who oppose vaccination in 
some localities (such as the Albaicin in Granada) limits 
the protection of collective immunity locally and facil-
itates the spread of epidemic outbreaks. In other cases, 
however, insufficient vaccination coverage seems more 
attributable to ignorance, indifference or social exclusion 
than to hesitancy.
Some barriers to achieving effective vaccination cover-
age against measles have to do with a distrust of official 
information, the perceived interests of laboratories and 
eventual biases of health professionals involved. There 
are also difficulties with underestimating the severity of 
complications from measles, while the impact of possible 
adverse effects from vaccination is exaggerated.
The increase in social and economic inequalities after 
the recent financial crisis has led to an increase in 
extreme poverty. This does not support the demand for 
vaccination.
a working group has been created that is preparing a pro-
posal for new indicators of vaccine coverage.
Provision
The recommended vaccines are usually administered in 
primary care centres in the public network. These centres 
include paediatric and family medicine units and some 
other medical specialties. The nursing staff administer the 
vaccines to the people who request vaccination according 
to the official schedule.
The nursing or medical staff of provider entities that 
have authorized vaccination centres can also administer 
the influenza vaccine to the indicated population groups 
(risk groups, people aged over 65 years and public service 
personnel).
The nursing staff of the occupational risk prevention 
services of companies – including health care providers, 
such as hospitals – can administer influenza vaccines to 
the workers as and when recommended. In the case of 
health professionals working in hospitals, this is frequent.
Pharmacy offices can sell vaccines with prescription for 
sale in community pharmacies.
The official councils – of medicine, pharmacy and nurs-
ing – have an obligation to guarantee adequate conduct 
from their members.
The quality control bodies of the health service providers, 
as well as the inspection units of the autonomous health 
services and the public health authorities, are responsible for 
the proper functioning of the official vaccination centres.
Financing
The recommended vaccines – including measles and 
in fluenza vaccines – that are administered in officially 
accredited centres – mostly public primary care cen-
tres – by the nursing staff of the paediatric and family 
medicine services are fully funded by the regional health 
administrations (the majority of the public health budget 
is independent of the health care services but they both 
come from the same source: general taxes).
A small part of the Spanish population – the group of 
civil servants of the general administration, the armed 
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Society of Occupational Health, through the involve-
ment of occupational risk prevention services, adminis-
tered some 7500 vaccinations to about 47 000 workers 
(15.8%, range 5%–33%) from 27 centres, while in the 
2017/18 season it administered some 21 000 vaccines 
among 90 500 workers (23.2%, range 2.7%–51.7%) in 
61 centres.
References
Castilla J et al. (2013). Trends in influenza vaccine cover-
age among primary healthcare workers in Spain, 2008–
2011. Preventive Medicine, 57:206–11.
Centro Nacional de Epidemiología [National Centre 
for Epidemiology] (2016). Plan Nacional de Eliminación 
del Sarampión y de la Rubeola [National Plan for the 
Elimination of Measles and Rubella. Annual report]. 
Informe anual. Madrid.
Coberturas de Vacunación. DATOS ESTADÍSTICOS 
[Vaccination coverage. Statistical data]. Ministerio de 
Sanidad, Servicios Sociales e igualdad [Ministry of 
Health, Social Services and Equality]. Online at: https://
www.msssi.gob.es/profesionales/saludPublica/prevPromo-
cion/vacunaciones/coberturas.htm.
Comisión de Salud Pública. Consejo Inter-territorial del 
Sistema Nacional de Salud [Public Health Commission. 
Inter-territorial Council of the National Health System]. 
RECOMENDACIONES DE VACUNACIÓN 
FRENTE A LA GRIPE Temporada 2017–2018 
[Recommendations for vaccinations against the flu season 
2017–2018]. Online at: https://www.msssi.gob.es.
Deloitte (2018). Las vacunas en España. Situación actual 
y perspectivas de futuro [The vaccines in Spain. Current 
situation and future perspectives]. Madrid: p. 126. Online 
at: https://www2.deloitte.com/es/es/pages/life-sciences-
and-healthcare/articles/informe-vacunas-espana.html.
Diaz Fernandez R (2015). Vaccination in immigrant chil-
dren or children for international adoptions. Trabajo fin 
de Grado. Universidad de Cantabria. Online at: https://
repositorio.unican.es/xmlui/handle/10902/7950.
Dominguez A, Toledo D, Guayta-Escolies R (2018). 
Factores asociados a la vacunación antigripal en personal 
sanitario en España [Factors associated with influenza vac-
cination in health personnel in Spain]. Eidon, 49:4–17.
The free provision of vaccinations and their administra-
tion in NHS primary health care centres is probably the 
most important facilitating element. There are 13 000 pri-
mary health care centres in the country and vaccines can 
be administered at any time during working hours (from 
8am to 9pm). Massive institutional initiatives support the 
widespread demand for vaccines, but they do not always 
convince people who are against vaccination.
Influenza
In contrast, the current coverage of influenza vaccination 
for the population group over 65 years of age is 55%, the 
lowest proportion in the last ten years. In the 2009/10 
season of the AH1N1 pandemic, coverage was estimated 
at 65.7%.
Vaccination coverage among health professionals in the 
years 2010–2015 has been less than 30%. For the 2015/16 
season, information is available from eight Autonomous 
Communities from which it has been estimated that 
approximately 31.5% of health professionals were vacci-
nated. The main reasons why workers reject vaccination 
are the perceived low risk of getting sick, the fear of adverse 
reactions and doubts about the vaccine’s effectiveness.
The barriers to influenza vaccination have to do with the 
low adherence of health personnel that is due, in part at 
least, to the degree of uncertainty of protection, due to 
the characteristics of the causal virus in each season. The 
likely discomforts, even mild ones, associated with vac-
cination without a guarantee of personal benefit do not 
seem to motivate enough people.
Inadequate preparation of health professionals to pro-
mote vaccination in adults and risk groups is potentially 
another barrier. The heterogeneity of registries and infor-
mation systems to quantify vaccine coverage in adults and 
risk groups complicates the issue.
The specific facilitating factors have to do with the devel-
opment of vaccination programmes directed at adults and 
the relevant strategies that have been initiated in Spain.
The involvement of scientific societies, particularly those 
concerned with occupational health, and occupational 
risk prevention services could be a facilitating factor in 
promoting the vaccination of health workers. In the 
2012/13 season the initiative to promote vaccination 
against influenza for health professionals of the Catalan 
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Sweden
Ann Lindstrand
Governance
National immunization programmes are developed by 
the Public Health Agency but decisions about which dis-
eases will be included in the national immunization pro-
gramme are made by the government. County Councils 
and municipalities are responsible for the implementation 
of the national immunization programme, including the 
procurement of vaccines. All the vaccinations included 
in the national immunization programme must be pro-
vided free of charge to the target population. The Public 
Health Agency may issue national recommendations on 
vaccinations against diseases that are not included in 
the national immunization programme, e.g. vaccination 
against influenza and hepatitis B. Such recommenda-
tions are not binding, but County Councils, regions 
and municipalities decide on the implementation of the 
recommendations and on possible costs for the patients. 
County Councils can even decide on regional vaccination 
programmes (e.g. rotavirus, hepatitis B) which are free 
of charge.
All vaccinations are voluntary in Sweden. There are no 
sanctions in place for non-vaccination. Vaccinations 
according to the national immunization programme 
should be offered to all children up to 18 years of age, 
including migrant children. An assessment of immuni-
zation status is included in a health examination offered 
to migrants. The vaccination of adult migrants is not 
funded and in general they have to pay for vaccinations 
themselves.
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been vaccinated except age. This means it is impossible 
for nearly all counties to calculate a vaccination cover-
age rate in any risk group except among older people 
(65+). Likewise, at the national level only a combined 
weighted average (by population) can be calculated for 
people aged 65+ years. Data from a subset of counties 
is used to calculate a coverage rate for lower age groups, 
but this is as a percentage of the total population in 
each age group (as noted, no other denominator is 
available). One or two regions can estimate coverage 
among pregnant women but no such estimate is possible 
at the national level. The only denominator for adults 
that can be used for estimating vaccination coverage is 
the population registry. Risk group specific denomina-
tors are missing and thus it is impossible to calculate 
vaccination coverage by risk group or for “risk group 
adults” in general. For those aged 65 and over, there is 
a clear denominator (number of people aged 65 years 
and older).
Provision
Measles
Vaccination against measles is given to children at age 18 
months and 7–8 years. The first dose of MMR-vaccine is 
provided by Child Health Care and the second dose by 
School Health Care. Vaccinations are in general admin-
istered by Child and School Health Care nurses.
Vaccinations within Child Health Care are provided 
during regular health visits according to the schedule for 
the National Child Health Care Programme. The same 
visits also include other items, such as the assessment of 
a child’s health and development. The National Board 
of Health and Welfare has issued guidelines for Child 
Health Care, available at http://www.socialstyrelsen.se/
publikationer2014/2014-4-5 (in Swedish only).
Influenza
Most influenza shots are given in primary care. 
Community nurses may administer influenza shots in 
long-term care facilities. Some pharmacies also began 
in 2018 to offer vaccinations. In these cases, nurses visit 
certain days a week to administer vaccines, including 
influenza. These are private initiatives but with some 
remuneration from the County Councils.
Measles
For vaccinations in the national immunization pro-
gramme, annual vaccination coverage data are collected 
regarding children at the age of 2 years from all Child 
Health Care Units. Every unit reports data about the 
vaccination status (vaccinated, unvaccinated, unknown) 
among their enrolled children. Reports are first collected 
and compiled at the regional level and then sent to the 
Public Health Agency. The denominator used for esti-
mating coverage is the number of children enrolled in 
Child Health Care Units. Reports on vaccination status 
cover about 99% of children registered in the national 
population register.
Since 2013 the vaccinations included in the national 
immunization programme should be reported to the 
national immunization register. In the future, vaccina-
tion coverage will be estimated using the data from the 
national immunization register; in that case the number 
of children registered in the national population register 
will be the denominator.
Influenza
Most activities regarding vaccination against influenza in 
Sweden are performed by the 21 County Councils. These 
are responsible for procurement of vaccines, communi-
cation campaigns, administration of vaccines, payment 
schemes, etc. As a result, there are 21 different levels of 
activity regarding influenza. Some counties do more to 
try to get adults in risk groups to get vaccinated, while 
others do less.
At the national level the Public Health Agency of Sweden 
publishes recommendations on influenza vaccination, 
including defining the recommended risk groups. These 
recommendations are not mandatory for counties to 
adopt, but they are widely adopted. For risk groups, see 
the English summary in the recommendations: https://
www.folkhalsomyndigheten.se/publicerat-material/publika-
tionsarkiv/r/rekommendationer-om-influensavaccination-
till-riskgrupper/.
Varying methods are used to estimate the vaccination 
coverage rate at county council level, including data from 
the regional vaccination registry (for about a third of 
the counties), financial systems, surveys of older people 
(65+), patient record systems, and doses distributed. 
Most counties have no information on why a person has 
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Financing
Measles
Vaccines within the national immunization programme 
are funded via taxation and are provided free of charge.
Influenza
In most counties, but not all, influenza vaccination is 
free of charge for risk groups, e.g. adults with medical 
risk factors and older people (65+). The regional county 
councils collect taxes locally to finance the provision of 
health care services in their regions. Patients pay a fee for 
influenza vaccination in four of the 21 regions. Employers 
pay for the vaccination of their staff, for example health 
care workers.
Key barriers and facilitators
Measles
Vaccination coverage for childhood vaccination against 
measles has been high in Sweden since the introduction 
of the MMR vaccine in 1982; 96% of children are vacci-
nated at the age of 2 years. The coverage for two doses of 
MMR-vaccine has been 95%.
Facilitators: a long tradition in Sweden of well organized 
child health care, school-based vaccination delivery and 
high levels of trust in Child Health Care nurses among 
parents.
Influenza
Barriers: decentralized procurement, different levels of 
funding for communication and vaccination efforts, var-
ying by county council; difficulties in reaching target 
groups (e.g. it is not possible to do vaccinations within 
prenatal care); low vaccine effectiveness.
Facilitators: high levels of confidence in health care staff 
recommendations regarding vaccination, high internet 
connectivity of the population, high media interest in 
influenza, good compliance through the childhood vac-
cination programme.

United Kingdom
Sandra Mounier-Jack
Governance
The United Kingdom (UK) has a single, over-arching 
immunization schedule. However, governance of health 
care and public health is complex. In England these func-
tions are the responsibility of the Department of Health, 
which also has some UK-wide responsibilities, for exam-
ple those involving international relations. However, the 
organization of health care and public health services is 
devolved to the governments of the other three nations 
of the UK (Scotland, Wales, Northern Ireland), the three 
crown dependencies (Jersey, Guernsey, Isle of Man), and 
the 14 United Kingdom Dependent Territories (including 
Gibraltar, which is inside the EU). Given the complexity 
involved, this description is confined to the situation in 
the four nations of the United Kingdom. While each 
has, to varying degrees, autonomy in relation to immu-
nization policy, all are advised by the Joint Committee 
of Vaccinations and Immunisations, with members from 
the UK and abroad.
The practical arrangements in England are the most com-
plex, reflecting changes in the health system introduced 
in 2012. Until then, public health services (including 
immunization services) were part of the national health 
service (NHS), as is still the case in the other three juris-
dictions. In that year, the Health and Social Care Act 
greatly expanded market-based mechanisms that were 
already in place in England. These necessitated sepa-
ration of public health from health care. Local public 
health functions were transferred to local government but 
national ones, including oversight of immunization and 
screening, were transferred to a new organization, Public 
Health England, which also brought together a range of 
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health services, such as school nursing and sexual health, 
which can include immunization activities. Each local 
government body has a specialist public health team, 
headed by a Director of Public Health.
In Scotland immunization policy is set by the Scottish 
Government Health Directorates on the advice of the 
Joint Committee of Vaccinations and Immunisations 
and other appropriate bodies. NHS Health Protection 
Scotland works with NHS Health Board Immunisation 
Coordinators and other national organizations, such as 
Health Scotland, NHS Education Scotland, and NHS 
National Services Scotland, to monitor and coordinate 
the Scottish immunization programme, as part of the 
Scottish Health Protection Network. There is currently 
a programme of redesigning and modernizing how 
local vaccination services are delivered in Scotland. It 
will implement new models of delivery based on local 
decision-making and leadership.1
In Northern Ireland immunization policy is set by the 
Department of Health, on advice from the UK Joint 
Committee for Vaccines and Immunisation. Northern 
Ireland has implemented all the Joint Committee’s rec-
ommendations, although occasionally with slight varia-
tions, e.g. with regard to ages of eligibility (Public Health 
Agency, 2017). The Department of Health tasks the 
immunization team in the Health Protection Directorate 
of the Public Health Agency to implement and monitor 
all national immunization programmes. All pre-school 
and most influenza immunizations, along with adult 
vaccines for pneumococcal disease, shingles and pertussis 
in pregnant women, are administered in general prac-
tice. The Public Health Agency works with colleagues 
in the Health and Social Care Board to support these 
programmes, and with the Child Health Information 
System to send invitations and monitor uptake. Teenage 
immunizations (HPV, Men ACWY, diphtheria, tetanus 
and polio, and MMR), along with flu immunization 
for all primary school children, are delivered by school 
nurses in each of the five Health and Social Care Trusts. 
The Public Health Agency works with these teams on the 
delivery and monitoring of these programmes, produces 
all materials to support the immunization programmes, 
and delivers communications campaigns to the public.
In Wales immunization policy is monitored and coordi-
nated by Public Health Wales and NHS Wales.
1 http://www.healthscotland.scot/health-topics/immunisation/
vaccination-transformation-programme
existing bodies such as those responsible for radiological 
protection. Consequently, responsibility is now divided 
among a number of different organizations. In the other 
three nations these functions are, to varying degrees, 
integrated.
In England responsibility for immunization is based on a 
tripartite agreement between the Department of Health, 
Public Health England and National Health Service 
England (NHS England). NHS England’s area teams, 
supported by specialist staff from Public Health England 
embedded within them, commission immunization ser-
vices from community and primary care providers. The 
agreement assigns responsibility to the Department of 
Health for providing strategic oversight, to NHS England 
for commissioning services and to Public Health England 
for providing scientific support. Commissioning inten-
tions and budget requirements for the delivery of the 
immunization programme are agreed annually by the 
Department of Health and NHS England, and pub-
lished in a public health functions agreement. Public 
Health England supports the Department of Health and 
NHS England in system leadership and planning, and 
has specific responsibilities for the implementation of 
the immunization programme, the provision of service 
specifications for individual vaccines, the procurement of 
vaccines and immunoglobulins, and the provision of spe-
cialist advice and information at national and local levels.
At local level, arrangements involve NHS England, Public 
Health England and local government working together 
to commission and provide leadership for screening and 
immunization services. Public Health England employs 
screening and immunization teams embedded within 
NHS England local teams covering different geographic 
areas. This means that the screening and immunization 
teams are accountable to both Public Health England and 
NHS England. The screening and immunization teams 
are responsible for providing local leadership, encouraging 
multi-agency working, ensuring high-quality delivery 
of programmes based on national specifications, sup-
porting commissioning, providing advice to the public 
and to health professionals, and monitoring the perfor-
mance of community and primary care providers. Clinical 
Commissioning Groups, which are led by local general 
practitioners (GPs), are expected to support screening and 
immunization teams, particularly with quality improve-
ment in primary care. Local government is responsible 
for providing independent scrutiny of the local immu-
nization programme delivery, ensuring it is responsive to 
local population needs, and commissioning community 
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be updated. This record is held in their GP practice and 
contains clinical information about the care the person 
has received. It should enable every health care profes-
sional involved at different stages of the person’s care to 
have access to their medical history, including allergies, 
operations or tests, medicines and immunizations.
In addition, for children in England the Child Health 
Information System (a local population register of all 
children including those not registered with a general 
practitioner) acts as a source of data to estimate coverage 
for routine and selected childhood immunizations. The 
Child Health Information System is a patient administra-
tion system that provides a clinical record for individual 
children and supports a variety of activities related to 
child health, including universal services for population 
health (including immunization) and support for statu-
tory functions. It identifies registered eligible children, 
sends out lists to GP practices and sends appointments 
directly to patients. More generally for both children and 
adults, GP practices call and recall patients who have 
not attended vaccination. Similar systems exist in the 
other jurisdictions, such as the Child Health Surveillance 
Programme in Scotland and the Northern Ireland Child 
Health System and the Child Health System in Wales.
Targeted measures and interventions are deployed for 
specific groups based on an assessment conducted by local 
public health and National Health Service teams. In the 
past these have included outreach programmes for specific 
minority ethnic groups (examples include Travellers, and 
Charedi (Orthodox Jewish) communities). Refugees and 
asylum-seekers are entitled to National Health Service 
care, with different arrangements in each jurisdiction, as 
are certain other groups, such as EEA citizens, NATO 
personnel, and victims of human trafficking. However, 
undocumented migrants face many barriers to obtaining 
health care and are deterred from doing so by fears of 
deportation. Information on immunization is available 
in a number of languages, and interpreters can be booked 
through GP practices for non-English speaking individ-
uals. National Health Service/Public Health England 
commissioners also work with local public health depart-
ments located in local authorities to identify possible 
under-served populations.
There are no sanctions for citizens or parents who refuse 
vaccinations for themselves or for their children, but 
there have been many awareness campaigns to encourage 
people to come forward for immunization in the past 
(notably for MMR), and some are still on-going (HPV, 
Guidelines and schedules on immunization against infec-
tious disease, which are commonly referred to as the 
online Green Book, set out the principles, practices and 
procedures of immunization in the whole of the UK, 
with particular emphasis on those immunizations that 
comprise the routine immunization programme from 
birth through to adulthood. They apply equally to the 
devolved administrations of England, Wales, Scotland 
and Northern Ireland.
Although the Joint Committee of Vaccinations and 
Immunisations’ guidance is generally applied throughout 
the UK, there is some flexibility to adapt to specific epi-
demiological circumstances. For example, newborn babies 
are vaccinated with the BCG vaccine only in ‘risk’ areas 
(e.g. parts of London) where the prevalence of tubercu-
losis is higher. In England, with its more decentralized 
system, decisions about eligibility also vary based on local 
settings, such as some areas delivering HPV vaccinations 
in schools with two doses in one year, or two doses over 
two years (depending for example on the level of student 
mobility in some areas compared to others). Some local 
areas will use catch-up vaccination following outbreaks in 
certain communities using various delivery strategies, and 
develop interventions to reach specific under-vaccinated 
groups (e.g. inequalities immunization nurses work in 
some local authorities). At local level, specific area teams 
develop strategic/operational plans for their regions to 
improve uptake. In England local plans are developed in 
close collaboration with local authorities.
Vaccinations in the UK are not mandatory but are recom-
mended, including for health care workers. However, the 
Green Book recommends that all new employees should 
undergo a pre-employment health assessment, which 
should include a review of any immunization needs. The 
guidelines state that all health care staff should be up 
to date with their routine immunizations, e.g. tetanus, 
diphtheria, polio and MMR. Influenza vaccination is 
recommended for health care workers directly involved 
in patient care, who should be offered influenza immu-
nization on an annual basis.
In theory, all people ordinarily resident in the UK should 
be registered with a general practitioner in the jurisdic-
tion in which they live. These systems differ in each of 
the jurisdictions, in relation to content and linkage with 
other data, with linkage most advanced in Scotland. 
However, all these registers are known to be incomplete to 
some extent, and have some duplication. In theory, every 
time a person uses an NHS service, the record should 
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school-leaving age. In Northern Ireland data for children 
up to the age of 18 years for both general practitioner and 
school-based programmes are extracted from the Child 
Health Information System. The uptake of influenza, 
shingles and pneumococcal vaccines is extracted electron-
ically via the Apollo system and influenza uptake can also 
be calculated from general practitioners’ fee claim data. 
Uptake for the pertussis and influenza vaccines in preg-
nant women is extracted from the maternity computer 
system NIMATS.
Provision
The majority of vaccines included in the routine schedule 
are given in primary care by practice nurses working in 
general practitioner-led surgeries, although Scotland is 
undergoing a Vaccine Transformation Programme, as 
already described. In Northern Ireland the system is sim-
ilar to that in England, but some of the staff delivering 
vaccines in general practice are employed by the Health 
and Social Care Trust. The MMR vaccine is provided in 
two doses, with the first dose given at the age of 12 months 
and the second dose at around 3 years and 4 months, 
before children start school. The guidelines mention that 
there is an opportunity to offer unimmunized or partially 
immunized individuals the MMR vaccine with diphtheria, 
tetanus and polio boosters at around 13–14 years of age, 
and this should be considered as routine practice.
In the past, catch-up campaigns have been conducted 
for MMR vaccines, particularly following outbreaks. 
Catch-up vaccinations have been delivered through com-
munity services, schools and general practice.
In terms of adult vaccinations against influenza, most 
adults are vaccinated by their general practitioner. For 
adults a range of trivalent and quadrivalent inactivated 
vaccines against influenza are available from suppliers for 
GP practices to purchase. NHS eligible patients include 
people over 65 years old and risk groups as detailed in 
Table 1. As mentioned below, all pregnant women should 
be offered an inactivated influenza vaccine while preg-
nant, regardless of their stage of pregnancy. Scotland and 
Northern Ireland undertake central procurement of influ-
enza vaccines each year, based on the Joint Committee 
of Vaccinations and Immunisations’ recommendations.
Health care professionals are generally vaccinated by 
nurses in the occupational health services of employers 
(e.g. hospitals). The influenza vaccine is also available in 
meningitis, shingles, influenza). Campaigns have included 
posters, leaflets, NHS websites and mass media.
There are incentives for GP practices to encourage vacci-
nation, for example with payments for vaccine uptake at 
2 and 6 years of age and separate specific incentives for 
achieving a target percentage for the cluster of three-dose 
vaccines: DTaP/Polio/Hib + MenC + MMR. In England 
GP practices need to achieve at least 70% coverage of 
their target population before the 2nd birthday to receive 
a standard payment and over 90% for a premium pay-
ment. English general practices receive an incentive pay-
ment if they achieve a set target for immunizing specific 
at-risk groups against influenza every year as part of the 
Quality Outcomes Framework; this is not currently the 
case in Northern Ireland.
Since the 1980s the Child Health Information System 
and its national equivalents have been used as sources of 
data to estimate coverage for routine and selective child-
hood immunizations as part of the Cover of Vaccination 
Evaluated Rapidly (COVER) Programme. Child Health 
Information System vaccination data mainly originate 
from general practitioners’ data, as well as other settings 
where vaccination is delivered. The COVER Programme’s 
vaccine coverage measurements are published quarterly as 
official statistics and annually as national statistics.
To estimate the coverage of some programmes delivered 
after the age of 5 in England and for most new vaccine 
programmes since 2013, data are extracted from GP 
practice systems. This approach started in 2004 with 
the influenza and pneumococcal polysaccharide vaccine 
programmes for people aged over 65 and has now been 
extended to an increasing number of vaccine uptake col-
lections. Reporting was originally undertaken manually, 
but by 2008–2009 it had moved to automatic extrac-
tion from around 50% of practices and this has now 
increased to over 95%. In England this data collection 
is done through the system called ImmForm2 which is a 
secure, web-based system used to collect data on vaccine 
coverage for selected immunization programmes and 
provide vaccine ordering facilities for the National Health 
Service. The denominator for childhood MMR is based 
on the Child Health Information System (see below). The 
denominator for influenza vaccination for adults is based 
on records of the population registered in GP practices. 
In Scotland data for children are extracted from the Child 
Health Surveillance Programme for immunizations, to 
2 www.immform.dh.gov.uk
United Kingdom 179
The list in Table 1 is not exhaustive, and the health prac-
titioner should apply clinical judgement to take into 
account the risk of influenza exacerbating any under-
lying disease that a patient may have, as well as the risk 
of serious illness from influenza itself. Influenza vaccine 
should be offered in such cases even if the individual 
is not in the clinical risk groups specified in Table 1. 
community pharmacies, administered by pharmacists, 
and since 2016 has been provided free to eligible patients 
under the National Health Service, and to others (i.e. those 
not in clinical risk groups) for a fee. Pregnant women are 
vaccinated either by midwives in antenatal clinics or in 
primary care services (by general practice nurses).
Table 1 Clinical risk groups who should receive influenza immunization.
Clinical risk category Examples (this list is not exhaustive and decisions should be based on clinical judgement)
Chronic respiratory disease Asthma that requires continuous or repeated use of inhaled or systemic steroids or with previous exacerbations 
requiring hospital admission.
Chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema; bronchiectasis, cystic 
fibrosis, interstitial lung fibrosis, pneumoconiosis and bronchopulmonary dysplasia (BPD).
Children who have previously been admitted to hospital for lower respiratory tract disease.
Chronic heart disease Congenital heart disease, hypertension with cardiac complications, chronic heart failure, individuals requiring 
regular medication and/or follow-up for ischaemic heart disease.
Chronic kidney disease Chronic kidney disease at stage 3, 4 or 5, chronic kidney failure, nephrotic syndrome, kidney transplantation.
Chronic liver disease Cirrhosis, biliary atresia, chronic hepatitis
Chronic neurological disease  
(included in the DES directions for Wales)
Stroke, transient ischaemic attack (TIA). Conditions in which respiratory function may be compromised due to 
neurological disease (e.g. polio syndrome sufferers). Clinicians should offer immunisation, based on individual 
assessment, to clinically vulnerable individuals including those with cerebral palsy, learning disabilities, multiple 
sclerosis and related or similar conditions; or hereditary and degenerative disease of the nervous system or mus-
cles; or severe neurological disability.
Diabetes Type 1 diabetes, type 2 diabetes requiring insulin or oral hypoglycaemic drugs, diet controlled diabetes.
Immunosuppression Immunosuppression due to disease or treatment, including patients undergoing chemotherapy leading to immuno-
suppression, bone marrow transplant, HIV infection at all stages, multiple myeloma or genetic disorders affecting 
the immune system (e.g. IRAK-4, NEMO, complement disorder)
Individuals treated with or likely to be treated with systemic steroids for more than a month at a dose equivalent to 
prednisolone at 20mg or more per day (any age), or for children under 20kg, a dose of 1mg or more per kg per day.
It is difficult to define at what level of immunosuppression a patient could be considered to be at a greater risk of 
the serious consequences of influenza and should be offered influenza vaccination. This decision is best made on 
an individual basis and left to the patient’s clinician.
Some immunocompromised patients may have a suboptimal immunological response to the vaccine.
Asplenia or dysfunction of the spleen This also includes conditions such as homozygous sickle cell disease and coeliac syndrome that may lead to 
splenic dysfunction.
Pregnant women Pregnant women at any stage of pregnancy (first, second or third trimesters).
Morbid obesity (class III obesity)* Adults with a Body Mass Index ≥40 kg/m²
* Many of this patient group will already be eligible due to 
complications of obesity that place them in another risk category
Source: UK Government (2018)
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The costs of routine vaccines and vaccination services are 
fully covered through the statutory financing system via 
general taxation with no contribution from employers, 
local government or patients.
Key barriers and facilitators
Measles
The UK achieved measles elimination status from the 
World Health Organization in 2017. The overall coverage 
rate for the MMR vaccine is high, with MMR coverage 
across the UK as a whole at 91.6% for the first-dose vac-
cine, and 88.0% for the second-dose vaccine. However, 
this level remains below the 95% target set by the World 
Health Organization.
MMR uptake rates have recovered from the ‘Wakefield 
controversy’, erroneously linking the measles vaccine and 
autism, which has hampered MMR vaccine uptake in the 
UK in the past 20 years. However, there may still be some 
in the original cohort who may not have been vaccinated 
with MMR in the 1990s or who may not have received 
two doses as recommended.
Under-immunized groups: A report published by the 
National Institute for Health and Care Excellence in 2016 
highlighted a number of groups of the population who 
might not be fully immunized with childhood vaccines, 
including MMR. These include:
• those who have missed previous vaccinations 
(whether as a result of parental choice or otherwise);
• looked-after children;
• those with physical or learning disabilities;
• children of teenage or single parents;
• those not registered with a general practitioner;
• younger children from large families;
• children who are hospitalized or have a chronic 
illness;
• those from some ethnic minority groups;
Vaccination should also be offered to household contacts 
of immunocompromised individuals, i.e. individuals who 
expect to share accommodation on most days over the 
winter and for whom continuing close contact is una-
voidable. This may include carers.
In addition to the above, immunization should be pro-
vided to health care and social care workers in direct con-
tact with patients/clients to protect them and to reduce 
the transmission of influenza within health and social care 
premises, to contribute to the protection of individuals 
who may have a suboptimal response to their own immu-
nizations, and to avoid disruption to services that provide 
their care. This would include:
• health and social care staff directly involved in the 
care of patients or clients;
• those living in long-stay residential care homes or 
other long-stay care facilities where rapid spread 
is likely to follow the introduction of infection 
and cause high morbidity and mortality (this does 
not include prisons, young offender institutions, 
university halls of residence, etc.);
• those who are in receipt of a carer’s allowance, or 
those who are the main carer of an older or dis-
abled person whose welfare may be at risk if the 
carer falls ill. Vaccination should be given on an 
individual basis at the general practitioner’s discre-
tion in the context of other clinical risk groups in 
their practice; and
• others involved directly in delivering health and 
social care so that they and vulnerable patients/cli-
ents are at increased risk of exposure to influenza.
Financing
All routine vaccines recommended in the national immu-
nization programme are free at the point of delivery for 
both children and adults. This means that there is no 
direct financial barrier to childhood vaccination.
Vaccination against influenza in adults is also free of 
charge at the point of delivery for all recommended 
groups (described above). For non-recommended groups, 
influenza vaccination is accessible in a pharmacy for a fee 
(around £12, but each pharmacy is free to set its own 
prices). Most travel vaccines also have to be purchased.
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understanding of the UK immunization schedule and 
health services, lack of trust, and issues around language 
barriers.
In terms of facilitators, steps are required to minimize 
time to uptake in those families who do eventually catch 
up, through the reduction of practical barriers. National 
Institute for Health and Care Excellence guidance out-
lines actions to reduce inequalities in immunization, 
including provision of information in multiple languages, 
offering immunization checks and administration in alter-
native settings, and sending out reminder invitations from 
general practitioners.
In terms of specific groups, such as Traveller or Orthodox 
Jewish communities, tailored strategies have proven to 
be effective, particularly when they involve close engage-
ment with the communities. For example, outreach 
programmes such as the one carried out following an 
outbreak of measles on a Traveller site in Manchester 
involved containing its spread with daily visits by the 
same health visitor (Reynolds et al., 2008). A strategy 
to provide vaccinations during a child health clinic was 
also successful in increasing MMR uptake in Hackney 
(WHO, 2016).
Adult vaccinations against influenza
The National Institute for Health and Care Excellence 
has identified a number of groups that are underserved by 
seasonal flu vaccination (NICE, 2018), including:
• people who are homeless or sleep rough;
• people who misuse substances;
• asylum-seekers;
• Roma and Travellers;
• people with learning disabilities; and
• young people leaving long-term care.
Factors at general practice level, where the vast majority 
of vaccinations are conducted, include the lack of a lead 
member of staff, the lack of uptake targets, no systematic 
use of additional prompts within IT systems to identify 
eligible patients, and little or no opportunistic vaccinat-
ing and using phone calls as a first-line strategy to invite 
• those from non-English speaking families; and
• vulnerable children, such as those whose families 
are travellers, asylum-seekers or homeless.
There was some evidence that uptake of MMR has 
declined at a greater rate among children of more highly 
educated parents and among those living in more affluent 
areas. Maternal education to degree level was a risk factor 
for not receiving the MMR triple vaccine. A study of over 
a million children born in Scotland between 1987 and 
2004 found that children of more affluent parents were 
generally either vaccinated with MMR on time or not 
at all. In contrast, late MMR vaccination was associated 
with socioeconomic disadvantage.
An analysis of factors for under-immunization for MMR 
(2013 UK Millennium Cohort Study) showed that just 
over 40% of children who were unimmunized with MMR 
vaccine at age 3 had either partially or fully caught-up by 
age 5. The likelihood of catching up varied markedly 
with a number of social factors, and more so for full than 
partial catch-up. Some families, particularly those from 
ethnic minority groups, appear to have difficulty accessing 
vaccination in a timely fashion. Advantaged families and 
those citing non-practical reasons for non-vaccination at 
age 3 are more likely to persist in not immunizing their 
child against MMR.
Regional variation: There are regional variations in 
uptake. In England, for example, London, Manchester 
and Birmingham have lower uptake rates for most vac-
cines, including MMR. This has been attributed to higher 
mobility of the population in urban centres, and also to 
issues with the quality of data, particularly the denominator.
Some ethnic groups have been reported to be under-
immunized for MMR and have experienced outbreaks 
in recent years. These include Roma and Traveller com-
munities, the Somali population, and Orthodox Jewish 
communities. A recent study on Traveller and Roma 
communities in the UK identified language, literacy, dis-
crimination, poor school attendance, poverty and housing 
as barriers across different communities. Trustful rela-
tionships with health professionals were important and 
continuity of care valued (Jackson et al., 2017).
Migration: the occurrence of measles outbreaks in 
2017–2018 in Eastern European communities indicate 
that these populations are under-vaccinated, primarily 
because of a combination of factors such as a lack of 
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deaths among older adults. As of 2018 the universal 
influenza vaccination programme is available for 
children aged 2 to 9 years (Hodgson et al., 2017). 
In Scotland and Northern Ireland the vaccine has 
been offered to all those aged 2 to 11 years.
• the Health and Safety at Work Act (1974) makes 
employers responsible for offering the influenza 
vaccination to health and social care staff who have 
direct care responsibilities;
• support from national bodies, professional groups 
and royal colleges (organizations such as the British 
Medical Association and the Royal College of 
Nursing) helps to encourage their members and 
others to accept the influenza vaccination;
• provision in general practice is driven by a nation-
ally enhanced service specification. This requires 
all eligible patients to be called (invited); records 
to be kept up to date; vaccination status (or reason 
for declining a vaccine) to be recorded accurately; 
appropriate skills and training for those admin-
istering the influenza vaccine; consideration of 
accessibility so that service users’ needs are met; 
and regular monitoring and reporting of vaccina-
tion activity;
• availability of influenza vaccination in some phar-
macies in England, through NHS provision. The 
highest percentage of vaccinations outside GP 
practices was given to patients aged 65 years and 
over in pharmacies (5.6% of all vaccinations for 
those 65 years and over). Vaccinations in pharmacies 
have increased for adult and at-risk groups; and
• existing examples of best practice guidance for 
increasing influenza vaccination uptake in general 
practice as well as for health care workers.
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